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ABSTRACT 
In 1994 the author of this thesis proposed a new role of medicines management (MM) 
for dispensing community pharmacists, requiring systematic collaboration with GPs. In 
1998 the Minister for Health approved the proposal and commissioned pilot trials which 
are currently proceeding. 
This thesis explores cultural, inter-professional and operational factors which may 
impede or facilitate service roll-out nationally. A review of management literature 
explored two areas, marketing and change management theory, which could be applied 
to a community pharmacy context. This review revealed innovative ways of presenting 
new services to target audiences and novel means of engineering organisational change. 
'Culture~; 'leadership~; 'motivation"; 'communications"; and, 'competitive force~ were 
studied alongside the psychology of 'attitudes'; 'needs'; and, 'wants'. The Burke-
Litwin change model was selected as the most applicable to pharmacy service change. 
Triangulated field research has revealed forces which impede and facilitate change. A 
series of key informant interviews and focus groups helped identify crucial issues which 
informed the content and structure of national postal surveys to GPs (1000) and 
pharmacists (750). Key 'attitudes'; 'needs'; and, '~ants of both professions were 
revealed: 
i. 75% of GPs and 81 % of pharmacists wish to engage in MM; 
ii. 36% of GPs already receive pharmacist assistance at varying levels; 
iii. 58% and 48% of GPs respectively, do not support pharmacist involvement 
with medication selection or identification of sub-therapeutic dosage; and, 
iv. 89% of pharmacists do not have the ability and 81% do not have time to do 
MM. 
ii 
The literature research fmdings were theoretically applied to these issues and 
suggestions made for managing the proposed transformation of pharmacy service. 
This thesis recommends cultural support of the GP by styling and branding the MM 
service accordingly with the GP as the lead figure, directing the programme of work. It 
further recommends urgent action by pharmacy leadership, to provide the framework 
for dispensing pharmacists to acquire the knowledge and time to undertake this 
transformational service. 
iii 
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GENERAL INTRODUCTION 
TO THE THESIS 
In the words of 'The New NHS - Modern Dependable' 
' ... in a changing world no organisation, however great, 
can stand still. The NHS needs to modernise to meet 
the demands oftoday's public ... ' 
(White Paper Foreword - Tony Blair) 
It is in this context that this thesis is undertaken, seeking an entirely new approach to 
moving the primary care pharmaceutical profession - specifically independents - from 
its traditional dispensing role, into one of patient-focused cognitive care. 
To this end, a unique approach to effecting change in community pharmacy is 
investigated and developed through a detailed study of the relatively modem disciplines 
of marketing and change management. The bodies of literature in both fields are 
researched, to reveal those proven principles, techniques and processes, which have 
achieved successful change in other major fields. By re-applying such approaches in 
pharmacy, it is hoped that a systematic means of traI1sforming the dispensing service 
and role of pharmacy can be devised. 
To the best of the author's knowledge, no such approach has hitherto been attempted. 
In one notable scheme for change (the Royal Pharmaceutical Society of Great Britain, 
with its 'Pharmacy In A New Age' initiative - PlANA) the final phase was designated 
as: 
' ... over to you. ' 
meaning the responsibility for moving into new service was passed to individual 
community pharmacists. Whilst such exhortation may encourage a number of 
individual pharmacists to pursue some new services, it is not clear, to the investigator, 
how effective movement of the whole profession was going to be engineered on a 
national scale without: 
xxiii 
• Continued and 'expressed' vision, leadership, motivation and management of 
the change process; 
• Studied design and presentation of the new service to the purchasing 
stakeholders; 
• Detailed consideration of the target markets and their views on the new service 
offering; and, 
• Setting out and facilitating, for contractors, acquisition of the required resources 
by which to engage the new role, e.g. knowledge, administrative systems, 
physical space, human resources and time. 
The RPSGB initiative at that time lacked an operational plan and an underlying detailed 
study of the stakeholder impact of any new pharmacy service. The transfonnational 
nature of the change contemplated, will specifically impact upon one other major 
professional stakeholder in patient health care, the doctor. 
General medical practitioners (GPs) are traditionally the head arbiter of routine patient 
treatment in primary care and any significant change in their role, triggered by another 
, 
health profession, could be resisted or entirely blocked' ~y them. Indeed, the history of 
medicine and pharmacy, as well as some modem developments (competition for 
dispensing rights in specified areas) may indicate some divergence of cultural interests. 
Such effects, by defInition, revolve around the deeply held values, beliefs and 
underlying assumptions of any cohesive group. In turn, these affect the group or 
individual attitudes, needs and aspirations, as expressed through their social, or in this 
case, professional context. Such powerful motivators therefore require careful study, in 
contemplating the operational and conceptual change required in primary care pharmacy 
and medical practice. 
xxiv 
This thesis addresses these complex issues and is set out in nine detailed chapters as 
listed below: 
Chapter 1 Describing relevant historic and cultural influences which may effect: 
the medico-pharmaceutical interface today; the changing modem 
environment; and, the competitive nature oftoday's market place and its 
relevance. 
Chapter 2 Setting out the overall thesis rum, specific objectives and strategic 
importance of the study. 
Chapter 3 Setting out the research method. 
Chapter 4 Comprehensively investigating the marketing function; necessarily 
addressing in detail the motivational, communications and cultural 
issues; and, the attitudes, needs and wants of people so as to enable 
effective design of the new pharmacy service offering and introduction to 
the market, the medical profession. 
Chapter 5 Investigating in detail the theory and practice of organisational 
development and change, specifically 12 potential models as templates 
of change activity, to enable selection- of the most appropriate for 
effecting change in pharmacy. 
The detail of Chapters 4 and 5 is considered essential by the author to enable a 
thorough consideration of the cognitive and operational issues involved in the change 
of both pharmaceutical and medical practice. Without the detailed investigation of the 
twelve change models, confident selection of an appropriate model of change would not 
realistically be possible. At this stage of planning new service content for pharmacy in 
England and Wales, it is of the utmost importance to use the right template for targeted 
change effort. 
Chapter 6 Setting out the field research results of phase 1 and relating these to the 
theoretical research in Chapters 4 and 5. 
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Chapter 7 Setting out the field research results of phase 2 and relating thse also to 
Chapters 4 and 5. 
Chapter 8 Summarising the whole work and discussing some major implications. 
Chapter 9 Offering conclusions and recommendations for further research. 
By this scheme and content of work, the problem of change on a national scale is 
addressed for the primary care independent segment of the pharmacy profession (but 
with relevance to all dispensing contractor pharmacy) as well as the primary care 
medical profession as affected by pharmacy role change. The operationalisation of 
strategic intent then becomes a realistic possibility and outcome from this work. 
Within pharmacy, although the target of research is the independent sector, some of the 
work may also be useful in the publicly quoted multiple segment. In the latter also, 
resides the profession of pharmacy operated by pharmacists who may well have similar 
needs and wants to those in the independent sector. Especially will this be so if the 
multiples continue to expand by acquiring independent pharmacies. 
It is recognised, however, that expansion of the multiple sector, could possibly take 
place through some future modification of the control of entry regulations. 
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CHAPTER 1 
BACKGROUND AND HISTORIC INFLUENCES 
This chapter is set out in six sections as follows: 
1.1 Introduction; 
1.2 Ancient History - Outline; 
1.3 The Changing Environment; 
1.4 Latest Developments; 
1.5 Competition, Marketing and Stakeholder; and, 
1.6 Chapter Summary 
1.1 INTRODUCTION 
This introductory chapter sets out the background, historic and current, which may have 
a major effect on the task of moving community pharmacy into a new order of service 
within the National Health Service (NBS) of England and Wales. Historic cultural 
traditions as well as some of the health professions own perceptions of their relative 
importance in the health care 'hierarchy' may have profound effects upon pharmacy's 
aspirations for its own future. Key issues are explored in-this chapter. 
In 1927, La Wall (1927 V), writing his treatise on the history of pharmacy, 
commented: 
'".the primary function of pharmacy is to prepare 
medicines for those who require them ... ' 
Today, however, seventy five years later, the world has dramatically changed. The 
early bi-plane has been replaced by the swept wing, jet engine aircraft of inter-
continental capability and advanced rocket projectiles are now able to probe the solar 
system. Likewise, medical remedies, derived from plants and animals and compounded 
by the skills and knowledge of the nineteenth century 'chemist and druggist', have been 
progressively replaced by sophisticated fonnulations and delivery systems, 
manufactured by the pharmaceutical industry. 
The role of the community phannacist has thus, due to a number of influences, of which 
technology is one, (pEST analysis: Appendix 1, page 413) progressively shifted from 
compounding and supply, to counting, pouring and supply with some service elements 
attached. 
These influences, or change drivers, may be summarised as follows: 
• New technological processes, leading to new dosage fonns (e.g. spansules 
and sustained release fonnulations); 
• Replacement of plant derived medicines with modem synthetic 
compounds e.g. Reserpine replaced with methyldopa in hypertension and 
with the benzodiazepines in anxiety states; 
• New therapeutic approaches to illness management e.g. Kaolin mixtures 
for diarrhoea replaced with replacement electrolyte therapy; 
• Peer pressure on community pharmacy to fonn new models of service has 
been influenced by successful hospital pharniacy development into clinical 
services; and, 
• Political initiatives have brought increasing focus upon the role of 
community phannacy and a need to develop its role: 
i. The Nuffield Enquiry 1984 - 86; 
ii. White Paper - Promoting Better Health 1987; 
iii. Department of Health Working Party 1991- 93; 
iv. National Audit Office Report 1993; 
v. White Paper - Choice & Opportunity, 
Primary Care - The Future 1996 (Nov); 
vi. White Paper - Primary Care - Delivering 
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the Future 
vii. White Paper - The New NBS: Modern, 
Dependable 
viii. Green Paper - Our Healthier Nation 
ix. DH Document - A First Class Service 
x. DH Document - GP Prescribing Support 
xi. DH Document - Pharmacy in the Future 
1996 (Dec); 
1997; 
1998 (Feb); 
1998 (June); 
1998 (Sept); and, 
2000 (Sept). 
Documents v to xi all emphasise the pharmacist's core expertise as medicine's 
knowledge and from 1997 progressively indicate the need for collaboration between the 
professionals in Primary Care. This view is expressed in its highest terms as 
partnership, in 'The New NHS: Modern Dependable, , (1997: 40). 
However, operational developments to date have failed to transform the traditional 
supply service into one of in-depth patient care and pharmacy is still perceived as the 
dispensing service of the nation. Arguably, pharmacy remains essentially what it was 
two centuries ago, without the medicines compounding requirements of that time. 
It is now recognised by the leadership in pharmacy that the modem competitive 
environment of the NHS provides opportunities, as well as threats. If pharmacy wishes 
to expand its responsibilities and playa bigger part in p~imary health care, then changes 
in operations and inter-professional relationships will almost certainly be required. In 
marketing parlance, pharmacy will, in fact require repositioning in the primary health 
care process. 
Such repositioning may be affected by issues such as: 
• The patient's perception of the value of the pharmacist's service; 
• The priority given to pharmacy expertise in the primary health care process 
by government and the medical profession; 
• The process sequence in which each of the health care professions makes its 
contribution to the patient's medicines prescription; and, 
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• The relative contribution made by each health care professional in the chain 
of care, involving doctor, pharmacist and sometimes nurse, as perceived by 
government, health professions, patients and patient representative 
organisations. 
The medical profession, arguably at the top of the health care pyramid, may well 
perceive expanded roles of other health care professions as a threat to some of their own 
responsibilities. 
1.2 ANCIENT HISTORY 
1.2.1 The Medical and Pharmaceutical Professions 
The relationship between pharmacy and medicine has been forged in the crucible of 
history and certainly since the emergence of the modem professions within the NHS, 
underpinned with an element of competition and unease. (Competition, that is, in rural 
areas, where both professions vie in some instances for dispensing rights and unease on 
those occasions when a pharmacist must query some aspect of a patient's prescription, 
which is medically suspect). There may be also, some: adversely disposed GP attitudes 
to any proposed expansion of the pharmacist's role as il!dicated in research by Spencer 
and Edwards, (1992: 1671) and Sutters and Nathan, (1993: 70 - 84). Spencer and 
Edwards report GPs' opposition to pharmacist supervision of repeat prescriptions, 
(64%) and about half of the 744 respondents expressed the view that doctors should 
dispense. Approximately ~3% of respondents thought pharmacists 'should stick to 
dispensing'. Sutters and Nathan reported that overall, GPs disagreed that pharmacists 
should 'become more involved in the selection of prescribed medicines. ' 
1.2.2 Early Relationships 
Early origins of both pharmaceutical and medical professions are discernible in the 
realm of ancient Egyptian mysticism and religion, evidence of which lies in the hieratic 
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writings and in particular, the Ebers Papyrus, now residing in the Department of 
Egyptology of the Metropolitan Museum of New York, USA, (La Wall, 1927 : 3). 
Certain other ancient prescriptions, preserved in the British Museum are said to date 
from Cheops, circa 3700 BC, (La Wall, 1927: 3). 
Although there was no real equivalent of the apothecary or pharmacist at that time, 
Hunting, (1998: 11) records that the 
' ... activities of Pa-heri-pedjet, during the reign of Ramses II, (1279 -1213 Be) 
might qualify him for the title of the first recorded pharmacist. ' 
The early efforts of the Egyptians were superseded by the influence of the Greeks and 
Hippocrates and Galen are enduring names of note. Diostorides compiled De Materia 
Medica, containing some six hundred remedies, which were still used in sixteenth 
century London, (Hunting, 1998 : 11). 
La Wall (1927 : 11 - 12) lists seven papyri as being important to our knowledge of the 
early origins of drug application and these are set out in Table 1 together with an 
additional papyrus listed by Kremers and Urdang,· (1976 : 498). 
Table 1 IMPORTANT PAPYRI - HISTORY OF PHARMACY 
i. The Kahon Papyrus 2000 BC, dealing with gynaecology and veterinary medicine; 
ii. The Edwin Smith Papyrus 1600 BC. dealing with surgery and internal medicine; 
iii. The Hearst Medical Papyrus 1600 Be, similar content to the Ebers Papyrus; 
iv. The Lesser Berlin Papyrus, same period as the latter and also dealing with sorcery; 
v. The Ebers Papyrus circa 1552 BC, detailing much polypharmacy in prescriptions with 
up to thirty five ingredients and in all, some seven hundred prescriptions; 
vi. The Berlin Papyrus circa 1350 BC, comprising some twenty three pages with similar 
content to the Ebers Papyrus; 
vii. The Chester Beatty Papyrus· circa 1200 BC, a formulary for anal diseases; and, 
viii. The London Medical Papyrus circa 1000 BC, concerning medicines and magic. 
Whilst it is accepted that some early evidence of Chinese medicines exists, little appears 
to he known of their remedies or prescriptions, which pre-date the Christian era, but 
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these are said to be based more upon mysticism than medicine. However, as Kremers 
and Urdang, (1976: 498) point out, regarding pharmacy's origins: 
'Various opinions about pharmacy's origin continue to be put forward 
because speculation is tempered by logic and analogy, when 
there is not much real evidence. ' 
Nevertheless, it is evident that there have existed, even from earliest times, separate 
strands of medicine and pharmacy, (Jonckheere 1955: 160 - 161). European pharmacy 
is thought to be credited to the works of Mesue Marinate who studied at Baghdad. The 
Grabadian Medicinarum Particularum, prepared by him, was used for about five 
hundred years as an apothecaries' manual, according to La Wall, (1927 : 105). Another 
Persian, Ibn Sina or A vicenna, was a physician and philosopher of the tenth century and 
is credited with founding the Graeco Arabic School of medicine and his writings were 
used in Europe until about 1650 AD, in both medicine and pharmacy. 
However, emergence of a clear separate identity of the two professions was given 
momentum by the German Emperor Frederick II (1224), in his edict affecting that part 
of his realm known as the Kingdom of the Two Sicilies, (Osler 1923: 69). Pharmacy 
and medicine were thus separated and medicines were required to have uniform 
presentation and to be made to regular standards. Both professions, unfortunately, 
transgressed the lines of demarcation, records Kremers, (1976 : 99) and dual education 
in Germany for both professions created conflicts of practice and interest, (Adlung and 
Urdang, 1935: 190 - 192). 
In England, spicers from overseas, notably France, it is conjectured, began to take over 
the drug trade (pepperers as wholesalers and spicers as retailers). The spicers became 
increasingly involved in compounding medicines and by the beginning of the fourteenth 
century were known interchangeably as spicers or apothecaries. The pepperers became 
grocers, whilst the apothecaries became more specialised, until in the sixteenth century, 
they became referred to as assistants to the physician. As well as independent preparers 
and dispensers of drugs, they not infrequently took a hand in medical practice 
(Thompson, 1929 : 86 - 100). Some competition, or conflict of interest, was thus 
evident between the physician and the apothecary. 
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In 1511, the professions in London became regulated by Act of Parliament and 
medicine could not be practiced unless the applicant was examined by the Bishop of 
London or Dean of St. Paul's, assisted by four doctors. In 1518, Henry vm 
incorporated the College of Physicians. The provinces too later came under this system. 
In 1540 the College of Physicians was empowered to ' ... search, view and see the 
apothecary's wares, drugs and stuff .. ' following continental tradition, (La Wall, 1927 : 
208). 
In 1617, King James I granted the apothecaries independence in a new charter and so 
founded the City Guild of the Society of the Art and Mystery of the Apothecaries of the 
City of London, (Copeman, 1967: 16). The powers of the College of Physicians were 
strengthened in 1618 and extended to examining the stocks of apothecaries, druggists, 
distillers and sellers of waters and oils, as well as all preparers of chemical medicines. 
Thus, it may be conjectured that, the opportunity for conflict between physicians and 
apothecaries was perpetuated. 
The ethos of protected territory and extension of authority, of one profession over 
another, may have begun a cultural mindset, pre-conditioned for later years, to 
encourage similar attitudes in the emergent strands of the apothecaries' guild. 
For two further centuries, some confusion and cotlflict of roles existed between 
physicians and apothecaries and some physicians were opening dispensaries, thus 
perpetuating the rivalry. The other strands of the apothecaries' ranks were 'druggists 
and chemists', who in turn were challenging the pharmaceutical function of the 
apothecary, creating further confusion and antagonism. The 'Rose Case', 1703, (Hunt, 
2001 : 191 - 195) illustrates the point. Rose, a compounding and dispensing 
apothecary, treated a butcher, one William Seale, who subsequently claimed to have 
been overcharged for a failed treatment. Seale enlisted the support of the College of 
Physicians, who then brought a case against the Apothecary, in the Court of the Queen's 
Bench, under Lord Chief Justice Holt. The basis was that Rose had performed his 
duties ' ... without licence from the College, without the direction of a physician and 
without taking or demanding any fee for his advice.' 
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The College won its case in law, even though previous custom and practice supported 
Rose. However, the Lords subsequently overturned the judgement, holding that it had 
been contrary to custom and not in the public interest. This is one example, albeit 
notable, of the feuding relationship between the early Apothecary and the Physicians, 
who in their day were more akin to today's general practitioner. The general 
Apothecary was subsequently allowed to prescribe and compound the medicines used 
for treatment. 
In 1815 the Apothecaries achieved a Parliamentary Act giving them powers over 
medical education and standards in England and Wales. This had to be amended, 
through contest and pressure from 'chemists and druggists', giving these the control 
rights to the supply of pharmaceutical services, in other words the buying, compounding 
and dispensing of drugs and medicinal compounds. 
The separation of the two disciplines in England, medicine and pharmacy, was thus 
confirmed in law and the evolution of the apothecary into the medical practitioner, was 
given added momentum.. In 1841, amidst opposition from the Apothecaries Society, the 
Pharmaceutical Society of Great Britain was formed, bringing together chemists and 
druggists in one society. A Royal Charter was granted to them in 1843, followed by the 
first Pharmacy Act in 1852. Thus, the medical and pharmaceutical practitioners were 
individually identified by royal statute and law, as was the College of Physicians. 
The first British Pharmacopoeia appeared in 1864 and La Wall interestingly records that 
one of the earliest factors to bring about change in the practice of pharmacy' ... was the 
introduction of the large scale pill machine ... I which replaced much extemporaneous 
preparations, (La Wall, 1927 : 504). Even in those days, technology was driving 
change. 
Figure 1 (Trease, 1964 : 32) summarises the progress of the professions between the 
twelfth and nineteenth centuries. This gives a snapshot of the major milestones in 
pharmacy development, as well as indicating an abbreviated route of development of 
today's medical practitioner. 
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Figure 1 THE DEVELOPMENT OF PHARMACY AND MEDICINE IN 
ENGLAND 12th _19th CENTURIES 
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1.2.3 Summary and Implications of History 
The history of both professions, particularly in the last century and a half, is one of 
some sensitivity and jealously guarded professional rights. In like manner, but different 
setting, responsibilities are contested today in both rural and fringe urban areas, where 
medicine and pharmacy compete for dispensing rights. Both professions have been, to 
some extent, conditioned by history in their values, beliefs, attitudes and fonns of 
tradition, from which cultural change may now be difficult to achieve. This could, 
nevertheless, be necessary in securing a new role for pharmacy, as contemplated by the 
RPSGB and PSNC, in seeking to transfonn pharmacy's place in primary health care 
through a focus on ' ... specialised medicines knowledge and management ... " rather than 
simple medicines supply, (pSNC 1998: 10). 
As Malinowski, (1945: 28) tenned it, the ' ... living history of a long established 
organisation may dominate its ideology ... ' Pettigrew, (1985: 117) also argues that 
culture change rests very much on the ability to ' ... think the unthinkable and say the 
unsayable ... I 
1.3 THE CHANGING ENVIRONMENT 
1.3.1 Outline Developments - 2(/h Century 
The first half of the twentieth century witnessed the transition from private dispensing 
by chemists, to a government funded insurance scheme (1911), giving contractors a per 
capita payment of one shilling and sixpence. The doctor received seven shillings, whilst 
six pence floated between the two professionals based upon actuarial calculations of 
prescription costs. 
The system was replaced for pharmacists by a reimbursement of the cost price of drugs 
(1916), plus a payment for pharmacist services and overheads. Since that time, 
variations of the theme have been implemented, based upon drug cost reimbursement, 
professional fees, practice allowances and at one stage, an on-cost on pharmacy drug 
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acquisition costs. This latter was, however, ultimately held by the DH to be an adverse 
upward force on the pressure of drug costs, because the higher the price, the higher the 
on-cost for the pharmacist. Also, because of high drug cost inflation, the on-cost helped 
to exceed the "global sum" (remuneration) allocated by the government at the beginning 
of each fiscal year and became a cash flow benefit to pharmacists. 
Currently, NHS contractor pharmacists are paid by a fee structure and practice 
allowance derived from a global sum, fixed by government, with reference to the 
previous year's allocated sum. Costs are no longer taken into account in negotiations. 
The so called cost-plus contract was unilaterally terminated by the government in 1989. 
(pSNC minutes, November 1989). 
Nevertheless, the DH has consistently encouraged the pharmacy profession to develop 
its service and indeed look to a new role in the light of the redundant manipulative 
skills, rendered so by the pharmaceutical industry. 
Government has, particularly within the last two decades, invited pharmacy to revise its 
raison d'etre and design for itself a new role. Gerard Vaughan is usually credited with 
starting this process and on September 19th 1981 said, when Minister of State for Social 
Services (Vaughan, 1981 : 300) 
' ... the thrust for change and extension of role had to come clearly 
from pharmacists themselves. It was for pharmacists to work out 
their destiny and thenfor government to tell them whether it was 
legally) parliamentarily and financially possible ... ' 
The author of this thesis would contend that pharmacy's leadership did not pick up the 
challenge, perpetuated the status quo and let matters rest by simply continuing with the 
drug supply function, as specified by the doctor on an FP 1 0 (NHS prescription fonn). 
That pharmacy failed to respond positively to the ministerial invitation is underlined by 
the number of subsequent government initiatives, that attempted to pursue the same 
objective: 
• The Nuffield Enquiry 1984 - 86; 
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• The Department of Health Working Party 
• The National Audit Office Report 
1991 - 93; and, 
1993. 
All recommended an expanded role in primary health care for community phannacy and 
sought to realign the phannaceutical service with new societal demands. 
There was no immediate address of the possibilities of expanded responsibility in the 
cognitive opportunities related to pharmacist / patient interaction, in other words, 
compliance advice, address of side effects, drug interactions, adverse medicines effects 
and therapeutic substitution. Nor was there consideration of a more formalised 
relationship with the medical profession to address, for example, formulary 
development and better drug economics. 
More recent government policy has also facilitated new opportunities for pharmacy, as 
enshrined in the following White Papers / Resource Documents: 
WHITE PAPERS 
• Choice and Opportunity, Primary Care - The Future Nov. 1996; 
(medication review) 
• Primary Care: Delivering the Future Dec. 1996; 
(as above) 
• The NewNHS: Modem, Dependable Dec. 1997; and, 
(New equal partnerships between professionals) 
• Our Healthier Nation (Green Paper) Feb. 1998; 
(A contract for health - partnerships) 
NHSE RESOURCE DOCUMENTS 
• GP Prescribing Support 
(medication review) 
• Pharmacy in the Future 
• Modernising Medicines Management (NPC) 
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Sept 1998; 
Sept 2000; and, 
Apr. 2002. 
These government initiatives may be regarded, in the terminology of modem 
management, as external change drivers or triggers. However, internal change drivers 
have also played their part in encouraging pharmacy to seek a much higher stake in 
primary health care. Individuals of vision, at all levels and in all sectors of the 
profession, have seen the necessity of becoming more patient focused, rather than 
prescription focused, in the delivery of pharmaceutical care. 
Moreover, since the publication of the 1996 Conservative Government White Paper, 
Choice and Opportunity and the creation of the competitive market place, the 
professions have no longer had absolute security of tenure in their own domains, other 
than for their core functions. Nurses are creating new opportunities for their profession 
and encroaching upon some of the doctors' traditional territory. Nurse practitioners are 
now running clinics for patients and in some areas, becoming the first port of call for 
patient treatment within the NHS. 
Conceptually, the competitive internal market of the NHS, created by the Conservative 
Government, has now been removed by the new Labour Government White Paper, The 
New NHS: Modern Dependable, (1997 : 2). The competitive internal market was 
constructed primarily to create competition between hospitals for GP funds and 
therefore, hopefully drive efficiency and quality upwards and cost downwards in the 
secondary care sector. Secondly, by giving GP practices their own funds to manage, 
with incentives to make savings, it was hoped by government that GPs themselves 
would become more financially efficient prescribers. 
However, in reality the Labour Government's formation of Primary Care Groups and 
Trusts, of which all GPs are members, (New NHS : Modem Dependable, 1997: 19,65) 
has, in the author's view, rather cleverly perpetuated competition by benchmarking 
performance. Improved clinical excellence and quality are now driven by the new 
National Institute for Clinical Excellence and the new organs of the restructured NHS. 
Every GP is thus now a member of a fund holding group, (a peT). Entirely new 
services, unless already proscribed by law, are thus the domain of whichever profession 
is able to lay claim to them. 
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In the drive by all health care professions to achieve new responsibilities and perhaps 
additional rewards in primary care, new pharmacy aspirations may easily be threatened 
by competing professions. If sensitively handled, however, the medical profession in 
particular, could conceivably become a facilitating force rather than a competitor in the 
development of the pharmaceutical profession. This may be possible, for example, by 
presenting any new pharmaceutical service as a work-reducer for GPs, an extension of 
their authority in directing an extended team and a route to better practice budgetary 
control. Such issues may well be culturally related to preserving the status of the GP as 
the lead health care professional and indicating that the GP's lead position in primary 
health care is to be sustained and even strengthened. These issues will be explored in 
the research for this study. 
If a new pharmaceutical service is presented in a threatening way, then doctors could 
easily oppose it. If pharmacists were to overtly press for increased clinical authority, in 
selecting patient medication for new practice fonnularies, or an increased role in 
managing patient medication, doctors may oppose any proposition which could be 
perceived as diminishing their own role or status. A carefully orchestrated marketing 
approach, using sensitively worded communications, may become both desirable and 
necessary. These latter two processes will be examined more fully in Chapter Four. 
1.4 LATEST DEVELOPMENTS 1992 - 2002 
Having observed a general lack of response to government overtures to the profession to 
re-examine their role, in 1996 a small sub-group of the PSNC, organised and chaired by 
the author of this thesis, developed a structured approach to a proposed new community 
pharmacy role of medicines management. A mission statement for community 
pharmacy was developed, together with an overall working definition of this new role. 
The work was completed in August 1998 and it is hoped that this new cognitive role 
will transfonn community pharmacy into a new order of service, medicines based and 
patient focused, giving the profession a much higher stake in primary care and a new 
position in the health delivery chain. The mission statement and definition of medicines 
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management, as agreed by the sub-group and confirmed by PSNC are set out in Tables 
2 and 3. 
Table 2 MISSION STATEMENT - COMMUNITY PHARMACY 
IN THE CONTEXT OF MEDICINES MANAGEMENT SERVICES 
Community pharmacy will develop its resources and services in such a way as to deliver: 
• Health gain for the patient; 
• New partnerships with other health professionals in quality driven care; 
• More effective use of medicines through expert knowledge of the pharmaceutical 
sciences and unique relationship with the public; and, 
• A major contribution to public health. 
Health gain as described in Table 2 means improving longevity and / or quality of life. 
(Drummond and Maynard, 1993 : 138). 
Table 3 MEDICINES MANAGEMENT IN COMMUNITY PHARMACY 
- A DEFINITION 
Medicines management is maximising benefit and minimising risk for patients from all 
medicines, by ensuring on an ongoing basis: 
• The safe and appropriate choice of medicines and therapeutic regimens; 
• Structured discussion with the patient on specified aspects of their medicines; 
• Systematic collaboration with the prescriber and other members of the primary health 
care team in addressing patient needs; and, 
• Record and report maintenance for GPs in agreed format. 
A more current definition by Jones and Tweedie (2001 : 248) is: 
'The systematic provision of medicines therapy through a 
partnership of effort between patients and professionals to 
deliver best patient outcome at minimised cost. ' 
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Currently, community pharmacy is making progress towards this transformed role, as 
evidenced by approval from the Secretary of State for Health for pilot trials of a new 
service, that began in 2000. This will, in effect, treat the traditional NHS prescription 
as a contract o/patient care, managing the progressive medication of the chronically ill, 
as their conditions and responses change over time. It will manage multiple regimens 
for the chronically ill and integrate acute illness treatments for them, when necessary. 
For the historically aware, in the medical profession, this could, conceptually, represent 
a return to the blurred responsibilities of the strands of the Society of Apothecaries in 
the seventeenth century, a threat to medical autonomy and consequently, a threat to 
pharmaceutical progress in the current environment of health care reform generally. 
1.4.1 New Role - Core Detail 
The core detail of this proposed new community phannacy service is set out in Tables 4 
and 5 (See also Appendix 10, page 433, Phases of Medicines Management). 
Table 4 NEW CORE ROLE FOR COMMUNITY PHARMACY 
MEDICINES MANAGEMENT - PHASE 1 
Structured discussion with the patient at regular interv.als to identify: 
• counselling needs for patient compliance and commitment to therapy; 
• drug side effects and toxicity; 
• ineffective drugs; 
• drug interactions; 
• adverse reactions; 
• patient acceptability of dosage fonn (liquid-v-tablet-v-capsule etc.); 
• perceived acceptability of drug (e.g. taste, dose frequency, tablet size); 
• potential NHS - aTe drug interactions; 
• potential food - drug interactions; 
• general feeling of well-being, or otherwise; 
• family support problems; and, 
• referral back to the doctor (Appenrux 2, page 419). 
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Involvement of the patient will need their approval and collaboration. Assistance in this 
respect may well come from patient associations, who wish to be seen acting on behalf 
of improved patient care. 
TableS NEW CORE ROLE FOR COMMUNITY PHARMACY 
MEDICINES MANAGEMENT - PHASE 2 
Structured discussion with the doctor at regular intervals for: 
• drug interaction removal; 
• replacement of patent expired brands with generics; 
• reduced side effects; 
• therapeutic interchange I substitution; 
• reduction of polymedicine; 
• more economic prescribed quantities; 
• more effective drug regimens; 
• reduction of combination products and replacements by generics or individual branded components; 
and, 
• tactics to increase patient compliance. 
Patient review is likely to take place at three to six mOl?-th intervals, or as indicated in 
the pilot trials and discussion with the GP as locally agreed. 
The role outlined above is not traditional territory for pharmacy and no such formally 
recognised, structured intervention exists at present, in either community medicine or 
pharmacy. A search in the database Healthstar in January 2000, for example, indicated 
some eighty five ad hoc projects between pharmacists and doctors, involving one or two 
elements of the above. There is no example of a comprehensive address of patient 
care, which is multi component, structured, routine and a recognised pharmacist 
intervention, as part of a national contract. 
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1.4.2 Progress up to January 2003 
Since publishing this initiative in the Pharmaceutical Journal, (1998, May 2 : 616), an 
outline operational plan, developed by the author of this thesis (Appendix 3, page 420) 
has been adopted by the new leadership group, comprising senior personnel in the 
representational organisations of pharmacy. Unity is important to signal to government 
the profession's commitment to change. Mixed messages could weaken government 
will to support this far reaching restructuring of the pharmacist/patient/physician 
relationship. The author's concept of the new relationships, are summarised in the 
diagram in Figure 2 showing also the political initiative underpinning change. 
The heavy large black triangle represents the new connection between the community 
pharmacist and GP, driven by performance criteria, in raising the quality of primary 
care through a partnership in medicines management between physician and pharmacist. 
The light grey large triangle represents the political initiative of the White Paper, (The 
New NHS - Modern, Dependable, 1997) newly bringing together 'primary health care' 
and 'public health' in patient support. The small triangle, created by the overlap of the 
two former triangles represents strengthened patient care, being supported in the new 
political initiative and structural links between 'public health' supporting 'primary 
health care'. 
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Following DR agreement to commission pilot trials in medicines management, another 
initiative heralded by the government document, Pharmacy in the Future, has 
commenced. This is the medicines management so called 'collaborative', managed by 
the National Prescribing Centre in Liverpool. Its approach to medicines management is 
in the development of systems and processes which will facilitate the beneficial delivery 
of medication to the patient from the health care professionals. By developing such 
systems, a partnership between health care professionals is facilitated. 
The composition (of the leadership group) is shown in Table 6 and is chaired by the 
writer, who brought the group together because of the need to deliver a unified approach 
and strategy for the community pharmacists. 
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Figure 2 WIDTE PAPER RELATIONSIDPS IN THE 
NEW HEALTH CARE STRUCTURE-
PHYSICIAN, POLITICIAN, PATIENT & PHARMACIST 
Performance 
Political 
Initiative 
Primary Care Public Health 
Physician Comm unity Pharmacist 
Note: Author's schematic representation of the new partnerships in patient care as outlined in the 
government white paper, 'The New NHS - Modern, Dependable ', driven by the political agenda 
benchmarking performance. 
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Table 6 LEADERSIDP GROUP - COMPOSITION 
LEAD BODY REPRESENTATIVE 
• The Royal Pharmaceutical Society GB • President; Registrar 
• The Pharmaceutical Services Negotiating • Chairman; General Secretary 
Committee 
• The National Pharmaceutical Association • Chairman; Director 
• The Company Chemists' Association • Superintendent Pharmacist, Boots; 
Director of Pharmacy Services, Unichem 
• The Co-operative Pharmacy - Chief Executive; Head of Planning 
Technical Panel 
CHAIR -A.M. TWEEDIE, PSNC 
Note: The 'Leadership Group', comprises the senior figures in the major pharmacy 
representative bodies of community pharmacy contractors, plus the RPSGB and is 
responsible for leading the community dispensing contractor into cognitive service. 
The leadership of the profession is a compound structure, (Figure 3) and can, on 
occasions, pursue overlapping, or even conflicting agendas, as evidenced by the NP A 
proposition to graft the medicines management initiative on to their repeat dispensing 
project and the Royal Pharmaceutical Society wishing to present it as an element of 
their PlANA initiative, Pharmacy in a New Age ('Over to You' phase RPSGB Doc., 
Sept. 1998). 
Since this time, the repeat dispensing project has failed and PIANA has quietly 
disappeared into a phase which supposedly handed over the process to pharmacists in 
the community, who do not have the resources or authority to make progress in a 
systematic way. 
This phase of the PIANA initiative, designated as ' ... Over to you ... ' has seemed, to a 
number of people in the Northern Region canvassed on the subject during LPC 
meetings, (Gateshead; Sunderland; Newcastle March - May 2001) to be an abdication 
of further RPSGB involvement in the initiative. This' ... Over to you ... ' phase (RPSGB 
Doc., Sept. 1998) may also be an indication of the Royal Pharmaceutical Society's lack 
of knowledge and expertise in creating and managing an operational programme of 
activity, leading to a transformation in pharmaceutical care within the NHS primary 
care team. 
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Figure 3 
Independent 
LEADERSHIP BODIES COMMUNITY PHARMACY 
STRUCTURE AND CULTURE 
Royal Pharmaceutical Society of Great Britain 
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Representative 
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Representative 
Body 
~ 
Contractors -------t~~ 
(power Cultures) 
I I I 
Publicly Quoted 
"'~I-------- Multiples 
(Role Cultures) 
I I I 
National Super- Dept. Sole Health Groups 
Practitioner Centre Small + large 
R,flil Practices .. 
I 
1 
I 
I 
: Pharmacies 
I 
I 
1 
I 
1 L __ ~.!ll'lllUrbap. ____ _ 
Divide 
CCA 
Representative 
Body 
CPTP 
Representative 
Body 
Vertically Integrated Multiples 
(Wholesale and Retail) 
(Role Cultures) 
Professional Ethics and Responsibility 
Legal Framework of Operation 
Education and Training 
Chains markets Stores 
.. 
I 
I 
I 
I 
Pharmacies : 
I 
I 
1 
.1 
1 1 
1 RurallUrban 1 ~------ ----~ Divide 
Note: The above diagram is the author's representation of the official leadership bodies 
in community pharmacy, together with the sectors of the operational profession. 
CCA Company Chemists Association 
CPTP Co-operative Pharmacy Technical Panel 
NPA National Pharmaceutical Association 
PSNC Pharmaceutical Services Negotiating Committee 
Key: _______ • Structural variants of pharmacy in the health care market (NIlS) 
----I~. Profession & Trade Associations influencing the community pharmacy domain 
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Visions and aspirations may be relatively easy to create and conceptualise, but it is, of 
course, quite another matter to be able to design and operationalise a change 
management programme. Such a programme would need to be able to effectively re-
engineer, not only the practice of community pharmacy, but a new relationship between 
pharmacy and medicine, which would more closely resemble a partnership on equal 
terms with each profession contributing its own expertise. 
Although it could be said that the first major panoramic vision created for pharmacy 
was developed by the Royal Pharmaceutical Society in 1997, (PIANA), the origin of the 
medicines management initiative pre-dates it by some three years, through another paper 
written by the author of this thesis, proposing this new role and published in the 
Pharmaceutical Journal, (1994, vol. 252 : 507). Both initiatives have encouraged 
pharmacists to look to the future in health care and see the possibilities for the 
profession's development. However, the RPSGB vision was never transposed into an 
operational plan, without which, systematic progress towards meeting its objectives 
could not be fulfilled. The PSNC has closed that gap with its medicines management 
programme and commenced what is calculated to be a transformation and repositioning 
of the community professional service. 
In pursuit of this objective, the writer, as Chairman of the leadership group, created five 
integrated sub-groups to develop the elements of medicines management roll-out and 
hold the leadership programme together, giving a unified approach with support from 
the lead organisations in pharmacy. The sub-groups were: 
Education I training 
Communications 
Practice Research 
RPSGB 
PSNC 
RPSGB 
Repeat Dispensing Development NP A 
Premises Function / Image Change CCA / CPTP 
(Appendix 4); 
(Appendix 5); 
(Appendix 6); 
(Appendix 7); and, 
(Appendix 8). 
(pages 421 - 432) 
Abbreviated general guidelines for all these groups are set out at Appendix 9. Each of 
these sub-groups has a membership of two representatives of each of the lead bodies 
listed above, supporting the nature of an integrated change effort. 
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Meetings were then arranged with the Minister of State for Health and subsequently 
representatives of the General Practice Committee (GPC) to discuss proposals. On both 
occasions reception was very positive and follow up review meetings were agreed to set 
up pilot studies and evaluate the proposals. 
However, other agendas are being pursued by the nursing profession and indeed, 
elements of the medical profession, through new training and IT schemes for GPs in 
medicines' review, e.g. MIQUEST, (NHSE, 1997: E5273) and PRODIGY, (DH, 2000) 
targeted upon specific disease groups. Currently these ideas are in their infancy, but 
could develop more widely. NHS Direct, staffed by nurses, is already offered to the 
public and is referring patients to locations other than pharmacy. Competition for new 
services is thus a real issue. 
What of competition generally? Who could conceptually offer a similar service to the 
pharmacy profession, as described above? These questions will be addressed in the 
following section. 
1.5 COMPETITION, MARKETING AND STAKEHOLDERS 
1.5.1 Introduction 
As already indicated, competition within the NHS is a real issue and is briefly examined 
in the following section. 
Kotler and Clarke, two eminent researchers and authorities in the field of marketing, 
argue that just as marketing was not an accepted concept in health care until the early 
1980s in America, neither was the term competition, in spite of the fact that the USA 
private health care sector, by its very nature, must compete for its own private following 
of patients. As they point out, it was perceived by a conference of hospital 
administrators, (Kotler and Clarke, 1987: 24) in the following terms: 
'Hospitals don't compete. There is a sisterhood 
o/hospitals. Hospitals help each other. ' 
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In the UK, Shaeff (1995 : 1) similarly points out: 
'Marketing is reaching the NBS. Few organisations yet 
practice marketing consciously, but many of its ingredients are 
already familiar to them. ' 
He goes on to cite the ftrst Griffiths Report, (1979: 9) and the White Paper, Working/or 
Patients, (1989 : 24) as containing major elements of marketing. These he argues, 
signalled the introduction of new thinking for the NHS, in terms of placing patients in 
the role of customers, in having consumer needs and expectations of a quality product. 
In pursuit of the latter, medical audit and the internal competitive market are cited by 
Shaeff, (1995 : 1) as driving towards this aim. In seeking to improve service, Griffiths, 
(1979 : 12) sets out one of the objectives of the NHS as being to provide a service 
' ... responsive 10 local needs ... " which is a similar marketing principle to addressing the 
needs and wants of the consumer, in general markets. 
The internal market which followed Griffiths, placed marketing and competition on the 
health administration agenda. This report was quite possibly the forerunner of the 1990 
Act. The 1997 White Paper, The New NBS: Modern Dependable, (1997: 5) purported 
to remove the internal market, some of its structures and competitive tendering, and 
create integrated care: 
'This White Paper marks a turning point for the NHS. It 
replaces the internal market with integrated care ... based on 
partnership and driven by performance. ' 
A framework of national standards and excellence will be guaranteed to patients, so that 
they can have confidence in the quality of the services they receive. The White Paper 
further recognises that people (not patients) expect more in terms of speed of service 
and range of treatment. Both these concepts of speed and range of choice are derived 
from marketing and modern management. Finally, in evidence of the new consumer 
focused trend in health care, it is reported that a new survey of patient and user 
experience will be carried out each year, (The New NHS, 1997 : 66) with the intention 
of assessing the quality of service and identifying potential improvements. This survey 
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will be conducted by a government agency and is similar, in principle, to market 
research surveys of customer views, in consumer marketing. 
The 1997 White Paper also encourages dialogue between government and the health 
care professions, to suggest how they may best develop their contributions to the new 
NHS. This is clearly an opportunity for pharmacy development, especially in the new 
primary care structures, Strategic Health Authorities (SHAs) and Primary Care Trusts 
(PCTs). It is conceptually also a threat, as other professions may wish to encroach upon 
the traditional pharmacy domain. New services, which are currently not the traditional 
tenure of a particular profession, may clearly be competed for, by any health care 
professional, for example patient counselling, medicines advice and review. 
The latest strategy of pharmacy, to become the manager of patient medicines therapy, 
(pSNC report 1998), could, for example, be delivered by other health professionals. 
The nursing profession, in particular, is active in promoting its own professional 
services and the 'round the clock' nurses help line in NBS Direct, is already giving 
advice in this respect. It is not difficult to conceptualise a position where they could 
extend this to a follow up system, where patients are referred on, to their own medical 
practices to see a resident nurse practitioner. The medicines management circle is then 
complete, without pharmacist involvement and resident in the doctor's surgery, where 
the doctor may feel more satisfied that matters then ai-e totally under medical control. 
The history of the medical profession indicates that, in extending their sphere of 
influence, they could again be successful in exploiting current opportunities. 
Pharmacy is thus operating in a well supplied market place of competitive professional 
resources, which in terms of the new services contemplated, is not impeded by 
constraining laws, as is the core role of dispensing. Even the latter is not as secure as 
previously because technology has rendered complex compounding of medicines 
redundant and a simple supply function is easier to manage. Information technology 
also facilitates access to drug knowledge. 
Patient packs containing the correct number of days' treatment for a suitable course, 
have made dispensing even more mechanical and consequently, easier. Somewhat more 
threatening is a consultation circular from the Medicines Control Agency (MLX260 : 
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13th March, 2000) indicating that modification of the group dispensing and supply 
regulations, giving wider dispensing rights to other health professionals, is under 
consideration. 
Whatever else this means, the indications overall, within health care, are that 
competitive forces are potentially increasing. There is, conceptually, no apparent 
absolute reason why the DR or any other health authority would want to automatically 
select community pharmacy for a new medicines management role. 
Generically expressed, the five competitive forces (threats) of any 'market' as originally 
conceptualised by Professor Porter of the Harvard Business School, (1980 : 4) help to 
expose community pharmacy's position with respect to its proposed new role. 
Porter conceptualised new arrivals in the market place simply as 'entrants' rather than 
'new entrants'. The rationale is that old entrants become part of the established domain 
and therefore any new company entering the market for the first time is adequately 
described as an 'entrant'. 
The 'market' may be described as that part of any target population, specifically 
availing itself of a distributed product or service. The 'competitive forces' are created 
by the interplay of the market, its suppliers and new approaches to market exploitation. 
The effects are summarised in Figure 4 and dealt with in more detail under separate 
headings following. 
This analysis is the author's conceptualisation of the potential competitive elements 
which may face community pharmacy dispensing contractors as new services are 
developed in primary care. 
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Figure 4 PORTER'S FIVE COMPETING FORCES OF THE 
MARKET PLACE APPLIED TO NEW PHARMACY 
MEDICINES MANAGEMENT 
AD pharmacist 
expertise 
THREAT OF BUYER 
POWER - (STRONG) 
-NHSE 
-SHAs 
-PCTs 
THREAT OF ENTRANTS 
-Hospital phannacists 
-Peripatetic phannacists [ -PCT extended board with phannaceutical team 
-SHA operational unit headed by phannacist advisers 
PHARMACY COMPETITION 
IN THE DOMAIN 
THREAT OF SUPPLIER 
POWER - (WEAKER) 
• Independents .... ~ .. ___ -IT Packages - Medicines 
• Multiples management 
• Co-operatives 
-Patient Organisations (ascending) • Supennarkets 
-Pharm. Industry. Disease 
prognosis packages; meds. 
ABnon 
pharmacist 
expertise 
Note: The detailed bullet 
points under each of the 
five major headings, 
(threats) are the author's 
view of where the 
increased competition 
could arise. 
THREAT OF SUBSTITUTES 
-Nursing profession with IT 
-Medical profession with IT (GPs) 
-IT review packages via healthy 
living centres 
-PeTs with extended nurse 
practitioner teams 
-Pharm. Industry (managed care) 
-SHAs with doctor incentive 
packages for good prescribing 
Abbreviation s 
GP General Practitioner 
IT Information Technology 
MM Medicines Management 
Infonnation packs; clinics 
-Community pharmacy 
employee pharmacists 
-Wholesale IT packages & 
vertically integrated retail 
specialists peripatetic teams 
inMM 
NHSE National Healtb Service Executive 
PCT Primary Care Trust 
SHA Strategic Health Authority 
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1.5.2 Competitive Advantage 
If competition is to be encountered in attempting to deliver a new service to the NHS, as 
potentially indicated in the Porter's competitive forces analysis, then the notion of 
competitive advantage becomes important. Why should government choose one 
particular profession, or segment of a profession, to discharge a particular new role? 
Much could depend upon the advantages offered by each alternative, not necessarily 
based upon the cost of the unit of service. According to Lambin, (1993 : 242), 
competitive advantage equates to the superiority of a particular protagonist over the next 
best placed competitor in the market place. It is not the net superiority over all other 
competitors. He goes on to argue that competitive advantage may be external or 
internal. It is external when based upon some distinctive qualities of the total product 
offering, attractive to the buyer or user. It is internal when the organisation making the 
offer has superior cost control, administrative and product management. The ability to 
exploit a competitive advantage depends, according to Porter, (1980 : 22) not only upon 
the competition but the role played by the balance of the competitive five forces of the 
market place at a period in time. One simple example of this would be as in the 
nineteenth century situation, where the medical I apothecary blurring of activity was 
somewhat chaotic and perhaps, made it easier for chemists and druggists to proceed 
with their own agenda. An orderly structured proposition, in a generally complex and 
uncontrolled situation, can be an attractive option to th~ problem holder. The elements 
of Porter's five forces are described briefly in the following paragraphs. 
1.5.3 Threat of Entrants (Figure 4) 
This is conceptualised by Porter simply as more of the same service entering the market 
place, creating more internal competition. Within pharmacy, for example, Lloyds 
arrived in an established, stable market and built a chain of retail outlets. The chain 
then became vertically integrated and thus a new multiple entrant to compete with Boots 
and other national pharmacy organisations, but offering the same service. This situation 
can lead to price depression and pressure upon profit margins in a retail setting, 
although not in medicines supplies through the NHS. 
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1.5.4 Threat of Substitute (Figure 4) 
A threat of substitute is more difficult for an organisation to anticipate, unless it has a 
corporate strategy, continually observing and analysing the business environment. Who 
could have seen that the fax machine would compete with the postal service, or indeed 
that e-mail would then compete with the fax. Neither comprised a new postal service, 
as understood at the time, but the new products powerfully compete with the older 
means of delivering communications. 
Within pharmacy, the emergence of the electronic prescription means that postal 
dispensing becomes a nearer possibility. Similarly medicines reviews could be 
performed in healthy living centres, staffed by nurse practitioners, IT-linked to GPs. 
Indeed, the pharmaceutical industry, with vertically integrated new community outreach 
centres for patients, could do likewise. This is, of course, to think the unthinkable, but 
certainly not the impossible. 
Threat of substitute is much more dangerous than threat of entrant because it represents 
a wholly new approach, which is much harder to compete against by the traditional 
suppliers. It is about total replacement and redundancy of a whole product I service in 
the traditional market, which is unlikely to be regained by the obsolete product I service. 
, 
The total replacement of typewriters with word process~rs and then computers, further 
epitomises the effect and no amount of engineering refinement of the typewriter could 
conceivably displace the word processor or computer. If pharmacy were to be replaced 
by nursing, in medicines management, it would have a much more serious effect than 
community pharmacy being replaced by, for example, hospital pharmacists or 
peripatetic pharmacists. These latter are independent pharmacists self-employed, 
working exclusively in GP surgeries. If community pharmacy were to be manoeuvred 
out of this new role by doctors themselves undertaking the responsibility, this could 
well be an irretrievable position. The way in which pharmacy presents and pursues its 
new aspirations could be crucial to its success. Threat of substitute probably poses the 
most serious threat to pharmacy's new future potential in primary health care. 
Independent community pharmacists would be less well placed to compete with nursing 
than the multiple who can employ pharmacists to specifically work in the GP surgery 
along with other health care staff. 
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1.5.5 Threat of Buyer Power (Figure 4) 
The threat here lies with the potential to compete for profit in the value chain and to 
exploit competition to drive prices downward for the product or service itself. With the 
NHSE and indeed, PCTs being in a monopoly position for buying NHS services, this, in 
turn, could threaten ability of contractor pharmacists to provide the service if funding 
(profit) is inadequate. More dangerously, this could open the door for competing 
services which are cheaper, or have a smaller cost base than pharmacy contractors, for 
example: nurses; peripatetic pharmacists; pharmaceutical advisers. The threat of 
substitute is thus potentially magnified. 
The strength of potential threat of the powerful NHS buyer to squeeze the price for a 
new quality product (and quality is a central tenet of the 1997 White Paper), may vary 
according to internally competing demands. For example, what is the value to the NHS 
of freeing up hospital beds occupied by patients suffering iatrogenic reactions and the 
effects of non compliance with medication? The Audit Commission Report (1994: 23) 
suggests that some 5% of hospital beds are so occupied. Col et aI, (1990 : 15) suggest 
that as many as 11.4% of hospital admissions are caused by poor compliance. What is 
the value to the Gross Domestic Product in reducing iatrogenic illness, thus creating 
more man years of production per calendar year by healthier people? 
From yet another perspective, 363,000 man years per year are reported as lost by 
industry due to stress related illness, with a cost to employers of between £ 1-2 billion 
each year, (Jenkins and Coney 1992 : 25). Could this be mitigated by, firstly, better 
selection of drugs, to assist the sufferer; secondly by medicines related patient 
counselling and encouragement by the, pharmacist; thirdly by an effective system of 
onward referral by the pharmacist to other health professionals, providing extra social 
support and advice. A higher cost but higher value pharmaceutical service, carefully 
constructed and marketed to the key stakeholders already appears to be a prerequisite of 
success in reducing the threat of buyer power, which could create a barrier to the new 
role for the NHS pharmacy contractor service. 
Threat of Buyer Power has important implications for negotiating pharmacy 
remuneration and could act as a positive force in stimulating new more effective 
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approaches. Such cost benefit equations have never been conducted on community 
pharmacy's behalf, with respect to a quality medicines management pharmacist 
intervention. 
1.5.6 Threat of Supplier Power (Figure 4) 
With regard to pharmacy's traditional role of dispensing, this market force is by no 
means simple and illustrates the effects of competitive advantage, for example, within 
the pharmaceutical manufacturing industry. The suppliers of branded and patented 
drugs, at manufacturing level, create their own unique product advantage by new 
research and development, as well as by market perceptions of the product through 
image, pharmacology and the marketing profile of the medicine itself. Generic 
manufacturers do not have such power, being deficient in either brand image or 
demonstrable pharmacological advantage over the same competing medicines. Indeed, 
branding of generics may become a ploy by generic manufacturers in order to improve 
product profit margins, provided they can find a suitable marketing platform to justify 
the branding. Potentially, a generic manufacturer of a calcium channel blocker, for 
example, by branding the product, could offer the doctor a means of prescribing a 
cheaper product of consistent bio-availability. The BNF (British National Formulary) 
recommends that such products are prescribed by brand name to guarantee such 
consistency. The generic manufacturer, having branded the generic, could then match 
the drug tariff price for the generic product, creating the cheapest brand on the market, 
in other words, best quality at best price. 
Likewise, the wholesaling sector fmds itself competing in a market place of near 
identical services, in quality and delivery. Thus, supplier power in the past has been 
generally mixed and not powerful. With the prospect of the new medicines 
management service, the suppliers of the new product will be the employee pharmacists 
themselves and single practice proprietors. This could, in turn, create a major shift in 
the focus of the pharmaceutical industry, which will then need to influence pharmacists 
as part of the drug selection chain. However, the other potential suppliers of this new 
medicines management service are likely to lie in the realm of IT and software 
suppliers, with packages of algorithmic diagnosis and review programmes. These, in 
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turn, may well constitute a threat, perhaps through offering such expertise to professions 
other than pharmacy. 
The potential emergence of supplier power for the future could merit careful analysis by 
those strategists now working on behalf of the profession to design new medicines 
management services for pharmacist contractors. Strategic alliances between traditional 
pharmaceutical manufacturers and community pharmacist contractors could well form a 
powerful new partnership in delivering patient care. 
1.5.7 Stakeholders 
It could be argued that alongside a consideration of the competitive forces of the market 
place, as set out by Porter, lies the concept of stakeholders and their potential influence 
in affecting the future of an organisation. Whilst not necessarily falling into a category 
of competitive influence, stakeholders may drive or impede change in any 
organisational programme of effort. They can thus affect competitive effectiveness 
positively or negatively. They are important as a consideration in this section because 
at least one key stakeholder, (the OP) could easily turn out to be a competitor in 
pharmacy's new aspirations. 
Early economic theory took account of the priority of shareholders in decision making. 
The assumption was, according to Thompson, (1993 : 129) that in the beginning of the 
formalised business organisation, owners (shareholders) were seen as synonymous with 
managers and so, were the major source of power. 
The author would also agree with other writers that in the third millennium, 
organisational decision making is much more complex and must take account of the 
major external, as well as internal, agencies which can affect the interests of the 
organisation, (Newbould and Luffman, 1979 : 127). Freeman, (1984 : 62) defines such 
stakeholders as "any individual or group who can affect, or is affected by, the 
performance of the organisation." Their relative power is, of course, different and may 
even vary with the passage of time. eyert and March, (1963 : 151) proposed that the 
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goals of any organisation are a compromise between the aspirations of those 
stakeholders with sufficient power to affect the course of the organisation's progress. 
This may be particularly true of pharmacy and its new service development within the 
NHS and where the two professions of pharmacy and medicine are so closely connected 
in the daily transactions of dispensing and communicating on various aspects of 
prescribed medicines. Their agendas may be different, as may be the corporate 
aspirations of the different companies / chains, delivering the present dispensing 
service. 
With respect to pharmacy and its proposed new service, Figure 5 summarises the 
author's concept of the stakeholder power / interest position. Considered together with 
the competitive market forces and an analysis of the political, economic, sociological 
and technical forces in the business environment, it forms a basis which may assist 
forward strategy formulation and exposes some potential barriers as well as 
opportunities for progress. 
Whilst the DH is arguably the most important of the major stakeholders, they are not 
regarded in this thesis as a potential barrier to change since Government has approved 
the new MM philosophy. 
More latterly, the DR has approved and funded pilot trials for the service and 
encouraged the pharmacy profession to move into this new role via the Department of 
Health Medicines Management Advisory Committee, of which the author is a member. 
On the other hand, the medical profession is a very powerful social and political entity 
and could impede, or completely block, pharmacy progress toward its new role. It 
could do this, for example, by engaging nurse practitioners as practice employees to 
undertake medicines management duties. Alternatively, it could engage secondary care 
pharmacists on a sessional basis, to undertake similar duties and 'gate-out' the 
dispensing pharmacist. It is for this reason that, of the major stakeholders, the medical 
profession has been selected for study. 
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Figure 5 STAKEHOLDER POWER I INFLUENCE MATRIX 
• PHARMACY AND PRIMARY CARE 
AUTHOR'S CONCEPT OF MAJOR PLAYERS 
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IN TIME 
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-CHCs 
- Financial Markets 
- Local Authority SSDs 
- Hospital Trusts 
Keep Satisfied 
-LMCs 
-HAZs 
-LRCs 
-NHSE, SHAs 
- Nursing Profession 
Keep Informed 
- Patient Associations 
- University Pharmacy / 
Medical Schools 
- Royal College of General 
Practitioners 
- Consumer Associations 
- Appropriate Media 
- Nurses 
Key Players 
- PSNC / RPSGB 
- DH / Government 
-BMA/GPC 
-GPs/PCTs 
- Community Pharmacists 
-PAs 
- Patients 
LEVEL OF INFLUENCE 
Low ------- IN TIME ~ High 
Note: Author's interpretation of the relevant stakeholders in pharmacy role change; their respective 
power and influence position at the time of writing (2002) 
BMA 
CHC 
GPC 
GPs 
HAZs 
LMC 
LRC 
British Medical Association 
Community Health Council 
General Practitioner Committee 
General Practitioners 
Health Action Zone 
Local Medical Committee 
Local Representative Committee 
NHSE 
PAs 
PCGs 
PCTs 
PSNC 
RPSGB 
SSD 
SHA 
National Health Service Executive 
Pharmaceutical Advisers 
Primary Care Groups 
Primary Care Trusts 
Pharmaceutical Services Negotiating Committee 
Royal Pharmaceutical Society 
Social Services Department 
Strategic Health Authority 
Some of the above stakeholders will require careful address in any marketing and 
commilllications programme, calculated to influence and facilitate the way forward for 
pharmacy. 
1.6 CHAPTER SUMMARY 
Pharmacy's history, with its close connections and interwoven strands of development 
with the medical profession, can be seen to be either a hindrance, or a help, in taking 
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matters forward. Cultural prejudices may exist, borne of past custom and practice, 
which could form barriers to progress, as could both professions' perceptions of their 
traditional territorial rights. Other stakeholders may also have an influence on future 
possibilities. Groups such as patient organisations, consumer representatives, 
competing professions and government itself with its new organs of administration are 
likely to play important roles. 
A brief consideration of the modem primary health care market place within the NHS 
and with respect to new pharmacy contractor services, particularly medicines 
management, shows a potentially more complex situation than previously experienced 
in this country. Structures within the new NHS, in the form of PCTs, Health Action 
Zones and new strategic Health Authorities, are likely to facilitate competition for the 
provision of new services. This creates, for pharmacy, the need to carefully prepare its 
own case, delivering and showing competitive advantage to the NHS in using the 
profession as a strategic resource for the development of a new primary care 
intervention. Other professions which can target the efficient use of prescribed drugs to 
deliver quality patient care, especially for the chronically ill, are already well placed to 
plan a similar intervention. 
New techniques of case construction and presentation to the DH are likely to be 
required of the pharmacy profession, in, for example, computing the cost efficiency 
ratio of the proposed new service. The term cost efficiency has been created by the 
author of this thesis, to encompass recognised economic ratios, (such as cost-benefit) 
together with other health improvement measures, which may be suggested from the 
implications of this study. The health economist, with the expertise of analysing cost 
benefit and cost utility outcomes is one promising option for re-evaluating the pharmacy 
input into primary patient care and constructing a more robust case to present to the DH. 
The following two chapters set out the objectives and scheme of research, and Chapters 
4 and 5 explore modem management approaches to introducing new concepts into a 
market place and effecting change. In the context of this thesis, the change desired is in 
the concept and practice of primary health care, within the doctor I pharmacist 
relationship as it impacts upon patient care. 
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CHAPTER 2 
OBJECTIVES OF THE THESIS 
This chapter is set out in seven sections as follows: 
2.1 The Thesis 
2.2 Motivation 
2.3 Strategic Importance 
2.4 The Overall Aim 
2.5 The Research Problem 
2.6 Specific Objectives 
2.7 Summary 
2.1 THE THESIS 
The thesis of this study is that there are cultural, professional and operational barriers 
to repositioning community pharmacy in the primary health care delivery chain, 
through a new role of medicines management, resident within the medical and 
pharmaceutical professions; and that these can be systematically addressed by original 
research and a novel application of modern management techniques. 
In this context: 
'Cultural' means collective mindset based upon historical customs, traditions, 
values and beliefs; 
'Professional' means the professions' abilities to discharge their allocated tasks; and, 
'Operational' means the communication channels, systems, policies and procedures 
linking the two professions. 
(Note: In this context, 'the health care delivery chain' means the usual order in which patients 
encounter the NBS primary health care service, i.e. fIrstly the treatment specifying professional, then the 
medicines delivering professional- the phannacist.) 
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2.2 MOTIVATION 
The author has spent forty five years in the pharmaceutical profession, twenty of which 
have been partially occupied with work for the national negotiating body, the 
Pharmaceutical Services Negotiating Committee. 
As chairman of various sub-committees and latterly, the Strategy Group of the PSNC, it 
has been possible to guide the main committee toward a consideration of an expanded 
role for community pharmacy within the NHS. Such a role was first written up by the 
author of this work in the Pharmaceutical Journal, (Tweedie, 1994 : 507 - 508) and 
developed, amidst initial resistance, to the stage when, in 1998, the proposition was 
presented to the Minister of State for Health (Mr. Alan Milburn) with full committee 
backing. Subsequently (April 2000), funding was allocated by the DH for national trials 
of a new medicines management package. 
The subject of this thesis represents the culmination of seven years work in seeking to 
reposition the whole community pharmacy profession within the primary care sector of 
the National Health Service. Such repositioning will require careful analysis of cross 
professional cultural issues; polished internal communications within the pharmacy 
profession to lead, persuade and motivate the membership into a new order of service; 
, 
and systematic management of medical stakeholder int~rest to engage collaboration at 
all stages of change. 
2.3 STRATEGIC IMPORTANCE 
Strategy, by its nature and definition, implies consideration of future trends, competitor 
activity and other influences. The importance of this work, therefore, is to provide a 
structured approach to the repositioning of community pharmacy in primary care. To 
achieve such repositioning, implies movement from the present state of the service to a 
different state, which offers new approaches to patient care, using pharmaceutical 
expertise and knowledge of medicines. Repositioning must also achieve benefit for the 
profession and ideally, ongoing security of tenure for current, developing and new 
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professional services. This implies a dynamic attitude to change, so that a theoretical 
ideal state is not pursued for its own sake, but rather to create a culture of ongoing 
change and improvement in all areas of current and potential service, as well as revision 
of objectives as new opportunities arise. 
Strategically, therefore, this study should hopefully signpost a route to a new pre-
determined future for the pharmaceutical profession, as well as suggesting a new 
philosophy of ongoing change, within what is an increasingly dynamic health service 
environment. 
2.4 THE OVERALL AIM 
The overall aim of this thesis is to ftrstly expose those key issues which may impede or 
facilitate the development of a new operational partnership, between doctor and 
pharmacist. It seeks to do this by determining key 'attitudes', 'needs' and 'wants' of 
both professions in collaborative management of patient medication. Secondly, the aim 
is to investigate marketing and management expertise as a means of engineering change 
at the medico-pharmaceutical interface and within the community pharmacy profession 
itself. 
2.5 THE RESEARCH PROBLEM 
The research problem is therefore to devise a method whereby samples of GPs and 
pharmacy dispensing contractors in primary care can be investigated, so as to determine 
those 'attitudes', 'needs' and 'wants' and enable generalisation of results to their 
respective popUlations in England and Wales. 
2.6 SPECIFIC OBJECTIVES 
The specific objectives of the study are to: 
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1. Identify barriers to pharmacy change, within the medical and 
phannaceutical professions, together with any facilitating factors which 
may assist change; 
ii. Identify some of the key attitudes, needs and wants of medical and 
pharmacy stakeholders in the new pharmacy role; 
iii. Develop suitable marketing approaches which may address the medical 
stakeholders' key attitudes, needs and wants; 
iv. Evaluate the role of leadership in repositioning the profession in primary 
care; and, 
v. Inform a communications strategy to both professions, in initiating and 
delivering change, for pharmacy. 
2.7 SUMMARY 
The objectives of this thesis address the problem of ~oving the community pharmacy 
profession from its present medicines supply function,jnto patient focused cognitive 
service in collaboration with the medical profession. 
In doing so, modem management and marketing techniques and original research will 
be examined and theoretically applied to determine means of introducing the new 
pharmacy driven concepts of medicines management to the medical and pharmaceutical 
professions. 
Edict and directive to change is unlikely to work alone in the medico-pharmaceutical 
cultures and so persuasive means appear at this stage, to afford the best route forward. 
The following chapter on research methods sets out the selected means of achieving the 
aim and objectives of this thesis and approaching the research problem. 
39 
CHAPTER 3 
RESEARCH METHOD 
This chapter is set out in six sections as follows: 
3.1 Introduction; 
3.2 Research Rationale; 
3.3 Design of Research; 
3.4 Methods and Techniques - Field Research; 
3.5 Key Informant: GP Postal Surveys, and, 
3.6 Chapter Summary. 
3.1 INTRODUCTION 
As part of the research for this thesis, two fields of literature are studied, and although 
not part of the field research itself, are mentioned here, for the sake of completeness. 
3.1.1. The Literature Research 
The literature research is directed toward the exploration of two subjects: 
• Marketing expertise and techniques; and, 
• Change management principles and systems. 
The body of literature which deals with marketing and also change management is 
researched to determine those techniques and particular areas of expertise, which may 
assist the process of repositioning community pharmacy within the NHS from a supply 
function to a patient centred cognitive role. Marketing has much to say about product or 
service presentation, as well as productive communication of the service message. 
Change management is a field of complexity requiring careful address. 
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3.1.2 The Field Research 
The field research in this thesis is targeted at revealing GPs' and phannacists' attitudes, 
needs and wants, with respect to a new service offered by community phannacy 
contractors. This is of strategic importance to the phannacy profession in achieving a 
larger stake in the health care market within the NHS. It is also likely to strengthen 
pharmacists' influence in primary health care provision and more effectively enable the 
introduction of further new pharmaceutical services by virtue of a more structured 
pharmacy involvement with the patient and GP. 
Collaborative practice between GPs and pharmacists involves participative clinical 
decisions and medicines selection for the patient. This research deals with doctors' and 
pharmacists' attitudes to working together. By focusing upon this relatively narrow 
area, it is hoped that lessons of practice and principle can be exposed and applied in this 
study, to engineering a co-operative partnership between doctors and pharmacists. 
It is also directed toward exposing any contentious issues which are culturally, 
professionally or operationally related, so that again, properly targeted change effort in 
community pharmacy can be applied in attempting to resolve areas of potential conflict 
between the medical and pharmaceutical professions. It is the pharmacist who will be 
, 
involved in major role change, but the doctor, in turTI_ will experience consequential 
changes to practice, which could become an impediment to progress if the GP feels 
threatened or overloaded with additional work and no added benefit. On the other hand, 
issues which may be productive, in delivering collaboration between the two 
professions, may also be revealed and beneficially inform the subject of this work. 
The attitudes, needs and wants of pharmacists, as the role change profession, are of 
key importance in bringing together two groups of professionals, in a symbiotic, 
structured collaboration, for the benefit of patients. There may be apprehensions and 
antipathies toward the changing NHS environment. There may be a lack of appreciation 
of operational matters, such as revised systems and management of the time resource, 
which could form barriers to change. Research will be undertaken seeking to reveal 
such factors which, in turn, will help inform change management activity directed 
toward the repositioning of the community pharmacy profession within primary care. 
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3.2 RESEARCH RATIONALE 
3.2.1 The Hypotheses 
The hypotheses under investigation are: 
(i) The attitudes of GPs are such that they will resent incursion into their 
traditional area of responsibility for patient medication and constitute a 
barrier to change; and, 
(ii) The attitudes of independent dispensing pharmacists are such that they 
will wish to remain in the traditional dispensing role. 
3.2.2 The Purpose 
The purpose of the method selected for investigating these hypotheses is to: 
• Improve the validity of results; 
• Enable the collection of a large volume of d~ta; 
• Enable generalisation of results; 
• Reduce any prejudice induced by respondent pharmacists' knowledge of the 
role of the author, in seeking to move the profession into a new order of 
service; 
• Explore some attitudinal issues of a representative sample of pharmacists, 
with regard to the new pharmacy role in primary health care; and, 
• Explore some attitudinal issues of a representative sample of GPs with 
regard to the new pharmacy role in primary health care. 
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3.3 DESIGN OF RESEARCH 
Having determined the core purpose of the method, the design of research selected for 
this study is a triangulation of three approaches, which comprise: 
• A series of key informant interviews; 
• The use offocus groups; and, 
• Surveys of a larger number of individual units of research (doctors 
and pharmacists) suitably piloted. 
Key informant interviews were Wldertaken for the doctors' research but not the 
pharmacists, as previous unpublished work undertaken by the author had clarified the 
key issues involved, from the profession's point of view. 
Using this design, it is hoped that consistency of themes may emerge, or indeed 
disparate perspectives, which will expose both barriers to change, or facilitating issues. 
These may then be used in designing a change process and programme of effort, in 
seeking to build an effective collaborative partnership in patient care. 
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3.4 FIELD RESEARCH METHODS AND TECHNIQUES 
The methods and techniques chosen to support the design of the research are 
summarised in Table 7 and discussed in detail below. 
Table 7 METHODS AND TECHNIQUES OF TIDS RESEARCH 
METHODS TECHNIQVES 
1. Key Informant Interviews Semi-structured interviews: Open and Closed questions; flexible order of 
(Taped and I or notes as permitted) topics to allow interview to develop a theme; notes taken. 
2. Focus Groups Schedule 01 Topics in the form of questions; Prompts by facilitator at ad 
National Level hoc stages of discussion; Free story responses encouraged. 
(Notes by Secretariat) 
J. Pilot Surveys A postal survey of ISO randomly selected GPs. 
1. Doctor Respondent (GPs) A purposive group of 14 pharmacists. 
2. Pharmacist Respondent 
4. National Surveys Postal distribution: 4 sections - Attitude; Attribute; Behaviour; Belief. 
1. Doctors (GPs) Structured to enable comparisons between the sections. 1000 GPs and 750 
2. Pharmacists pharmacists. 
Abbreviations: GPs : General Medical Practitioners 
LMC : Local Medical Committee 
LPC : Local Pharmaceutical Committee 
Note: The above table summanses a triangulation of approach to the field research methods together 
with the corresponding techniques for each method. 
3.4.1 Key Informant Interviews (Appendices llA, lIB, 11 C, pages 434 - 445) 
The use of key informants in this study is occasioned by a need to gain special insights 
and interpretations of some of the underlying issues in doctor attitudes to pharmacist 
collaboration; some answers to the who, why, what and how issues of the research aim. 
(Crabtree and Miller, 1992 : 78). Spradley, (1979 : 52) emphasises the usefulness of 
this approach, in informing the formulation of questions to a wider audience where 
planned. This view is supported by De VallS, (1996: 53) and Jancowicz, (1995: 212). 
Oppenheim (2001 : 51) also records that ' ... talks with key informants ... ' can be 
exploratory in the earliest stages of pilot work. The informants for the medical 
interviews were selected in consultation with one pharmacist and one GP colleague. 
The basis of selection, was an agreed preference of achieving views from several sectors 
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of the medical profession, those who were opinion formers and those who were as 
described by Johnson (1990: 30) as: 
' ... trustworthy, observant, reflective, articulate and good story tellers ... ' 
Each was telephoned, seeking an interview, after explaining the purpose of this 
research. The sectors selected were: 
• A professional body; 
• A university; 
• General practice medicine; 
• A political representative body; 
• A health authority; and, 
• A government organisation. 
The informants are listed in Appendix liA (page 434) See also page 270. 
3.4.2 Interview Format (Appendix lIB, page 435) 
Each interview was conducted face to face, as a semi-structured discussion in a relaxed 
format, wording questions in such a manner as to avoid prejudicing the replies, or 
presupposing a particular attitude. For example, the f6110wing type of question format 
was used: 
rather than: 
' ... What are your views of current relationships between general 
medical practitioners and community pharmacists? .. ' 
' ... Do you have any concerns regarding current relationships 
between general medical practitioners and community 
pharmacists? ..• 
3.4.3 The Order of Questions 
The order of questions was flexible, allowing the respondent to stray into other aspects 
of the discussion which may appear later in the question sequence. Confidentiality was 
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also guaranteed, together with anonymity, because of the potential sensitivity of both 
question and answer and the position of the informant, as suggested by Babbie, (1994 : 
450). As recommended by Oppenheim (2001 : 66) the interviewer involvement in 
conversation was minimised to reduce bias in the interviewee responses. 
The subject of the research was introduced by referring to latest developments in 
primary care, as described in Government White Papers, for example; The New NHS : 
Modern, Dependable, (1997 : 40) 
Further reasons explained were: 
• The need to investigate the views of a wider OP audience and the important 
issues to raise with them; 
• The medical professions' widespread agreement that modem medicines are 
complex entities producing complex effects; and, 
• Government policy of encouraging inter-professional partnerships. 
The emphasis for the researcher was upon listening, as also recommended by Dobbert, 
(1982: 118): 
' ... the question is not, how do you talk to an informant, but how do you listen. .. ' 
Miller, (1991 : 161) and De Vaus, (1996: 113) were consulted on the advantages and 
disadvantages of personal interviews (Table 8) and these aspects together with an 
emphasis on listening, borne in mind in conducting the interviews and analysing the 
results. All interview times were kept below one hour. 
Notes were taken during the interview question responses, interjecting occasionally to 
clarify or pursue a particular point. At the end of the question sequence, the interviewee 
was asked if there were any other comments they would like to make, which they felt 
were relevant to the subject under discussion. After the close of each interview, the 
author retired for coffee to a local hotel to reflect and abstract the dominant issues 
relating to each question. 
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Table 8 ADVANTAGES AND DISADVANTAGES OF THE 
PERSONAL INTERVIEW 
ADVANTAGES DISADVANTAGES 
• Fuller explanation of questions can be given; • Time costliness; 
• Supplementary information can be obtained; • Number of interviewees possible to reach is limited; 
• Return visits to clarify and expand issues are possible; • Data inaccuracy potential, if questions are not adhered to 
by both participants; 
• More spontaneous answers can be achieved; 
• Difficult to arrange if busy people are involved; 
• Time can be more controlled; 
• Human interaction may distort the responses; 
• Sensitive issues can be more easily and delicately handled; 
• Access to key informants is sometimes difficult; and, 
• More empathy can be created between interviewer and 
interviewee; and, • Semi structuring may be too flexible - a garrulous 
interviewee can distort the response. 
• Interviewee can seek clarification of issue from 
interviewer. 
Note: Abstracts from Miller (1991 : 161); De Vaus (1996 : 113) contextualising the effectiveness of the personal interview in 
gathering social research data 
3.4.4 Analysis of Interviews (Appendix 11 C, page 438) 
Content analysis of each interview notes was employed to derive key issues and 
presented as a descriptive variable by case matrix, ' ... displaying reduced data in a 
systematic way' (Miles and Huberman, 1994 : 239) to identify common disparate / 
, 
themes. These were, in tum, used to inform cons1:r?ction of the national survey 
questionnaire to GPs as well as interpretation of some results from both of the returned 
surveys. Data obtained through key informant interviews, are ' ... well suited to content 
analysis ... ' argues Jancowicz, (1995 : 213). The validity of such interviews and 
analysis is subject to bias in the interviewer and interviewee but alongside other 
methods, is still useful in comparing emergent themes. Content analysis as further 
recorded by Babbie, (1994 : 307) ' ... may be applied to any form of communication. .. ' 
and its applicability to the key informant interviews seems particularly appropriate to 
the abstraction of key themes and a consequent comparison of such across the informant 
cohort. Rather than analysis by pre prepared template, a post interview matrix layout of 
key responses is used in this work and common themes exposed (Crabtree, B.F. and 
Miller, W.L., 1992 : 18, 19). 
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3.4.5 Focus Groups (Appendices 12A, 12B, 12C : 13A, 13B, 13C, 13D pages 446-
484) 
Purpose 
1. To elicit data relating to attitudes, beliefs, needs of the medical and 
pharmaceutical professions, as perceived by their leaders, in forming a 
collaborative partnership in patient care; 
ii. To expose leadership views on the practical issues of operating such a 
partnership in the community; 
iii. To elicit leadership areas of agreement which could fonn the basis of 
operational progress in building that partnership; and, 
iv. To elicit statements indicating commitment to progress; and factors upon 
which these may depend, if leadership was to support the initiative. 
3.4.5.1 Number and Size of Groups & Organisation of Content 
According to Jancowicz, (1995 : 216) exploratory, structured work usually requires 1 to 
4 groups. In this study, because of the levels and bipartite nature of the partnership 
proposed, it was considered appropriate to establish two groups with national 
responsibilities within their professions, through which to study the issues outlined 
under 'purpose,' above. By 'leading' or 'moderating' topic headings, the interchange 
was kept on target and relevant to the heads under review (Krueger and Casey, 2000 : 
131). 
The questions which were open ended were kept down to ten or fewer in number and 
the predetermined sequence maintained; (proceeding from the general to the particular). 
All views were legitimised by the author of this work as moderator, to encourage the 
development of a thought train and also to prevent domination of the discussion by 
strong personalities. 
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Two sets of focus groups were held: 
1. Pharmacy Medicines Management Leadership Focus Group (Appendices 12A, 
12B, 12C, pages 446 - 465) 
Consisting of representatives from leadership institutions in pharmacy, plus one 
HA medical director, to test some of the discussion from a medical perspective. 
Composition: 
Royal Pharmaceutical Society (RPSGB) - Two members 
Pharmaceutical Services Negotiating Committee (pSNC) - Two members 
National Pharmaceutical Assoc. (NP A) - Two members 
Leading Pharmacy Practitioners - Two members 
HA Medical Director - One member 
HA Pharmaceutical Adviser - One member 
Facilitator (notes taken) - A.M. Tweedie 
Secretary (notes of meeting) - PSNC 
This was held at the RPSGB in Lambeth and members invited by telephone, 
conftrmed by letter. The date of session was 4th June 1999. 
ii Medico-Pharmaceutical Leadership Focus Group (Appendices l3A, 13B, 13C, 
13D, pages 466 - 484) 
(Ex BMA I GPC) 
British Medical Association 
General Practice Committee 
Pharmaceutical Services Negotiating Committee 
Facilitator (notes taken) 
Secretariat (notes of meeting) 
- Three members 
- Three members 
- A.M. Tweedie 
- PSNC+ GPC: 
Two 
This was held at BMA headquarters, Tavistock House, London and members 
invited by telephone, conflrmed by letter. The date of session was 14th January 
1999. Six members in total were chosen, based upon their key decision-making 
authority in their respective organisations. 
49 
The participants of these two groups (1 and 2) contained elected members from the two 
professions respectively. They were all practising professionals in particular roles 
responsible for different aspects of their professions in terms of services rendered within 
their NHS responsibilities. They are people who are committed to thinking on behalf of 
their professions and weighing up propositions and consequences. Hence their selection 
as groups with special knowledge, who politically represent their professions and would 
have an input as opinion leaders for any new service proposition. 
3.4.5.2 Analysis of Group Results 
Note based results (Krueger and Casey, 2000 : 131) were jointly taken by the moderator 
and secretariat, (assistant moderators) using a narrative approach and recording specific 
individual comment. These were compared and common themes identified, by taking 
each point raised by each member and extracted. Important points picked up 
individually only, were listed in a final transcript, which set out the major themes. 
Content analysis was then employed, accompanied by a matrix presentation and 
interpretative comment (Miles, B.M. and Huberman, A.M., 1994 : 178 - 179). These 
views and results were compared with the key informant interviews, again looking for 
similarities and differences. A consistent style of transcribing was employed (Krueger 
and Casey, 2000: 142). 
3.4.6 The Postal Questionnaires (Appendices 16, 17, 18 & 19, pages 487 - 504) 
In this study, the postal questionnaire is the third and final element of triangulation in 
the research, to determine attitudes, needs and wants of general medical practitioners 
and community pharmacist contractors, relative to the proposed new partnership in 
medicines management. The sampling frame used for doctors was the medical practices 
lists for England and Wales, which comprise the geographical area of study in this 
thesis. Scotland and Northern Ireland operate independently and were excluded, 
whereas Wales was included as it still collaborates closely with England. Both medical 
and pharmaceutical service contract negotiation strategies for both countries are largely 
decided in England by the ope and PSNC respectively. 
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A simple random sample of GP practices was selected using the In-time computer and 
its comprehensive data base and address labels run off. In-time is a respected 
commercial organisation operating in the health care research field for such 
organisations as those in the pharmaceutical industry and the Royal College of General 
Practitioners Research Network, from whence the recommendation came. The list was 
run off twice to accommodate a follow up mailing so as to achieve hopefully a bigger 
sample return. The physical mailing was collated and despatched by the University of 
Portsmouth, after coding to allow follow up. Pre-paid envelopes were supplied. One 
thousand targets were selected to hopefully produce sufficient responses to enable 
generalisation of results. The expectation of approximately a 50% response rate was 
derived from the author's previous work in the pilot study. 
A random sample of independent pharmacy contractors (dispensing) was abstracted 
from a ready made sampling frame, the Statutory Register of Premises, compiled by the 
Royal Pharmaceutical Society of Great Britain. One in ten addresses were selected with 
a random starting point and where the tenth name was a mUltiple it was excluded and 
the next independent name used. (To follow the custom of the DH Statistical Bulletin, a 
multiple was classed as a group with more than five branches). The count stopped at 
750 names forming a 15% sample of independent pharmacies. This number was 
selected so as to theoretically give a sufficient return on which to base some comment 
, 
about the full population of 5026 independents (Statisii~al Bulletin: 2000 - 2001). A 
return of between 50 and 60% was expected, based upon past research (Jones, I.F. and 
Booth, T.G. 1975; 150 - 153; Smith, A.J., 1994 : 5 - 7; Thomas, K. and Jones, I.F., 
1996: 855). 
3.4.6.1 Purpose 
The purpose of the postal surveys is to obtain a large number of GPs' views and 
pharmacists' views, which may, at best, be generalisable, so as to realistically estimate 
the views of the total populations. At worst, a larger number of views than those 
previously obtained. will better inform change management activity and marketing 
approaches to introducing the new product to the medical profession. Some of the 
advantages and disadvantages of postal surveys are listed in Table 9, (Babbie, 1994 : 
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273 - 274 and Oppenheim, 2001 
contextualisation of survey results. 
102), to assist informed interpretation and 
Table 9 ADVANTAGES AND DISADVANTAGES OF POSTAL SURVEYS 
ADVANTAGES DISADVANTAGES 
• Low relative costs • Response rates are not guaranteed. (Only a sample of a 
sample may be achieved) 
• Reaches large sample 
• Respondent cannot seek any elucidation of question 
• Characteristics of population can be predicted 
• Non respondents may distort the statistical validity 
• Question sequence is wntrolled systematically (easy to 
difficult) • Question response categories may be misinterpreted 
• Categorised answers enable statistical treatment • Non respondent bias is not understood 
• No prejudice from interviewer presence • Length of questionnaire may deter responses 
• No question distortion by interviewer emphasis • The non respondents cannot be assessed and their sample 
view effects cannot be taken into account 
• Gives respondents privacy, freedom to state their true views 
Note: Abstracts from Babbie, (1995 : 273 - 274); Miller, (1991 : 141) and Oppenheim, (2001 : 102) 
to assist balanced interpretation of the postal survey results later in the work 
3.4.6.2 Structure 
Each survey is a computer generated simple random sample (1000 to GPs, 750 to 
pharmacists) abstracted from the general medical list and the contractor pharmacy list. 
The pharmacist survey is lower in number because of spme difficulty in identifying true 
'independents' at the time, as these are progressively being bought up by the multiples. 
The postal surveys consist of a mixture of questions, formulated to produce data on 
different aspects of respondents' views, in categories described by De Vaus, (1996 
82): 
• Attitudes; 
• Attributes; 
• Behavioural issues; and, 
• Beliefs. 
The content and sequence of questions were determined in advance as was the form and 
degree of the answers, making this a fully structured quantitative approach, as distinct 
from the previous two elements of triangulation, i.e. key informants; focus groups. 
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However, a degree of flexibility was created by including some open ended questions 
in... 'other, please specify ' ... categories. In this way, a more numerate and statistically 
based assessment is possible, both for analysis and generalisation. 
3.4.6.3 Question Categories 
Attitude questions are those which relate to what the respondents think is desirable. 
Belief questions relate to what the respondents believe actually is the case. 
Behavioural questions attempt to ascertain what the respondents do, m certain 
circumstances. 
Attribute questions seek to establish certain characteristics of the respondents, especially 
those which may have a bearing on responses in other categories of question, for 
example, some attitudes may be related to age (an attribute). 
Questions in each category were grouped on the survey form and led from easier to 
more difficult issues. The general principles upon which the survey questionnaire 
, 
structure was based are set out in Table 10 and derived 'from Miller, (1991 : 143); Bell, 
(1996: 82); De Vaus, (1996: 83) and Oppenheim, (2001 : 104 -105). 
Table 10 PRINCIPLES OF QUESTIONNAIRE DESIGN 
• Language tailored appropriately to the audience (doctors, pharmacists); 
• Contingency questions advisable; 
• Questions kept as short as possible; 
• Ambiguity avoided; 
• Negative Questions avoided; 
• Prestige bias avoided; 
• Objectionable connotations avoided; 
• Respondent ego protected; 
• Provide good instructions for each section; 
• Replies set up for coding; and, 
• Questions and sheets weJl spaced out. 
Note: The above principles were researched to infonn the structure and content of the postal surveys as 
well as 'cultural fit' so as not to offend respondents and thus avoid prejudiced replies. 
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3.4.7 Survey Pilots (Appendices 14, 15, pages 485 - 486) 
Pilot surveys were conducted to test the clarity of questions and response categories for 
each profession. One group of 14 pharmacists was used in the form of an LPC 
(Appendix 15, page 486). 
The questionnaire was applied individually, but in group session and in relative silence, 
precluding any supplementary questions from the group until after completion. An LPC 
was chosen as the group, as wider postal survey results from other unpublished 
research had already given an indication of question format and response categories. 
Each question was then rehearsed again, asking for comment, to allow for amendments 
to the survey questionnaire, if necessary. It is acknowledged that this was not a random 
sample of respondents, but the LPC chosen was politically representative of NHS 
contractors, having similar operational problems and professional perceptions. 
The GPs' survey pilot (Appendix 14, page 485) was a sample of doctors (ISO) selected 
at random, once again by the 'In time' computer and distributed by post. Responses and 
comments were taken into account in preparing the finished survey for mailing to 1000 
GPs in England and Wales and two questions added after considering the responses. A 
, 
number of response categories were amended to give bett~r clarity. 
3.5 KEY INFORMANT: GP POSTAL SURVEY LINKS 
As already stated (page 44) the purpose of the key informant interviews is to inform the 
formulation of questions to a wider audience (accessed by the postal survey). Table 11 
sets out the specific links between selected key informant and postal survey 
questionnaires. 
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Table 11 THE LINKS BETWEEN SELECTED KEY INFORMANT QUESTIONS AND 
QUESTIONS IN THE GP POSTAL SURVEY 
KEY INFORMANT QUESTION 
QI 
Are there any aspects of patient treatment which 
may be suitable for a new pharmacist involvement? 
Q2 
What do you feel will be the general reaction of 
GPs to a new structured relationship with 
pharmacists? 
Q3 
Do you see any particular problems arising with a 
proposition to bring the medical and 
pharmaceutical professions more closely together? 
Q4 
How, in your view, may these problems 
be addressed? 
Q5 
What in your view would be conducive 
to a new pharmacy involvement with 
patient care: 
a). for the patient 
b). for the doctor? 
Q8 
If a new role for pharmacists along the lines we 
have discussed was proposed, ¥e there any aspects 
you feel should be omitted from such a proposition, 
i.e. which may be regarded as unattractive? 
3.6 CHAPTER SUMMARY 
POSTAL SURVEY LINKED QUESTION 
QIl 
Government seems to be encouraging pharmacist / 
GP collaboration on aspects of medication review. 
Do you agree with this approach? (The detail is in 
the next question) 
Q12 
(A selection of 10 options were listed) 
Q11 
As above 
Q8 
If you answered 'never' to Question 6, would you 
like a pharmacist to work for you in the future? 
QIS 
Do you feel the pharmacist should become a formal 
part of the doctor's team, addressing selected items 
agreed by you? 
Q19 
Patient perception of your overall service could be 
enhanced by a pharmacist medicines management 
review service directed by you. Do you agree? 
Q4 
Please tick the age groups you all come within. 
Q11 
As above 
Q14 
If a pharmacist worked with you to undertake a 
patient review of those medication issues agreed by 
you, how frequently should this be done for those 
on long term medication? 
Q17 
Quality of care and clinical excellence are recurrent 
themes in the White Papers. What is your 
perception of. patient expectations of health care 
over recent years? 
Q18 
Patient perception of quality of care may be a 
factor in their commitment to the therapy. Do you 
agree? 
Q19 
As above 
Q12 
If you ticked any box from 11.1 to 11.3 which of 
the following items do you think a pharmacist 
could assist you with? 
(A selection of options were listed) 
The methods and techniques of research used in this study have been constructed to 
attempt to reduce the error factor of the final research by using triangulation. Key 
infonnant groups; focus groups and wider postal surveys, are used in an attempt to gain 
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the clearest picture of doctor and pharmacist attitudes to the new proposition of inter-
professional partnership in medicines management. 
Support for adopting this approach has been culled from research methods literature, 
written up by the following authors: Babbie; Bell; De Vaus; Dobbert; Jancowicz; 
Johnson and Miller; Miles and Huberman; Krueger and Casey; and Oppenheim. 
Analysis of results, in Chapter 7, should help expose common themes, problems and 
opportunities, which, in tum, will help inform managing change and marketing activity, 
if indeed progress is deemed possible. Figure 6 summarises the research programme. 
Figure 6 SEQUENCE CHART OF FIELD RESEARCH ACTIVITY 
AND LITERATURE RESEARCH 
HYPOTHESES 
! 
KEY INFORMANT INTERVIEWS 
(Eight) 
~ 
NATIONAL FOCUS GROUPS 
(1) Pharmacy - 12 members 
(2) MedicaVpharmaceutical- 7 members 
~ 
SMALL PILOT SURVEYS 
(1) Pharmacy - (14 members) Gr9uP Session 
(2) Medical - Postal Survey - ISO GPs (Net 73) 
t 
NATIONAL SURVEYS 
(1) Pharmacy - random sample 750 pharmacists 
(2) Medical - random sample 1000 doctors 
! 
ANALYSIS OF SURVEYS 
To determine potential barriers to change and facilitating issues, 
in effecting change at the medico pharmaceutical interface 
! 
SUMMARY OF RESEARCH RESULTS 
CONCLUSIONS AND RECOMMENDATIONS 
t 
LITERATURE RESEARCH 
t 
MARKETING 
LITERATURE 
t 
CHANGE MANAGEMENT 
LITERATURE 
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LITERATURE RESEARCH 
PREFACE 
The literature research in this thesis is focussed upon two areas: 
i. Marketing Theory and Principles; and, 
ii. Organisational Change and Management 
These two fields have been chosen because they directly bear upon the subject of this 
thesis, i.e. 'barriers 10 change in repositioning community pharmacy in the primary 
health care chain ... ' and their 'systematic address.' Given that physical resources, such 
as fmance and physical accommodation, can be made available, potential barriers to 
change lie in the realm of the needs, wants and attitudes of the key stakeholders, 
together with the motivation underlying these. 
If there are barriers to change, as the thesis suggests, then because of Government intent 
to use pharmacy in a more cognitive way, they will need to be overcome if progress is 
to be made. Change will be required, not only in operating procedures within 
pharmacy, but also in attitudinal reorientation on the part of doctors and pharmacists, 
with respect to their traditional interrelationships. 
Marketing according to Crozier, (1975 : 26) is the discipline which is tasked with: 
' ... identifying, antiCipating and satisfying 
customers' requirements profitably ... ' 
and argues Kotler, (1987 : 5) marketing designs an organisation's offering (services or 
products): 
' .. .in terms of the target market's needs and desires 
... using effective communications ... to motivate 
and service the markets. ' 
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The literature research explores relevant concepts, which are judged important to a 
consideration of introducing the new pharmacy role as a new service or product which 
can bring benefit to doctor as well as patient. 
Equally the theory of organisational change and its management, is explored to inform 
appropriate means of addressing the particular issues which may be involved in 
transforming the pharmaceutical profession in primary care from a supply function, into 
one of cognitive service. 
It is hoped, in exploring these two subjects, marketing and organisational change, a 
means may be found of integrating both in a concerted effort to achieve satisfactory 
change. 
This literature research seeks to theoretically explore the potential role of marketing and 
change management in addressing the above issues, to bring about the required 
transformation in primary care pharmacy service. Both subjects are highly complex 
modem management processes, which deal with psychological aspects of individual 
reorientation, as well as structural and systems reorganisation in complex organisations. 
A cursory study would not achieve the depth of consideration required for the task 
, 
ahead, involving transformational change in pharmacy and some restructuring of the 
primary care doctor's practice and administration. Considerable study and space is 
therefore dedicated in this thesis, to a thorough exploration of the issues involved in 
both disciplines of marketing and change management. 
Chapters 4 and 5 respectively explore each and will be related to the field research 
findings when completed. 
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CHAPTER 4 
LITERATURE RESEARCH AND COMMENTARY 
PART 1 
MARKETING 
Part one of this chapter is set out in eight sections, as follows: 
4.1 Introduction; 
4.2 Marketing History: 
4.3 The Marketing Mix; Relationship Marketing; Marketing and Health 
Care; 
4.4 Target Market Perception; Needs / Wants; Motivation; 
4.5 Customer Attitudes; Product Design; 
4.6 Marketing Communications; Models; Strategies; 
4.7 Message Chain; Source; Opinion Leadership; Channel: Receiver; 
and, 
4.8 Summary. 
4.1 INTRODUCTION 
The purpose of this chapter is to explore aspects of marketing, which is now a globally 
used discipline in modem economies, for conceptualising new products and services 
and bringing them to successful acceptance and usage by the target audience. This is 
not to say that all marketing campaigns are successful, but simply that the use of 
marketing philosophy and techniques is an accepted means of applying systematic and 
structured management approaches to introducing new, and sometimes re-introducing 
old concepts to the desired consumers. The old approach of pharmacy negotiators to 
government can be summed up on the basis of a comment by one member of Cumbria 
LPC: 
' ... we are a long established well known profession .. everyone 
knows what we do and we have a right to expect 
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proper payment for our services to the NHS ... ' 
The national negotiating body (PSNC) has historically, simply computed the cost of 
providing the service nationwide, added profit elements and tried to persuade the DH to 
agree the global sum of remuneration resultant therefrom. As explained in Chapter 1 
the cost plus contract has gone and additionally, new services from pharmacy are 
required. Marketing offers a unique new perspective on both new product I service 
development and successful influence of key decision makers for NHS contracting 
services. Most importantly in this latter respect, 'marketing' will address, through a 
structured approach, the attitudes, needs and wants of the targets of change, GPs and 
dispensing pharmacists and inform the communications strategy as set out in the 
objectives of this thesis (Chapter 2 page 38). It is in pursuit of an entirely new approach 
to community pharmacy transformation, that marketing is being investigated in such 
detail. The key stakeholders, (the DH and medical profession) in these modem times of 
rigorous evaluation, need a refIned and sophisticated approach to new service proposals. 
This chapter explores in outline, the history of marketing to contextualise its use in 
society and its expertise in new product I service introduction. 
4.2 MARKETING HISTORY 
The progressive development of marketing practice, if not theory, arguably has a history 
as old as pharmacy. Davidson, (1987: 29 - 30) states of marketing origins: 
' ... the practice of marketing is almost as old as civilisation. .. ' 
Baker, (1997 : 4) writing a decade later, made a similar observation when he wrote: 
' ... marketing came into being with the first barter exchange, when 
someone realised that exchanges add value for both parties 
to the exchange ... ' 
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Gilbert and Bailey, (1990 : 7 - 13) writing on historical approaches to the development 
of marketing, cite authors who propose that the smooth economic development of 
civilisation is causative of the emergent practices of marketing down the centuries, if 
not the theory. 
However, writers such as Baudet and Van de Meulen, (1982); Fullerton, (1988); and 
Middleton, (1989) are recorded as contesting this view. Their objections are based upon 
challenging the historic basis of the account of economic development, which they 
argue was anything but smooth in the UK. Fullerton also challenges the precept that 
demand is reactive to product availability and claims that demand must be actively 
promoted. These authors basically view marketing practices as having pre-dated formal 
economic development, but recognise its influence. 
Gilbert and Bailey themselves take the view that whilst elements of marketing practice 
existed from early times, modem integrated marketing techniques did not emerge until 
the beginning of the twentieth century, (1990: to). 
Alderson and Cox, (1948 : 137 - 151) as long ago as the 1940s, were arguing the need 
for ongoing development of marketing theory and nominated various institutions from 
which this could come; the universities figuring prominently. Baumol, (1957 : 413 -
, 
419) in reviewing this work, accepted their basic assumption, proposed in classical 
economics, that rational behaviour underlies individual choices; the concept being 
borrowed from behavioural theory in psychology and sociology. However, he does 
pose the question as to how far this theoretical concept can be assumed in practice, 
(Baumol, 1957 : 418). 
Bartels, (1970) in his treatise on ' ... marketing theory and meta theory ... ' proposed that 
there was an ongoing need for the development of marketing theory, because of the 
developing knowledge of the psychology of people. His work also showed the increase 
in original thought given to marketing, in the period 1950 - 1990. It was during this 
period that the marketing mix concept was formulated and relationship marketing, 
received a resurgence in popularity. These two approaches, as shown later, could be 
used within the context of this thesis, in developing propositions for assisting in the 
repositioning of community pharmacy in primary care within the NHS. 
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In 1960 Robert Keith asserted, (1960: 35 - 3 8): 
r ••• soon, it will be true that every activity of the corporation -from 
finance to sales to production - is aimed at satisfying the needs 
and desires o/the consumer ... ' 
This has been shown to be true of some organisations, but the number of journals 
continuing to exhort business enterprises to do this, right up to the present time, is an 
indication that the proposition is not yet universally accepted. Some professional 
institutions, such as the RPSGB may have little knowledge of the concept of marketing 
and problems may ensue in attempting to introduce such approaches to change. 
Recorded defInitions of marketing emerged during the development of the body of 
marketing theory and are in evidence from the 1950s. Crozier, (1975: 16 - 27) lists 
some forty seven versions in all. Particularly of note are those of the American 
Marketing Association and the British Chartered Institute of Marketing. These are set 
out in Table 12. 
Table 12 INSTITUTIONAL DEFINITIONS OF MARKETING 
-
AMERICAN MARKETING ASSOCIATION BRITISH CHARTERED INSTITUTE OF 
MARKETING 
• The process of planning and executing the • The management function which organises and 
conception, pricing, promotion and directs all those business activities involved in 
distribution of ideas, goods and services, to assessing and converting customer purchasing 
create exchange and satisfY individual and power into effective demand for a specific 
organisational objectives. product or service and moving the 
product/service to the fmal consumer, so as to 
achieve the profit target, or other objectives set 
out by the company. 
• Later, this was amended and shortened to: 
Marketing is the management process 
responsible for identifYing, anticipating and 
satisfYing customers' requirements, profitably. 
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For the purposes of this thesis a more comprehensive definition has been used which 
encompasses the whole essence of the marketing process and so marketing, as defined 
by Kotler, (1987 : 5), is: 
' ... the analysis, planning, implementation and control of carefully 
formulated programmes, designed to bring about exchanges of values, 
with target markets, for the purpose of achieving organisational objectives. 
It relies heavily on designing the organisation's offering, in terms of the target 
markets' needs and deSires, and on using effective pricing, communications 
and distribution to inform, motivate and service the markets ... ' 
Kotler's perspective is used as the definitive article, because of its comprehensive 
address of the marketing process, from initial market analysis to after-sales-service of 
the markets themselves; this latter factor being a crucial aspect of the new proposed 
pharmacy service to medical practitioners. Kotler's defInition also accommodates the 
concept of relationship marketing, through its address of ... motivation and service of the 
markets. 
This literature review and commentary, therefore, seeks to explore those aspects of 
marketing enshrined in Kotler's definition, which may inform potential approaches, in 
, 
introducing the new pharmacy product to the medicaI_profession and engaging their 
commitment to use it. 
It further seeks to explore how marketing effort may be targeted to appropriate elements 
of a suitable model of organisational performance and change, in order to assist the 
repositioning of community pharmacy in primary care. 
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4.3 THE MARKETING MIX; RELATIONSHIP MARKETING; 
MARKETING AND HEALTH CARE 
4.3.1 The Marketing Mix 
The marketing mix was conceptualised as an integrated selection of activities, which a 
marketing programme would ideally embrace, to comprehensively address the 
marketing exchange process. That is, the activities set out in Kotler's defInition relating 
to the transactional dealing of the exchange process. Introduced originally by Professor 
Borden of the Harvard Business School, (Borden, 1964 : 2 - 7) it consisted of twelve 
elements within the control of the marketing company and four elements determined by 
the external factors of the business environment. At the time of introduction to general 
marketing theory, he did record that the original broad concept came from a colleague 
in the same business school, James Cullinton. 
The long list of elements has since become attenuated to some four basic tenets, 
popularised by McCarthy, (1978 : 35) and known as the 4Ps, to which other workers 
have added three items, (Booms & Bitner, 1981 : 47 - 51). Tables 13 and 14 set out the 
related approaches: 
Table 13 
• Product policy 
• Pricing 
• Branding 
• Promotions 
THE ORIGINAL MARKETING MIX 
AS DESCRIBED BY BORDEN 
INTERNAL FACTORS 
• Packaging • Personal selling 
• Display • Servicing 
• Distribution channels • Physical handling 
• Advertising • Fact finding + analysis 
EXTERNAL FACTORS 
• Customer buying behaviour 
• Trade behaviour 
• Competitor behaviour I 
position 
• Government regulations 
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Table 14 
Product 
Promotion 
Price 
Place 
THE MARKETING MIX AS DESCRIBED BY McCARTHY 
AND THE EXTENDED MIX FORMmLATED BY BOOMS 
AND BITNER 
McCARTHY - 4Ps 
-
Tailored to market needs / wants 
-
Profile targeted at specific groups 
-
Maximises profit and market acceptability 
-
Located for best distribution 
(McCarthy, 1978: 35) 
BOOMS & BITNER EXTENDED MIX - 7Ps (including above 4) 
People 
-
The parties involved in the transaction 
Process 
-
The complexity of making it happen 
Physical Evidence 
-
Environment in which the product/service occurs 
The '4Ps' became the core approach of what is called the marketing management school 
of thought, which is simply to see marketing as management of a system of elements 
which are structured to each marketing situation and programmed to deliver the 
marketing objectives. This is viewed by critics of the: school, (McKenna, 1991 : 148; 
Webster, 1992 : 1 - 17; Gronroos, 1993 : 11 - 12)- as manipulating the customer 
response by applying marketing techniques to them on behalf of the supplier, rather than 
operating primarily on a mutually beneficial basis, within a healthy commercial 
relationship. McKenna, (1991 : 148) sees the marketeer as: 
' ... integrator, both internally - synthesising technological capability 
with market needs - and externally - bringing the customer 
into the company as a participant in the development and 
adaptation of goods and services ... ' 
This concept is considered very important in this study, as it seems to make eminent 
good sense to bring doctors into the planning process of any new pharmaceutical 
offering which affects them. 
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Webster, (1992 : 14) argues for increased relationship management and for long term 
commitment from the fIrm (organisation), to maintaining that relationship, with quality 
service and innovation. He goes on to argue that repeated transactions over a period of 
time form the basis of a developing relationship. Within the context of this thesis, 
prescribing by doctors and dispensing of their prescriptions by pharmacists, comprises a 
multi-transactional relationship established over many years. Although these theories 
were not primarily written for community pharmacy services, clearly they concur with 
the spirit of the 1997 White Paper, (The New NBS - Modern, Dependable). They have 
specifIc implications for the pharmacy initiative, in developing a new partnership with 
the medical profession. The White Paper emphasises the importance of relationships 
between the health care professions in a fully developed form, Le. partnerships of 
patient care. 
Webster, (1992 : 14) sees a continuum of marketing approaches as shown in Figure 7. 
Figure 7 MARKETING APPROACHES - A CONTINUUM 
1 2 3 
Transactions --~ Repeated Transactions ~ Long term relationships 
.,. Marketing Management + 
4 
Buyer/Seller 
Partnerships 
5 
Strategic Alliances -. 
- 6 
Network ~ Vertical 
Organisations Integration 
Pharmacy may be regarded as being positioned for stage '4' in preparing to market the 
proposition in this thesis to the medical profession, which could easily form a barrier to 
change if they do not like the concept of close working relationships with pharmacists. 
However, the marketing management approach, as distinct from partnership 
development, exemplifIed in the application of the 7Ps, is still widely practised. The 
elements of the mix still need consideration in relationship marketing, but with the 
emphasis on partnership collaboration. Such an integrated approach is practised in both 
profit and non-profit organisations such as charities and is effective across a wide 
variety of settings, (Belch & Belch, 1995 : 6). 
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Profession to profession marketing, as a routine fonnal practice, is relatively unusual, 
but in this study, and potentially for the future, it seems to be suited to a combination of 
both the 7Ps and relationship marketing. Before examining relationship marketing in 
more detail, the elements of the 7Ps will be addressed individually. 
4.3.2 The Product 
Kotler and Clarke, (1987: 328) defme a product as: 
• ... anything that can be offered to a market to satisfy a need 
It includes physical objects, services, persons, places, 
organisations and ideas ... ' 
They conceptualise the product offering as having three distinct components: 
• The core product or service; 
• The tangible product; and, 
• The augmented product. 
This is apparently a crucial consideration in preparing any product or service for its 
potential market, as each of the elements has appeal to different aspects of consumer 
perception. 
Diagrammatically, this concept is represented in Figure 8. Its relationship to the new 
pharmacy service offering is set out in the paragraphs following and relates also to 
psychological effects of the new potential pharmacist relationship with the doctor. 
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Figure 8 
Service 
THE THREE CONCEPTUAL LEVELS 
OF PRODUCT OFFERING 
Styling 
Packaging 
AUGMENTED 
PRODUcr 
Installation of Product 
TANGmLE 
PRODUcr 
CORE PRODUCT 
OR 
SERVICE 
Brand Name 
Features 
Quality 
(Kotler & Clarke. 1987 : 331) I Warranty 
Note: The authors demonstrate that a product or service is not simply the article itself but a complex of 
factors which can be constructed to appeal to the target consumer at three different levels - the 
article itself; its presentation; its after effects or impact. 
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4.3.2.1 Core Product (Service) 
The core service, which will help reposition pharmacy within primary care is as set out 
in tables 4 / 5, (Chapter 1) and is derived from recognised inadequacies in patient 
treatments involving medicines. Such defects span economic inefficiency, as well as 
pharmacological problems. These issues are documented in the USA as well as the UK: 
1. The Audit Commission, (1994) reported that 3 - 5% of hospital beds 
were occupied by patients suffering from adverse drug reactions; 
11. Patient non-compliance with treatment accounts for 11 % of hospital 
admissions, (Col et al, 1990 : 150); 
iii. Average generic drugs dispensed in England and Wales is recorded as 
52%, but best performance is 63%, (Statistical Bulletin 2001). Expired 
brand patents could further be replaced by cheaper generics, bringing 
generic dispensing up to the order of 80%, generating savings of up to 
£400m annually; 
IV. Morrow et al, (1993 : 25 - 27) showed that patients were dissatisfied 
with the level of information they receiVe from doctors about their illness 
-
and medication; further that there is poor compliance with advice given; 
and, 
v. Patient satisfaction and compliance are related. Morrow et al, (1993 : 25 
- 27) found that GPs often ignore, or fail to attend fully, to the 
psychological needs of the patient. Ferner and Whittington, (1994 : 145 
- 148) found similar evidence in the USA. 
Patients themselves may be unaware of the adverse effects of medicines and the 
complexity of their interactions, but the issues are now well known at professional level 
in pharmacy and medicine. Clearly however, for pharmacy to present a medicines 
management service in a way which is critical of the doctor could be seriously 
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unproductive, if not detrimental to progress in marketing the service. These issues will 
be addressed in due course. 
The elements of the augmented product, for example, will thus need careful handling in 
the total 'packaging' of the concepts, so as not to imply a failure on the part of the 
doctor. Over-emphasis on the flawed elements of prescribing such as serious drug 
interactions and sub therapeutic dose levels, may produce resentment. 
4.3.2.2 The Tangible and Augmented Product - Attributes 
This is a somewhat more complex issue, in that it relates to the way in which the core 
product is presented and the messages it sends to the customer. The new product for 
pharmacy should also take account of competitors in the market place. The New NBS: 
Modern Dependable, (1997: 56, 70) promoted new partnerships in patient care and new 
care packages, which by implication, may well be presented by a number of 
professionals, such as nurse practitioners, doctors, peripatetic pharmacists and so on, 
(Chapter 1, Figure 4). The new core service, (Chapter 1, Tables 4, 5) could, in reality, 
be supplied by competing professionals. It is therefore sensible from a strategic point of 
view, to structure the Tangible and Augmented Product, in such a way as to create 
barriers to entry against other professional incursion. : 
Myers and Alpert, (1976 : 106 - 110) also make the very cogent point that common 
attributes among competitive products, whilst not being determinant in differentiation, 
probably become the expected norm of the specification in the given market. General 
upgrading of car quality and extras lists, in the consumer market, illustrates the point. 
Specifications below expectations are not likely to achieve a significant market take up 
and so, in the case of the present medicines management product, the basic specification 
should be as comprehensive as possible, whilst the tangible I augmented product, should 
create substantial determinant benefits I attributes, which may not be easily replicated 
by competitors. A number of routes of achieving this, are suggested through the work 
of researchers in the field of consumer behaviour and will be applied later to medicines 
management. 
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In researching the subject of product attractiveness, the core phannacy product 
attributes will require testing for doctor acceptability along with the cultural 
implications they may represent. This will help avoid potentially threatening aspects to 
the GP's cultural expectations. 
4.3.2.3 Tangible and Augmented Product - Utilities 
Lancaster and Massingham (1993 : 79) propose that products should be distinguished 
by the perceptions that purchasers have of the product's utilities, based on earlier work 
by Haley (1968 : 30 - 35) on benefits segmentation, which related to the benefits 
conferred by the product as perceived by the purchaser. Such benefits may include 
status implications, resource savings (time and money), resolved problems and 
enhanced favourable opinions of others, i.e. patients. Benefits should be tailored to the 
value perceptions of the selected market (OPs) and how the selected market in turn, 
believes that others see them. 
The product utilities explored by Lancaster and Massingham relate to the benefits 
conferred by the use to which the product may be put, or which it fulfils, such as ego 
protection. It seems appropriate, therefore. that research in this study is directed toward 
exploring doctors' perceptions of the new service and e:Xposing such needs and wants of 
the OP, that resultant appropriate utilities may be built into the tangible augmented 
product. 
If the product (the medicines management service) could be designed taking such 
considerations into account, then in Levitt's terms. (1980 : 83 - 91) this would give the 
product distinctive features, (attributes) directly appealing to doctors' needs. 
4.3.2.4 Tangible and Augmented Product - Risk 
Work by Bauer, (1960) indicates that buyers of products or services, (especially of a 
technical nature), try to reduce perceived risk in their purchases by developing strategies 
which protect them from ' ... the incalculable consequences of their decisions ... ' {Bauer. 
71 
1960 : 120). Whilst GPs are not directly the purchasers of the services within the 
present structure of the NHS, they are specifiers and in due course, as primary care 
groups achieve trust status, will perform the role of direct purchasers through the boards 
of these structures. 
Bauer's research has a direct bearing upon the present study, as the new pharmacy 
product offering may be perceived as baving risk, as it could take on some of the 
present responsibilities of the doctor, in medicines selection, whilst still leaving the 
medical profession fmally accountable for the activity. Clearly, the presentation of the 
product to doctors will benefit from, in Kotler's terms, warranty, quality of service and 
safety features, such as regular audit and quality assurance. 
Risk, however, not only applies to the shift in responsibility to another professional, but 
risk in more abstract terms, such as: perceived loss of prestige; loss, or diminished 
leadership in the health care team; and reduced status in the perception of the patient. 
Pinson and Malhotra, (1988 : 53 -73) have observed that the perception of the buyer / 
customer is selective and will reject threatening or even disturbing information. If this 
is so of simple information, then a positive, challenging proposition, such as medicines 
management, may create even more disturbance in a long established culture such as the 
medical profession. 
Doctor culture disturbance and consequent self protection, in the new phannacy product 
situation (MM), could take the form of rejection of the service provider, the 
pharmacist, in favour of, say, the practice nurse, who is employed by the doctor. The 
nurse is in a clearly subordinate position in the primary care hierarchy and therefore is 
not a potential threat to GP authority. This is a real consideration, despite the fact that 
the nurse is not qualified to the same degree as the pharmacist. 
Risk eradication, therefore, may be a consideration which could be addressed within 
Kotler's perception of packaging, styling and branding elements of the tangible 
product. 
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4.3.2.5 Tangible and Augmented Product - Packaging; Styling; Branding 
The packaging of the product, in this case conceptually rather than physically, could 
assume key importance in protecting the doctor's ego, status and visible headship of the 
primary care hierarchy. The dynamics of these issues will also be addressed under 
section 4.4. 
The styling and branding of the product may change, according to its physical settings. 
The core product consists of two distinct parts or phases: 
• The pharmacist-doctor interface; and, 
• The pharmacist-patient interface. 
The former phase is where the doctor will be directly confronted with another 
authoritative health care professional, the pharmacist, advising within the doctor's 
traditional domain. It may be beneficial, therefore, to brand and style the meeting as the 
medical review group rather than pharmacist medicines review. In this way the doctor 
chairs and retains the symbolism of medical leadership in primary health care. 
In this model the doctor would set the agenda, schedule progress over the following 
three to six months and prioritise disease group focus. i~ quality outcomes are probable, 
then the doctor is heading up a quality drive with desirable effects for the NHS and his 
own team, of which he is visibly the head. 
This leads to a brief review of Kotler's fifth element of the tangible product, quality. 
4.3.2.6 Tangible and Augmented Product - Quality; After sale service; Warranty 
If the GPs' needs, can be ascertained through research and the pharmacy product I 
service specifically tailored to meet those needs, it should follow that quality assurance 
will help reassure the doctor that there is safety, in technical terms, in engaging the 
service of the pharmacist. 
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Webster, (1988 : 36) states: 
' ... not only must the business be defined by customer needs .. .it 
must also define its distinctive competence in satisfying 
those needs ... ' 
Zeithaml et aI, (1996 : 187) have also written extensively on the quality aspects of 
product differentiation and service delivery, emphasising its powerful influence on 
building reassurance and commitment in the perception of the customer. 
Garvin, (1987 : 101 - 109) proposed eight dimensions of quality which are measurable 
and applicable to products generally and also relate to the product at the heart of this 
study. Kotler and Clarke's 'augmented product' (quality; after sale service and 
warranty), are also covered by the application of these dimensions as shown in Table 
15. It can be seen that there is a progression from the tangible aspects of the service, to 
those more intangible, dependent upon the value judgement of the customer, such as 
perceived quality. 
Garvin's approach has similar implications to the Sheth / Newman I Gross value theory, 
(Table 20, page 102) at the aesthetics and proprietary features levels in impacting upon 
the image and thus ego of the customer, here the medicat practitioner. This is described 
later in the chapter. Any implied threats to the doctor image could be programmed out 
in the branding and styling of the product. 
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Table 15 
DIMENSION 
Service 
Performance 
Proprietary 
Features 
Conformance 
Reliability 
Durability 
Servicea bility 
Aesthetics 
Perceived 
_Quality 
GARVIN'S DIMENSIONS OF QUALITY RELATED 
TO THE PROPOSED NEW PHARMACY PRODUCT 
AND THE CUSTOMER - THE DOCTOR 
EXPLANATION 
Ability to deliver basic function 
Range of additional benefits to 
basic function 
To a level of excellence with 
small tolerances 
Constant performance over time 
The product or service will not 
deteriorate 
Extent, speed and efficiency of 
service 
Design and appearance of the 
product service 
PHARMACY PRODUCT 
APPLICATIONIRELEV ANCE 
Qualifications I special training of community 
pharmacist + audit trail; outcomes measured 
GP NeedslWants fulfilment; more satisfied 
patient; fewer doctor problems; GPlPhannacist 
interface suitably styled - supports GP ego. 
Royal Pharmaceutical Society sets exacting 
standards - inspects (Warranty). Continuing 
training & education. 
Constant inspection RPSGB; revision of 
protocols, constant positive results. 
Updating/upgrading of knowledge by IT. New 
product information fed in. (After sales service) 
Frequency of patient review set by doctor-
continually audited. (Warranty) 
Pharmacist image as doctor's assistant and team 
member. Reporting system of patient review 
back to doctor reinforces this in patient 
perception. Doctor headship protected. 
Image/reputation of the service Resulting action x GP of Pharmacist 
recommendations recognisable x patient & NHS. 
Bold Print in this column - Kotler'S Extended Product 
ABBREVIATIONS: GP = General Practitioner; 
RPSGB == Royal Pharmaceutical Society, Great Britain 
Note: Author's extrapolation of Garvin's 'dimensions of quality' related to the proposed 
New pharmacy service 
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Kotler and Clarke, (1987 : 333) set out three options for the way in which the issue of 
quality in health care can be dealt with over time and these are set out in Table 16. 
Table 16 DEALING WITH QUALITY: THE OPTIONS 
ACTION EXPECTED RESULT IN PHARMACY NEW ROLE 
(i) Improve quality over time by training and Encourages ongoing quality performance. 
rewarding employees and improvement in Improved market interest and response. 
facilities. 
(ii) Maintain initial quality and emphasise other Retains interest; develop competitive advantage by 
dimensions of the business. integrating OTC medication with NHS; improved 
outcome ofNHS treatments. 
(iii) Allow quality to decline over time. Organisation decline; extinction in extreme cases. 
Community phannacist becomes a technician. 
A combination of option (i) and option (ii) may well indicate the correct route for 
phannacy. as no other health care professional can integrate OTC and NHS treatments, 
in real time, to avoid incompatibilities and reduction of effectiveness of NHS doctor 
prescribed treatments. Currently, for example, cardiac disease patients, who are also 
taking co-codamol effervescent tablets for pain from other conditions, should be given 
alternative medication because of the high sodium content. However, patients can buy 
similar solpadeine tablets over the counter. This they may decide to do if co-codamol 
non-effervescent are prescribed by the GP to save cost and if they were previously on 
effervescent tablets. Vitamin B6, bought over the counter could negate the effect of 
NHS prescribed Levodopa. Currently, neither the doctor, nor the pharmacist would 
know of the conflicting therapy and the patient's condition would not improve. 
Conceivably it could deteriorate and cost the NHS time and expenditure in trying to 
correct a patient lack of response. Such an integrated service, bringing concurrent 
knowledge of NHS/OTC treatment would reduce risk, create technical security, and 
bring some psychological comfort, for the GP and increase his prescribing 
effectiveness. 
Groocock, (1986 : 27) summarises quality pursuit as follows: 
' ... conformance of all the relevant features and characteristics 
of the product (service) to aI/ aspects of the customer's needs ... ' 
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This is consistent with the dimensions of quality as set out by Garvin (Table 13), but 
implies ongoing review of how those needs manifest themselves in the customer's (GP) 
changing wants (and I or patient condition) over time. Such change and its address, 
may well become another competitive advantage over time if pharmacy is made aware 
of it and creates a system whereby it is methodically addressed to deliver optimum 
outcomes tailored to the changes. 
If pharmacy is successful in securing introduction of the new product / service and 
repositioning itself in primary care, then ongoing development of the service will not be 
totally visible to competitors and therefore, more difficult for them to replicate. The 
consultation process in both phases, (pharmacist / doctor; pharmacist / patient) is a 
relatively private affair. Threat of substitute and threat of entry, should reduce to an 
indeterminate level at this time. 
A brief review of one element of the marketing mix, the product, has illustrated the 
complexity and opportunity inherent in good product (service) design. Its implications 
for the customer (doctor) have been visited in outline and further study of the customer 
and product implications will be dealt with later in the chapter. Kotler's 
conceptualisation of the product offering, exposes potential ways of creating doctor 
appeal for medicines management especially at tangible and augmented product levels. 
Even if there were no barriers to product accep~ce in the doctor's mind, ego-
supporting aspects of the MM package and clear benefits in practice, can help establish 
pharmacy as the preferred supplier for the GP. New product design also offers the 
opportunity to build barriers to entry for competing professionals - a re~ issue in 
pharmacy health care within the NHS and its competitive structures. 
4.3.3 Promotion 
This second element of the marketing mix addfesses the process of: 
• Informing; 
• Persuading; and, 
• Fteinforcing. 
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This is achieved by appropriately worded communications, calculated to persuade the 
potential customer to use and continue to use the promoted product or service. The 
subject of communications will be dealt with in detail in a section of its own (4.6), as 
marketing communications has apparently become a specialist subject in its own right. 
The promotion strategy of an organisation is geared to achieving recognition of the 
product or service and improvement in the way that the service provider and product are 
perceived. The ultimate objective seeks to secure an increasing uptake of the 
commodity being promoted. The routes of promotion routinely used are: 
• Advertising 
~ Sales Promotion 
• Public Relations 
• Personal Selling 
Media channels; 
Temporary marketing techniques to make 
the product offering more attractive by 
providing benefit in cash or kind (free 
offers, vouchers, etc.); 
Publicity generated without payment due 
special interest of the media; and, 
Face-to-face or person-to-person 
presentation of the product. 
General promotion. through these routes, with the exception of specific sales promotion 
activity, (which has a more specialised meaning) may be appropriate at different stages 
of new product introduction to the medical profession. -'Give aways', in this intensely 
professional setting, could be construed as bribery, in the sensitive environment of the 
NHS and do not seem to be appropriate for profession-to-profession marketing. It is 
perhaps best omitted, as the other three channels, at this stage, appear to offer sufficient 
opportunities for publicising and engaging the initiative. 
4.3.4 Price 
Sufficient to comment at this stage, that the price of services to the NHS, whether it be 
negotiated centrally with the NHS, or locally with the HAs, or peTs, will be 
constrained by budget limits on the one hand, and on the other, moderated perhaps by 
financial savings generated by the new service intervention. In theory, if such 
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intervention as described so far in this thesis, were to save £300m of taxpayers' money, 
then the theoretical budget for the new service may be flexed advantageously for 
pharmacy. 
Such intervention effects may, at some point, need to be subjected to the rigour of 
health economics analyses by the sellers, (PSNC) if not government. Such analyses 
help to indicate potential new PSNC approaches to negotiations, by exposing new ways 
of presenting outcomes of an intervention by a health care professional. These options 
may also assist marketing approaches to the new pharmacy service. Drummond et al., 
(1999 : 2 - 3) have comprehensively described such analyses and these are outlined in 
Table 17. 
Table 17 HEALTH ECONONUCS ANALYSES 
TYPE OF ANALYSIS PURPOSE I BENEFIT 
Cost Minimisation To seek the route ofleast cost 
Cost Effectiveness To establish the relative cost/effect ratio of 
alternatives 
Cost Utility The cost of the service compared to the extra utility 
it brings - sometimes expressed in quality adjusted 
life years (QAL Ys) compared with an alternative 
: 
The gold standard analysis - Total benefits 
Cost Benefit measured against total cost of service compared 
with an alternative 
A cost minimisation analysis would be used for example, in seeking a straight forward 
reduction in service costs, an appealing prospect for government. Cost effectiveness 
analysis is employed for straight comparison of two or more alternative interventions. 
The need to find specific pharmacist advantages may be crucial. Cost utility equations 
could be used, for example in computing the utility benefits in optimal prescribing, of 
keeping people out of hospital, improving the quality of their lives and delivering more 
man days of work to the economy. Cost benefit studies are engaged to comprehensively 
evaluate alternative interventions in tenus of pounds sterling, not units of utility. 
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Price considerations, for a new pharmacy service therefore, are not the simple issue of 
computing the expense input, adding a gross I net profit margin and submitting the 
proposal to the DH. Even the present dispensing contract was originally based upon a 
more complex formula, as outlined in Chapter 1. If pharmacy wishes ultimately to 
proceed as a 'value added' service, rather than a 'cost-plus' supply function, then a 
value added case would need to be constructed and health economics analyses and 
computations will need to be part of the process. 
Whilst in the economist's perception of aggregate market dynamics, the pnce 
mechanism is generally seen as the major cause determining sales volumes. Demand in 
the case of the new medicines management services is, in reality, disease I patient led, 
but may be susceptible to some regulation by government. However this possibility 
remains to be seen. The service may then be described as inelastic in the economist's 
t~rms, as the volume uptake is likely to be independent of price, at the consumer end. If 
the GP is regarded as the consumer, then the pharmacy profession may be faced with 
'--
consideration of a competitor professional, such as the nurse. 
The situation with respect to pharmacist uptake of the service is somewhat different, as 
the price finally offered by government may be well below the expectations of the 
profession. On the other hand, the competitive forces of the domain, (Chapter 1, Figure 
4) may well lead the vertically integrated companies and multiples into implementing 
the service, after doing their own cost-benefit analysis, with increased consumer in-store 
footfall figuring importantly. This, in turn, may become an internal profession change 
driver, ultimately bringing a majority of the contracting pharmacists into the service, 
some against their natural inclination if the price reward is below expectation. 
Clearly, price considerations have complex ramifications and are dependent upon many 
variables. 
4.3.5 Place, Physical Evidence, Process 
The fmal three elements of the marketing mix to be examined are grouped because of 
their close inter-relationship, especially with respect to pharmacy. Again, the 
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competitive forces of the market place, (Chapter 1, Figure 4) make these issues very 
important to the commlIDity pharmacist contractor. 
Why should government conceptually regard the community pharmacy as the best 
location I setting in which to place the proposed new service? Why should the DH not 
visualise the whole scheme resident in the doctor's surgery? After all, a physically 
close proximity of the professionals may be regarded as beneficial to inter-professional 
collaboration, partnership and patient convenience. It may also be cheaper. 
The force militating against this, is of course, the exponential development of 
information technology, the tendency of which, in one aspect, is to encourage effective 
distance communication, ultimately by audio-visual. Beyond this, into the future 
perhaps, potential lies as far as holographic clinics, where a group of patients can 
network into a three dimensional T.V. clinic, gaining from each other's experience and 
enjoying the experience of professional-led group dynamics. 
For the present, design of the in-pharmacy facility for consultation and medicines 
review, could become one key determinant in both the doctor and patient perception of 
a thoroughly professionalised service. It feeds into the tangible and augmented product, 
as 'quality' and 'warranty'. The two major stakeholders (patient and doctor) need to be 
confronted with an impressive visual impact, which: sends a conscious message of 
professionalism. In other words, a comparable facility, to that of other primary care 
professionals in tenns of privacy, relaxing environment and appropriate equipment. 
The potential competitive advantage, (Chapter 1, section 5) for community pharmacy, 
may require concentrated thought by the leaders of the profession. It is suggested by 
the author (Figure 9) and is related to patient I pharmacist interaction within the 
community pharmacy, (place, physical evidence, process), as distinct from location in 
the doctor's surgery. This could be a key issue in securing the MM service for the 
dispensing pharmacist contractor. 
Figure 9 POTENTIAL COMPETITIVE ADVANTAGE-
PHARMACIST I PATIENT INTERFACE IN 
CO~TYPHARMACY 
PLACE 
Community ~ 
Pharmacy - a non 
threatening; friendly 
environment-
important for personal 
interaction & 
concordance issues 
Integrated review ~ 
OTe + NIlS Meds. 
plus 
+ 
RoutineOTC 
intervention of all ~ 
customer requests 
for medication 
+ plus 
Advice on aTe 
medicines, back 
related to NHS 
treatment 
SERVICE SCOPE 
-PRODUCT 
RANGE 
ADVANTAGE 
PHYSICAL EVIDENCE 
Ph~ically .de~med consultation -+ 
pomt; seml-pnvate; greater 
professionalisation (patient 
must visit for FP 1 0 dispensing 
anyway) 
Ethical Livery Design and -+ 
signing relating to OTC-
NHS service; friendly 
surroundings 
Consultation bench; display 
surface for medicines -+ 
identification and 
demonstration (inhalers 
etc.); compliance aids 
discussion 
GP, IT - Link for immediate 
records access I doctor 
discussion. Relaxed 
environment of regular 
patient port of call 
ENVIRONMENT 
ADVANTAGE 
PROCESS 
+ 
IT screen - Review 
Algorithm; review forms 
for joint patient 
phannacist input -
Partnership 
Pharmacist/patient interactive 
discussion; problems 
explored; reassurance 
lencouragement to patient; 
commitment to therapy 
+ 
Pharmacist recommendations 
owned by patient (side 
effects; adverse effects; lack 
of drug performance 
addressed) 
Pharmacist/patient 'sign 
off' the course of action; 
new review date set; 
distribute patient copy of 
review form; transmit to 
GP (or via IT) 
COMPETITIVE 
ADVANTAGE 
Note: The above figure is the author's conceptualisation of delivering 'competitive advantage to 
community pharmacy via three elements of the marketing mix and suggests the inter-relationship 
between each. 
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Such a scheme, fully developed through training in interpersonal skills, could create a 
productive pharmacist I patient consultation process and hopefully enhanced patient 
participation. This could be developed into an holistic patient partnership, in a friendly 
relaxed setting. Patients are rarely given bad news in a pharmacy and a specialised, 
enhanced pharmacist / patient consultation facility, in a comfortable ambience, could be 
a welcome change in surroundings from the doctor's surgery. If presented as taking 
weight off the doctor's workload, pressure off waiting room space and producing a 
satisfied patient, this could also enhance the doctor's view of the service. 
If the doctor is abrupt, or too controlling of the doctor / patient encounter, patients can 
be inhibited from properly describing and discussing their health problem, (Street & 
Butler, 1987 : 234 - 253, Goleman, 1991 : Ch. 1, Ch. 8). Such patients, arriving at the 
pharmacy, may be stressed; good communication skills and reception could avert these 
problems, (Hays & Di-Matteo, 1984 : 1 - 20). 
A further possibility may be that patients in the lower socio economic groups, (C2, D) 
are less able to cope with health problems, because of the likelihood of having little or 
no knowledge of their physiology and more difficult access to good information. Low 
self esteem may also playa part in their motivation to adhere to the regimen of therapy. 
Browne & Mankowski, (1993: 421 - 430) showed that those who are already low in 
self esteem are especially vulnerable to negative mo~ds. These may aIso prejudice 
patient interest and commitment to therapy on a short and long term basis. Greenberg et 
ai, (1992: 913 - 922) showed that positive feedback of information to individuals, in a 
test situation raised self esteem and Solomon et al, (1991: 21 - 40) showed, in 
experimental circumstances, that raised self esteem reduces anxiety. 
In a relaxed frame of mind, pleasant surroundings and supportive dialogue, the 
pharmacist may, therefore, be able to achieve patient commitment to therapy and 
patients' willingness to become more involved in their own health treatment. If stress is 
reduced, in the health I illness care continuum, the body's immune system is said to 
function more efficiently, (Stone et ai, 1987 : 988 - 993). Cohen, et aI., (1993 : 131 -
140) have shown that even susceptibility to the common cold is increased by negative 
events and perceived stress. 
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Clearly, the place of pharmacist I patient encounter, physical evidence and the process 
of interchange between the two, can be of crucial importance in delivering real patient 
benefit, involvement and commitment to a new professional service. Such extended 
professionalisation of the patient I pharmacist interface, may constitute some 
reassurance to the medical profession, if they need it, that a quality pharmacist 
consultation is on offer to the patient, in like-paradigm of their own physical amenities 
and doctor I patient interchange. Perhaps too, this may be seen as a threat in terms of 
the doctor image, prestige and traditional patient relationship in the health care 
hierarchy of the NHS. 
The current pharmacy facility for patient consultation is usually not specifically 
designed for patient interview. In the experience of the author, attending LPC 
discussions and visiting pharmacies in the Northern NHS region over twenty years, a 
medicines counter-end, or part of a dispensary, is commonly used, but without any 
formally recognised system of interaction or content. Such amenities could be criticised 
for lack of confidentiality or formally recorded outcomes and in marketing terms, could 
be viewed as inadequate for creating confidence at doctor level and relaxed involvement 
in patient terms, for best interchange. Pharmacy facilities will need to be reviewed, 
with both patient and doctor consulted in the process. This leads to a consideration of 
relationship marketing. 
4.3.5 Relationship Ma,.keting 
In the previous section, Figure 8 shows a theoretical continuum of marketing effort and 
focus of address, in the development of what some believe to be the heart of marketing. 
This has come to be known as relationship marketing. Gronroos (1999 : 11 - 12) 
defines it as: 
' ... the establishment, maintenance and enhancement of relationships 
with customers and other partners. This is achieved by a mutual 
exchange and fulfilment of promises ... ' 
Building long term relationships in business, by development and management of the 
buyer I seller joint interests, argues Webster, (1992: 12 - 14) can lead to sources of 
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competitive advantage that are knowledge based and difficult to copy. This is a 
particularly important concept, bearing in mind the potential professional competition 
facing pharmacy in the future (Figure 4, Porter's Five Forces). Anderson and Narus 
(1990: 42 - 58) see the development of partnerships between customer and supplier, as 
being dependent upon long term commitments to maintain quality service and 
innovation. Consequently, they go on to argue, increased attention will need to be paid 
to relationship management. This, according to Connor, (1991 : 121 - 154) will 
become a real cultural issue for customers' suppliers and can create success and 
competitive advantage; the doctor is the pharmacist's customer in the new role. 
Cultural issues appear to become increasingly important to the subject of this study, 
involving two professional constituencies with a common interest and who may be 
mutually inter-dependent. This is not currently the case, with community medicine and 
community phannacy simply collaborating on behalf of the patient, on the basis of 
'when needs must'. The real question is, could such a mutual dependence be developed 
through the proposed new pharmacy service? The present relationship is really through 
a third party, the patient, and it may be through this link: that a true lasting relationship 
could be solidly established. 
The health care field has now changed, primarily through a restructured NHS, into a 
more competitive and quality demanding environment~ where professional boundaries 
are blurring. Nurses now prescribe and prescribing is also on the agenda for 
pharmacists, (Simpson, D., 1999 : 267). Sale and supply of medicines under patient 
group directions, is also about to be changed, (DH circular, MLX260 : March 2000) 
which could mean other agencies supplying medicines. This is a serious development 
as is indicated in the consultation document, which sets out the various regulative 
instruments that would need to be changed, i.e. 
• Section 55 (91) (b) Medicines Act 1968; 
• The Prescriptions Only Medicines Order, 1997; 
• The Medicine Order (pharmacy and General Sales - Exemptions) 1980; and, 
• The Medicines Regulations (Sale and Supply Miscellaneous Provisions) 
1980. 
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The circular limits this change to: 
' .. . NBS bodies, or to NHS funded services provided through the 
private, charitable or voluntary sector ... ' 
'Patient group directions' must be authorised, according to the circular, by the NHS 
Trust, Health Authority or Primary Care Trust. Whilst this is not a blanket order for 
universal dispensing of FPl Os, it is a modification of supply, which further stretches the 
boundaries of community pharmacy's majority rights of NHS dispensing in England 
and Wales. It is not beyond the bounds of credibility that the new walk-in health shops, 
staffed by nurses, could be given some dispensing rights. 
A medical / pharmaceutical partnership, which could be viewed as a strategic alliance, 
may now be opportune between the professions to construct a new NHS 'product " in 
marketing terms, which also has major benefits for doctor and patient. The product is, 
of course, a partnership in medicines management. 
Relationship marketing is not new, as evidenced by the statement made by Henry Ford 
(1922: 67) 
•... when one of my cars breaks down, I know I am to blame ... 
a manufacturer is not through with his: customer when 
a sale is complete ... the sale of the product is only the introduction ... ' 
However, this form of marketing has experienced an upsurge in popularity in the 19805 
when the automotive industry recognised the need to compete in new ways, (Womack, 
et al., 1991 : 138 - 139). The underpinning theory is that old customers are a highly 
valuable commodity and retaining these by developing the relationship, whilst attracting 
new ones, enhances market share and profits. Sasser, (1978: 93) has shown in the 
commercial model, that retaining just 5% more customers than nonnal, can actually 
double profits. 
Relationship marketing is thus the effort to build an enduring relationship by the 
supplier with each of its customers on a one-to-one basis. This it seems, is especially 
appropriate in the doctor / pharmacist relationship, within primary health care, where it 
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will be not so much a question of the pharmacist building a relationship with many 
customers, (doctors) but a small number, who are the source of patient flow and 
prescriptions, routinely dispensed by the pharmacy. However, on a pan-profession 
scale, leadership at various levels, will have responsibilities too, in building the inter-
profession relationship. It must, argues Conner, (1981 : 122) and Fiol, (1991 : 191 -
211) become part of the organisation's culture in co-ordinating mission and objectives 
towards the partnership goal. 
From the foregoing discussion, it is apparent that relationship marketing and selected 
elements of the marketing management approach (7Ps), could have a function in 
applying marketing theory to the problem of change and the repositioning of pharmacy 
in primary care. A summary of the differences between the two approaches is shown in 
Tablel8. The importance of relationship marketing theory to the research in the thesis, 
is in its application to doctor attitudes, needs and wants related to the new service. 
These latter are discussed in Section 4. Table 18, (Gronroos, 1993 : 11 - 12; Adcock et 
al., 1998 : 187; Dibb et al., 1994 : 4) sets out a comparison between the marketing mix 
and relationship marketing. 
Table 18 KEY DIFFERENCES BETWEEN EXCHANGE 
MARKETING AND RELATIONSHIP MARKETING 
EXCHANGE MARKETING RELATIONSHIP MARKETING 
DEFINITIONS 
• The process of planning and executing the • To establish, maintain and enhance 
conception, pricing, promotion and relationships with customers and other 
distribution of ideas, goods and services, to partners, at a profit, so that objectives of the 
create, exchange and satisfy individual and parties are met. 
organisational obj ectives. 
• This is achieved by a mutual exchange and 
fulfilment of promises. 
CONTRAST 
• Importance of single sale • Importance of customer retention 
• Importance of product features • Importance of customer benefits 
• Short time scale • Longer time scale 
• Less emphasis on service • High customer service 
• Quality is concern of production • Quality is concern of all 
• Competitive commitment • High customer commitment 
• Persuasive communication • Regular customer communication 
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4.3.7 Marketing and Health Care 
The purpose of this section is to examine briefly the place of marketing in health care 
and specifically within the NHS. Whilst it is true to say that marketing has been used in 
the health industry, through drug promotion and advertising for many years, marketing 
practice within the NHS is a relatively recent phenomenon. 
According to Schaeff, (1991 : 1 - 2) the origins of formalised marketing in the NHS are 
traceable to two major government sponsored reports, some twenty and ten years ago 
respectively: 
• The Royal Commission on the National Health Service (1979); and, 
• White Paper- Workingfor Patients (1989). 
Both promoted a locally responsive servIce, focusing upon patients' needs and 
emphasised individual services. The 1989 White Paper additionally recommended 
pleasant working facilities, clear patient orientated information and optional extras and 
amenities in hospitals. 
The White Paper: The New NHS, Modern, Dependable, (1997: 66) further guarantees 
, 
an annual patient survey of users' views of the servic~,_ taking consumer orientation a 
stage further. This and supportive White and Green Papers, (Chapter 1) have developed 
the concepts of clinical excellence / governance, benchmarking, performance 
frameworks and new partnerships in patient care, (1997: 40) to raise the quality of 
service and consumer participation. 
Although the Competitive Internal Market is said to have been removed, (1997: 2) the 
measures outlined above effectively retain competition rather more subtly and drive 
perfonnance toward the best in the market place. 
Primary Care Trust structures will be budget controlled, audited and given authority to 
commission new services. These will be based upon best quality / cost benefit and 
effectively places the other bidding professions in competition for new services, where 
alternative health qualifications are acceptable. 
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As has already been said, (Chapter 1, Figure 4) the traditional community phannacist, 
therefore faces competition from other professions, as well as other sectors of its own 
profession, in other words hospital phannacists, peripatetic phannacists and Health 
Authority Trust phannaceutical advisors through expanded staffing and responsibilities. 
Marketing then, appears to offer a means whereby community pharmacy may 
strengthen its position within the NHS and by quality of service and comprehensive 
medicines knowledge, create barriers to entry for competing professions. 
There are, however, prejudices to the use of what is seen in marketing, as an essential 
commercial activity. Some of these objections are set out in the following sections. 
4.3.8 Specific Objections 
4.3.8.1 Economic Objections 
Here, it is held that health care cannot be efficiently distributed by markets, nor 
consequently by marketing methods. Medical treatments and especially surgery, are 
often one-off events. Customers (patients) therefore, have reduced opportunity of 
learning about the product by experience and cannot easily exercise choice, a pre-
requisite of market dynamics, (Klein, 1983 : 153). Furthermore, the customer, it is 
held, cannot anticipate the need for specific health care. Consequently, price decisions 
cannot work exactly as proposed by economic theory, (Kotler and Clarke, 1987 : 369). 
Capacity for informed and rational decision making is further prevented, or reduced, by 
the nature of the incidence of acute illness. Rational decision making may be impaired 
because of patient reluctance to antagonise the doctor, (Cartwright, 1967 : 22). 
Finally, as an example of market distortion, it is seen that in economic terms the doctor 
is the product I service supplier and arbiter of patient needs. Supply and demand curves 
are, therefore, not independent and the market thu~ cannot act in a utility maximising 
way, (Culyer, 1987 : 21). 
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4.3.8.2 Ethical Objections 
The core of the problem here, seems to be that marketing effort is directed toward the 
patient agent, (e.g. doctors) and decision making is thus removed from the ultimate 
consumer / patient, (Culyer 1976 : 180). It is also held by some critics that marketing 
techniques usually increase consumer demand, whilst in health service practice this may 
not be desirable, (Illitch 1977 : 22). It could be equally argued, of course, that de-
marketing is a legitimate function of the marketing process and has the opposite effect, 
so that patients could be influenced toward more cost-effective services and medicines. 
Marketing pharmacy to the medical profession is different because the benefits are 
transparently patient orientated and DH backed. 
Tolliday, (1978: 25) raises the issue of clinical judgement and counter-prejudice, 
engendered by sales promotion / advertising, so that the clinician's decision may not be 
based upon best practice. In a wider context, Daniels, (1981 : 153 - 158) argues that a 
market place in welfare generally can only function with equal opportunity of choice 
and so marketing, in this context, may well distort audience mix awareness. Those who 
are most needy, in the lower strata of society may not be in a position to hear of, let 
alone evaluate, health care information. Hammond and Jurkus, (1993 : 15) found that 
whilst marketing is generally held to be unethical by health care professionals, they 
themselves are of the view that I ••• marketing per se is not unethical...' Further, that 
attention given to ethics by the stakeholders, would seem to be especially strong in 
health care, (Hammond and Jurkus, 1993 : 16). 
4.3.9 General Objections 
In the USA, the Council of Medical Speciality Services still publishes guidelines 
indicating classifications of fraudulent product advertising, which should be avoided. 
Widgery, (1979: 88) two decades ago, cited the Federal Drug Administration (FDA) as 
having found that 60% of products it examined produced no evidence for the claims 
made. A decade ago, Kotler and Clarke, (1987: 431) raised the same issue as an 
indication of the tendency of some ' ... less than ethical suppliers ... ' to distort their case 
in promotional literature. 
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So far as the UK NHS is concerned, it is clearly essential, according to the Industry 
code of ethics, that all product propositions must be transparently blameless of prejudice 
and distortion. Similar standards must apply in the marketing of a new professional 
pharmaceutical service, which is likely to have a major impact upon primary care. In 
view of historical tensions between the medical and pharmaceutical professions, 
(Chapter 1) this concept will be crucial to reciprocal trust and empathy. Promotional 
communications should, therefore, ideally take account of this. 
4.3.10 General Positive Considerations 
Despite reservations and criticisms of marketing as applied in the health care context, 
the NHS does, as already indicated, employ some marketing practices with varying 
degrees of success, for example: meeting consumer illness needs and even convenience 
wants; health promotion initiatives; evaluation of care package outcomes in quality 
pursuit; and, consumer research. Social marketing in the pursuit of healthier living 
practices is well established through anti-smoking campaigns and better diet initiatives. 
Exercise encouragement is quite well developed, especially in the physiotherapy area of 
treatment, as well as in general health promotion. 
Boonekamp, (1994: 12) is of the view that network m~rketing and interdependence of 
the related parties, such as the provider, purchaser, patient and competitors, is of 
growing importance in the NHS. Together with a focus on solutions rather than 
product, this is, she feels, a distinct advantage to patients. Quality, she goes on to say 
' ... is a paramount consideration in services and their delivery ... ' (Boonekamp, 1994 : 
22). 
Berkowitz and Hillestead, (1991 : ix) are assured that marketing method fills the gap 
between master plans (of health care organisations) and tactical implementation. 
Hassan and Foltz, (1990: 97) wrote at that time: 
' ... Health care organisations are rising to the challenge of a dynamic 
environment and learning to market their services ... ' 
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Undoubtedly overload and inadequate resources with the NHS distort the 'ideal' 
marketing situation, but equally, the benefits of good marketing strategy may assist in 
changing patients' perceptions of what should be expected and preferred. In this way, 
available resources may be maximised, inadequate resources relieved and priority needs 
given adequate attention. 
4.3.11 Summary 
It is clear that marketing as applied within the NHS is a somewhat controversial and 
relatively new practice, even though the pharmaceutical industry has successfully 
marketed to the health field, including the NHS, for some fifty years. Marketing 
strategy and application of the tools of marketing will need thoughtful and careful 
application in the market place, as a radically new pharmaceutical role is introduced into 
primary health care, requiring substantial change in medical routine. Relationship 
marketing, already begins to emerge as a key consideration in this thesis. 
4.4 TARGET MARKET PERCEPTION; 
MOTIVATION 
4.4.1 Introduction 
NEEDS I WANTS; 
It is appropriate at this stage to state, as clearly as possible, the target market for the new 
community pharmacy service I product. It may be argued from Chapter 1 that all the 
stakeholders are elements of the potential market. Whilst this may be generally true, the 
original stakeholder analysis, (Chapter 1, Figure 5, page 34) indicated priority address 
of those interested parties. in the High I High quadrant of the matrix. These were the 
key players: 
* 
* 
* 
PSNC/RPSGB 
DH / Government 
BMA/GPC 
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+ GPs/PCTs/S~/HAZs 
+ Community Pharmacists 
* PAs 
+ Patients 
Those marked with an asterisk are known to be favourably disposed toward the new 
proposition, as indicated at conferences, Government White Papers, (Chapter 1, pages 2, 
3), meetings attended by the author, (October 1998 to June 1999) and in 
correspondence, (Tweedie, 1999 - letters from GPC). Those marked with a cross have 
yet to be fully presented with the proposition (via LPCs and practising pharmacists) and 
form the key market for the service. Without the collaboration of doctors, (which could 
become active opposition) patients themselves could be dissuaded from accepting new 
pharmacist involvement in their medication. If a beneficial service is presented to 
patients by the doctor, it is unlikely that they would refuse and so doctor commitment to 
the proposed pharmacy intervention is judged to be of pivotal importance and comprises 
the target market of this thesis. Government directive, that a new service should be 
offered, would not necessarily make doctors select the pharmacist as the 'professional 
of choice.' The new proposition, therefore, needs careful introduction to the general 
body of GPs and the following sections explore some of the complex psychological 
issues underlying product or service selection by any consumer. 
4.4.2 Target Market Perception 
Perception has been defined by Harrel, (1986: 66) as, 
' ... the process by which an individual receives, selects, 
organises and interprets information, to create 
a meaningful picture of the world .. ' 
Perception, in the context of this thesis, is about the way in which concepts are 
regarded, rather than just visual perception, upon which considerable research has been 
done. Visual perception does, however, raise some interesting related perspectives and 
in the 1950s and 1960s Bruner and his colleagues made certain observations from their 
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experiments on visual perception, (Bruner et aI., 1964 : 1 - 15). Here, it became 
apparent that perception would be influenced by several factors, including: 
• Expectations 
• Motivational states 
• Attitudes 
• Cultural values 
- which may be in the mind of the individual at the 
time; 
- particular needs at the time; 
- predisposed perspectives on the subject; and, 
- the peer group perceptions. 
Much earlier, Sandford, (1936: 129 - 136) had shown that the motivation relating to 
specific needs, directly affected perception and in the 1950s, Gordon Allport, the 
notable psychologist had shown that prejudice could affect perception, (1954: pp. 1 -
20). In the following decade, studies by Mundy-Castle, (1966: 290 - 300) illustrated 
how radical culture, in this case racial could influence the interpretation of even visual 
perceptions. Gregory, (1973 : 23 - 31) argued that perception was not simply decoding 
of visual information but is a process of making inferences about the data being 
presented. 
Harrell, (1986: 66) in relationship to consumer behaviour, asserts that perception 
depends upon internal factors such as, 
' ... beliefs, experiences, needs, moods, expectations ... ' 
Assael (1998: 84,205) also in relationship to consumers, states: 
and ... 
' .. . perception is the process 0/ selection, organisation and interpretation 
o/marketing and environmental stimuli into a coherent picture ... ' 
stimuli are more likely to be perceived when they: 
i. Conform to consumers' past experiences; 
ii. Conform to consumers' beliefs about the product; 
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iii. Are not too complex; 
iv. Are believable; 
v. Relate to a set of current needs; and, 
vi. Do not produce excessive fears and anxieties. 
Particularly important in the doctor's perception in this list may be items i, ii, v, vi, 
indicating a potential route into the doctor's psyche, avoiding threat; emphasising 
current patient needs; and, relating in some measure to the doctor's traditional 
experience in leading the health care team. 
So far as the new pharmacy product is concerned, environmental stimuli, as mentioned 
in the defInitions of perception may be increasing, in the form of political, sociological. 
economic and technological forces, as described in Appendix 1. A government driven 
(patient) culture change in the NBS, will be a powerful force for change in health care 
practice, even for doctors. If this can be used and portrayed by pharmacy as a general 
need in patient care enhancement, rather than being used as a threat, it may become an 
aid to new product introduction. The doctor's needs, therefore, in the new quality 
driven NBS with clinical practice focused on as never before, (The National Institute of 
Clinical Excellence NICE) may then revolve around a nwnber of issues: 
, 
• The need for security of professional tenure' ~d self esteem to be preserved 
in an increasingly critical environment; 
• The need to perform well in practice; and, 
• The need to be seen as an (if not the) authoritative health practitioner. 
This leads to a consideration of needs, wants and motivation, which may be important 
avenues of successful presentation of the new pharmacy service to the individual doctor. 
The following sections explore this potential and inform the marketing process. 
4.4.3 Needs / Wants; Motivation 
This section is considered by the author as being necessary to gain new insights into 
how to influence doctors into accepting and feeling comfortable with the new pharmacy 
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service offering. In the experience of the author, committee decisions in the lead bodies 
of phannacy relating to introducing the new service have concentrated on emphasising 
the pharmacist as the medicines expert. This assertion has not been linked to resultant 
benefits for the doctor but rather another general assertion that pharmacist involvement 
with the patient, in addressing medication needs, is bound to bring patients benefit, 
(Combined Leadership Group meeting, July 2001, Chapter I, page 20). As a major 
stakeholder with blocking power, it seems sensible to spend time reflecting upon 
potential benefit to GPs as well as patients. 
Wells and Prensky, (1996: 227) assert that all consumer behaviour begins with 
motivation and motivation is, according to them: 
' ... the process whereby an individual recognises a need and begins 
to take action to satisfy it ... ' 
They go on to define a need, as: 
' ... a discrepancy between an individual's current state and some 
ideal state desired .. ' 
Needs, drives and instincts have been described inter-changeably by some researchers as 
the precursors of motivation to act and in the early part of the twentieth century, were 
regarded as mainly instinctually based. Workers in psychology research, such as 
McDougall, (1932) investigated how instinct affected behaviour, using animals as the 
subjects. It was concluded that the presence of a drive or need could be inferred from 
the animal's behaviour under conditions of the experiment. Following work by 
Morgan, (1943) a distinction was drawn between primary drives (basic needs within the 
organism) and secondary drives, which were learned. Morgan further classified 
primary drives as 'physiological' (thirst, hunger, etc.) and 'general' (fear, affection). 
Theories of human needs followed and Maslow, in 1943 proposed a number of 
complex interacting needs, some more important than others at any point in time. He 
went further, suggesting that such needs were expressed and fulfilled in an hierarchical 
progression, so that when the more fundamental needs were satisfied (for example, 
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physiological), the individual then went on to satisfy other needs in a further priority 
order. In his construct, basic physiological needs were thus of prime importance, 
followed by safety needs and so on, up the hierarchy. He theorised that as each need 
was satisfied it therefore no longer acted as a motivator. 
Whilst Maslow's hypothesis is often categorised as having five elements, there were in 
reality seven, (Maslow, 1954 : 15 - 25). The five basic needs he proposed were 
physiological; safety; love; esteem and self actualisation. However, he also 
acknowledged the existence of cognitive needs, (to know and understand) and aesthetic 
needs, of order, beauty and symmetry. These latter may not be consciously recognised 
at any particular point in time. Figure 10 represents the hierarchical concept. 
Figure 10 MASLOW'S HIERARCHY OF NEEDS-
DIAGRAMMATIC REPRESENTATION 
SELF-ACTUALISATION 
NEED 
Beauty; order; 
symmetry 
COGNITIVE NEEDS 
Curiosity; search for 
meaning; knowledge 
ESTEEM NEEDS 
Respect from others; self 
respect 
SOCIAL NEEDS 
Love; belongingness; affection; 
discourse 
SAFETY NEEDS 
Shelter; security; protection 
PHYSIOLOGICAL NEEDS 
Rest; sleep; sex; food; water; activity; health 
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ASPIRATIONAL 
NEEDS 
HYPO TII ETI CAL 
ORDER OF 
PURSUIT 
MOTIVATION 
Interestingly, a few years earlier than Maslow, Murray, (1938: 85 - 86) had set out 
what he considered were states of need in an individual relating to motivation, which 
could lead to positive action. These were: 
• Refractory 
• Inducible 
• Active 
in which no incentive will arouse it; 
inactive, but can be aroused; and, 
where need is determining behaviour. 
A refractory state of need may illustratively be exemplified by the drug addict, who has 
no desire to change his/her state of existence. Rather there is a compulsion to 
perpetuate it and so, for some such addicts, no incentive will arouse the primacy of 
natural, physiological or safety needs. An inducible state of need, may in turn be 
illustrated by the present state of the medical profession, which has come under 
increasing pressure to improve the efficiency and cost effectiveness of prescribing and 
engage in clinical governance, (NHS Executive, 1998: 1 - 3). In the author's opinion, a 
societal need for better prescribing is there, (Chapter 4, page 69) but not necessarily 
widely accepted by GPs. Careful persuasive effort at medical leadership level may 
succeed in creating that conscious need and begin communicating it to the wider 
membership. 
Continued pressure, through such avenues as NICE (p. 9~) and the boards ofPCTs, may 
further generate such an increasingly conscious need as to become active and start 
determining GP behaviour toward welcoming the proposed medicines management 
service. Motivation, in Murray's terms, would then be actively directed to fulfilling the 
need and determining the GP behaviour. 
McClelland, (1961) in his book ' ... The Achieving Society ... ' expresses his belief that 
although motivation can be conceptualised as arising from needs, these would be likely 
to be social, such as, achievement; affiliation. Carl Rogers, a clinical psychologist, 
(1961 : 95) in his researches into personality, agreed that certainly two basic needs 
provide motivation, in other words, self actualisation and positive regard from others, 
(affection, love, respect). Some twenty years later, Harre, (1979) confirmed that social 
respect was possibly the most important motivator of all. Alongside this concept lies 
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the related subject of self image and Tajfel et al., (1971 : 149 -178) from their studies 
of social groups, showed that group identity is an important part of self image. 
In this present research, professional group affiliation of the doctors is likely to be 
strong and the medicines management service proposed by pharmacy should clearly 
take account of their needs, especially in relationship to the social and self actualising 
aspects of their position in health care. Safety needs, as described by Maslow and again, 
relating to the doctor's ultimate responsibility for the care of the patient, are also a real 
consideration. 
In presentation of the new product to doctors, characterisation of the service could be 
constructed around: 
• increased doctor authority and importance in directing an extended health 
care team; 
• safety from increasing NHS clinical audit, (NICE) through engagement of 
another highly qualified professional (the pharmacist); 
• self actualisation in perfonning the core clinical task of diagnosis and 
, 
treatment, to an elevated level of quality and eJfectiveness; and, 
• increased doctor esteem in the eyes of the patient, through improving 
medication and disease prognosis. 
Wants, according to Kotler and Clarke, (1987: 261) are exercised by people who see in 
a product the potential to satisfy various of their needs and therefore, attract them to the 
product or service. In this case, doctor satisfaction may come from a complex of 
factors, some of the most important of which may revolve around the doctor's culture, 
which is long established in history as the dominant figure in the treatment of illness. 
Schein, (1986: 6) persuasively argues that group culture is important in sustaining the 
values, customs and norms of that group and it seems sensible, therefore, to construct a 
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new product proposition, which ostensibly supports the medical culture, rather than 
challenges it. Cultural tolerance, argues Charles Handy, (1991 : 98) is required in 
organisational change, which is what the new medicines management partnership 
entails. Direct challenge to the core of any culture (the paradigm) is known to be very 
difficult in effecting change and more circumspect approaches may be indicated so as to 
avoid such head on challenge. As Clarke and Clegg (2000 : 11) have suggested: 
' ... being locked into a paradigm can. .. become a form 
of conceptual imprisonment ... ' 
If the GP can be persuaded, by sensitive and supportive communications, to want the 
new pharmacy service, then further adjustment of the complete product design can be 
made during pilot trials, building in doctors' suggestions for improvement. In this way, 
as Barnes et al., (1998: 140) put it, 
' ... satisfaction can be created by a fully developed product ... ' 
4.4.4 Values and Needs 
In design of the new product offering, (medicines m~nagement) as briefly discussed 
under The Marketing Mix, (pp. 61 - 89), it was clear that whilst the core product may 
satisfy the basic market need, other functions which provide other desirable features can 
also be built into it as the tangible and augmented product. A Ferrari sports car will 
certainly take its occupants from point A to point B but the style and charisma 
associated with Ferrari also provide features associated with image and wealth. 
Emotional and symbolic values, thus become additional attributes of the product, 
satisfying multi-dimensional needs. Rokeach, (1973: 28) identified eighteen cultural 
values of general society and categorises them as terminal or instrumental. The former 
relate to the end goals which people strive for, (in the case of GPs, perhaps status; 
professional satisfaction) and the latter relate to beliefs about desirable routes of 
achieving the end goals. Table 19 sets them out with relevant product attributes, 
(Rokeach, 1968 : 554; Vinson et aI., 1977 : 47). 
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Table 19 CULTURAL VALUES - TERMINAL AND INSTRUMENTAL: 
PRODUCT ATTRIBUTES 
Cultural (Terminal) Consumption Specific (Instrumental) Product Attributes 
Values Values 
A comfortable life· Prompt service· Service quality 
An exciting life Reliable advertising claims Reliability 
A world at peace Responsiveness to consumer needs· Perfonnance 
Equality Accurate infonnation* Safety 
Freedom Elimination of pollution Ease of use 
Happiness· Free repair of defective products Durability 
National Security Convenient store locations Economy 
Pleasure No deceptive advertising Convenience 
Salvation Courteous and helpful salespeople Accuracy 
Self.respect· Low prices 
Social recognition* Solutions to urban decay and unemployment 
A world of beauty Legislation to protect the consumer 
Wisdom* No product misrepresentation* 
Family security 
Mature love 
Accomplishment* 
Inner harmony· 
Rokeach, (1968 : 554); Vinson et aI., (1977: 47) 
Note: * PotentIal values of GPs, which the product attrIbutes could especIally satISfy, If carefully 
tailored to doctor appeal 
He went on to describe the following two functions of values which are important to the 
individual: 
• They serve as standards by which to evaluate other items or propositions. 
(If the pharmacy offering and presentation is excellent, it could become a 
benchmark against which other similar services by other professionals are 
measured); and, 
• They motivate behaviour so as to enable the individual to act in accordance 
with their attitude appropriate to the circumstance. 
Although some psychologists regard values and attitudes as being the same thing, it 
appears that values are more deeply culturally embedded, whereas attitudes are 
developed in response to situations requiring some thought at the time, or over a period 
of time. 
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· In the case of medicines management the route to achieving acceptance of the product, 
seems again to be partly through constructing the augmented product around increased 
doctor importance, in directing an extended team with enhanced results for a more 
satisfied patient. The medical culture appears to be increasingly important in a 
consideration of new service which can affect self perception. 
Important work by Sheth et al., (1991: 18 - 25) shows how values affect market 
choices. Table 20 sets out these researchers' five categories of value and the related 
potential implication for the new pharmacy product in the view of the author of this 
thesis. 
Table 20 SHETH/NE~N/GROSSTHEORYOFVALUE 
CATEGORIES - PHARMACY PRODUCT IMPLICATIONS 
VALUE CATEGORY 
FUNCTIONAL VALUES 
SOCIAL VALUES 
EMOTIONAL VALUES 
EPISTEMIC VALUES 
CONDITIONAL VALUES 
EXPLANATION & CHOICE 
FACTORS 
The utility of the product's core; its 
physical purpose. 
The utility of the social grouping (s) 
within which the product is placed. 
The utility acquired by the product -
through its ability to create 
emotional association of ideas. 
The utility acquired through novelty, 
curiosity, or in satisfying a desire for 
knowledge. 
The utility of the product through the 
situation or context, faced by the 
choice maker - social or functional 
value is thus enhanced. 
ABBREVIATIONS: GP == General Practitioner 
peTs == Primary Care Trusts 
SUGGESTED PHARMACY 
PRODUCT IMPLICATION 
Improvement of patient health 
through illness alleviation. Esteem 
for doctor increased. 
Specifically for the elderly I 
chronically ill on multi medicines -
gives reduced drain on medical 
resources; Doctor effectiveness and 
performance increased. 
Added care for the emotionally 
evocative segment of the illness 
market - elderly; needy; housebound 
- reduced workload in GP practice; 
caring image enhanced. 
New service addresses illness in a 
new way; delivers measurable 
benefit outcomes, economic I health 
gain. Doctor abilities and prestige 
increased. 
OP elevated to new, more important 
leadership of the widened primary 
care group in the new PCT; director 
of an extended team; seen as head of 
the pharmacist; ego protected. 
Note: The suggested pharmacy product implications are the author's views of how Sheth's value 
Categories would relate to the new pharmacy.service. 
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These product value categories may prove useful in fInalising product design for 
presentation to the medical profession's leadership and subsequently, if successful, the 
general membership. Furthermore, design of the medico-pharmaceutical interface, 
rather than just the product itself, may also be used to enhance the total perception of 
the new product! service. This would equate to Kotler's tangible product discussed 
earlier in the chapter. 
In summary, the new pharmacy medicines management service could be influenced by 
a complex of the factors already discussed: 
Motivational Elements 
• Safety; 
• Esteem; 
• The professional! cultural values of the doctor; and, 
• Self actualisation. 
Product Aspects 
• Quality of product; 
• Quality of marketing; and, 
• Design of the medico-pharmaceutical interfa:ce. 
The way the doctor ultimately balances these issues in relationship to selecting from 
competing options, is similar to any consumer choice. In other words, it is through the 
totality of information, beliefs, cultural influence and values perceived by the 
individual. It is clearly a matter of the greatest importance that careful attention is paid 
to creating a product offering which sits comfortably and supportively with the doctor's 
perception of how it affects him / her in the totality of things. The perception of the 
product will, in part at least, determine also the doctor's attitude towards it. 
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4.5 CUSTOMER ATTITUDES AND PRODUCT DESIGN 
From a consideration of needs, wants, motivation, values and perception in the previous 
sections, it is apparent that the construction of a fInal product offering by the 
pharmaceutical profession for GPs, will require very careful thought. The attitude of 
individuals in the medical profession is likely to be one determinant of acceptance, or 
otherwise. 
In the nineteen thirties, Gordon Allport, (1935 : 798) defmed attitude as: 
' ... a mental and neural state of readiness, organised through experience, 
exerting a directive or dynamic influence upon the individual's response 
to all objects and situations with which it is related .. ' 
Rokeach, (1948: 254 - 278) defmed attitude in simpler terms as: 
' ... a learned orientation or disposition ... which provides a tendency 
to respond favourably or unfavourably to the object or situation ... ' 
More recent views regard attitudes as a composite construct that summarises a person's 
feelings toward the product / service, (Zajonc & Markus, 1982 : 123 - 131). Judd et 
aI., (1991 : 366 - 379) express the defmition of attitude as elevations of objects that are 
stored in memory and relate to any aspect of the social world; they are linked to other 
attitudes and stimulation of one of them may invoke response of another. 
Allport went on to propose the following three components of the customer's choice 
process, in a buying situation: 
• Brand beliefs 
• Brand elevation 
• Intention to buy 
The cognitive effect; 
The affective effect; and, 
The conative effect. 
Wilkie and Pessemier, (1973: 428 - 441) view attitude formation as the process by 
which people form their opinions, which can be based upon: 
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• Learned knowledge 
• Evaluation of the product -
• Predisposition to act 
• Important criteria in the 
purchase decision 
from experience; 
based upon knowledge of it; 
based upon evaluation; and, 
related to aspects of the product. 
Attitudes are thus the result of motivation, perception and learning. 
As attitudes are learned, they can be affected by new information, imparted or 
experienced even though some attitudes are very hard to change. For example, because 
of long cultural practices, the central values, assumptions, beliefs and traditions of the 
established professions, become accepted norms of practice which are regarded as 
axiomatic. 
The question is, in the marketing situation: Can attitudes be influenced so as to deliver 
the required behaviour of the consumer, that is, the purchase of the service or product? 
Although some early researchers found little evidence to support the link, (Wickes, 
1969 : 41 - 78) and studies by Newcombe et aI., (1992: 780 - 800) showed that 
specific attitudes, relating to particular subjects, rather than general attitudes, were good 
predictors of behaviour. Heightened self awaren~ss, according to Hutton and 
Baumeister, (1992: 68 - 75) increases the degree of consistency between specific 
attitudes and resultant behaviour. Self awareness, in this context, relates to the situation 
where the individual is focused for some reason upon their own attitude toward a 
particular issue, as might be the case in confronting the doctor with the new pharmacy 
product and the perceived effect upon his traditional position and role. 
According to Fazio, (1989: 153 - 179) attitude accessibility plays a key role in the 
attitude-behaviour link, so that if attitudes can be easily stimulated or recalled, they 
influence perception of the proposition presented. Again, in the marketing situation, it 
would perhaps be helpful to look for past common GP / Pharmacist joint experiences 
which were good, such as in appropriate published collaborative practice and use these 
as a basis for presenting the new partnership service. The functions of attitudes are now 
briefly visited, together with their implications. 
lOS 
4.5.1 Functions of Attitudes 
Smith et al., (1956: 22) were of the view that attitudes serve three functions: 
• Object appraisal - a relatively quick assessment of new propositions; 
• Social adjustment - helps affiliation with peer groups; and, 
• Externalisation help to externalise fears and rationalise internal 
dissonance. 
Katz, (1960: 163 - 204) amongst his proposed four types of attitude function, lists ego 
defence and value expression as two of the most important, reinforcing earlier 
speculation in this work that cultural perspectives are key issues; (also see Sutters and 
Nathan, 1993 : 70 - 84). Katz's four attitude functions in relation to product purchase 
are set out in Table 21, together with suggested implications for desirable product 
attributes of the new pharmacy service: 
Table 21 ATTITUDE FUNCTION 
FUNCTION OF OBJECTIVE IMPLICATION IN CURRENT 
ATTITUDE STUDY -PRODUCT ATTRIBUTES 
DESIRED 
• Utilitarian To assess core product functions in N;ew core product evaluated in scientific 
utilitarian tenns; is the utility tenns; scientifically sound? Should 
attractive? correct adverse effects and improve 
effectiveness? 
• Value Expressive To assess the product values in Tangible product to reflect patient 
esoteric terms; personality, lifestyle benefit - supports doctor values in 
(personal values of doctor, quality of care of patient. 
reflected). 
• Ego Defensive To assess effect on self concept. Must not reflect doctor inadequacy; 
rather a new doctor-driven enhancement 
of care; reflects concern; reflects lead 
position ofGP. 
• Knowledge To evaluate product comparisons Phannacy product more comprehensive; based upon hard facts; certainty in more knowledge driven than any 
choice. competing profession. 
Note: Column three is the author's interpretation of the desirable attributes of the new 
. pharmacy service 
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To be attitude-friendly, therefore, the new pharmacy service needs to be constructed 
presentationally to support the doctor's opinions on all four fronts. None of the above 
are mutually exclusive or necessarily dominate a hierarchy of functions, but there may 
well be one attitude function which predominates over the others for a particular person 
at a particular time; or in a product seller's terms, one which is overridingly effective. 
Wells and Prenskey, (1996: 314) express the view that attitudes are important to 
marketing considerations because: 
' ... a consumer with a positive attitude toward a product is 
more likely to buy it ... ' 
One of the difficulties in divining customer attitudes, according to Eiser, (1971 : 1 - 10) 
is the discrepancy between attitudes expressed and tested behaviour relating to those 
attitudes. Fishbein, (1963: 65 -116) suggested that intentions, which attitudes help to 
form, are the important determinant of behaviour, rather than simply the attitude itself. 
In further work, a decade later, relating to attitude research, Fishbein and Ajzen, in 
assessing 109 studies, found that there were substantial differences in expressed 
attitudes and behaviour purporting to result from these attitudes, (Ajzen & Fishbein, 
1977 : 888 - 918). The implications are that great care should be exercised in 
interpreting answers to research questions when attempting to correlate with predicted 
behaviour. 
Within the context of the new medicines management proposals and the medical 
audience I market place, influencing attitudes, reinforcing some and changing others, is 
clearly of key importance in engaging the new service. Persuasion, through marketing 
communications, is geared up to influencing buyer behaviour, through their needs, 
attitudes and motivation (Rossiter & Percy, 1987: 132). Marketing communications 
will be addressed later in the chapter. 
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4.5.2 Models of Altitude Components 
Different views on attitude development and the components thereof have been offered 
as theoretical constructs, in order to understand better the motivation of consumers and 
their decision to buy, or not to buy. Allport, (1935 : 798) was an early proposer of the 
tri-component model, in other words: 
' ... the cognitive; affective and conative predisposition to act ... I 
Such models propose that behaviour involves knowledge, feeling and action and 
emphasise the affective element, which evaluates the depth to which a product will meet 
the customer's needs. It is not at all certain, however, that there is a linear sequence in 
this process and in some instances of marketing, the initial sampling distribution of a 
product places the conative component fIrst, hoping that this will provide the affective 
and cognitive beliefs necessary for further action. This revised sequence may be the 
most important of all, with respect to achieving a positive reception of the medicines 
management service by GPs. Such sampling would take the form of pilot trials to 
engage the service with a representative sample of doctors, building relationships, 
allaying fears and proving the quality. Success here would be powerful evidence and 
persuasion to extend the service to a wider sample of medical practitioners. 
Multi-attribute models, consider the product or service's multiple attributes and propose 
that the potential consumer's attitude is due to evaluation of each one, leading to a 
summary net view. Fishbein, et al., (1963: 223 - 240) suggested three components of 
this scheme: 
• Product attributes, whereby the product / service is evaluated; 
• Beliefs about the actual presence of the attribute, (is it there as advertised or 
not?); and, 
• Evaluation of the relevance of each attribute to the individual's perception of 
worth. 
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They further went on to distinguish two categories in this model, firstly: 
The Theory of Reasoned Action Model 
Here Fishbein et. al., (1967 : 477 - 492) conceptualise the customer as having beliefs 
and attitudes about the particular reason for the purchase, rather than about the 
purchased object itself. For example, it is the occasion such as a birthday, that drives 
perception of the need for the product, as well as the subjective norm for a particular 
product purchase that exists in a specific social context. Thus in a particular cultural 
group, there will be the commonly accepted expectations of what calibre and quality a 
birthday present should be. This influence might prevail, for example, in a gentleman's 
club in London, where pin stripe dark suits and other customs are the norm. Bequests to 
the club would be expected to be of a particular quality and interest. The model is 
diagrammatically set out in Figure 11. 
Figure 11 THEORY OF REASONED ACTION MODEL 
Group cultural ... .. Motivation to Belief that the ..... ~ Evaluation of ~ ... ~ , 
"" 
.. 
expectations comply with 'behaviour' of the outcomes 
associated with the cultural buying will lead that the 
the speculative norms to special buying will 
purchase outcomes 
-
give 
I I I J 
~ ~ 
SUBJECTIVE NORM ATTITUDE FORMATION 
I'-____ -.~ DECISION ..... r-----.l, 
~ 
BEHAVIOUR 
Again, implications in a medical profession context, might include a requirement of 
pharmacy to designate its product as the medical (rather than medicines) review group 
service, giving the doctor the security and comfort of medical culture lead associations; 
the context and occasion would be medical rather than pharmaceutical. 
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The second category of Fishbein's multi-attribute model is: 
The Attitude Toward Object Model 
Here Fishbein, (1963 : 233 - 240) held that the customer's overall attitude to the 
product is the net effect of the sum total of the individual's beliefs about each product 
attribute and the evaluation of the importance of each attribute, in satisfying the 
consumer needs. 
Heider's Balance Theory - A Balance of Beliefs Theory 
Heider's Balance Theory proposes that people seek to achieve balance between their 
beliefs and actual evaluation of a product, situation, or service, (1958: 20 - 39). The 
theory is based upon established behavioural principles, specifically cognitive 
consistency, implying that consumers seek harmony between beliefS and evaluations. 
If, it is argued, inconsistency occurs, attitudes will change to create harmony in the 
cognitive perception. Research by Sheth and Talarzyck, (1972: 6 - 9); Lutz, (1977: 
197 - 208) and Bass and Wilkie, (1973 : 262 - 269) confirm this effect. 
The implication for marketing the new pharmacy serVice to the medical profession, is 
that the service should ideally be constructed in such a way as to deliver satisfaction in 
clinical terms, support in cultural terms and a want, in terms of professional 
reinforcement. It should be a non-threatening conceptual partnership in enhanced 
patient care. In support of creating the right sort of medical beliefs about the new 
product (the other component of balance theory), work clearly needs to be done at 
leadership level, (GPC) to ensure positive messages to the medical profession in 
constructing a belief framework, for the proposition. 
Before leaving this brief consideration of attitudes, in the context of market persuasion, 
one flnal element of the attitude formation process, which will be important during and 
following any pilot trials of the new pharmacy service, is experience of the product. 
Experiences during pilot trials can become positive or negative forces for development 
of the service and for the medical trialists, a potential determinant of their own future 
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attitude to phannacist partnership. Strongly developed culture, such as in the medical 
profession, is one of the key influences in determining group attitudes and behaviour, 
(Stafford and Cocanougher, 1981 : 329 - 343). 
This leads to a consideration of communications about a product or service generally. 
4.6 MARKETING COMMUNICATIONS, 
MODELS AND STRATEGIES 
4.6.1 Introduction 
Whatever processes and methods are eventually used in endeavouring to reposition 
community phannacy within NHS primary health care, appropriate quality 
communications to the key stakeholders, GPs in particular, may be reasonably regarded 
as one pre-requisite of success. In this context, communications would need to be 
persuasive in nature, sensitive to inter-professional cultural issues and expressive of 
benefit to the consumer, the general medical practitioner and patient in this study. 
Writing some four centuries ago Thomas Hobbes, (16:51 : 46 - 48) in his major work, 
'Leviathan', dealing with the ' ... matter, form and power of the commonwealth, 
ecclesiastical and civil ... ' declared that men are at best: 
' ... complicated automata, influenced by internal material 
perceptions of an external material world .. ' 
Kotler, writing more than three centuries later, (1992: 161 - 164) characterised one 
model of customer behaviour as ' ... a black box of consumer characteristics and 
decision making processes ... ' and went on to argue that this 'black box' is influenced 
by environmental inputs, such as political, economic, social, technological, cultural 
forces and marketing effort. This in turn, he suggested. could lead to attitudinal and 
behavioural change with respect to a promoted product. In this context the word 
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promoted, is used generally to mean, 'offered to the consumer with persuasive 
communication. ' 
Professional customers, evaluating propositions which affect their future operational 
practice, have the ability and knowledge to be analytical, critical, supportive or 
obstructive in dealing with any new proposal. The following section deals with some of 
the more important aspects of marketing communications generally and relating these to 
the target market for the new pharmacy service where appropriate. These theoretical 
considerations are to be used alongside the results of field research, in helping to 
construct a suggested way forward in establishing the new pharmacy service. 
It is interesting to note, that in studying communications between animals, Slater, 
(1983 : 10) defined the term as: 
' ... the transmission of a Signal from one animal to another, such that 
the sender benefits, on average, from the response of the recipient ... ' 
The 'on average' qualification, apparently, takes account of those occasions, (such as 
birdsong) where there appears to be no tangible benefit from recipient to sender. Krebs 
and Davies, commenting upon the same subject, suggest that the benefit to the sender 
arises from the ability to manipulate the receiver's behaviour in some way, (Krebs & 
Davies, 1978: 22). Marler, (1982: 87 - 94) proposed the view that both animal 
receiver and sender receive benefit, in that both are concerned with what is going on and 
it is this aspect, in human communications, that interests the marketing practitioner. In 
the latter context, Schram, (1955: 23) defined communications as: 
• ... the process of establishing a commonness or oneness ofthought, 
between sender and receiver ... ' 
Rossiter and Percy, (1987: 34) express the view, based upon their studies in marketing, 
that persuasion of potential customers to acquire products must take account of: 
' ... needs, wants; attitudes; and motivation. .. ' 
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and these were discussed in outline in the last section. The following discussion seeks to 
explore the key issues in persuasive communications, as they apply in a situation 
requiring a message sender to persuade a target market to engage in a new model of 
buying preference. In this study context, medical approval of a new service, pharmacist 
partnership, in the management of patient medication comprises the potential buying 
preference with which the doctor is faced in possible competition with other suppliers of 
similar services. The section content will again be linked with field research results, to 
inform the way forward in introducing the new pharmacist role. 
4.6.2 Models of Persuasive Communications 
As early as 1925, researchers such as Strong, (1925: 9) proposed that promotional 
communications should aim to secure from the target audience a hierarchy of effects: 
• Attention-
• Interest 
• Desire 
• Action 
(AIDA) 
of the target individual; 
in the message content; 
to acquire the proposition; and, 
to achieve possession. 
Almost forty years later, Lavidge and Steiner, (1961 : S9 - 62) postulated a hierarchy 
of effects, in attempting to describe the thought process through which a person might 
proceed, in deciding to acquire, or not to acquire, a product, after being exposed to a 
promotional communication. They suggested six stages: · ... awareness; knowledge; 
liking; preference; conviction; and purchase, (or no purchase} ... ' 
In 1962, work on customer response to innovation, in a product I service offering, led to 
what was termed the innovation - adoption model of customer response to promotional 
communications, (Rogers, 1962 : 79 - 86). This comprised the following elements: 
• ... awareness; interest; evaluation; trial; and adoption ... ' 
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Almost two decades later, McGuire, (1978: 156 - 180) proposed a further sequence of 
consumer engagement as: t ••• presentation,· attention; comprehension; yielding; 
retention; and, behaviour ... ' 
Again, this appears to be similar to earlier models, with the additional idea that retention 
of information should be the outcome of successful marketing communications. 
The above four examples of the hierarchical concept of customer response to 
promotional communications, are summarised in Figure 12, which also shows the 
elements of each, grouped into what became known as the cognitive, affective and 
conative phases of the sequence. 
Figure 12 
PHASES 
COGNITIVE 
AFFECTIVE 
CONATIVE 
MODELS OF CONSUMER RESPONSE TO 
PROMOTIONAL COMMUNICATIONS 
MODELS 
AIDA HIERARCHY INNOVATION 
OF EFFECTS ADOPTION 
Attention Awareness Awareness 
Knowledge 
Interest Liking IJ;lterest 
Preference 
-
Desire Conviction Evaluation 
Trial 
•• 
Action • Purchase t . Adophon 
AIDA eo AttentIon, Interest, DesIre, ActIon 
INFORMATION 
PROCESSING 
Presentation 
Attention 
Comprehension 
Yielding 
Retention 
• Behaviour 
All the hierarchical models set out above have become known as high involvement 
models of customer response because of the implied in-depth consideration by the 
consumer. They propose a sequence of orderly stages through which the individual's 
thought process moves, in order to reach a decision to purchase, for the successful 
communication outcome. Like Maslow's hierarchy of needs, there is an attractive 
natural logic about these proposals, but it seems, little hard evidence of a fixed hierarchy 
of stages. 
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Nevertheless, all models assume that marketing communications do not exist or operate 
in a vacuum, but through social interaction with others, (Berger & Luckman, 1991 : 56 
- 57). Other investigators in the communications field take the view that the arrival of 
the promotional message to the potential customer is all that may be achieved. 
Selective perception may screen out the central theme of the message, through certain 
'cues', which are said to have an effect, such as group cultural values or existing 
consumer beliefs. These operate to make the task of handling the realities of a complex 
world, much easier for the recipient. Engel et al., (1993: 391 - 417) view consumers 
as information processors who combine cognitive learning with rational response, based 
upon a continuously updated view of the world, or society as more information is 
progressively gathered. 
Another school of thought in the fields of sociology and marketing, rejects the concept 
of a hierarchy of elements in consumer persuasion, on the broad thesis that consumers 
receive information on a more passive basis without much ordered processing at all, 
(Palada, 1966: 13 - 24; Ray, 1973 : 147 - 175; Smith & Swinyard, 1982 : 81 - 93). 
According to Lastovicka, (1987: 174 - 179) such a passive process could be described 
as catching information rather than processing it. It is, according to Ray, (1973 : 147 -
175) a 'low involvement' model of consumer response, as distinct from the above 
mentioned high involvement models (p. 114), which he saw as conceptually useful, 
where the consumer is highly involved, for some special reason, with the product. 
Krugman, (1965 : 353) did, in fact, suggest that personal involvement of the consumer 
was the key to success in advertising: 
' ... the number of conscious bridging experiences, connections or 
personal references that a person makes between his or her life 
and the stimulus received .. is likely to be the decidingfactor ... ' 
Krugman later argued for the need of repeated exposure of the target consumer to the 
promotional message so as to ' ... build potential for the ability to see a product 
differently ... What is next required .. ' he went on to say ' ... to trigger the potential 
action, is behavioural opportunity, such as shopping routine ... ' 
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Therefore, it is considered that such models as described above have uses in setting out 
stages through which a consumer could be led, in reaching a purchase decision even 
though the message may require repetition. Equally, a consumer may well already be at 
one of the suggested stages of preparedness in the hierarchical sequence before active 
promotional communication begins. This may turn out to be the case with the medical 
consumer of pharmacy services, through some prior conditioning effected by new 
government policy on health, NICE guidelines and pressure on practice medicines' 
budgets. This could be ascertained by research of the particular market and appropriate 
action taken by the communication sender, to move the customer on to a purchase 
decision. Conversely, the effectiveness of promotional communications could be tested 
at different points in a marketing programme, to see at what stage the customer is placed 
with regard to perception of the product being marketed. 
As outlined above, the three phases of the high involvement hierarchies of effects with 
respect to market consumers are shown in Table 22 together with a proposed low 
involvement hierarchy. (Lastovica, 1987 : 174 - 179) 
Table 22 HIERARcmES OF PROMOTIONAL MESSAGE EFFECTS 
IN CONSUMER DECISION MAKING 
PHASES OF THE TYPE OF HIERARCHY AND THEORETICAL ROUTES 
HIERARCHY OF ENGAGEMENT BY CONSUMER 
HIGH INVOLVEMENT LOW INVOLVEMENT 
'LEARN' LEARN DO LEARN 
(Cognitive Phase) (phase 1) (phase 1) (phase 1) 
Consumer is aware of and Active learning Product is acquired for Passive learning by repeated 
comprehends the product. whatever reason, e.g. by message 
sampling 
'FEEL' FEEL FEEL DO 
(Affective Phase) (PhaseZ) (Phase Z) (phase Z) 
Consumer has feelings and Choice deliberation; Disappointment Impulse purchase 
preferences toward the favourable outcome 
product. 
'DO' DO LEARN FEEL (Conative Phase) (phase 3) (pbase 3) (pbase 3) 
Consumer now evaluates, Purchase Dissonance: Experience of product creates 
compares and buys I does not Change the product or favourable or unfavourable 
buy. Rationalise first decision decision for future purchase 
A positive outcome theory A dissonance· attribution A passive learning - decision 
theory theory 
Note: This table is the author's tabular summary of the theoretical hierarchies of effects which consumers may go through, in 
response to promotional messages. The extreme left hand column outlines the phases proposed by the researchers listed 
in the foregoing paragraphs. 
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These hierarchies are, in some measure, derived from Krugman's theory of passive 
learning, (1965: 349 - 356) formulated after researching television advertising effects. 
His hypothesis was that TV advertising communication was low involvement - low 
attention activity, leading to passive learning. Such communication is, therefore, not 
linked to needs, wants or even brand beliefs, as they would be in high involvement 
purchase decision making. 
Subsequently, Krugman argued that there was little opportunity for matching up needs 
with product benefits in this communicating situation, (Krugman, 1966 : 584 - 585). 
Grass and Wallace, (1974: 19 - 23) confirmed Krugman's findings relating to passive 
and active learning with regard to television and press advertising respectively; the 
latter because press reading was found to be a high involvement activity. 
In any proposed pharmaceutico-medical verbal seminar and workshop communications 
programme, for an agreed change project, the high involvement, hierarchical sequence 
of persuasion could be employed. Quality promotional articles in respected medical 
journals could also be a powerful means of communicating and reinforcing messages to 
the target GP audience, because of the high involvement nature of journal reading and 
theoretically improved response. 
According to Petty et al., (1981 : 847 - 855) the degre'e~ofindividual high involvement 
processing of marketing communications depends upon motivation, (needs dependent) 
which, in turn, is highly correlated with involvement in the message. 
Doctors experiencing increasing demands for quality and cost efficient prescribing, 
could be encouraged to become involved with messages conveying non-threatening 
solutions to their needs. Marketing communications strategies, based upon Ray and 
Petty's work have been suggested by Vaughn, (1980: 27 - 33) of the advertising 
agency, Foote, Cone and Belding and are summarised in the following Figure 13. 
117 
Figure 13 COMMUNICATIONS STRATEGIES RELATING DEGREE 
OF CONSUMER INVOLVEMENT TO RESPONSE THEORY -
THE FOOT CONE BELDING GRID 
Thinking Feeling 
High 
Involvement 
1. Informative (thinker) 2. Affective (feeler) 
e.g. car-house-fumishings-new products e.g. jewellery-cosmetics-fashion 
apparel-motorcycles 
model: Learn-feel-do (economic model: Feel-learn-do (psychological 
decision?) decision?) 
Possible implications Possible implications 
Test: Recall Test: Attitude change 
Diagnostics Emotional arousal 
Media: Long copy fonnat Media: Large space 
Reflective vehicles Image specials 
Creative: Specific infonnation Creative: Executional impact 
Demonstration 
Low 
Involvement 
3. Habit formation (doer) 4. Self satisfaction (reactor) 
e.g. food household items e.g. cigarettes-liquor-candy 
: 
model: Do-learn-feel (responsive model: - Do-feel-Iearn (social 
decision?) decision?) 
Possible implications Possible implications 
Test: Sales Test: Sales 
Media: Small space ads Media: Billboards 
10 second television adverts Newspapers 
Radio; point of sale Point of sale 
Creative: Reminder Creative: Attention 
Communication strategies, would, in this scheme, link variants of the alternative 
response hierarchies with variants of the do-feel-learn process as GPs would be in pilot 
trials of the new phannacy service. The cognitive infonnation processing concepts 
proposed in all the above models assumes that external messages and information 
generally are absorbed to one degree or another by the individual and converted to 
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organised data. This systematically arranged information (conscious or not) is then 
used to evaluate other information received and construct an attitudinal response by the 
recipient. Decisions to buy or not to buy are then said to be based on economic utility, 
(Hirshman & Holbrook, 1982: 92 -101). The degree of involvement of the consumer 
with the message, is linked in this matrix with the four types of learning response and 
potential implications for promotional strategies are set out under each alternative. 
Vaughn's strategies are not, however, held to be mutually exclusive. The four 
promotional variants are provided as a thinking matrix, rather than a guaranteed 
solutions route and are amplified as follows: 
i. Informative Strategy 
ii. Affective Strategy 
iii. Habitual Strategy 
iv. Self Satisfaction 
Strategy 
For highly involving services / products, 
where careful thought and economic 
considerations are relevant, e.g. Medicines 
Management - the learn-ftel-do sequence; 
For highly involving / feeling purchases; 
psychological and emotional motives 
should be emphasised; self esteem and 
image enhancement - thefeel-learn-do 
sequence; 
For low involvement / thinking products 
in the routines of life; learning may come 
from trial i.e. learning by doing (do-feel-
learn),' an4, 
For low involvement / feeling products; 
sensory pleasure and social motives are 
key issues; do-feel-learn sequence is 
operating. 
In this way, appropriate communications strategies can be developed after researching 
the target consumers' perceptions of the proposed product, in the aspects of 
involvement and thinking and feeling about the associated issues. This is likely to be a 
very important consideration in the selected approaches to GPs where culture and 
position in primary care needs to be considered. According to Sheth, (1979: 47) 
consumers receive information provided, combine it with other experiences and their 
existing store of knowledge and use this to make judgements. McCracken, (1981 : 32) 
comments: 
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' ... each culture establishes its own special vision of the world; this 
incorporates understanding and rules that have particular 
significance for its members ... I 
Finally, a model providing a further perspective on the way high and low involvement 
consumer audiences process persuasive messages is proposed by Petty and Cacioppo, 
(1983 : 3 - 23). In this model the researchers are attempting to explain the internal 
cognitive process by which consumer attitudes are influenced and lead to positive 
decisions, for or against the product. This so called elaboration likelihood model 
(ELM) parallels Krugman's theory of passive leaming, except that he was studying 
message exposure and consumer response, whilst the ELM perspective is related to 
how the consumer actually processes the information. 
The model suggests that elaborate processing of information takes place in the mind of 
the potential customer when they are highly involved with the proposition. This 
elaborate, high involvement position sits at one end of a continuum of potential 
customer response with low elaboration / low involvement at the other. 
Schumann et al., (1990: 192 - 203) also found that less involved consumers are 
influenced more by presentational variations in the message, (picture; colour; layout 
etc.) and highly involved consumers, by message content, in terms of product benefits 
and attributes. 
The elaboration likelihood model is set out diagrammatically in Figure 14 and depicts 
elaboration likelihood as being dependent upon: 
• motivation 
• ability to process the message 
related to individual needs and 
relevance; and, 
intellect and opportunity to think 
about the message. 
Involvement of the medical profession leadership in joint promotional approaches to 
selling the new service to GPs may be positively influenced by, perhaps, linking the 
service to providing doctor solutions to cost effective prescribing and improved patient 
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compliance, under the new NHS quality demands, (NICE). In this way, highly involved 
doctor audiences (with the medicines management rationale) could be managed to 
ponder and elaborate their own thoughts on the proposition whilst being encouraged to 
reach the desired conclusion. 
The elaboration likelihood model (ELM) may thus be engaged. (Figure 14) 
Figure 14 THE ELABORATION LIKELIHOOD MODEL 
OF PERSUASION 
PERSUASIVE MESSAGE 
t 
COGNITIVE ROUTES 
High Elaboration (Highly involved customers) 
of Message 
(Centrnl!"ute) 
Careful processing of information 
t 
Degree of attitude change depends 
upon quality of message, message cues 
important content and rationality 
ACTION· POSITIVE 
OR NEGATIVE 
Low Elaboration (Uninvolved customers) 
of Message 
(Peripheral ioute) 
Little cognitive effort 
- t 
Degree of attitude change is 
apparently automatic if it occurs 
at all; depends upon persuasion 
cues relating to source credibilityl 
prestigemkeability; (peripheral 
cues) style and form of message 
t 
ACTION OR NO ACTION 
(petty, Cacioppo & Schumann, 1982 : 143) 
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Persuasion message cues, (for example, quality of patient benefits) as used in the 
involved customer situation could help largely with doctor selection from a number of 
alternatives, whereas uninvolved customers are more likely to notice advertising 
messages by form, colour and character cues involved with the message delivery, 
(Gardener et al., 1990: 192 - 203). 
In addition to a consideration of conceptual perspectives on communications models, 
there are other elements in the message chain which are important to the process of 
persuading target consumers to acquire the product or service. These are considered in 
the following paragraphs. 
4.7 MESSAGE CHAIN 
The phases of the message communications chain are sequentially set out as follows, as 
conceptualised by Barnes et aI., (1997: 336) and show that messages are transmitted 
through factors which can affect the clarity and impact of the communication generally. 
Basically, five elements are shown as being present in the process, which also allows 
for message modification, through the feedback facility, in the light of experienced 
response: 
• Sender; 
• Message; 
• Channel; 
• Receiver; and, 
• Feedback. 
Figure 15 diagrammatically sets out the Barnes proposal. 
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Figure 15 A DEVELOPED MODEL OF THE MARKETING 
COMMUNICATION PROCESS 
Sender/source (1) 
Message (2): write and test 
Code (3): select and app ly Channel(4~ 
Validate: decode and verifY 
Channel: select and secure 
I 1..-___ _ 
(Barnes et. aI., 1997 : 336) 
Feedback 
Monitor: Each stage of the 
process 
Evaluate: Action taken 
Receiver (5) 
Channel: select and 
activate 
Decode: select and apply 
Validate: decode and verifY 
Message: read and action 
Note: Noise in this context, includes SUbjective iss~es which are socially, culturally or 
perceptually based and environmental factors, such as competitor communications or 
pre-occupation with general news items. 
The sender will be discussed in detail under source and opinion leadership, but it is 
noted for the present as being a crucial factor in the whole process. 
The message itself, it seems must take account of intellectual ability and the language 
culture of the audience; its expressions, implications, shorthand references and jargon. 
In using message jargon, the communication is then said to be 'encoded' and must be 
capable of being easily decoded by the recipient. 
Selection of the channel is also a key issue. Some journals are read in detail because of 
special interest and others are skimmed for items that catch the attention, similar to 
passive television advertising impact. Some journals are lightweight and some are 
respected, such as 'The Lancet' and 'The British Medical Journal' and so the channel 
123 
can greatly assist the impact of the message. Personal interaction between source and 
receiver, through verbal interchange with both parties present, is judged to be one of the 
most effective means of persuasion. Because of higher receiver involvement and ability 
to seek answers to queries, problems and apprehensions can be resolved and benefits 
emphasised, (Cash.& Crissy, 1965 : 56 -75). 
Kotler and Clarke, (1987: 436) list four main groups of channel tools, or routes by 
which the promotional message can be transmitted. These are shown in Table 23, 
together with some suggested applications to communicate the new product to GPs. 
Table 23 PROMOTIONAL TOOLS - PURPOSE AND APPLICATION 
IN THE NEW PHARMACY PRODUCT OFFERING 
TOOLS PURPOSE APPLICATION FOR 
NEW PRODUCT 
ADVERTISING Non personal mass ProCessional Journals; LMC 
communication Bulletins: HA Letters 
SALES PROMOTION Short tenn incentives to Research grants for pilot work, 
encourage the purchase/sale/or practice expenses, facilities for 
use of the product locums 
PERSONAL SELLING Oral presentation to prospective National, Regional, Local 
purchasers to gain uptake of the Seminars I Focus Groups I 
product offering : Workshops. LMC I LPC Joint 
-
meetings 
PUBLICITY Creation of demand for the Press conferences with the 
product-offering, through unpaid professional journals - Launch 
publicised media interest - progress - review - initiatives 
Note: The Kotler proposed tools and purposes have been extended by the author to suggest 
Specific applications in the medical context. 
Finally, there is the approach of the message content and its linkage with the 
prescribing problems, which have given rise to the proposed new pharmacy service 
offering. Should the marketing communication focus upon the serious effects of poor 
prescribing and risk creating doctor dissonance, that may be resolved in an unfavourable 
way by the medical profession? Alternatively, should the message portray an 
opportunity, based upon the growing complexity of modem drugs and the emergent 
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need for doctor leadership, in addressing and directing a new beneficial intervention in 
primary care? 
Festinger's theory of cognitive dissonance, (1957) indicates that when a conflict 
between attitude and behaviour arises, or when a strongly held belief is challenged, 
psychological dissonance arises. Usually this is resolved by screening out the offending 
stimuli (avoidance), or rationalising the stimuli to suit a preferred belief. 
It is suggested in this work that dissonant messages should be avoided in 
communications and positive focus is directed toward OP-Ied joint professional 
management of the complexity of modem drugs. 
The communications requirement is clearly a sensitive issue and guidance in this section 
has been sought from the literature on its application to some of the behavioural aspects 
of marketing. 
The receivers, their needs, aspirations, culture and situational factors need to be studied 
carefully and messages tailored accordingly. 
Feedback is essential to establish v,alidity, or otherwise, of the message and to further 
, 
refine the approach. Persuasive communication has be~n identified ideally as a two-
way process, with benefit to both parties. Feedback exposes attitudes, needs and wants, 
which when properly addressed facilitate persuasion. 
Schramm, (1995: 22) indicates that four conditions need to be fulfilled if the message 
is to be effective: 
1. The message must be attention getting; 
ii. It must employ common receiver experience and reference terms, to 
properly convey intended meaning; 
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iii. It must cause awareness of recipient needs and suggest the means of 
fulfilment, e.g. for doctors; product benefits and solutions delivered; 
needs satisfied; and, 
iv. The means of fulfilment should be appropriate to the recipient's peer 
group. 
The latter conditions, again point to cultural issues and relate, amongst other 
considerations, to the application of Maslow's Hierarchy of Needs, as also indicated in 
point iii above. Gilliland and Johnstone, (1997: 21) propose that contextual 
involvement is a strong influence on buyer behaviour and is linked to the buyer's 
personal sources of relevance, which are judged to be important, (such as peer group, 
respected sources of relevant information) as well as his or her own values and ego. 
Message source is thus an important consideration in promoting any new idea, 
especially in such a market as GPs, with customs, traditions and peer group values and 
norms of practice within primary care. Message source requires some detailed 
consideration. 
4.7.1 Message Source and Opinion Leadership 
Hovland and Weiss, (1951 : 635 - 650) in their early formative work on this subject, 
have shown that consumers in general, interpret promotional messages in the context of 
source credibility. Later workers in the field have found likewise, (Homer & Kahle, 
1990 : 30 - 39; Goldberg & Hartwick, 1990: 172 - 179). Wilson and Sherrell, (1993 
: 101 - 112) have also confirmed this effect in their meta-analysis of effect size in 
various studies. 
Kelman, (1961 : 57 - 58) argued three basic characteristics of source effectiveness; 
i. 
ii. 
iii. 
Credibility 
Attractiveness 
Power 
Relevant knowledge, expertise, authority; 
Similarity, likeability; and, 
Authority to give reward or penalty. 
126 
It is reasonable to postulate in the context of this thesis, that authoritative medical 
sponsorship, perhaps combined with National Health Service Executive (NHSE) 
medical division support, for example, may well fulfil characteristics i and ii. 
However, source credibility has been shown by some researchers to not be an absolute 
guarantee of message acceptance. Work by Sigall and Helmreigh, (1969: 70 - 78) also 
showed that where the message was threatening the credibility of the source did not 
increase message acceptance. This effect was observed in the early anti-AIDS 
advertising, which subsequently had to be changed. Where the consumer is more reliant 
upon past experiences, relating to a similar product or service, this becomes a precedent 
consideration, (Dholakia and Stemthal, 1997 : 223 - 232). Where the message appears 
to be against the consumer's best interest, this also overrides source credibility, (Eagly 
and Chaiken, 1975 : 136 - 144). This suggests that if medicines management as a 
service is perceived as threatening to doctor status then it could fai1. This in turn 
indicates a need for careful and sensitively worded promotional communications. 
These issues are clearly key considerations in marketing the new pharmacy service to 
doctors, both in formulating message content and for example, the use of medical 
leaders in supporting their proposition. 
, 
General research into source attractiveness may also have a bearing upon the 
consideration of selecting a medical authority as a source, or supporter, of the agreed 
presentational message to doctors about the new pharmacy package. Research by 
McGuire, (1985: 233 - 346) showed that source attractiveness does increase message 
acceptance and additionally a greater likelihood of message empathy is achieved when 
the recipients see the source as similar to themselves, (Woodside and Davenport, 1974 : 
198 -202). 
The concept of opinion leadership is closely allied to source credibility and 
attractiveness, and in the general market place personal influence appears to be used for 
a specific product or closely allied article only, (King and Summers, 1970 : 43 - 50). It 
would seem reasonable to suppose that this effect might actually be even more 
important in medicine where there are many specialities and different leaders in various 
fields. Additionally, featuring the opinion leader in public relations releases, or printed 
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articles, appears to add impact to the message, (Burroughs & Feinberg, 1987 ; 295 -
299) given that person's authority, relevance and knowledge of the specialist subject. 
The implication of the medico-pharmaceutical context may be that, for example, well 
kno'Wn professors of general medical practice, rather than medical secondary care 
specialists, could be a suitable choice of message source. Especially might this be so if 
they are perceived as defenders of general practitioner services, rather than critics. 
Interestingly, studies by Eagley and Chaiken, (1975: 136 - 144) indicate that both high 
and low credibility sources (for example, doctors and film stars) operating as message 
purveyors, are equally effective when arguing for a position against their o'Wn best 
interest. For example, the film star may convey an effective message in health, relating 
to, say, warning against certain plastic surgery operations when they have had such an 
operation themselves. This would apparently have equal weight with a doctor arguing 
the same theme. 
4.7.2 Summary 
The issue of persuasive communication in a marketing context is a complex process, 
involving the needs, wants, motivation and attitude of the target consumer. Models of 
, 
conceptual consumer response to persuasive messa~es have been proposed by 
researchers, as have various concepts of cognitive processing in the mind of the target 
consumer. Audience involvement with the message, because of its content and 
relevance, as may be the case with general practitioners and the subject of medicines 
management, is a key component of effective communication and requires careful 
consideration in the context of this study. 
The values and common group practices of strong cultures, such as the medical 
profession, can also affect the response to messages which attempt to engineer change 
in long-held customs. However, because there is a framework of reference to all these 
considerations, the communicator can at least take a systematic and structured approach 
to the task and review progress and feedback during any communications programme. 
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Each element of the message chain, source, message content, receiver and competing 
messages, all require careful address in constructing the communication strategy. 
Perhaps most noteworthy is the fact, proposed in the Barnes developed model of 
communications, that promotional messages are a two-way process, taking note of 
market feedback and adjusting message content accordingly. As Cearnal records, 
(1992: 23 - 32): 
' ... as audiences become more sophisticated, they demand a higher 
level of information before making a decision.. solid, data based 
information, prioritised and integrated, is required to ensure 
cost effective communication. .. ' 
4.8 CHAPTER SUMMARY 
This chapter has been devoted to exploring aspects of marketing which may be applied 
to the problem of: 
• Gaining acceptance of the new pharmacy medi~ines management service by the 
primary care medical profession; and, 
• Effecting change in primary care pharmaceutical service from supply to 
cognitive service, in conjunction with recognised organisational change 
techniques. 
4.8.1 The Medical Profession 
The new pharmacy service (or product) has the potential to be a perceived threat to 
doctor autonomy in prescribing and managing patient care. It also has the potential to 
increase doctor effectiveness in medicine treatment and enhance doctor image in both 
the patients' eyes and in the doctors' self perception, if properly handled. 
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Maslow's hierarchy of needs, although flawed in its hierarchical concept, is 
nevertheless recognised as being an appropriate tool, in describing common inherent 
human needs. Of these, the individual elements of Maslow's model which could be 
issues of address, are: 
• Safety needs; 
• Esteem needs; and, 
• Self actualisation needs. 
This is to say, safety from negative image effects and safety in committing some 
responsibilities to the pharmacist (Table 14). Esteem needs, to the doctor, imply self 
esteem and esteem from others, notably the patient and the pharmacist. The potential 
threat of negative image and loss of safety effects, as interpreted above, should if 
possible, be programmed out of all communications and implications of the proposed 
medicines management service. The route to achievement of these criteria could lie in 
promoting 'self actualisation' of the doctor, in directing the efforts of an extended health 
care team by the addition of a pharmacist and increased safety in having a new 
professional partnership participating in medicines management. All marketing 
communications therefore could benefit from promoting the medicines management 
service via this aim, be doctor ego~supportive and s~stain the cultural values of the 
medical profession, as generically described in Table 19. _ 
The tangible and augmented product, as illustrated in Figure 8, could also be tailored to 
promote this approach and appeal to medical conditional values, such as those set out in 
Table 19, Column 3. It follows that copywriting should be of a very high order, as 
should person~to-person promotion, consistent in this theme of 'doctor culture support' 
and presenting the new service or product as a doctor's extended team effort, which of 
course is consistent with the definition of medicines management (Jones and Tweedie, 
2001 : 248) 
'The systematic provision of medicines therapy through a 
partnership of effort between patients and professionals 
to deliver best patient outcome at minimised cost. I 
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Copy should be attention drawing, have real interest issues for the doctor sufficient 
ideally to create a desire to engage the service and act, in coming together with the 
phannacist, in collaborative medicines management (Figure 12). 
Opinion leadership could be helpful through engaging, for example, recognised doctor 
leadership in promoting the service, as well as highly regarded medical practitioners, 
possibly professors of general practice medicine, who are seen as being 'at the coal 
face'. Medical journal articles, collaborative pilot work between phannacists and 
doctors, local seminars for medical and phannaceutical practitioners are all potential 
routes of promotion for the new medicines management service. One crucial element of 
an ongoing campaign, which the new service will require until full national 
implementation is achieved, is meaningful feedback from the target market (general 
practitioners) on its response to the marketing of this product so that refinement can be 
introduced, aberrant messages programmed out and increasingly positive messages 
planned in. The ultimate aim is the construction of a partnership between phannacy and 
medicine through relationship marketing (fable 17), perhaps even into a formalised 
strategic alliance between doctors and pharmacists. In this concept, doctors and 
phannacists would jointly plan the future development of collaborative service and be a 
powerful influence on Government, as well as an alliance for patient benefit. 
This all indicates that the supportive marketing pro~amme needs careful thought, 
careful monitoring, nurturing and developing and the personal relationships with key 
medical people, nurturing and developing. Such a sample programme is 
diagrammatically represented in Appendix 3, page 420. 
4.8.2 Marketing in Pharmacist Role Change Management 
The problem here is slightly different in concept and in practice. Here, the phannacy 
profession is not overtly threatened by another profession encroaching upon its 
traditional territory, at least as a formal strategy. Covertly, it may be so via practitioner 
nurses, but certainly not as a government driven policy. By natural development from 
government strategy real opportunities exist for other professions to take up new 
potential pharmacy roles, including medicines management. 
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Pharmacy therefore is well advised to have a systematic programme of change for its 
members if it is to reach its goals of transformation ahead of potential competition and 
secure the new role. Unlike the medical situation. where new opportunities have not 
been formally offered for major role change. pharmacy which has received formal 
government encouragement to change. needs to be engaged in actively pursuing this 
advantage to fulfil its potential. 
The role of marketing here is to communicate motivational messages about the benefits 
of change and to give assurance that the wherewithal, in terms of knowledge and 
physical premises facilities will be made available. It is also to provide a framework of 
selected activity. whereby the techniques and methods of marketing can effectively 
assist progress and help create a positive forward view. Some market research is 
advisable to ascertain the concerns. if any. of community pharmacists in pursuing the 
new role. In this way any barriers to progress may be addressed. offering solutions and 
guidance on their pursuit. This research will assist in exploring such barriers by the 
fieldwork to follow. 
Additionally. because change of a transformational order requires careful structuring 
through well researched and tried methods. change models need selecting and at least 
some of their components targeting with effort. in this approach. by marketing 
techniques. Communications. to pharmacists once ag~. need to be sensitive and take 
into account cultural predispositions following traditional approaches anchored in 
outdated concepts. such as those relating to supervision. 
Again Maslow's concept of innate needs is important for pharmacists and in this case 
similar to those of the GP: 
• Safety needs 
• Esteem needs 
• Self actualisation 
needs 
Safe in moving to a new order of service 
Safe in moving some responsibilities to 
technicians; 
Higher order of service; greater recogtJ.ition 
Recognition by patients from more involvement 
in their illness care; and. 
Full use of the pharmacy degree; full 
contribution to patient health; fulfilment 
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of a complete professional service offering 
and recognised member of the primary health 
care team. 
Promotion of the need for partnership with medicine is a central consideration, as is 
construction of the new pharmacist / patient interface. 
Marketing communications based upon benefits delivered by MM, some of which are 
indicated by the Sheth-Newman-Gross theory of value categories, will again be 
important (Table 20). 
4.8.3 Marketing Approach Summary 
The potential marketing approaches indicated at this stage are illustrated in outline in 
the following schema, (Tables 24, 25, 26) and will be related, in due course, to the 
process of change management and its elements of intervention in effecting change. 
Table 24 indicates in the author's view where the elements of marketing can be targeted 
at the behavioural and cognitive perceptions of the OP to reinforce his / her status and 
build a collaborative relationship with the customer, the: ~octor. 
Table 25 sets out elements of the marketing mix and how these can be used to promote 
the new service to doctors through selected channels with consonant messages. 
Table 26 is also the author's suggested promotional approach, to target pharmacists with 
the right relationship messages for OP collaboration and also encouraging pharmacists 
themselves to engage the service. Tables 2S and 26 also tie in the principles of the 
motivational aspects based upon 'Lewin' and 'Maslow'. 
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Table 24 THE MARKETING MIX : BEHAVIOURAL IMPLICATIONS 
AND RELATIONSHIP MARKETING RELATING TO 
GENERAL PRACTITIONERS 
MARKETING MIX 
ELEMENTS 
BEllA VIOURAL CONNECTIONS 
(MASLOW) 
- FOR DOCTORS & PHARMACISTS 
RELATIONSHIP MARKETING 
IMPLICATIONS 
Product 
core} 
Attributes Self actualisation Customer (GP) culture 
Benefits Self esteem ~ATION preserved; customer autonomy ] -Tangible (MM) Augmented Packaging 
Branding 
Values Safety: f -" preserved; customer authority 
Utilities Attitudes and beliefs of expended and ongoing control 
Quality GPs dictate route & of process (MM) assured 
Promotion Consonant messages; 
evidence based; leader 
sponsored at national and ~ 
People 
Proce$$ 
Place 
local levels. Targeted at GP 
structures - PCTs, LMCs, 
Practices 
Skills training & 
audit of 
pharmacy input 
assured 
Structural processes; 
systematic programmes & 
pharmacist input; 
structured meetings; 
consistent recording & 
reports. GP led & chaired 
in joint meetings 
-. 
-. 
presentational theme 
-
Utility of patient 
satisfaction & doctor 
enhanced image. Doctor ~ 
ego protected. Self 
actuaJisation carefully 
emphasised 
Ongoing pharmacist 
training now essential; 
quality assurance 
measures are 
necessary. Clinical 
expertise essential 
Supportive of doctor 
lead & self esteem; 
also helps guarantee 
safety in clinical terms 
Doctor image as health 
-~ 
-. 
i 
-
Surgery for all decisions 
in prinCiple, prioritisation 
of focus, by disease group 
& programme content for 
each period GP -led 
-~ care lead is supported -. 
t Consonant Communications 
Emphasis on collaborative 
effort to help patient; 
pharmacist is additional 
support service for GP; 
minimises workload for 
increased returns in 
effectiveness of GPs 
t 
Doctor is part of reviewing 
pharmacists' input; contributes 
to modifications of service 
requirements 
t 
Doctor lead strengthened; 
partnership made 
comfortable. Confidence 
built in the relationship with 
doctor in driving seat 
I 
T 
Motivation to engage the 
service is supportive not 
threatening 
.. 
I 
Note: Author'S concept of where the elements of the 'marketing mix' can be applied to behavioural needs of doctors and 
pharmacists and the linkages with relationship marketing, leading to potential motivation of the GP to engage in the new 
pharmacy service. 
ABBREVIATIONS: 
GP General Practitioner 
LMC Local Medical Committee 
MM Medicines Management 
PCf Primary Care Trust 
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Table 25 SCHEMA OF MARKETING ACTIVITY IN A 
PROGRAMME OF INFLUENCE TO GPs IN 
ENGAGING IN MEDICINES MANAGEMENT 
MARKETING 
ELEMENT 
ELEMENT 
COMPONENTS 
PROPOSED CHANNEL 
OF APPLICATION 
The Product 
(or service) 
Promotion-
Via 
Place 
Psychology 
Core ] As tables 4 & 48 
Message is patient benefit 
Tangible -
Branded as 'OP Review 
Group'. Quality assured OP 
Chair - OP prioritisation 
of work 
Augmented 
(Fig. 8) Delivery at agreed 
intervals; simplified paper-
work; Installed at surgery 
for the prescribing review, 
audited by the group 
-
-
OPC & medicaljoumals 
series of PR articles 
Agree with GPC, LMCs, PCTs 
Use LPC locally. 
Individualise for each practice. 
DH agreed; Use internal OPC 
letters to members. Series of 
med journal articles jointly 
authored by docs & pharms. 
Via social services (SSDs) for 
elderly I disadvantaged. 
Patient Associations, e.g. 
Diabetes UK. Heart Foundation 
etc. SHAt; 
National & local pilot 
Engagement; LMC/LPC 
workshops; industry 
sponsored compliance 
seminars; PCT disease 
targeted initiatives; social 
services - elderly initiatives. 
Portray as OP support in 
busierNHS. 
Channel of message via 
direct mail and personal 
_ LPCvisits 
OP surgery for planning & ] 
Reviewing pharmacist 
recommendations. 
GP chaired and led. 
-
GP benefits clearly defined; 
patient benefits characterised 
as good reflection on GP. 
MM characterised as OP 
support - complementary 
not competitive 
GP self esteem promoted & 
Self actualisation as 
directing an expanded team _ 
Promoted through OPC, PCT 
andSHAs. 
To theme all communications in 
all channels at a 
psychologically consonant 
level 
i.c. Messages to be consonant & 
supportive orop cultural 
perspectives of their place in 
primary health care 
!+ Marketing management -+ t Maslow driven needs 
I , approach , approach t Relationship building orientation 
FUNCTION OF THE 
APPROACH 
Leader sponsorship and 
opinion forming 
Disseminates message at all 
levels for top - down and 
bottom - up change 
Engages government policy of 
local authority and NHS 
collaboration, with patients' 
involvement 
Supports OP control & avoids 
any loss of face I self esteem 
Supports medical culture of 
lead health care professional 
& image with major 
stakeholders 
Calculated to help reduce A ~ 
potential change barriers 
Note: ApplicatIon of marketmg prmclples I clements dIscussed ID the chapter as conceIved by the author, for an outlme 
promotional programme. 
ABBREVIATIONS: 
GPC 
GPs 
LMC 
LPC 
General Practitioner Committee 
General Practitioners 
Local Medical Committee 
Local Pharmaceutical Committee 
PA per 
SHA 
SSD 
Patient Association 
Primary Care Trusts 
Strategic Health Authority 
Social Services Departments 
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Table 26 SCHEMA OF MARKETING ACTIVITY IN COMMUNITY 
PHARMACYCHANGEPROG~ME 
MARKETING ELEMENT 
The Product 
Promotion - via 
Place 
Psychology 
Marketing management • +, 
approach I 
ELEMENT 
COMPONENTS 
eM' j As tables 4, 4a; message is: 
full use of pharmacist 
expertise 
-
Tangible 
Styling; branding; quality 
assured; reduced OP worle 
load; new patient 
Relationship 
Augmented 
Constant support for GP. 
Audited results - assurance 
for GP. Patient review at 
pharmacy - space & time 
saving for doctor 
-
National pilots; selected-
elements built into new 
contract - incremental 
introduction of components 
LPC I LMC collaboration 
industry sponsored seminars. 
Local monitoring schemes. 
SSD linkups. 
New professional fulfihru:D1.. 
-Pharmacy for patient review; 
patient - friendly; facilities 
for patient + partner + 1 
other + pharmacist - relaxed 
environment Surgery for 
treatments review generally 
-
-
Pharmacist benefits defined: 
Enhanced role in primary 
care patient & doctor 
partnership engages whole 
participative team effort. 
Professional fulfilment; 
Cognitive v. technician-like 
role at present 
Self esteem + self actual -
isation promoted 
-
Culture change through 
Maslow I Lewin approac 
~--------------~ 
I PROPOSED CHANNEL FUNCTION OF THE OF APPLICATION APPROACH 
Creates strong lead and 
Leadership bodies in pressure for change -
pharmacy. Pharm. Journals & universally visible indicates 
trade journals & internal universal momentum 
information supplements 
+ 
Internal NPA. PSNC, RPSOB 
news letter. CCA organis- Internal communications 
ational communications. strategy for themed approach 
Psychology strategy for OP - to doctors avoids OP feeling 
Approaches by internal news of being patronised or 
letters only manipulated 
An organised programme of Evidence base will be 
local promotion via LPCs & provided by national pilots: 
regional conferences but local OP I Pharm. 
structured ;resentation~ relationship building is of key importance in generating OP comfort zone. Dissonant 
PCTs&SHAs messages re-present service-
non-satisfYing work I rewards 
(Lewin's discomforting 
technique) 
Promoted via patient Pharmacy is a non-threatening 
organisations, local SSDs, environment. Additional 
LMC & PCT presentations. effort to create relaxed 
Message of professionalisation surroundings will help 
of premises and i1nage , pharmacist I patient interface. 
New physical amenjties Present service I environment 
inadequate in NEW NHS 
Targeted at a psychological Will encourage pharmacists to 
approach through MasloW'S see rewards in: 
needs principles + progressively 
unsatisfactory contract of Personal fulfilment 
service (1989 loss of cost +) Financial retum 
Visible importance in primary 
PSNC letters + LPC seminars care 
Journal I Trade press Stronger customer allegiance? 
Organisational systems -r~ Disconfirmation of 1 
approach present & momentum bui 
for ch8n~e 
Note. Author S outllOe of communications content I programme for commuDlty pharmacists. 
ABBREVIA nONS: 
CCA 
GP 
LMC 
LPC 
NPA 
Company Chemists Association 
General Practitioner 
Local Medical Committee 
Local Pharmaceutical Committee 
National Pharmaceutical Association 
PCT 
PSNC 
RPSGB 
SSD 
Primary Care Trust 
Pharmaceutical Services Negotiating Committee 
Royal Pharmaceutical Society - Great Britain 
Social Services Department 
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CHAPTERS 
LITERATURE RESEARCH AND COMMENTARY 
PART II 
ORGANISATIONAL CHANGE AND ITS MANAGEMENT 
This chapter is set out in eight sections, as follows: 
5.1 Introduction,' 
5.2 Outline History of Organisational Development; 
5.3 The Change Drivers and Strategic Capability; 
5.4 Theory of Organisational Development; 
5.5 Culture; Climate and Organisational Development; 
5.6 Leadership and Management - Roles; 
5.7 Motivation; and, 
5.8 Summary 
5.1 INTRODUCTION 
Organisational development and the change it demands, involves a complex of issues, 
some of which are not self-evident and do not emerge until after detailed analysis of the 
organisation's situation internally and in relation to its environment. Where 
management directive and the issue of suitable new rules would perhaps have succeeded 
in effecting successful change in earlier decades, consultation and consensus have now 
become the order of the day in modem society. Particularly, this is so in the context of 
this thesis, where independent pharmacists and doctors are required to substantially 
change the way in which they operate and interrelate. As will be seen later in the 
chapter, understanding of the term organisational change, cannot be taken for granted 
and the views of one local pharmaceutical committee on this subject are illuminating. 
Expressions such as 'leadership', 'strategic intent', 'motivation' and 'culture I were 
never mentioned by the LPC members in that discussion. 
137 
These crucial aspects of change will be explored in the following pages, together with 
an outline of the history of organisational development, which gives insights into the 
elements of the process and why they are important. The notes of the discussion at the 
LPC meeting are not offered as structured research, but simply a glimpse of the 
spontaneous views expressed by grass roots pharmacists about 'organisational change '. 
This chapter is important in identifying important change models and clarifying key 
elements of a wide ranging change process which may be suitable for community 
pharmacy in its potential role change. To the best of the author's knowledge, this is the 
first time such a comprehensive review has taken place of such models. 
5.2 OUTLINE HISTORY OF ORGANISATIONAL DEVELOPMENT 
Early examples of organisational practice, if not theory, can be traced back several 
thousand years from such diverse sources as The Bible and the writings of Xenophon, in 
ancient Greece. Exodus, circa 1490 BC, (Ch. 18, v. 13 - 26) records Moses as having 
delegated authority for jUdging people, to ' ... rulers of thousands '... 'hundreds ' ... 
'fifties '... 'and tens.' Structure, function, management and delegation were thus 
recognised as essential in dealing with an organisational problem involving considerable 
magnitude and complexity. 
Likewise, Xenophon, circa 370 BC, (Xenophon; trans., 1869 : 430 - 433) recorded a 
conversation between Socrates and Nicomachedes, discoursing upon the abilities of 
'Leaders', in the context of army organisation. Socrates is held to have said: 
r ... over whatever a man may preside, he will, ifhe knows what he needs 
and is able to provide it, be a good president, whether he have the 
direction of a chorus, a family, a city, or an army ... ' 
Perhaps, at the time, Socrates was simply illustrating a principle rather than expressing 
an absolute assertion. It is not necessarily true that individuals can scale up their 
abilities and competence in the way Socrates suggested. Other considerations enter the 
equation, such as personal courage, ability to lead very large groups of people, mass 
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communication skills and the strength of psychological constitution to cope with ever 
increasing responsibility, to name but a few. 
However, if such a point had been put to him, his proviso may well have been 
emphasised: 
' ... ifhe knows what he needs and is able to provide it... ' 
Therein lies the essence of the problem for pharmacy. The centrality of the issue, the 
quality of human resource in leadership, is well recognised in modem management and 
will be discussed later in the chapter. 
Notwithstanding ancient recognition of organisational problems, systematic study of 
organisational behaviour, in a more modem context, is usually attributed to the time of 
the Industrial Revolution. In the late eighteenth century Adam Smith, (1776: Chapter 
1) wrote comprehensively about the organisation of factory work and the relationship 
between equipment, labour and the economics of production. 
Some fifty years later, Babbage, a mathematician and scientist studying the organisation 
of work, concluded that there were fundamental underlying principles and systems 
applicable in a wide range of manufacturing activities, (Babbage, 1832 : 121 -140). 
Other researchers and writers, (McCallum, 1856; Metcalfe, 1885; Towne, 1886) 
pursued this line of thinking, the systematic arrangement of work procedures, and began 
to develop the principles of methodical arrangement of the job components and the 
labour resource in factories. Such workers in the field comprised the forerunners of 
what became known as the 'Classical or SCientific School of Management. ' 
Foremost in the latter field were Frederick Winslow Taylor, (1911), Gilbreth (1908), 
Gantt, (1919) and Fayol, (1949). Fayol took Taylor's systems of arranging the 
individual's working efficiency and applied them to whole companies and 
organisations. Whilst technically efficient, these rigid systems of labour activity, 
created psychological and social problems in the work place and were open to 
exploitation by management, (Gantt, 1919). Nevertheless, large corporations such as 
the Ford Motor Company, adopted the scientific management system on its production 
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lines and many of the principles still operate today in some vehicle manufacturing 
companies. 
Amidst the increasing complexity of the new manufacturing systems of the time and the 
effect on labour, other researchers were looking at alternative methods of addressing 
labour organisation and activity related to product output. They were particularly 
interested in 'people behaviour' rather than just behavioural efficiency. 
Such theorists became know as the 'Human Relations' school of thought led by such 
workers as Barnard (1938), Roethlisberger and Dickson (1939) and Elton Mayo (1933-
1949), the latter becoming famous for his studies at the Hawthorne Works of the 
Western Electric Company, USA. Here, the effect of worker participation in the 
experiments actually increased their efficiency in the work process, creating an 
enhanced effect, which would not have been the norm on the ordinary production line. 
This became known as the 'Hawthorne effect' in social research projects. 
The general approach of the 'human relations' school was to regard organisation of 
work forces as human co-operative systems, where interpersonal relationships were 
recognised as important and could be used to improve work efficiency. In due course, 
combined approaches using both scientific principles of efficiency and human resource 
relationships were brought together in a further group_of theories, known as 'socio-
technical' approaches. 
Trist and Bamforth, (1951 : 3 - 38) performed a series of studies in the coal mines of 
Yorkshire where the technology of new coal cutting machines was forcing 
reorganisation of the labour force. Management imposed a three shift system allocating 
separate tasks to each shift. The system failed and the miners got together themselves to 
sort matters out, forming what became known as the autonomous working group 
(A WG). Instead of differentiating separate distinct tasks to different shifts, all tasks 
were performed on each shift by the group on that shift. Thus production was 
continuous and each group (not individual workers) possessed, in total, the task abilities 
for each shift. The A WG became self-regulating, freeing management time for longer-
term planning. Production rose from 78% of theoretical maximum to 95%. The 
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concept spread world wide in the industrial economies and is still being used today in 
such companies as Volvo and Atlas-Copco. 
Prior to his studies on workforce organisation in the mines, Trist, based at the Tavistock 
Institute, London, had been working on individual and group behavioural problems and 
therapy. The purpose was the resolution of socio-psychological problems in the family 
setting. 
Bowlby, a medical doctor, also at the Tavistock Institute was simultaneously working 
on family group therapy in the context of mental illness, where he reasoned that family 
understanding and support could materially improve the patient's condition. Even at 
this early stage, (1945) Bowlby is recorded as having expressed the view that the next 
logical focus for his work was in organisational development, (Salter, 1992: 668). 
At about the same period in the USA at the Massachusetts Institute of Technology, 
Festinger, Radke and Lippett were also working on group dynamics, with the purpose of 
changing behaviour patterns in the discordant family situation. These groups eventually 
developed into training research workshops, involving what became termed action 
research feedback, (Marrow, 1969: 210 - 214; Benne et al., 1969: 100 - 102). This 
required a skilled group leader, or trainer, working with a group of people in their 
, 
interactive discussion topic and an observer assistant. '1?e observer fed back results to 
the trainer after the group session for analysis. Suitable adjustments were made for the 
next session, where the group in turn responded to the feedback from the trainer and 
observer. 
This procedure then developed into group members listening in at the original trainer / 
observer feedback session and correcting misinterpretations. The double feedback 
mechanism became very effective in effecting behaviour change of the group, (Coan, 
1991 : 11-15). 
This group behaviour change system was gradually trans-located into the commercial / 
industrial situation, with the intent of effecting organisational change in the workplace. 
The change of context was not successful to begin with, but refinements introduced by 
workers in their specialised field such as McGregor, became effective, (Beckhard et al., 
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1967 : 2). This researcher worked with an industrial relations executive at Union 
Carbide, forming an internal consulting group and delivered the required change for the 
company. He named the group the 'organisation development group', (Burke, 1965 : 
147 -149). 
This work merged well with earlier research by Tannenbaum in the 1950s, directed 
toward team building, (Tannenbaum et aI., 1954 : 3). The sessions dealt with 
interpersonal relationships, communications and socio-metrics, policies, procedures and 
inter-departmental relations, (Kallejian et a1., 1955 : 55 - 64). A modem definition of 
the word 'team' by Katzenbach and Smith, (1993 : 112) is: 
' ... a small number of people with complementary skills who are committed 
to a common purpose, set of performance goals, and approach, for 
which they hold themselves mutually accountable ... ' 
and such team effort is used today in effecting change in the workplace. It will be a 
relevant consideration in perhaps reconstructing regionally based teams of trained 
pharmacists as change agents, in effecting introduction of pharmacy's new role of 
medicines management. 
, 
Parker, (1990 : 30) researching into successful teams, ,has set out the characteristics 
found in all such groups, 
'Clear purpose; good participation; agreeable disagreement; 
consensus decision making,' clear roles for each member; 
shared leadership; self assessment. ' 
Such factors will be useful in considering change techniques in the movement of the 
pharmacy profession from supply services to cognitive servic;. Druker records, (1981 : 
24) that the capacity of individuals to handle change is limited and vested interest 
groups can also be major barriers to change, as was shown in Pettigrew's studies at ICI 
with Sir John Harvey Jones, (pettigrew, 1985). These issues may also need specific 
address within pharmacy. 
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Finally, in this brief outline of the history of general organisational development, three 
other modem approaches are worthy of mention: 
i. Total Quality Management (TQM); 
ii. Business Process Re-engineering (BPR); and, 
iii. Macro Systems business change. 
5.2.1 Total Quality Management 
Dale and Cooper, (1992: 12) define TQM as: 
' ... an organisation-wide effort to improve quality, through changes 
in structure, practices, systems and attitudes ... ' 
This approach to developing, or changing, the structure and culture of an organisation 
has been used very successfully by Japanese corporations in the last two decades. 
Perhaps as a consequence of the global growth of Japanese enterprise, TQM has been 
thought of by some as a Japanese innovation. 
, 
According to Clarke and Clegg, (2000: 217) however, ,TQM originated in the USA in 
the 1950s but was adopted most effectively by the Japanese soon after its publication as 
a concept. Its birth is credited to Deming, an American business consultant, (Wild, 
1995 : 582) and rests upon a number of key principles set out in Table 27, together with 
the author's view of suggested implications I corresponding measures within the NHS. 
Table 27, also contains references from the Government White Paper ... 'The New NHS: 
Modem, Dependable', indicating that some thinking at least, about reorganisation of the 
NHS, closely mirrors the principles ofTQM. 
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Table 27 PRINCIPLES OF TOTAL QUALITY MANAGEMENT 
AND MODERN NBS EQUIVALENTS 
TOTAL QUALITY MANAGEMENT THE NEW NHS: MODERN - DEPENDABLE: 
PRINCIPLES (Peters & Peters, 1991 : 23) WHITE PAPER (Refs. as shown) 
Primary emphasis on outcomes Patient health improvement; Commission for Health 
Improvement (pp. 4, 28, 49) 
Organisational Departments are each other's 'Interdependence' not 'Independence' (p.12) 
customers 
Measurement of Processes and results Clinical Governance and Audit, Quality Assurance 
(pp.47, 56,58) 
Competitive Benchmarking against the best in the Benchmarking; Perfonnance Frameworks (pp. 49, 
world 60,65) 
Continuous Search for defects and their elimination 'NICE' Patient Surveys; Professional Self Regulation 
(Japanese = 'Kaizen') (pp.29,58,59,66) 
Participative Management emphasis on teams I Partnership 'of users, carers and staff: 'Everyone in 
teamwork NHS should take responsibility to improve quality'; 
Development and improvement of staff (pp. 10, 17, 
51,52,66, 77) 
Continuous Training of Employees Human Resource development (p.St) 
Top Management commitment to the philosophy of Three Government White Papers promoting quality; 
Total Quality Management PM; Secretary of State for Health; leadership 
promoted (pp. 56,60 - 61) 
Note: This table seeks to expose similarities between TQM principles and some of the underlying 
themes of the Government White Paper. The right hand column is the author's view of the 
elements oflink-up. 
The same White Paper also underlines the importance of forward thinking and strategy 
as well as a new vision, (p.3). The Prime Minister, (Tony Blair) says: 
' ... we can again create an NBS that is truly a beacon in the world .. ' 
This strategic approach is again emphasised by Steele, (1993: 425 - 441) who asserts 
that for TQM to have full impact in an organisation, it is essential that there is clear 
'strategic direction' and undoubtedly this will be crucially important for pharmacy as 
the way forward is planned, within the new NHS environment. The whole culture of 
the organisation, which is based upon TQM, argues Sashkin, (1992: 4 - 5) needs to be 
anchored in teamwork. the generation of valid data (regarding change effects, processes 
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and progress) and continuous learning. These issues will be alluded to in examining the 
change programme later in the thesis. 
5.2.2 Business Process Re-engineering (BPR) 
This approach to the redesign of business processes was pioneered by Michael Hammer 
and fust published in the Harvard Business Review, August 1990. The concept was 
further developed by Hammer and Champy, (1993 : 32) and defined as: 
' ... the fundamental thinking and radical redesign of business 
processes, to achieve dramatic improvements in critical 
contemporary measures of performance, such as cost, 
quality, services and speed ' 
They saw this process as one which made 'quantum leaps in performance,' not 
incremental change. Interestingly, they view this as a top-down process, arguing that 
people lower down in the organisation do not have the knowledge or conceptual mind-
set to visualise the change that is needed throughout, (Hammer and Champy, 1993 : 
206 - 208). However, other workers in the field of BPR argue that everyone in the 
organisation can partake in the thought and action pr~cess, (Janson, 1992 I 93 : 45 -
53). The author of this thesis takes a similar view to Janson, based upon the study and 
work completed as a member of PSNC in community pharmacy, with regard to 
medicines management prior to the current research. 
In BPR, each process within the company is reviewed and radical redesign undertaken. 
Talwar, (1994: 43 - 45) sets out a spectrum of re-engineering intervention as: 
• Process improvement 
• Process re-engineering -
• Business re-engineering -
• Transformation 
parts of the process only; 
redesign of the whole process; 
redesign of the entire business architecture 
and all processes; 
re-invention of the business, i.e. what 
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• On-going renewal 
business are we in? - Re-think the whole 
purpose and philosophy of the 
organisation; and, 
constant review and improvement. 
So far as pharmacy is concerned, within the avalanche of change in the 'New NBS', it is 
the view of this thesis that stages four and five in the above list need special 
consideration in moving community pharmacy into a new order of service, through 
medicines management and interpersonal relationships with the patient and doctor. 
In the latter part of the twentieth century (1980s) interest turned to a different order of 
change, as large corporations such as British Airways, saw the need for company 
turnaround. Such wide scale change has been called transformational or second order 
change and is defmed by Levy and Merry, (1986: 5) as: 
' ... a multi-dimensional, multi-level, qualitative, discontinuous, 
radical organisational change, involving a paradigmic shift··· ' 
Culture change will be dealt with in detai11ater in this chapter. 
5.2.3 Macro Systems Business Change 
The nature of the business is re-conceptualised and change effected through multiple 
organisational development techniques. Intemalleadership training is required at board 
level and lower group levels. Normally a long period of time is involved and this is 
likely to be the case in community pharmacy. This is based upon experience of the past 
seven years to reach its present stage from the first UK published paper on the subject of 
a proposed new nationally recognised role for community pharmacists, managing 
patient therapy, (Tweedie, 1994: 507 - 508). 
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5.2.4 Section Summary 
Organisational structure and change has been recorded and practised for thousands of 
years in general society and especially in the development of battle forces and religious 
orders. Formal business organisation study and development has evolved through a 
number of strands, which have been classified into broad approaches: 
• The nineteenth century, early pre-scientific approaches to work organisation; 
• The emergence of the scientific school of thought in the early twentieth 
century; 
• The human relations school, recognising the need to take account of socially 
interacting forces in the workplace; 
• The socio-technical amalgam of principles which integrated systematic 
working, with sociological considerations and group behaviour; and, 
• Recent developments based upon quality pursuit, greater efficiency of 
business processes and transformational tec~ques for whole organisations, 
redefining the business they are in. 
The address of change in community pharmacy may well involve elements of all the 
above approaches in attempting to re-position the profession in the health care delivery 
chain. The mechanistic processes of dispensing, checking, supervision and pharmacist 
time apportionment, as well as knowledge development, will need to be addressed. A 
new patient focus, doctor focus and interaction between primary health care 
professionals, is likely to require a 'major paradigmic shift'. This is defined by Levy 
and Merry, (1986 : 5) in culture, from fulfilling the FPlO, as a medicines order, to 
conceptual cognitive address of the psychology and motivation of patient, physician and 
pharmacist in addressing medicines usage, in a new collaborative effort. 
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5.3 THE CHANGE DRIVERS AND STRATEGIC CAPABILITY 
It is generally accepted in the modem business management literature that the major 
change drivers in industry and commerce as a whole originate through the interplay of 
the following external influences in society, (Table 28) i.e. Politico-legal; Economic; 
Socio-cultural; Technological (p.E.S.T. analysis). 
Table 28 GENERIC P.E.S.T. ANALYSIS 
SOCIETAL CHANGE DRIVER EXAMPLE ELEMENTS OF IMPACT 
POlitico-Legal- Government policy and legislation on Health, 
Education. Taxation policy, Employment law, EU 
Trading arrangements 
Economic 'The Trade Cycle' - recession/recovery; 
Traditionally known 
inflation/deflation; employment levels; import/export 
balance (X - M); investmentJborrowing rates; stock 
as 'P.E.S.T.' market movements; 'Global economy'. 
analysis 
Demographics - age movement in population; 
Socio-Cultural redistribution trends in income; education 
availability, i.e. fee or free; emphasis on leisure, 
lifelong learning; consumer power and knowledge 
trends - quality expectations; media power. 
Exponential developments in IT systems; growth of 
automation in industry; global communications 
Technological_ speed; int~met access by growing segment of 
population and thus knowledge availability. 
-
Note: The left hand column, societal change drivers, impact upon the pharmacy domain directly and 
with speed. Infonnation technology and government policy have had far reaching effects in 
recent years. 
A suggested analysis of these effects, with respect to community pharmacy, is set out at 
Appendix 1, (page 413) but in addition to the above forces, there are the 'domain' or 
sector-of-industry forces, generating competition. These have been summarised 
generically by Porter, (Chapter 1 : 27, Figure 4) and comprise on the one hand 
competition for profit (as down the supply chain in community pharmacy) and 
competition for market share on the other. 
Supplementary to these overall forces within the business and societal environments 
another effective force for change lies within the organisation itself, the human 
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resource. Individuals with vision, who can see opportunity and room for improvement 
in overall organisational performance are also responsible for radical change in culture, 
structure, custom and practice. 
Such has been the case in community pharmacy where a dedicated group of individuals 
has designed and developed the medicines management proposal. However, it is also 
true to say that this same group was undoubtedly aware of the generic environmental 
change drivers as described above, impacting upon community pharmacy at the time. 
Table 28 summarises key issues arising from the P.E.S.T. analysis, (Appendix 1, page 
413) together with suggested implications for primary health care pharmacy. 
149 
Table 29 KEY ISSUES - PSNC AND COMMUNITY PHARMACY 
CHANGE DRIVER FOCUS OF IMPACf IMPLICATIONS - PSNC II\1PLlCA TlONS 
COMMUNITY PHARMACY 
I POLITICAL • NHS Policy and structure change; new pharmacy New case presentation for new funds; evidence based proposals New expertise in clinical pharmacology required; new 
I strategy; new emphasis on aged patients; NICE; to Government; anti-competitor strategy required; understanding relationship with other health care professionals needed -
competition for new services opened up. (LPS) of health economics; understanding of market research; interpersonal skills development for patient relationships; 
Collaboration of health professionals, an objective application of both the last two to case presentation at practice audit. New premises facilities for patient privacy ! 
of Government. Govemment level. consultation. Build relationships with PCfs. 
(The New NHS: Modern, dependable) 
ECONOMIC Proportion ofNHS funds devolved to local control Construction of local negotiating tearns - via LPC? Acquisition of new negotiating skills; time allocation for 
(HAZ I PCf). Government demand for maximal Responsibility for revised expertise in clinical practice - ongoing education; time allocation for new tasks! relinquish 
return on investment; value added practice in education modules accessed. Marketing expertise engaged for old slavery to label generation and dispensing. All 
favour. Increased investment in NHS. (The New local! national application, in constructing and selling new mechanistic tasks - delegate to technicians. 
NHS: Modem, dependable) service. 
SOCIO-CULTURAL Patient empowerment; growing knowledge I Strategic alliances with patient organisations (e.g. Heart Liaison with local GPs on OTC treatment protocols and 
awareness of health issues; healthy living = health Foundation) recommended; research of patient needs and wants referral information where necessary. System for 
promotion; healthy eating; self treatment for minor by disease group and by age group. harmonising OTC ! NHS treatments increasingly important as 
illnesses encouraged. more potent medicines transferred from POM to P. 
TECHNOLOGICAL Electronic prescriptions; 'supervision' by remote Assessment of skill-mix implication; development of review FPIO volume will be redistributed by electronic access to GP 
control; computer assisted medicines review. NHS software and diagnostic aids; patient concordance! motivation surgery and ease of pharmacy supply to local popUlations. 
net to be developed, onus for information exchange technique development. Greater pull oflocal patients to local pharmacy for 
between GPs and pharmacists. medication review and OTC prescribing. Loss to GP 
proximal pharmacies? 
• SET UP STRATEGIC GROUP-NATIONAL EVALUATION & CASE CtNSTRUCfION FOR VALUE Rt-INVENT PHARMACY ptCflCE & ADAPT TO BODIES ~~_~~ , ADDED REWARDS NEW WORLD,lI- Century 
• Ref: New NHS, Modern: Dependable 
Note: The above table is the author's view of the 'PEST' impact, in the market place of2001 and the required activity ofPSNC and community pharmacists to take advantage. 
ABBREVIATIONS 
FPIO National Health Service Prescription 
GP General Practitioner 
LPC Local Pharmaceutical Committee 
LPS Local Pharmaceutical Services 
NICE 
OTC 
P 
PCf 
National Institute for Clinical Excellence 
Over the counter medicine 
Pharmacy only medicine 
Primary Care Trust 
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POM 
PSNC 
Prescription only medicine 
Pharmaceutical Services Negotiating Committee 
5.3.1 Strategic Capability 
Although it is an accepted corporate practice to systematically address environmental 
influences in attempting to formulate forward strategy, some workers in the field of 
management have argued that excessive focus has been directed toward this approach, 
in other words, from the outside looking into the organisation. Such workers have 
proposed that an equally effective approach is through the analysis of internal resources 
and expertise together with new potential market opportunities, (Wernerfelt, 1984 : 171 
- 178; Collis, 1991 : 49 - 68). The core competencies of the organisation (internal 
resources) and its 'end products', according to Prahalad and Hammel, (1991 : 281) 
comprise the whole core product of the organisation. Assessment of the potential of 
these core competencies in planning strategy has, according to these authors, been 
under-utilised. 
This may also be true of community pharmacy and its current internal resources. In 
brief, these are its professionally qualified people, together with their physical premises' 
amenities. The current core role of community pharmacy is undoubtedly dispensing but 
is this its core expertise or competence? Surely not; surely its core expertise is its 
specialist knowledge base of medicines' actions and interactions, which is what the 
concept of medicines management is based upon. With respect to the importance of 
core knowledge, Druker, (1993 : 22) more specifically has said: 
' ... the productivity of knowledge is going to be the determining 
factor in the competitive position of a company, 
an industry, an entire country ... ' 
This has particular relevance to community pharmacy, where in the 'New NHS', new 
roles are not the prerogative of anyone profession. Several may compete for any new 
service and even some traditional services. For example, doctors, pharmacists and 
nurses may compete to deliver medicines management. Dispensing pharmacy 
contractors may, additionally find themselves in competition with peripatetic 
pharmacists, offering cognitive services only, or hospital pharmacists offering the same, 
(Figure 4, Chapter 1). 
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The strategic capability of the organisation, in this case the collective primary care 
dispensing pharmacy network, needs assessing, in tenus of its current and desired 
resources in order to position itself for any increased role in cognitive service. This is a 
task for the representative leadership body for pharmacy within the NHS contract, the 
PSNC. 
In turn, this implies a need for PSNC to examine its own internal resources and fitness 
to adopt such a leadership role. As part of the work for this thesis, the author set out a 
proposed new committee structure (since adopted) to equip PSNC for this work. The 
new titles and outline purposes of each sub-committee are set out below and amplified 
in Appendices 4 to 9. 
The sub-committee structure has been completely transfonued to focus upon creative 
strategic planning, marketing and resource development, instead of a largely 
administrative and bureaucratic processing of information based upon past routines and 
custom. The comparisons are shown in Table 30 on the next page. It can be seen from 
this that Wernerfelt's approach, (1984 : 171 - 178) to fonuulating strategy by examining 
internal resources / expertise has been employed, within the limitations imposed by the 
PSNC organisation and constraints, i.e: 
• Inexpert internal resources (committee members) well qualified in 
pharmacy, but not management specialities; 
• Inadequate time input from individual committee members who meet only 
eight times a year; 
• Small back-up office resource, again with few executives and none with 
speciality business management experience or qualifications; and, 
• Consequently no previous structured and systematic address of the market 
environment, i.e. the NHS. 
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Table 30 COMPARISON OF PSNC SUB-COMMITTEE STRUCTURE 
PRE AND POST 14th JUNE 2000 
PRE JUNE 2000 SUB COMMITTEE POST JUNE 2000 SUB COMMITTEE 
TITLE: Finance & General Purposes Resource Development & Finance 
ROLE: Administration ofPSNC fmances Development of human; fmancial; systems 
resources ofPSNC to facilitate achievement of 
strategic objectives. 
TITLE: AUDIT Review and Audit 
ROLE: Annual audit of fmances Quarterly review ofPSNC resources, activities and 
results; review of progress toward objectives; 
recommendations for improvement where 
necessary; corporate governance, quality assurance. 
TITLE: Contract & Policy Contract Planning 
ROLE: Process communications between PSNC Develop new approaches to DR policy; proactively 
and DH. React to DH initiatives; create take initiatives to DH; develop new contract 
PSNC policy on address of aspects of the proposals at national and local levels. 
dispensing contract. 
TITLE: Strategy Strategic Planning and Policy 
ROLE: Envision futures and construct strategies As before, but with systematic structured approach 
for address; identify strategic objectives, to the NHS I business environment, plus economic 
prioritise and pursue. analysis of the environment. 
: 
TITLE: Public Affairs Marketing a~d Public Affairs 
ROLE: Conference planning; administration of Development of new services and income 
communication with LPCs; liaison with potentials; promote to DH, GPC, Patient 
MPs when necessary and special organisations and LPCs. Analysis of health 
communications to Ministers. markets; market research; creation and promotion 
of issues to Inter-Parliamentary Group ofMPs to a 
regular programme; create marketing plans for new 
roles; create training packages for presentational 
skills. 
Note: Author's reconstruction of the PSNC structure and functions to address the 'New NHS'; 
implemented June 2000. 
ABBREVIATIONS 
DH 
GPC 
LPC 
MPs 
NHS 
PSNC 
Department of Health 
General Practice Committee of British Medical Association 
Local Pharmaceutical Committees 
Members of Parliament 
National Health Service 
Pharmaceutical Services Negotiating Committee 
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The strategic capability of the PSNC is thus assisted by the new sub-committee 
objectives which impose disciplined consideration of relevant future issues by the sub-
committee remits. However, it is impeded by the competency level of individual office 
and committee members in the relevant management disciplines. 
The exceptions to this analysis are, of course, the members who represent the vertically 
integrated companies. Even so, the author's discussions with these indicate that their 
individuals' experience is based almost solely in their own companies. They have no 
recognised qualifications in sophisticated management and marketing theory, 
economics or market research. Perhaps their head office resources possess such 
expertise, but do not share it with the PSNC. 
A further external impediment to strategic effectiveness is the limited global sum by 
which pharmacy contractors are paid. This has delivered diminishing profit returns 
since 1989, as shown in Table 30 and leaves little scope for additional new services / 
products, for marketing and fmancial return. 
However, discussion is underway (as at April 2002) to deliver a new contract, which 
may give scope for new services and new money, some of which may be accessed 
through local budgets. 
The strategic capability of PSNC, even if made effective internally, does need to find a 
route to relaxing the external constraints of funding and this may well be through local 
budgets via the Primary Care Trusts. This may, in tum, require central regulations to 
ring fence enhanced budgets for local medicines management needs at PCT level. 
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Table 31 COMMUNITY PHARMACY DISPENSING CONTRACT 
SHIFf IN GROSS PROFIT % 1989 - 2001 
YEAR GLOBAL SUM % GROSS PROFIT 
£M (CORE) 
1. 2. 3. 
1988/89 504.7 22.1 
1989/90 502.8 20.3 
1990/91 553.2 20.6 
1991192 601.4 20.0 
1992/93 631.1 18.9 
1993/94 640.6 17.5 
1994/95 655.3 17.3 
1995/96 671.7 16.6 
1996/97 692.7 15.9 
1997/98 709.3 15.2 
1998/99 732.4 14.8 
1999/00 755.1 13.8 
2000/01 777.8 13.1 
2001/ 02 806.6 13.0 
Note: 'Core' in column 3 means the core dispensing serv~ce excluding • oxygen' . 
Although it has been argued by Prahalad and Hammel, (1991 : 281) that core 
competencies are a key factor in determining strategic capability, and by the author, that 
the core competence of pharmacy is its medicines knowledge, the latter remains to be 
established. It is a claim frequently rehearsed by the profession and part of the research 
in this work is geared to investigating this supposition, in other words that pharmacy 
contractors' clinical expertise is up to the task of medicines management. 
The opportunities for cognitive service development and the core competencies of the 
organisation, in this case community pharmacy, need to be congruent, or to be made so, 
by adequate training, appropriate physical premises and equipment resources. If 
community pharmacy is not clinically competent, then this is a major barrier to entry 
into the new service. Other strengths and weaknesses need to be assessed. 
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The SWOT analysis, below, begins to expose the tactical position with respect to 
PSNC's and the profession's strengths and weaknesses as seen through the perception 
of the LPCs in Gateshead and South Tyne, as well as Sunderland. The opportunities 
and threats were also investigated. Here sessions were conducted by the author, 
amongst these politically aware, locally elected groups of people, who are all practising 
dispensing pharmacists, to gain their views upon the current situation of pharmacy in 
primary health care. 
The views cannot be generalised from these small purposive samples (n = 27) but 
nonetheless, constitute a qualitative 'taste' of what may, or may not, turn out to be a 
general view held by a wider audience. It was also mentioned to the LPCs that their 
views should be set against the background of planning the profession's move into 
medicines management. These groups are politically representative of the various 
factions in the community pharmacy service, in other words, 'multiples'; 
'independents'; and 'co-operatives' who have a more detailed awareness of the 
changing effects of the new NHS upon pharmacy than an ordinary contractor, hence 
their selection, as a useful reference group. The LPCs possess this knowledge through 
the volume of correspondence and communication with the PSNC. 
The strengths and weaknesses are what could be described as perceived matters of fact, 
whilst the opportunities and threats. may be morel ~peculative, because they are 
dependent upon LPC knowledge of the 'external' economic world outside pharmacy, 
which may not be comprehensive. Indeed, it could be argued that establishing the 
opportunities and threats for any organisation is an expert task requiring specialist 
informed views of external forces. Figures 16 and 17 summarise the LPC assessments. 
As the matrices are dynamic, the issues noted inside the quadrants can change position 
over time and in accordance with changes in the business / NHS environment. This 
exercise was conducted at Sunderland LPC on 12th March 2002 (12 present) and 
Gateshead / South Tyne LPC (15 present) on 19th March 2002 and amalgamated on 22nd 
March 2002 by the author. Flip charts were used to list the SWOT elements and then 
pre-prepared matrices explained, for inserting the appropriate prioritisation. 
Figures 16 and 17 set out strengths / weaknesses, opportunities / threats respectively in 
dynamic matrices for prioritisation purposes. 
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Figure 16 DYNAMIC SWOT ANALYSIS - PSNC & COMMUNITY PllARMACY - STRENGTIIS I WEAKNESSES 
High 
RELATIVE 
IMPORTANCE 
Low 
STRENGTIIS 
PSNC 
In depth knowledge of drug 
pricing mechanisms 
CP 
Wide range ofOTC products 
Relaxed relationship with patients 
WEAKNESSES 
PSNC 
No knowledge of'valuc' 
pricing systems 
No direct regular 
communications with 
contractors 
CP 
No formal presentation skills to 
approach new NHS structures 
Culture anchored in the past 
STRENGTHS 
PSNC 
Good relationship with PPA 
Good relationship with NPC 
Good relationship with RCN 
CP 
Potential to influence health promotion 
Friendly relationship with public 
WEAKNESSES 
PSNC 
No line authority with LPCs 
No line authority with 
contractors 
CP 
Mixed range of retailer I professional 
No formal structure of communication 
with other health care professions 
No formal requirement for updating of 
skills I knowledge 
STRENGTHS 
PSNC 
Regular access to high level Government and 
Civil Service 
Excellent relationships with GPC I BMA 
Patients' representative organisations 
Experience spans all sectors of community 
Pharmacy (CCA; CPTP; NPA; RPSGB) 
Determination to modernise 
CP 
Easy access via LPCs to HAslPCTsIHAZs; 
Social Services 
Strong patient I customer allegiance 
Widely distributed throughout the community 
Reduces workload on NHS 
Good relationships with GPs 
Willing to extend role 
WEAKNESSES 
PSNC 
Has to represent disparate agendas 
Minimal modern management resource or 
understanding 
Under resourced - manpower - new management 
expertise absent at executive level 
Little influence on funding 
CP 
Clinical expertise inadequate 
Premises not currently suited to patient 
consultation 
Workload distribution not conducive to MM 
STRENGTHS 
PSNC 
Good NHS law knowledge and advice to LPCs 
CP 
6 million people per day visit pharmacies - high 
public profile 
Cost effective service 
Reduces costs of drugs budget - NHS 
WEAKNESSES 
PSNC 
Only one of five representative bodies talking 
to government 
Known by DH to have divided interests 
Not a statutory body 
CP 
High proportion of non-professional products in 
pharmacies 
Low ....... 1------- MAGNITUDE OF STRENGTH/WEAKNESS ------------1~~ Higb 
ABBREVIATIONS: 
BMA British Medical Association 
CCA Company Chemists' Association 
CP Community Pharmacy 
CPTP Co-operative Pharmacy Technical Panel 
GPC 
I1AZ 
MM 
NPA 
NPC 
General Practitioner Committee 
Health Action Zone 
Medicines Management 
National Pharmaceutical Association 
National Prescribing Centre 
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PPA 
PSNC 
RCN 
RPSGB 
Prescription Pricing Authority 
Pharmaceutical Services Negotiating Committee 
Royal College of Nursing 
Royal Pharmaceutical Society of Great Britain 
Figure 17 
High 
RELATIVE 
IMPORTANCE 
Low 
DYNAMIC SWOT ANALYSIS-I'SNC & COMMUNITY PHARMACY - OPPORTIJNITIES I THREATS 
OPPORTUNITIES OPPORTUNITIES 
PSNC CP PSNC CP 
Collaborative links (formal) - with Expanded patient involvement Government policy supports new role; - New position in primary care 
universities 
THREATS 
PSNC 
Multiples growing influence through 
acquisition policy 
OPPORTUNITIES 
PSNC 
Greater liaison I collaboration with 
other pharmaceutica1lead bodies 
Structured links with pharmaceutical 
industry 
TlIREATS 
PSNC 
Multiples pressure to increase seats 01\ 
PSNC 
Low~ 
ABBREVIATIONS: 
BMA British Medical Association 
CCA Company Chemists" Association 
CP Community Pharmacy 
strengthens negotiation New partnerships with doctors locally - new 
IT communications - development services local money potential 
welcome - new money potential; assists MM Higher stake in primary care - bigger image 
potential Increasing availability of University I CPPE 
New MM service opens door for new negotiating training courses 
TlIREATS 
CP PSNC CP 
LPS may weaken national contract De-limitation of contract - 'free for all" Reducing income; more local control of funding 
Rise in technician importance to take Aggressive stance ofNP A in seeking Competing professions for local money 
over dispensing contract amalgamation 
Change ofNHS structures-less impact 
on local affairs? 
OPPORTUNITIES 
CP PSNC CP 
Greater pedestrian traffic flow - highe New local funds for pharmaceutical service with New partnerships at grass roots with special 
OTC sales as POM moves to P health promotion and LPS services - nurses; social services 
Support with local initiatives when New initiatives with RCN to position nursing in 
developed a complementary not competitive position in 
primary care 
THREATS 
CP PSNC CP 
Contract remuneration redistribution? Multiples acquisition of independents - profession Volume of prescriptions increasing - reduced fee 
Flow from independent to mUltiple dominance - PSNC dominance? for prescription 
Multiples control of new IT systems in NHS? 
LPCs to end; new bodies not yet decided 
LIKELllIOOD .... IJigh 
GPC 
MM 
NrA 
NrC 
General Practitioner Committee 
Medicines Management 
POM 
PPA 
PSNC 
Prescription only medicine 
Prescription Pricing Authority 
National Pharmaceutical Association 
National Prescribing Centre 
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Pharmaceutical Services Negotiating Committee 
It may be significant that both groups expressed the view that a weakness of the 
community profession was its clinical expertise. On questioning by the author, on both 
occasions, each LPC volunteered similar reasons for their perceived assessment, e.g. 
• "We have been commercially based for so long, the clinical skills have 
disappeared " (Sunderland) 
• "Commercial interests and the need to keep maximising NBS profit has blocked the 
development of clinical services. " (Gateshead & South Tyne) 
Whilst the author would not necessarily agree with the chosen positioning of all the 
issues within the matrices the situation is dynamic and each element could change its 
position over a period of time. Emergent from this SWOT analysis is effectively an 
implied resource audit and opportunity options. The resource audit is commonly 
analysed under four headings: 
i. Human Resource 
ii. Intangible Resources 
iii. Physical Resources 
iv. Financial Resources 
Skills; adaptability; gaps between present 
and desired states; 
Image; stakeholder relationships; 
goodwill; 
Extent of distribution; equipment; 
amenities in' dispensaries and retail units; 
and, 
Source of funding; cash flows; relevant 
finance institutions; market stability. 
Table 32 links the exposed community pharmacy resource strengths / weaknesses, with 
opportunities, giving key address issues in repositioning pharmacy within primary care. 
Table 33, a so called 'TOWS' analysis, outlines strategies / activities to manage the 
strengths and weaknesses, opportunities and threats inter-relationships. The TOWS 
analysis matrix, designed by the Harvard Business School, provides a devise for briefly 
summarising link-up strategies to address the strength and weakness / opportunity and 
threat components of the SWOT analysis. 
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Table 32 RESOURCE AUDIT: OPPORTUNITY LINKS 
KEY ISSUES OF ADDRESS 
RESOURCE: OPPORTUNITY KEY ISSUE 
STRENGTHS & 
WEAKNESSES 
HUMAN - Qualified Conversion from supply Address of clinical / 
pharmacist degree based service to cognitive pharmacology knowledge -
upgraded (M. Pharm). role in MM. Greater tailored training courses to 
Clinical skills of present professional satisfaction suit market needs and time 
workforce questioned. and ftnancial reward? constraints. Options in 
Close gap with new skills training route are 
and training packages from important. 
universities and CPPE. 
INTANGIBLE - Image More in-depth friendly Polish the image; create 
with public held to be service to patients (MM) - more professional 
good; strong patient patient collaboration, in atmosphere with 'qualified' 
allegiance; friendly new support service made back up staff; improve 
atmosphere of pharmacy; easier / encouraged. interpersonal and 
good GP relationships. presentational skills. 
PHYSICAL - Premises Transform service into Create in-store privacy / 
not geared to consultation recognisable primary health conftdentiality facility; 
with patients; are set up for care professionalism; professional visual aids and 
merchandising; re- shadow the doctor IT amenity; consultation 
allocation of priorities is amenities; create right facility to accommodate 3 
necessary, but geared to image in perception of GPs people - pharmacist, 
finance availability. and patients. : patient, one patient helper. 
-
FINANCIAL - From DH Create new value-added Create new presentational 
for NHS contract; services worthy of expertise; case 
dependable, secure, but attracting new money in construction; new experts 
inadequate for new roles. DR perception. at PSNC level; new 
New money required. approaches at local PCT 
level via new training 
packages. 
Note: The above table is the author's extrapolation of the major SWOT analysis elements to clarify key 
issues of address in moving pharmacy into the new service. 
ABBREVIATIONS: 
CPPE Centre for Pharmacy Post Graduate Education 
DH Department of Health 
GPs General Practitioners 
MM Medicines Management 
NHS National Health Service 
PCT Primary Care Trust 
PSNC Pharmaceutical Services Negotiating Committee 
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Table 33 TOWS ANALYSIS - COMMUNITY PHARMACY PROFESSION 
STRATEGIES I ACTIVITIES TO MANAGE SWOT ANALYSIS 
ABBREVIATIONS STRENGTHS (S) WEAKNESSES (W) 
DH Department of Health 1. Strong patient allegiance; liked by public 1. Clinical expertise inadequate· 
GPs General Practitioner 2. Wide range of OTC medicines 2. Premises not suited to patient confidentiality· 
IT Information Technology 3. Good relationship with GPs 3. Current workload precludes extra cognitive roles· 
LPS Local Pharmaceutical Services 4. Willingness to widen role in primary care 4. Inadequate presentational! interpersonal skills· 
MM Medicines Management 5. OTC service reduces pressure on NHS 5. Mixed image - retailer' profession 
NSF National Service Framework 
OFT Office of Fair Trading 
OTC Over the counter medicines 
PCT Primary Care Trusts 
RPSGB Royal Pharmaceutical Society 
OPPORTUNITIES (0) STRENGTH-OPPORTUNITY STRATEGIES WEAKNESS-OPPORTUNITY STRATEGIES 
1. Construct integrated OTClNHS medicines service for 1. Engage new skills' training programmes to clinically 
1. New local services for PCTs patients - prevent interactions equip contractors - Distance learning· 
2. New national cognitive service MM - Government 2. Target medicines management on disease groups with 2. Install confidentiality facility in each pharmacy; with IT 
backed NSFs - collaborate with GPs links and space for 3 people· 
3. New position in primary care 3. Attempt to add LPS to national contract not substitute. 3. Move more mechanical work to technicians - ensure 
4. New partnership with social services - new money Present case for national benchmarking of national universal technician 'qualification'· 
5. New funding for LPS? contract; tailor additional LPS to local needs 4. Train pharmacists in interpersonal' presentational skills 
for p_atients and PCTs· 
THREATS(T) STRENGTH-THREAT STRATEGIES WEAKNESS-THREAT STRATEGIES 
1. De-limitation of contract - reduced income 1. Emphasise to DH patient' professional relationship and 1. Present case to OFT for new pharmacist' patient 
2. Competitors, take up new role opportunities pharmacists growing importance. Closures and openings relationship - similar to doctor - delimitation militates 
3. Decreasing profit in dispensing contract create instability and fragmented relationships against improvement with quality services 
4. LPS may weaken national contract 2. Build on medicines expertise; unique ability· to 2. Proceed with pharmacist training' skills upgrading -
5. Rise of technician power- 'take over' dispensing· intervene in real time for OTC ! NHS conflict in keep ahead of competition 
medicines· 3. Encourage technician training and bring under umbrella 
3. Attempt to add LPS into contract - not replace National of RPSGB authority - Pharmacist control of situation 
Contract. Preserving national contract helps eradicate 4. Proceed with new contract case 
post code variance (benchmarking). Develops a strong 
case 
---- --
Note: Author's extrapolation of the SWOT analyses from Sunderland and Gateshead LPCs into outline strategies of address. The key issues are marked thus, • 
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5.3.2 Section Summary 
The change drivers affecting community pharmacy, as with all organisations, arise from 
the political, economic, sociological and technological influences of society, as well as 
the competitive forces of the domain. Especially is this so for pharmacy as it is part of 
primary care and subject to political drive and intervention. Additionally, there are the 
internal drivers of change arising from those members of the profession who have 
studied the strengths, weaknesses, opportunities and threats relating to the profession's 
future. 
Strategic capability (fitness for the future) may be determined to some extent at least, 
by addressing the above factors and making appropriate responses, such as those 
outlined in Tables 29, 32 and 33. The PEST, SWOT, RESOURCE AUDIT and TOWS 
analyses all point toward similar key issues of address, which will be considered again 
later in this thesis. 
It has not been the practice of the profession to routinely think in a structured way about 
its future. The RPSGB did so as a particular exercise in 1998 (pharmacy in a New 
Age). but without a structured operationalisation programme to implement their 
strategy. 
-
As far as the PSNC is concerned it remains to be seen whether it is capable, after its 
own comprehensive restructuring of engaging in a programme of effort to achieve its 
aims. The connection between strategy and effective change activity is now crucial to 
achieving transformation of the pharmaceutical service in primary care to achieve 
primary resource I environment fit for the future. 
In seeking to reposition the profession in primary care, strategic capability is of the 
most fundamental importance; at PSNC level as well as the profession generally. The 
issue of the PSNC will again be addressed under 'leadership and management roles' 
later in this chapter. 
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5.4 THEORY OF ORGANISATIONAL DEVELOPMENT (OD) 
In organisational tenns, the primary care phannaceutical profession is comprised of 
single independent contractors, independent vertically integrated multiples, co-
operatives, independent and publicly quoted multiples. In structural I cultural tenns, 
these equate to power cultures (independents and independent multiples) with the 
remaining list of companies being role cultures. The 'profession' of pharmacy, 
however, is conducted by individual phannacists working within these commercial 
structures. 
OD is directed at effecting beneficial change through people and, in tum, has an impact 
upon organisational structures and systems, dependent upon the nature of the change 
desired. The history of the general development of organisations has been described in 
the introduction to this chapter but the specialist term organisational development has a 
more specific meaning, derived from the early work of researchers in the 1940s, centred 
upon 'group' dynamics and individual behaviour change. A number of specific 
definitions which have evolved over time help clarify the concept, whilst showing slight 
variations in emphasis. Organisational development is: 
i. (Bennis, 1969 : 2): ' ... a response to change; a complex educational 
strategy intended to change the beliefs, (lt~itudes, values and structure of 
organisations, so that they can better adapt to new techniques, markets 
and challenges, and the dizzying rate of change itself'; 
ii. (Margulies & Raia, 1972 : 24): ' ... a value based process of self 
assessment and planned change, involving specific strategies and 
technology, aimed at improving the overall effectiveness of an 
organisational system '; 
iii. (Beer, 1980 : 10): ' ... enhancing congruence between organisational 
structure, processes, strategy, people and culture; developing new and 
creative organisational solutions and developing the organisation's self 
renewing capacity '; 
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iv. (Burke, 1994 : 12): ' ... planned process of change in an organisation's 
culture, through the utilisation of behavioural science, technologies, 
research and theory'; 
v. (porras & Robertson, 1992 : 272): ' ... a set of behavioural-science based 
theories, values, strategies and techniques, aimed at the planned change 
of the organisational work setting, for the purpose of enhancing 
individual development and improving organisational performance, 
through the alteration of organisational members' on-the-job 
behaviours '; and, 
vi. (Cummings & Worley, 1993 : 2); ' ... a system-wide application of 
behavioural science knowledge, to the planned development and 
reinforcement of organisational strategies, structures and processes for 
improving an organisation's effectiveness. ' 
The author of this thesis contributes the following defInition: 
' ... enhancement of part or all of the organisation's structure, systems, 
resources and culture to better equip it for improving its performance. ' 
There are other deftnitions in the literature but all ultimately relate to the behavioural 
change of people who, in turn, effect beneftcial modifIcations of organisational 
behaviour in some way. Even when people are not mentioned as such (ii, iii and vi), 
they are there by implication through such tenns as 'beliefs: 'strategies : (people) or 
'culture, , which is a 'people phenomenon'. Whilst there are clear differences in focus 
of defInition, i.e. on technology (ii and iii); on externalities (i); and, internal effIciency 
(iv and v), the whole overall thrust, by implication, is toward creating greater 
effectiveness of the organisation's business in its domain and wider environment. In 
pharmacy and to a lesser extent in medicine, behavioural change will be essential in 
moving pharmacy into cognitive medicines service. New inter-professional 
relationships need developing, attended by new responsibilities for doctors and 
pharmacists. Some role 'exchange' will also be involved in transferring patient 
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medicines review from GP to pharmacist. This could signal inter-professional rivalry 
and must be avoided to achieve a smooth transition. 
It is apparent that there are two main approaches to implementing change within an 
organisation: 
• The planned approach; and, 
• The emergent approach. 
OD falls within the former approach and is a highly structured intervention to deliver 
beneficial change. The latter school of thought, views change as adaptive to the 
environment and is reactive to various influences when they arise on an iterative basis. 
Some writers go further; Pettigrew, for example, (1987: 649 - 670) argues that 
prescriptive models of change do not equate to the reality of the workplace situation, 
which is 'politically' driven, either for or against change. Change efforts are thus messy 
and anything but systematic and continuous. The theories of change thus have not, 
according to Sashkin and Burke, (1987: 401) reached an agreed synthesis. 
Having said this, it seems to the author that those writers who adopt the 'emergent' 
approach and argue that issues of change can only be tackled when they arise, leave 
themselves to the mercy of the environment in a much more dangerous way, than those 
who try to plan ahead. The approach in this thesis is that having analysed in some detail 
future prospects for pharmacy in primary health care, there is a need for planned, 
systematic approach to change in pursuit of clearly identified objectives, 
• repositioning pharmacy in primary health care, from the end of the supply 
chain to a co-authorship of medicines selection with the GP; and, 
• effecting role change from simple drug supply, to full medicines 
management in support of patients and doctors. 
In this situation, the NHS environment with its present universal restructuring and 
quality drive, the magnitude of change facing pharmacy is transformational, as 
illustrated in Figure 18. Because of the political initiatives driving change and a 
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specific White Paper for pharmacy, 'Pharmacy in the Future' it is the author's belief 
that a structured approach to change is preferred and is pursued in this thesis on the 
basis that future directions have been clearly signposted for the profession. 
Many organisations do not have the benefit of such clear possibilities as options for the 
future. 
Figure 18 
Strategic 
SCOPE 
OF 
CHANGE 
Tactical 
ORDER OF CHANGE FACING PHARMACY 
- PRIMARY HEALTH CARE 
TURNAROUND TRANSFORMATION 
Pharmacy in Primary 
Health Care 
REJUVENATION ADAPTING 
Evolutionary Revolu tionary 
Note: The above four commonly accepted categories of chang~ show the author's perception of the 
order of change facing pharmacy. The transformation -equates to a new order of service 
engaging in new doctor / patient relationships and role change for pharmacist and technician. 
Diagnosis or investigation of organisational behaviour appears from the management 
literature to rest upon a number of precepts which have been researched or developed 
over time. Since the 1940s and Lewin and Trist's work on group and individual 
behaviour, much modem thinking seems to derive from their research. Diagnosis of an 
organisation's position in its operating environment usually forms one phase of 
corporate strategic decision making, even when the decision process is not highly 
structured, (Mintzberg et al., 1976 : 246 - 275). Deciding 'futures' for a 'present' 
organisation involves a review of current resources, strengths and weaknesses, to enable 
the planning of progress and this has been done for pharmacy, in outline, earlier in the 
Chapter, pp. 157, 158, 160. 
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Models of organisational diagnosis and intervention have been developed to focus on 
certain organisational features, which are held to be key areas in determining the 
success of the enterprise. In using models in this way, managers, consultants and 
researchers are assisted in guiding specific activity which is calculated to result in 
beneficial change. Harrison and Shirom, (1999; 11) argue that: 
' ... Models can contribute more directly to diagnosis than can whole 
bodies of theory ... because models are generally simpler, 
less determined and less fully specified .. ' 
Additionally, models appear to serve as frameworks for organising data for feedback 
and communicating it to participants in the research (via surveys), (Lundberg, 1989: 61 
- 82; Schein, 1993 : 653 - 661). The complexity of pharmacy's position does require a 
'model' approach to ensure capture and address of key relevant issues. 
Surveys also, form a routine part of organisational development activity in obtaining 
data from individuals for analysis and feedback. 
Two other perspectives, or frames of reference in organisational analysis are worthy of 
note. Firstly, the conceptualisation of organisations as 'open systems' in active 
exchange with their surrounding environments - external or internal, (Von Bertalanffy, 
1956 : 23 - 28). Secondly, they can be seen as political domains, where sub-surface 
dealing is conducted outwith recognised structures and machinery, (Bennis, 1969 : 80 -
84; Pettigrew 1975 : 191 - 208). Politics in organisational settings have been defmed 
by Moyes and Allen, (1977 : 672 - 678) as: 
' ... the use of power, to modify or protect an organisation's exchange structure ... ' 
A 'system' in organisation development is defmed by Bertalanffy (1956: 1-10) as: 
' ... a set of elements standing in interaction ... ' 
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and by Hannah, (1990: 12) as: 
' ... an arrangement of inter-related parts ... 'arrangement' 
and 'inter-related' describe inter-dependent elements forming an 
entity that is the 'system '". ' 
A system is recognised as having inputs, throughputs and outputs, each of which must 
be in balance with the other for efficiency and each of which has a boundary which 
defines it. Much of the basic theory of organisational systems comes from Trist's work 
in the 1950s at the Tavistock Institute, London, in his socio-technical systems research. 
This concept was extended in the 1960s into open systems planning, a technique for 
addressing the interface between the system and its environment, (Hannah, 1990 : 12). 
Systems theory is thus a basic tenet of OD, theory and practice and is involved in 
managing organisational change at some point in any change process. Systems 
mapping is, therefore, a useful tool to expose the key systems within any organisation 
and, in consequence, potential targets of change effort. 
The planned approach to organisational change consequently addresses systems 
diagnosis by modelling the inter-related elements of the organisation. The change effort 
uses survey and interview work, with organisational members to provide the data. 
Models, consequently, serve a number of purposes; they: 
• categorise data within specific organisational systems and make handling 
easier; 
• help interpret data; 
• map out trouble areas by category and give relativity to problems; 
• therefore assist problem diagnosis and identify routes of change; 
• provide a common shorthand language for handling complex concepts; and, 
• assist understanding of the context and nature of the problem. 
For this reason, a study of some of the better known models of organisational diagnosis 
and change is necessary to give insight and direction to the course of pharmacy change 
being explored in this thesis. It is also essential to the process of selecting, if possible, 
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an appropriate model of change on which to base change effort in moving community 
pharmacy from its present to future desired position with medicines management in 
primary health care. 
Such choice, however, should not preclude the use of elements of other models if 
deemed necessary, as most, in any case, are rooted in Lewin's research of the 1940s in 
effecting behavioural change in individuals and groups. 
The following section, therefore, describes and comments upon notable models of 
change which have been used in practice to effect change in the organisational setting. 
This study is essential to arrive at a conclusion as to which model is best suited to the 
change required for community pharmacy. 
5.4.1 Models of Organisational Diagnosis and Change 
The models investigated in this section of the work are: 
5.4.1.1 
5.4.1.2 
5.4.1.3 
5.4.1.4 
5.4.1.5 
5.4.1.6 
5.4.1.7 
5.4.1.8 
5.4.1.9 
5.4.1.10 
5.4.1.11 
5.4.1.12 
Kurt Lewin's Model and Schein's development thereof; 
Tichy's Strategic Rope Model & TichY'sframework: 
The Nadler-Tushman Congruen:ce Model; 
The Berger-Sikora Change Model; 
HA Y Organisational Diagnosis / Change Intervention Model; 
The McKinsey 7 S's; 
Silverweig and Allen's Model; 
Bunker & Alhan - Whole Systems Change Approach; 
Action Research Model; 
Multi-Source Feedhack; 
Burke-Litwin Model of Change; and, 
Weisbord's Six Box Model. 
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5.4.1.1 Kurt Lewin's Model of Change 
As previously mentioned, Lewin was an early researcher into group dynamics and 
behavioural change at individual level. Whilst he viewed change as an ongoing process, 
he conceptualised it as taking place in three stages, (Lewin, 1951) i.e.: unfreezing the 
old behaviour, shifting to new behaviour, and re-freezing the new behaviour. 
Lewin's concept was later built upon by Schein, (1964; 199 - 213), Trice and Beyer, 
(1984 : 653 - 669) and Isabella, (1990: 7 - 41). The phases of Lewin's original 
concept were elaborated by Schein and are described below. 
Unfreezing of the undesired behaviour was achieved by creating the evidence of failure 
of the current position and thus evoking disconfirmation that the situation as it stands is 
acceptable. This required, according to Schein, three different processes to motivate the 
individual to change. Thus unfreezing involves: 
1. Sufficient disconfirming data to cause serious discomfort and 
disequilibrium in the present state; 
11. Connection of the disconftrming data to important goals, which cannot 
be achieved without moving - so causing anxiety and guilt; and, 
iii. Sufficient psychological comfort I safety in terms of resolving the 
problem and changing behaviour without loss of identity or integrity; 
thus allowing the discomforted party (parties) to admit and accept the 
disconftrming data, rather than defensively deny or reject it. 
This tripartite unfreezing stage related to pharmacy, may include emphasis on the 
progressively dwindling monetary I satisfaction position within the present national 
contract, together with the potential threat of strong competition for new funding from 
new roles. However, if the new goals for change are perceived to be so far away from 
current practice, even disconftrming data may be denied or rationalised and explained 
away, (Henderson & Clark, 1990: 30). This could possibly be the case for pharmacy, 
'we know dispensing remuneration is going down, but we covertly make extra profit on 
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reimbursement ... and new role payment may be sourced from the present global sum' 
(comment from Sunderland LPC). 
Once unfreezing of the old perspectives has been achieved then, what Schein calls 
cognitive restructuring must take place to achieve the new goals. In pharmacy's case, 
this is complete role change from overall mechanistic dispensing processes into 
cognitive service with the patient and doctor. New core perspectives must then be 
constructed in the organisational culture; new values, beliefs and assumptions. The 
approach in community pharmacy may also lie in reinforcing beliefs that the 
pharmacist's expert knowledge can be profitably and more satisfyingly employed by 
applying it in a new way, in other words, through medicines management. 
Such new beliefs and perspectives may then, according to the Lewin I Schein process be 
re-frozen by issuing confIrming information. For pharmacy this may be, for example, 
evidence of new role acceptance by the NBS together with suitable NBS rewards and 
stakeholder support. This could be effected through successful pilot trials, showing real 
benefit to government and consequently, DB commitment to fair additional funding for 
pharmacists. 
As Schein (1992 : 303) puts it: 
-
'Once confirming data from important environmental sources, 
external stakeholders, or internal sources are produced, 
the new assumptions gradually stabilise ... ' 
Research by Isabella (1990: 7 - 41) led to re-conceptualisation, by her, of the 
'unfreezing', 'moving' and 're-jreezing' phases of Lewin's change model as 
'anticipation', 'confirmation' and 'aftermath " as seen from the point of view of those 
managers having to undergo an organisational change process. Isabella relates the two 
approaches (Lewin's and her own) diagrammatically as follows in Figure 19, (Isabella, 
1990: 32). 
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Figure 19 EVOLVING INTERPRETATIONS OF KEY CHANGE EVENTS 
- LEWIN I ISABELLA COMPARISONS 
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Trigger events are those emergent incidents and events that signal change and may be 
~elf evident to those within the organisation or deliberate announcements by senior 
management that they must change. Such triggers are said by Isabella, to be interpreted 
by individuals through personalisation of implications and then sense made by their 
interpretation. In the aftermath of change a final retrospective interpretation takes place 
confirming, rationalising and accepting the change through evaluation of its effects. 
Thus, the research offers a different interpretation of resistance to change, i.e. it can be 
viewed as '0. 0 elements of the cognitive transition of individuals occurring during 
change .. 0 I Rather than trying to overcome resistance then, this model suggests using 
these deeper level elements to assist people through the transition stage, in other words 
by acknowledging concerns and helping people to interpret prospective change in a 
positive way by suggesting balanced perspectives. Trigger events in pharmacy can be 
considered to be all government initiatives to encourage change in pharmacy (the White 
and Green Papers, Chapter 1 : 12) since Gerrard Vaughn in 1981. 
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I 
j Isabella 
The theory of the Lewin and Schein / Isabella elaboration models has an attractive 
natural logic and contextualised in community pharmacy appears to have a sound basis 
for application. The present political and economic climate with the NHS would seem 
to provide powerful 'unfreezing forces' for the engagement of these models. In this 
overall model, individual cultural perceptions, behaviours and trigger events are of key 
importance. 
5.4.1.2 Tichy's Framework Model & Strategic Rope 
Tichy's Strategic Framework 
In this concept, Tichy set out, (1983 72) nine organisational 'levers' for change, 
illustrated in Figure 20. 
Figure 20 TICHY'S FRAMEWORK 
Engaging the relevant interest 
groups 
I INPUT I 
(Environment; History; Resources) 
MISSION & STRATEGY 
~--------.---------~ 
" 
",/"" 
,..-pr-e-sc-rl-·b-ed-N-etw-or-ks.-..;.....,'I r--P-E-O-P-L-E-' 
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~two separate items) 
Managing the mission & 
strategy processes 
(Communicating; problem solving; 
decision making) 
(Fonnal Structmes) It\\ l jI / ~I r--E-'~'--RG-E-N-T-NE-T-W-O-RK ..... ~_,/_' -" 
(Informal networks) 
Performance - Impact on People 
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-- == Strong impact 
----- == Weak: impact 
Superimposed on this model of change, through his nine change levers, he uniquely 
overlays three further influences or systems, which he called a 'strategic rope': 
• Technical 
• Political 
• Cultural 
Strategic Rope 
Production methods; management systems; 
structural design: resources. (In phannacy, the 
system of dispensing process; ordering drugs; 
stocktaking; stock rotation; quality assurance; 
equipment.); 
Power; leadership; decision making; staff 
relations; and, 
Tradition; professional protocols; assumptions of 
ethics; hierarchy of staff; rights in law. 
The 'strategic rope' concept derives from the degree of integration of the above three 
components, or indeed the lack of co-ordination of all three influences. The concept is 
illustrated in Figure 21, (Tichy, 1983 : 12): 
Figure 21 TICHY'S STRATEGIC ROPE MODEL 
High t 
Uncertainty Political --+-~~~+--+-i--i'---
Low Cultural 
Time 
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Need for problem 
solving 
I Low y 
To analyse the organisational situation before using the model and to expose key 
alignments, he used a matrix, with the 'rope' on the Y axis and his 'framework' as the X 
axis, in Table 34: 
Table 34 
r Technical I System 
Strategic Political 
Rope l System 
Cultural 
System 
Amount of 
component 
change 
required 
TICHY'S TECHNICAL POLITICAL CULTURAL 
MATRIX OF ALIGNMENT 
MISSION TASKS PRESCRIBED PEOPLE PROCESSES EMERGENT 
STRATEGY NETWORK NETWORK 
...... 1--------- Framework ---------~ 
Scoring 
Amount of 
alignment 
within 
system 
o -.36 
Min. Max. 
The matrix is simple in concept, but because of the strands of each variable requires 
thorough analysis of the organisational situation in each component as described above. 
Culture is a major issue, for the medical and pharmaceutical professions, with long 
embedded traditions and concepts which each may have of their respective places in 
health care. 
Lacking in this model is, of course, address of attitude change at individual behavioural 
level and this is acknowledged in Tichy's book (1983) as a certain skimming over of the 
psychological issues. 
5.4.1.3 The Nadler and Tushman Congruence Modelfor 
Organisation Analysis 
The key issue of address here is 'congruence', or the degree to which needs, goals, 
demands, objectives and structure, 'fit' with the same elements of other systems defined 
by the model (Nadler & Tushman, 1992 : 39 - 59), for example the systems of inputs 
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and systems of outputs. The relationship of the constructs and elements is shown in 
Figure 22. 
Figure 22 
Inputs 
Env ironment 
Reso urces 
Hist ory 
t 
THE NADLER AND TUSHMAN CONGRUENCE MODEL 
OF ORGANISATION PERFORMANCE 
I 
"f 
Strategy 
~ 
Transformation Process 
/ 
Work 
(Task) 
~ 
Informal 
Structures & 
Processes 
~~ 
~ ~ 
Formal 
Structures & 
Processes 
EJ/ 
Feedback 
Outputs 
Organisational 
level 
-. Unit/Group level 
Individual 
level 
I 
Nadler and Tushman view the organisation ftrstly as being the processor of inputs from 
the environment that is; resources, threats and opportunities and the effects of its own 
history (programmed / traditional attitudes). Secondly, it deals with these through its 
people, structures and systems and produces outputs at the three levels; individual; 
group; and, organisation, to give ideally, effective consideration of the business 
environment, thus meeting the organisational goals. 
In analysing the degree of organisational effectiveness, the internal transformation 
process is the target of address. According to Nadler and Tushman, this comprises four 
principal components: 
1. Task of the organisation its key resource and objectives; 
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11. The individuals of the 
organisation 
111. Formal arrangements 
IV. Informal arrangements 
their abilities and efficiency; 
structure, systems, procedures; and, 
cultural issues - values, norms 
of conduct; communication rituals; 
power; politics. 
The balanced relationship of these four with each other and therefore, the degree of 
suitable congruence is held to be essential to organisational efficiency. If, for example, 
the 'task' of the operation is not matched by the competence of the individuals, then 
there is no 'fit' or hope of achieving the output objectives. A fairly obvious conclusion 
to draw, but current staff competencies which match the current task, may actually not 
be adequate for strategic transformation into a future different task. In pharmacy, this 
may equate to current pharmacist I technician competence being conceivably inadequate 
for the new role of medicines management. The technician competence of the future 
will at least lie in the ability to deliver accurate dispensing plus a competent checking 
ability for quality assurance. Pharmacist competence revolves around knowledge of 
clinical pharmacology and interpersonal skills for patient dialogue. Cultural mindsets in 
pharmacy will affect the ease or difficulty of change in technician responsibility. 
5.4.1.4 Berger-Sikora Culture Change Road Map 
This model was developed by the Lance A. Berger and Associates Inc., Consultancy in 
the U.S.A. As previous Chief Executive of the HAY Group, Berger's clients have 
included Du Pont, GTE International and Pepsi Cola. The evidence for the validity of 
this model is the success enjoyed in transforming organisational cultures through using 
it as a 'road map' to encouraging change. Their template rests on the proposition that 
successful organisational change results from alteration of systems, skills and structure, 
which, according to them, affect organisational culture. Skills in this sense equates to 
competencies. This model is diagrammatically set out in Figure 23 and relates to 
pharmacy's position in primary care with its present skills and current systems for 
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liaising with the medical profession. Is community pharmacy clinically qualified for 
MM? Are its systems adequate for coping with this new intervention? Is the structure 
of pharmacy and medicine congruent with the new demands of MM? 
Figure 23 
Business 
Strategy 
t 
Corporate 
Culture 
THE CULTURE CHANGE ROAD MAP 
1\ Behaviour Improved ~ Change ~Performance 
Skills ~ Systems 
Note: Critical success factors are determined by assessing what is required to achieve the vision and 
the structure, skills and systems altered accordingly. Behavioural change is thus encouraged. 
Structure, skills and systems are described as levers of change in the process of 
changing individual's behaviour to give improved perf~rmance. Berger and Sikora cite 
Kotter and Heskett, (1992: 11) in • ... their empirical study of the impact of culture on 
organisational performance " as having found that there are • ... adaptive cultures and 
performance degrading cultures ... I that improve or diminish respectively the fmancial 
performance of the company. Whatever the future vision for a company or 
organisation, mechanisms to deliver the vision must be put in place for successful 
change to be delivered; it will not just happen, (Berger & Sikora, 1994: 320). These 
mechanisms will include appropriate systems, structures and skills that govern 
individual behaviour, (1994: 320). 
The critical success factors (CSFs) in the above scheme are, according to Irwin and 
Michaels, (1989: 4 - 19) what the organisation must address to deliver its strategy. 
Similar concepts have been confirmed by Stalk et al., (1992: 57 - 69) but calling them 
capabilities. 
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Lasting culture change, argue Berger and Sikora, requires a strong link from CSFs to 
individual, as well as organisation level behaviours, in other words, systems, skills and 
structures. Schein's disconfumation strategy is again an important means of helping to 
create this link (1992: 303). 
Pharmacy's clinical abilities are again exposed as an issue in the role change in 
considering the critical success factors of the dispensing pharmacy service in new 
medicines management. Will these devolve around professional abilities, premises 
facilities, inter-professional relationships and support staff or simply new systems and 
procedures, or both? The full research will help clarify these issues. 
5.4.1.5 HAY Organisation Diagnosis Model 
This model encompasses the Nadler-Tushman principles, as well as the elements of the 
Berger-Sikora Road Map. It also describes the detailed inputs and outputs of the 
Nadler-Tushman model and by implication the levers of the Berger Sikora Road Map, 
through its elements of people, structure and processes. 
Strategy and culture are again major issues of address in this construct, as with the 
former two models. The diagrammatic representati6n is set out in Figure 24 and 
comprehensively addresses all elements so far described in the foregoing models. It is 
partly derived from the Burke-Litwin model described later and more detailed 
discussion will be set out under that model. 
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Figure 24 THE ORGANISATION DIAGNOSIS MODEL - HAY 
NOW ------------i------.-.~ TRANSORMATION PROCESS --------~------------~~~ FUTURE 
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~ 
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5.4.1.6 McKinsey 7S's Model o/Change 
This model was used in the modernisation of British Telecom, West London District, a 
sub-unit of BT, with a staff of circa 6,000 and a multi-million pound turnover, (price & 
Mwphy, 1987 : 4S - 48). Following individual group interviews and postal survey 
questionnaires, the Board met to discuss and answer the questions: 
• Where are we now?; and, 
• Where do we want to be? 
and then agree how change could be effected. The 'fish bone' chart (Figure 25) was 
used to assist the process. 
Figure 25 FISHBONE CHART SHOWING STRATEGY FOR CHANGE 
Regular 'climate' surveys 
Skills development 
Wheredowe 
want to be? 
~ 
~--- Problem solving forums 
Employee involvement 
programme 
Team buil ing )C---- Communications programme 
Where are 
we now? 
7"'---- Objective setting 
It was after encountering difficulty in setting objectives en route to change, that the 
McKinsey 7S's were used to help identify the key issues of address. The McKinsey 
framework focuses attention on seven inter-dependencies that are prime determinants of 
organisational success, (peters & Waterman, 1982: 71). These are: 
• a clear organisational corporate strategy; 
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• sldlls of the organisation as a whole; 
• the systems used by the organisation; 
• the organisational structure; 
• the staff quality / competencies; 
• shared values of members toward collaboration / innovation; and, 
• style of management, i.e. autocratic or democratic. 
These are diagrammatically represented in Figure 26. 
Figure 26 McKINSEY 7S's MODEL OF CHANGE 
____ I STYLE I ~ 
r--SKIL- L-S ---., ~ t / Ir--S-TAF- F---' 
t SHARED VALUES t 
STRUClURE I / t ~ I SYSTEMS 
~ I STRATEGY I ~ 
This is similar to, but less detailed than, the HAY model shown in Figure 24. 
When an organisation is viewed as a network of interdependent parts as in this model, 
then major and sometimes minor changes in one sector affect all the others in some 
degree. This is also the case with resistance in one area, leading to blocking of change 
in another. 
In task changes, the duties of individuals are changed; in staff changes, individual 
knowledge, skills and attitudes are modified in some way; systems changes focus on 
procedures, work flows and use of technology (for example, I.T.); and, structural 
alterations change the grouping of staff procedures used to guide personnel interactions 
/ work relationships. Like other models, culture, (through shared values), is crucial to 
working collaboratively to the same strategy. The McKinsey consultancy has used this 
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model extensively, with such worldwide corporations as General Electric, General 
Motors and the Pepsi Cola company. The relevance to pharmacy is in the task change 
and staff skills change, together with inter-professional systems changes, which all must 
be addressed. 
5.4.1.7 The Normative Systems Model 
This model was constructed by Silverweig and Allen, (1976: 33 - 49) and is a four 
stage process, geared to changing what they describe as the 'norms' of the organisation, 
as perceived by the employers and leaders. Although comprehensive in its address of 
the levels of organisation structure, in other words, individual, group and leadership, it 
appears to have narrowly defined culture. They perceived this as being a set of 'norms' 
of the organisation as generally accepted by all employees, rather than also taking 
account of the more deeply held assumptions, beliefs and values of the paradigm, which 
would more correctly be regarded as the core of culture. The stages are shown in Figure 
27. 
Figure 27 
STAGEl 
STAGE 2 
STAGE 3 
STAGE 4 
NORMATIVE SYSTEMS MODEL 
Analyse culture 
Defme desired culture 
EstabHsh the gap 
-~-
Experience the desired 
culture 
• Modify the existing 
culture 
Maintain the desired 
culture 
The stages they propose are summarised in Table 35: 
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Table 35 STAGES AND ELEMENTS OF ORGANISATIONAL 
CHANGE THROUGH CULTURE MOVEMENT 
PHASE DETAIL IMPLEMENTA nON 
Stage 1 
Analyse existing culture; establish Through worker discussion 
'nonn' gap between existing and groups; opinion makers; leaders; 
desired culture - 8 influences: individual, group, discussions and 
• Leadership - modelling • Words; actions; envisioning futures; changing interviews; organisation wide 
behaviour emphases - exercises influence on employees surveys; publish results with 
objectives and 'necessity 
• Work team culture • Work teams develop own norms and ways of doing mtionale' 
things -implement change here 
• Organisational policies and • Can change organisation priorities and emphasis 
procedures 
• Training facilities • Develop competencies 
• Information and • Persuasive; inspimtional; leader sponsorship - role 
communications systems modelling 
• 1- line supervisor performance • The bridge between management and staff. 
Influence applied here is important 
• Performance! reward system • That which is appraised or rewarded influences 
behaviours; helps drive cultural change 
• Results orientations • Agreed measurable objectives at outset of change 
programme; enables directional drive and 
demonstrates satisfaction 
Stage 2 
Experiencing the desired culture: 
systems introduction - S influences 
• Arrange discussion which 
identifies preferred culture 
• Rehearse frustrations with 
present culture All members of workplace are given opportunities to 
• Construct new 'norms' and participate and experience a better way of working Construct involvement 
practice in selected work groups workshops to give impactful 
• Experience the benefits and experiences which will be 
satisfaction ef\ioyed and remembered. 
• Commit to new objectives Measure change in general 
which drive forward 
! workplace compared to these 
Stagel 
-Modify existing culture by systems 
installation 
• Focus on culture influences 
identified in Phase 1 
Retrain line managers/supervisors by mentors who have Build on previous strengths and 
• Reorientate all junior levels of introduce new techniques for 
leadership on-the-job success record - strengthen and enact leader greater success 
behaviours 
• Create action/study terms 
Brief to identify problems and propose solutions in each Train team leaders - enables 
of the 8 original influence areas development of work groups as 
• All teams meet regularly to 
modify their culture Discuss critical issues and problems 
necessary 
Stage 4 Publish and celebrate success. Programme continuing In-house bulletins; letters; house Maintain desired culture; ongoing magazine 
evaluation and renewal appraisal and adjustment 
• Involve all employees Measure; notify participants; evaluate Regular written and verbal 
• Emphasis on results communications 
Review policies and behaviours in all work systems for Usc work groups - studyl action 
• A total systems approach weaknesses and beneficial change opportunity teams to implement and evaluate 
• Build win-win solutions 
Note: This table exemplifies the Silverweig and Allen stages of culture change, through altering the 'norms' of the 
organisation. (Silverweig &. Allen, 1976 : 33 - 49) 
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Although this model, according to some researchers, is deficient because it does not 
address the deeper cultural issues, (Ogbonna, 1993 : 42 - 54) such as personal / group 
values and beliefs, it nevertheless is a route to engineering change in working practice. 
This involves the whole organisation membership from leaders to operatives. It has 
themes of Lewin's original concepts of unfreezing, shifting and re-freezing culture, as 
he saw it. It may be applicable to pharmacy in seeking to avoid the complex work of 
culture change in depth and simply pursue behaviour change to deliver the new role and 
services. 
5.4.1.8 The Whole Systems Change Approach 
This is a highly complex organisation-wide intervention at all levels of the organisation 
and where necessary, on a global scale for international companies. It also enables 
organisation development practitioners to work in parallel with environmental 
stakeholder interests, which are crucial in effecting change of this scale. The process 
relies upon individual interviews and written survey feedback. The full range of 
employees is involved. 
This approach aligns the internal organisational environment and its systems with the 
external environment and is applicable where, according to C. and W.A. Adams, (1999 
: 141): 
• the present service offering is inadequate; 
• there is an urgent need to change - driven by environmental forces; 
• opportunity for creating new approaches to the 'domain' will add substantial 
value; and, 
• competitive forces are showing real threat of blocking future development 
and marginal ising the current service / product offering. 
All systems in the organisation are reviewed, modified or recreated in alignment with 
each other and integrated in terms of operational workflow and objectives. Bunker and 
Alban, (1997: 31, 97, 157) set out three classifications oflarge scale intervention, each 
with four routes of accomplishment, which have emerged in the last decade or so from 
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different researchers. These are shown in, Tables 36, 37 and 38. Classification is by 
desired outcome, in other words, creating a future; (Table 36) work redesign; (Table 
37) and problem solving, (fable 38) all of which are applicable to pharmacy but perhaps 
too complex for use in the pharmacy context. 
Table 36 LARGE GROUP METHODS FOR CREATING THE FUTURE 
THE SEARCH CONFERENCE FUTURE SEARCH 
Purpose: To Create a Future Vision Purpose: To Create a Future Vision 
Merrelyn and Fred Emery We;sbord and Janoff 
• Set Format: Environmental Scan • Set Format: Past, Present, Future. Action 
History, Present, Future Planning 
• Criteria for Participants: Within System • Stakeholder Participation, No Experts 
Boundary • Minimises Differences 
• Theory: Participative Democracy • Search for Common Ground 
• Search for Common Ground • Self Managed Small Groups 
• Rationalise Conflict • 18 Hours over 3 Days 
• No Experts • 40 to 80+ Participants 
• Total Community Discussion • Larger Groups = Multisearch Conference 
• 35 to 40+ Participants 
• 1/3 Total Time is Action Planning 
REAL TIME STRATEGIC CHANGE ICA STRATEGIC PLANNING PROCESS 
Purpose: To Create a Preferred Future with Purpose: Strategic: Planning 
System-Wide Action Planning 
Dannemiller and Jacobs : 
-
• Format Custom-Designed to Issue Focus 
• Highly Structured and Organised 
ImPlemLon 
Question I • Theory: Beckhard Change Model 
• Common Data Base Practical 
• 2 to 3 Days + Follow-up Events Time Line Vision 
• Use of Outside Experts as Appropriate 
StraJgic undJIYing • Use of Small Groups and Total Community 
• Self Managed Small Groups Actions Contradictions 
• 100 to 2,400 Participants L I • Logistics Competence Critical 
• Daily PartiCipant Feedback Strategic Directions 
• Planning Committee and Consultants Design 
Events 
• Stakeholder Participation 
• 2 to 7 Days 
• 50 to 200 Participants 
• Planning Committee and Consultants Design 
Events 
(Bunker & Alban, 1997: 31) 
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Table 37 LARGE GROUP METHODS FOR WORK REDESIGN 
THE CONFERENCE MODEL FAST CYCLE FULL PARTICIPATION 
Dick and Emily Axelrod WORK DESIGN 
Pasmore, Fitz and Frank 
• System Wide Pre-conference • Orientation Events Educate and Include 
Education Everyone 
• Design Process in Five Conferences • Five Meetings 
- Vision - Future Search (2 Days) 
- Customer - Meeting External Expectations (1 Day) 
- Technical - Work Systems Analysis (2 to 3 Days) 
-Design - Work Life Analysis ( 1 Day) 
- Implementation - New Design and Implementation (4+ 
• Three Weeks Between Conferences Days) 
• 2+ Days for Each Conference • Up to 120 Attend Meetings 
• Data Assist Teams Work Between • Parallel Design of Support Process 
Meetings to Involve Larger Changes 
Organisation • 113 of System Participation Goal 
• 80+ Participants, Parallel • Design Ratification Events Include 
Conferences for Larger Groups Everyone 
REAL TIME WORK DESIGN PARTICIPATIVE DESIGN 
Dannemiller and Tolchinsky Fred and Merrelyn Emery 
I 
• Whole System Present at Launch • Bottom-upJ>rocess 
and Implementation • Company -Wide Education is First Step 
• 50 to 2,400 Participants • Management Sets Minimum Critical 
• Process, Design, Deep Dive Specifications 
Conferences Representative • Basic Principle: Each Level Co-ordinates 
• I-Day Conferences on Key and Controls Its Own Work 
Administrative Support Issues • Each Unit Designs Its Own Work 
• Design Team Manages Process and • Six Design Principles Used to Redesign 
Does Micro-Work Work 
• Implementation Team Oversees • Multiskilling is the Norm 
Mini-Conferences 
(Bunker & Alban, 1997: 97) 
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Table 38 WHOLE SYSTEM PARTICIPATIVE WORK 
- PROBLEM SOLVING 
SIMU-REAL WORK-OUT (GENERAL ELECTRIC) 
Purpose: Real-Time Work on Current Purpose: Problem Identification and 
Issues, Test Future Designs, Learn Process Improvement 
About System 
Donald and Alan Klein 
• Organisation Selects Issue for Work • Improvement Target Selected 
• Room Arrangement Reflects • Employee Cross-Functional Meeting 
Organisation's Structure • Process: Discuss and Recommend 
• People Act Their Organisational Role • Senior Management Responds 
• Decision Process Agreed to in Immediately 
Advance • Champions and Sponsors Follow 
• 1 Day Through to Implementation 
• 50 to 150 People • Follow-up as Needed 
• Facilitator Needs Expertise to Process • 1 t02 Days 
Consultation 
LARGE SCALE INTERACTIVE OPEN SPACE TECHNOLOGY 
EVENTS Purpose: Discussion and Exploration of 
Purpose: Problem Solving Systems Issues 
Dannemiller and Jacobs Harrison Owen 
Uses Same Methodology as Real Time • Least Structured of Large Group 
Strategic Change Technologies 
See Description in Table 36 • Divergent Process 
• Large Group Creates Agenda Topics 
• Many Different Uses • Interest Groups Forum Around Topics 
• Periodic Town Meetings for Sharing 
Information Across Interest Groups 
• One Facilitator Lays Out Format, 
Ground Rules, 'Holds the Space' 
• Requires an Understanding of Large 
Group Dynamics 
• 1 to 3 Days 
(Bunker & Alban, 1997: 157) 
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The large scale interventions approach is geared to become an inherent part of the 
business operation and thence, sustainable change. Holman and Devane, (1999: 153) 
set out three recommendations for sustaining the results of large scale interventions: 
1. Ensure that 'running' the business is consistent with 'changing' the 
business, in other words, if large group participation is used to change 
the business, then use this to run the business; 
2. Build organisational self reliance through reinforcing new behaviours 
and systems, building the core competence of self reliance; and, 
3. Sustain resource capacity by giving the same focus on resources as was 
given in changing the business. 
The whole system performance management model can be diagrammatically 
represented as follows in Figure 28. This connects leadership; teaming; morale; 
emotions; personal characteristics; critical customer behaviour; and, organisation 
climate, (Cady, 1995 : 43 - 56; Church, 1995 : 25 - 31; Church & Wac1awski, 2002 : 
131).: 
Figure 28 THE WHOLE 'SYSTEM' PERFORMANCE 
MANAGEMENT MODEL 
Employee characteristics 
competencies - training 
Climate 
Employee ....... 1----
Morale -
Employee 
Emotions 
i 
Climate - Leadership +- Climate 
l 
Critical Customer 
Service 
Behaviours 
---t~~ Performance 
Team Forming 
Climate 
r-c-us-to-m-e-r-c-~-c-te-ri-st-ic-S --" ~ Customer 
Morale 
1 
Customer 
Emotions 
Note: 'Climate' in organisational context means, employee perceptions of organisational elements such 
as norms of work, leadership style and control, decision making, personnel relationships, (derived from: 
Harrison & Shirom, 1999: 213). 
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The model is designed to show the inter-relationship between personal behaviours and 
performances at various levels of the organisation and identify appropriate 
interventions. The steps in the intervention process, according to these researchers are: 
1. Evaluate the existing practices and understand relationships - implicit 
and explicit; 
2. Enhance existing model and measures of performance; clarify 
understanding of the system; 
3. Implement data collection model and benchmark performance; 
4. Diagram the predictive (customised model); and, 
5. Action: facilitate group discussions to deliver appropriate action for 
change. 
At fIrst sight the scale of the 'whole systems' intervention may look attractive for 
application to the large scale of primary care pharmacy, but unfortunately, the latter is 
comprised of many small sub-organisations with their own cultures and some common 
systems. Parts of the large scale intervention, on the tither hand, could be useful, such 
as the 'survey feedback' and conftrming methods of communication. This will be 
explored as action research, as follows. 
5.4.1.9 Action Research Model (AR) 
Action research as originally conceived by Kurt Lewin, (1946 : 34 - 46) was defIned as: 
' ... A spiral of steps, each of which is composed of a circle of 
planning, action andfactfinding about the results of the action. ' 
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In the 1990s, action research as an ongoing practice was deftned by French and Bell, 
(1995 : 138) as: 
' ... A process of systematically collecting research data about an 
ongoing system, relative to some objective, goal or need of 
that system; feeding this data back into the system; taking 
action by altering selected variables within the system, based 
on both the data and hypotheses and evaluating the results 
of actions by col/ecting more data ... ' 
However, French and Bell (1995 : 140) go on to point out that action research can also 
be used as an approach to problem solving and therefore, is an intervention model in 
organisational improvement. Thus used, they defme it as: 
• ... the application of the scientific method offactfinding and experimentation 
to practical problems requiring action solutions and involving the 
collaboration and co-operation of scientists, practitioners and lay persons ... ' 
Rollinson (2002 : 669) deftnes AR more succinctly as: 
' ... a participative method of efficting change in human behaviour 
that involves stages of data collection, problem diagnosis, action 
planning, action and re-evaluation ... ' 
Although identified in the literature as a distinct model of change in organisation 
development, it could be regarded as an underpinning methodology of many OD 
interventions, in tenns of its survey research and feedback process. 
Chein, Cook and Harding, (1948: 43 - 50) set out four varieties of action research: 
1. diagnostic 
ii. participant 
a problem situation that needs diagnosing and 
remedial action taken; 
here, the people who are ultimately to take action, 
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iii. empirical 
iv. experimental -
are involved in the research from the beginning 
and '0\\11' the process; 
here the person who has to undergo change keeps 
a comprehensive record of the action taken and the 
effects it had. Clinical data from this activity may 
be flawed, because of the layman's approach; and, 
this is controlled research on the relative 
effectiveness of various action techniques, to find 
the best way of effecting change. 
The foregoing authors are of the view that the experimental variety may make the most 
useful contribution to scientific knowledge. Argyris. (1983: 115) argued that, action 
research, should be characterised by six elements: 
i. It should be problem driven; 
ii. It should be client centred; 
iii. It should challenge the status quo; 
iv. produce empirically disconfirmable propositions; 
v. propositions could be inter-related into a :theory; and, 
vi. be useable in every day life (of the person or organisation). 
He called this approach action science and expressed the view that this is similar to 
partiCipative action research, (Argyris & Schon, 1989: 612 - 623). Weisbord, (1987 
: 196 - 252) devised a new approach to action research, which starts not with the 
problem, but the strengths of the situation and the potential and desired future. Through 
his review of a series of action research projects, he discerned that the most successful 
were not what the organisational development consultant wanted to do, but what the 
organisational members wanted, having understood the need for change. 
Action research, like Lewin's original group work, seems to be an essential generic 
process in diagnosing and correcting organisational deficiencies. Through surveys 
researching employee views, followed by iterative action / feedback, action research is 
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used in many of the models so far discussed. It may be diagrammatically represented in 
Figure 29. (Rollinson, 2002 : 670) 
Figure 29 THE ACTION RESEARCH INTERVENTION 
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Church et al., (2002: 27) view action research as 'one of three fundamental 
dimensions' of organisational development, that is: 
i. action research itself; 
ii. understanding the organisation as a number of related systems; and, 
iii. a nonnative values-based framework in which individual, as well as 
organisational improvement is effected. 
They go on to say: 
' ... Collecting behaviourally based data about how individuals, groups, 
teams or an entire management population act on a day to day basis, is 
central to understanding, diagnosing, energising (throughfeedback) 
and ultimately improving that organisational system. ' 
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As matters progress with pilot trials of medicines management, action research may 
become an important feature of service development in pharmacy. This leads to 
consideration of the next model, described as multi source feedback. 
5.4.1.10 Multi-8ource Feedhack Process for Change 
This process consists of collecting information on individuals from their peers, clients, 
customers and suppliers; amalgamating the information into a structured report and 
feeding back to the individual of focus. This may be a facilitated process, or relatively 
informal but using the information to drive behaviour change. This method gained 
popularity in the 1990s, (Bracken, 1994: 44 - 45). 
It is based upon the psychology that any individual will feel a strong need to reduce 
discrepancy between their self view and the discordant view (if any) of others in the 
peer group. Self regulatory response in this way enhances self reflection and corrective 
action. At the feedback point, three issues are important to ensure the best effect of the 
feedback information: 
1. Confidence that the process and technique of data collection was fair and 
appropriate; 
2. The outcome (the data information) is perceived as positive, even when 
negative issues emerge; and, 
3. Delivery of the outcome data is perceived as positive help and 
constructively administered (Le. not destructive criticism). 
As Brockner and Wisenfeld, (1996: 189 - 208) have argued, matters of procedural 
justice and fairness in this context are crucial. Process and outcome treatment are key 
issues. 
It can be seen that multi-source feedback is time costly and a complex process to be 
handled by competent practitioners. The process is administered at individual, group, 
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team and whole division levels. In these cases, perceptions of the whole entity are 
sought from related stakeholders, related divisions, suppliers and customers. 
The principles involved are as Lewin's original work on group feedback, of how people 
interact and perceive one another. Organisational strengths and weaknesses relating to 
key competencies can be revealed in this way and change effort directed to specific 
developmental programmes. 
Multi-source feedback, interestingly, was used to effect organisational change and 
amalgamation in the Smith Kline Beecham merger, to communicate the new 'core 
values' to employees, (Burke & Jackson, 1991: 65 - 87). 
In the large scale data analysis for the feedback sessions, cultural trends can be detected 
from such issues that are more highly ranked / rated on the formalised survey sheets. 
This can be of key importance in understanding the inter-relationships of the 
group(ings) and so help management in directing appropriate effort for change. 
However, according to Church, (1999: 7 - 8) exploring relationships and cultural 
trends in this way is not widespread. Multi-source feedback is thus a potent tool for 
engineering behavioural change at individual level as well as diagnosing areas for 
development across the organisation. 
In the view of the author of this thesis, this is a less practical route to engineering 
change in community pharmacy with its multitude of outlets and restricted resources 
within independent pharmacy. Other models at this stage appear more realistic. 
The model is summed up in Figure 30. 
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Figure 30 MULTISOURCE FEEDBACK PROCESS FOR BEHAVIOURAL CHANGE 
(Church & Wadowski, 1998 : 82) 
I--
I 
I 
I 
I 
I 
Mentors, 
Coaches 
Managerial 
Workplace 
Behaviour 
and 
Perfonnance 
Vendors, 
Suppliers 
Clients, 
Customers 
Supervisors 
Peers, 
Colleagues 
Direct 
Reports 
:._ •• ______ •• _ ••• _ ...... _._ ••• -.. •• __ • ___ ••••••• __ ............ _ ....... _ ... __ •••••••••• _ ................ __ ••• R •• ___ ._ ... ____ _ 
Abbreviations: 
OD 
I/O 
HRD 
Organisational Development 
Industrial/Organisational Psychology Techniques 
Human Resource Development 
Self 
Assessment 
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00, I/O, or HRD Intervention 
---------~~--------r , 
Facilitated Feedback Coaching 
\... Psychological Reactivity ./ 
V-
Learning and Development 
and Change Loop 
i 
I 
I 
I 
............................................................... _ ...................... _ ........... __ . .1 
Awareness 
and Action 
Planning 
Note: The sources of information to the left of the model provide 
information on the individual, group, or division of the organisation 
and feed back for self assessment and change behaviour. 
Facilitation may be used. 
5.4.1.11 Burke-Litwin Model of Organisational Performance and Change 
Original work underlying this model was researched by Litwin and Stringer, (1968) and 
Tagiuri and Litwin, (1968) whilst investigating motivation and organisational climate. 
The latter, they argued, was created by such effects as employer I employee behaviour 
and relationships, as perceived by both, along with group norms and values. Climate is 
thus associated with the daily transactional issues of the work groups, whilst culture is 
concerned with processes of hwnan transformation, relating to deeply held values, 
assumptions and beliefs in the work place. The literature indicates that the 
distinguishing features of transformational and transactional concepts have been 
influenced by the formative work of I.M. Burns, (1978: 3) relating to leadership 
studies, as well as other researchers such as Zaleznik, (1977: 67 -78) and Bass, (1997 
: 130 - 139). Bums classified transactional political leaders as 'bargainers', or 
'bureaucrats', 'legislators' and 'executors'. Transformational leaders he categorised as 
' ... intellectuals, leaders of reform or revolution and heroes of ideologies', (1978: 3). 
Robbins, (1989: 329) a decade later defined transactional leaders as those who: 
' .. . guide or motivate their followers in the direction of established 
goals by clarifying role and task requirements ... ' 
and transformational leaders as those who: 
' ... inspirefollowers to transcend their own selfinterestfor the good of the 
organisation and who are capable of having a profound and 
extraordinary effect on their followers ... J 
Burke developed his model during major redevelopment work at British Airways in the 
1980s. The point is that Burke and Litwin see OD interventions, which are directed at 
'leadership', 'mission', 'strategy' and 'culture' as transformational. Those which are 
directed at structural change, management practices and systems are seen as 
transactional and affect organisation climate, not culture. Reichers and Schneider, 
(1990 : 5 - 39) however, believe there is overlap between the two concepts and Burke 
himself, (1993: 17) regards the two issues as similar but with important differences. 
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Climate, it seems, is the manifestation of culture. The relationship of culture to climate 
can be compared to that between individual personality and behaviour. Targeting 
climate change, therefore, through managerial behaviour change, is a practical route 
which may, in turn, help to begin culture change. This may be the simpler route for 
pharmacy. 
The two parts of the Burke-Litwin model are shown in Figures 31 and 32 and integrated 
on the next page in Figure 33: 
Figure 31 BURKE-LITWIN MODEL OF CHANGE TRANSFORMATIONAL FACTORS 
MISSION & 
STRATEGY 
External 
Environment 
LEADERSHIP CULTURE 
Figure 31 BURKE-LITWIN MODEL OF CHANGE TRANSACTIONAL FACTORS 
Structure 
Task Regs. & 
Individual 
Skillsl Ability 
Management 
Practices 
Individual 
Organisational 
Perfonnance 
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Systems 
Policies 
Procedures 
Individual 
Needs & 
Values 
Figure 33 THE BURKE-LITWIN MODEL OF ORGANISATIONAL 
PERFORMANCE AND CHANGE 
Organisation Levers 
Levers which are relevant for achieving change through people 
(MISSION STRATEGy) 
a) What top management 
declares itto be! 
b) What employees 
believe is the central 
purpose of the 
organisation. 
BUSINESS 
PROCESS & 
EXTERNAL ENVIRONMENT 
Any outside condition or situation that 
influences the performance of the organisation. 
MANAGEMENT 
PRACTICES 
AND STYLE 
'The way we do things 
around here'. The collection 
of overt and covert rules, 
values and principles that 
ensures and guides 
organisational behaviour. 
STRUCTURE ~~r---
What they do in the 
normal course of events to 
use the human and 
material resources to carry 
out the strategy 
SYSTEMS 
POLICIES & 
STRUCTURES 
Arrangement ofworkflo 
functions and people into 
specific areas and levels of 
responsibility, decision 
making, authority. 
t 
The collective current impressions, 
The standard policies and 
mechanisms that facilitate 
work, (e.g. HR systems and 
also accounting systems) IT 
systems and the impact 
these have. 
-----l~~ feelings and expectations that ... ~t---­
members have, that affect the 
TASK & INDIVIDUAL 
CAPABILITY 
Work processes and role 
requirements; the required 
skills, knowledge and 
behaviour to accomplish 
assigned work and 
responsibilities. 
FEEDBACK LOOP 
relationship with boss, each other and 
nonmembers 
~ ~nnDUALNEEDS AND VALUES '-----The behavioural tendencies to mOve 
towards goals, take needed action and 
persist until satisron is attained 
~MDUAL, TEAM & 
ORGANISATION PERFORMANCE 
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The enduring thoughts and 
feelings employees apply to 
determine the worth and 
satisfaction of their work. 
~Remuneration and 
development 
(Burke & Litwin, 1989 : 277 
This model does not emphasise 'congruence' of internal systems or 'alignment', as does 
the Nadler-Tushman model, but does imply environmental 'fit' with 'leadership " 
'mission and strategy' and 'culture '. It is a complex model, dealing comprehensively 
with the human and systems aspects of organisations and the input of the environment. 
The model should, according to Burke, be represented holographically, not two 
dimensionally, as in all systems theory, changing one factor will affect the others at 
some stage. 
It could be represented in a similar way to the Nadler-Tushman model, in other words, 
with inputs (environment) on the left and outputs (individual and organisational 
performance) on the right, with all the other elements in between as throughputs. 
Information for addressing the various components is obtained by individual interview 
and surveys, (very like action research). A change agent, helping organisations to 
change would interview up to 30 representative individuals to gather indicative 
information. From the findings, which would be checked with another sample and 
dependent upon a requirement for transformation, or simply transaction adjustments, a 
suitable change programme is constructed. The original British Airways privatisation 
was an instance where the whole model was used (Goodstein & Burke, 1991: 5 -17). 
It may be particularly suitable for application to the current situation facing community 
pharmacy in the NHS. It appears at this stage to hav~ a suitable mix of the relevant 
issues with which pharmacy is faced at present, both strategic, in terms of leadership, 
mission / strategy, culture and transactional in terms of task requirements / individual 
skills / abilities, motivation, individual needs and values, systems, policies, procedures 
and management practices. All these elements are likely to be affected in the role 
change of both pharmacist and technician as well as new pharmacist / doctor 
communications. The transactional elements are relatively easy to implement. 
5.4.1.12 We;shord's 6 - Box Model 
Developed in the early 19705, Weisbord conceptualises his model as a radar screen, 
which will from time-to-time exhibit 'blips' that inform the observer about key 
variables, good and bad. He identifies six crucial areas of organisation, where activity 
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must be right for organisational success. The model outline is shown in Figure 34 
(Weisbord, 1976: 430 - 447). 
Figure 34 WEISBORD'S 6 - BOX MODEL OF CHANGE 
PURPOSE: What 
~ business are we in? ~ .. ! 
RELATIONSIllPS I STRUCTURE ! 
How do we ! How do we arrange I /. manage conflict ! the work? 
among people? i 
• 1 With technologies? ....... __ ........ _.- LEADERSHIP Who keeps the boxes t in balance? // 
~/-- REWARDS HELPFUL ......... ,. Do all the necessary 
MECHANISMS ~ peoplebave Have we adequate ~ 
co-ordinating 
incentives? 
technologies? 
t Environment t 
Input 
Each box is diagnosed and analysed for both its formal and informal systems. Key to 
his rationale is the gap, if any, between the formal systems of the organisation and its 
informal arrangements. The larger the gap, the more ineffective the organisation. Key 
diagnostic questions attach to each box to enable the gaps to be exposed. 
The issue of 'leadership' (at all levels) is central in his view to organisational health and 
efficiency. His formalised route to establishing the current status of organisational 
health is via a diagnostic matrix, which specifies the elements of address most 
significant to each box. These questions expose the formal and informal systems, which 
are operating simultaneously in each of the 6 dimensions of the model and discern the 
internal dissatisfaction with outcomes or outputs of the organisation. The matrix is 
shown in Table 39. 
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Table 39 WEISBORD'S MATRIX OF DIAGNOSIS FOR 
SURVEY DESIGN AND DATA ANALYSIS 
MODEL FORMAL SYSTEM INFORMAL SYSTEM 
BOX 
Purpose • Goal clarity stated. • Goal agreement. 
Structure • Functional Programme set out. • How is work actually done? 
Relationships • Who deals with who; on what; • How well do they do it in 
which technology should be reality? 
used? Role descriptions. 
Rewards! 
• Explicit system. What is it? • Implicit psychological Incentives rewards. What do people 
feel about pay-offs? 
Leadership 
• What do top people manage? • How? Style of 
By what system? administration. 
• Budget system. Management • What are they actually used Helpful information systems. Planning for? 
Mechanisms 
and control systems. How do they function? 
How are the systems 
: subverted? 
. 
When diagnosis of an organisational problem(s) is a matter of urgency, this model is, 
according to Burke, (1982: 173) a model of choice. It would also apply in certain 
instances where the participants have no knowledge of open systems concepts. The sort 
of gaps looked for in the analysis are: 
What exists now? What ought to be; 
What is done now? What managers say they do; 
Gaps between layers of the hierarchy or units of operation (e.g. production; 
marketing) 
What rewards are given? 
Where does leadership strategy 
say we go? 
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What are expected; and, 
Where are we actually going. 
The weakness of the model appears to be its simplistic approach through six concepts of 
address, when in reality organisations are often more complex than the six issues of the 
model. Criticisms of this model include: 
• its lack of address of culture; lack of detailed attention to the environment; 
and, 
• lack of systematic route from expressed dissatisfaction, to the causes of such. 
This model would not easily align with the pharmacy situation because of the 
transactional detailed address required. 
As stated in the chapter introduction to this section, (p.169) elements of other models 
should not be precluded from use, if relevant and not already included in the chosen 
model of change. For example, Lewin's approach of 'unfreezing' the old behaviour, 
before shifting to new behaviour, is relevant in disconfmning for dispensing 
pharmacists their present situation in primary care. The other models discussed also 
make important statements about particular aspects of change and their co-ordination. 
Currently, community dispensing pharmacy is very much a transactional operation 
which must be developed to a cognitive level, to effect transformation of the role and 
position of the independent pharmacist in primary health care. Only the Burke-Litwin 
model deals with all the crucial elements affecting ch~ge, as envisaged in this study, 
i.e. 
Transformational: External environment; Leadership; Culture; Mission & Strategy; 
Individual, team and organisation performance. 
Transactional: Motivation; Systems, policies, procedures; Task and Individual 
Capability; Individual needs and values; Business processes and 
structure. 
It is also the model which integrates both transactional and transformational levels of 
change. The Burke-Litwin model offers a practical route into culture change - a 
notoriously difficult area to tackle, in organisational terms - through relatively simple 
adjustment of the factors comprising organisational climate, (Figure 36, pp. 216 - 217). 
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More importantly, the transactional elements of this model will be easily understood by 
the wider independent pharmacy profession, who may not be concerned with the more 
sophisticated concepts of strategy or environmental analysis. This model will also keep 
leadership focused on the health care environment of competitors and stakeholders, as 
well as inwardly to the profession itself. The former may be a critical aspect of 
pharmacy transfonnation if competitive forces increase. 
5.4.2 Summary 
An outline of organisational theory has been explored through twelve models of 
organisational perfonnance and diagnosis. These are calculated to inform certain areas 
to be addressed in effecting organisational change, but at the same time express some 
different emphases of focus. None appear to cover the whole spectrum of possibilities 
in change management but in such a complex area this may be expected. However, 
they have all been employed in major corporations within sophisticated societies and 
markets. All depend, at the end of the day, on the willingness of the leadership and 
employees to view them positively and actively participate in the techniques and 
methods required to deliver change. 
The chosen model for any organisational setting and pharmacy in particular, should be 
sufficiently comprehensive to address all major problem areas and as easy as possible to 
work with. All models testify to the fact that a systematic approach to effecting change 
is both popular and effective. From an examination of twelve models of organisational 
change, the Burke-Litwin model is recommended by the author for use in the role 
change of community pharmacy. Pharmacy is a 'transactional' operation at present, but 
in future will build upon the patient prescription for delivering cognitive service and 
increase transactional activity in doctor liaison. Equally with leadership responsibility 
in directing change, this model provides a template for so doing and through change in 
'work climate' may effect the required culture change in due course. 
Table 40 summarises the similarities and difference of the change models studied in this 
section. 
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Table 40 
MODEL NAME and 
APPROX. ORIGIN 
DATE 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
LEWIN-SCHEIN 
(1946) 
TICHY (19808) 
NADLER-
TUSHMAN (1980) 
BERGER 
(1994) 
SIKORA 
HAY 
CONSULTANCY 
(1993) 
McKINSEY 
(1981) 
7S', 
SILVERWEIG 
ALLEN (1976) 
& 
BUNKER & ALBAN 
(1970s) 
ACTION 
RESEARCH (19405) 
MULTI-80URCE 
FEEDBACK (19805) 
BURKE-LITWIN 
(1992) 
12. WEISBORD 6-BOX 
(1976) 
TABULAR COMPARISON OF CHANGE MODELS STUDmD 
SIMILARITIES - DIFFERENCES 
FEATURES 
Specified focus on individual behaviour change 
i.e. unfreeze existing behaviour, move to new 
behaviour: refreeze. (P) 
Systems based - overlaid with political; 
cultural; technical influences. Internal 
organisation congruence pursued. 
Advocates internal systems congruence. Like 
Tichy 6 pairs of systems routinely examined. 
Change systems, structures and skills (all 3 are 
adjusted); used to cbange culture of the 
organisation and effect behaviour change. (P) 
Comprehensive model focused on systems and 
people cbange. Driven by goals and strategy. 
Systems based - key interdependencies 
stressed. Congruences also crucial e.g. staff 
abilities and shared values. No external 
environment or performance elements. 
For cultural change; address only through the 
behaviours and norms of the people in the 
organisation. Installs 3 systems: reorientation 
of leadership; action study teams; organisational 
work teams. 
Large systems intervention; large event driven -
intervenes at all levels of organisational 
operations. Survey! feedback collated from 
whole system. 
Data driven - people based. Four varieties 
practised; surveys used for diagnosis of 
problems; through data collection. (P) 
People based; data from multiple sources 
collected on key individuals and fed back to 
encourage change of individual behaviour. (P) 
+ 
'Transactional' and transformational aspects of 
the whole organisation targeted for diagnosis 
and selected for change effort. Originated from 
19605 research. Survey based and 
environmentally interactive leadership key 
issue. Comprehensive approach. 
(SELECTED) 
Personal interviews and surveys; people and 
systems. Leadership central to maintaining 
balance of the 6 boxes. Most straightforward 
easy to use model of all. 
COMMENT 
Based on premise that all change comes from 
individual people. Systems and structures 
adjust in consequence. 
Lack of focus at individual behavioural level. 
Depends on systems leverage points to alter 
people. Seeks to align internal systems with 
each other. Includes environmental influences, 
mission and strategy. 
Comparing people construct & work. construct 
exposes bow people needs are met by work: 
tasks content. Also seeks fit between tasks and 
people skills I abilities. 
Before changing the 3Ss, the critical success 
factors are identified by analysing the 
organisational strategy and current culture. 
Environmental drivers addressed. All aspects 
of organisation examined - culture, structure, 
processes, technology and people. c. fBurke 
Strategy must be congruent with organisation 
skil1s and expertise. If strategy changes 
because of markets, skills and expertise must 
change etc. etc. 
Does not address more deeply held values, 
assumptions, beliefs of culture. Looks at 'norm 
gaps' between present and future desired states. 
\Rooted in Klein's work (1992: 566 - 578) and 
Owen in the 1980s addressing large groups of 
people at one time (up to 2,000). Gained 
greater usc in the 19905. 
Originated by Kurt Lewin (1940s). Developed 
in remainder of 20111 century. Widely used in 
America. Iterative process until change 
achieved. 
Creates psychological dissonance in the target 
individuals who then feel strong need to 
change. 
No emphasiS on system congruence or 
alignment Wide analysis, focused change 
effort on systems and people. Inter-
relationships of model's components 
emphasised. Does not account for 
organisation's technical position. 
Environment does interact with this model. 
Formal and informal arrangements within each 
system. Fit between purpose and internal 
structures essential. Similar to McKinsey 78 's. 
Note: Author's summary of models examined and commentary against each. A bold (P) in column 2 signifies that some 
clement thereo~ is mentioned as applicable to pharmacy. 
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5.5 CULTURE, CLIMATE AND ORGANISATIONAL 
DEVELOPMENT 
5.5.1 INTRODUCTION 
The importance of corporate culture in the context of organisational development 
appears to be generally acknowledged, if to some degree controversial. Organisational 
climate on the other hand has been fonnally studied for somewhat longer and has more 
conscious manifestations which are it seems, easier to alter in management tenns and so 
be susceptible to organisational change efforts. Nevertheless, culture has been taken 
seriously by the corporate world, as an influence on efficiency and excellence. 
Pharmacia of Sweden, for example, in the early 1980s set up a Personnel and Business 
Department to address this potential area of improvement (Alvesson & Berg, 1992: 
11). Likewise, in 1988 Ciba-Geigy, a Swiss based world wide pharmaceutical 
company, discerning a rift between their organisational culture and the aspirations of 
stakeholders, decided to develop a new vision (Vision 2000) and set out upon a massive 
programme of change. 'Leadership' and 'teamwork' were to contribute to a new 
corporate culture (Kennedy, 1993: 18 - 27) • ... and give employees a sense of 
identification with the company's goals ... ' These are o~y two examples amongst many 
whose culture is clearly an important issue requiring careful change where necessary. 
Consideration of group culture (in this case a profession'S culture) is important for the 
purpose of avoiding cultural conflict with the medical profession, in the process of 
persuading them to support role change in pharmacy. Arguably the roots of group 
culture, and probably whole organisation culture study, date back to Lewin and Trist's 
work (1940 - 1950) in group behaviour change, Later, workers in the field of culture, 
in an organisational context, such as Elliot Jaques, (1953: 3 - 24) who studied the 
concept on the basis of 'acquired customs and traditions', began to investigate the 
subject. He argued: 
'" .life in a company is an uninterrupted interaction between structure, 
culture and personality ... ' 
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It seems to be much later, however, (1970s) that corporate culture as a specific subject 
began to be investigated and written about (Harrison, 1972: 119). Pettigrew, (1979: 
579) writing in Administrative Science Quarterly, dermed culture as: 
' ... the system of generally and collectively accepted meanings which 
operate for a certain group on a certain occasion. I 
Schein, (1997: 12) dermed culture as: 
' ... a pattern of shared basic assumptions that a group learns as it solves 
its problems of external adaptation and internal integration. .. I 
In a large organisation, Schein (1997: 14) goes on to explain that culture variation in 
sub groups of the same organisation is substantial. 
Other theories and researchers with interest in corporate culture in the 1980s include 
Meryl Reis Louis, (1983: 39 - 54), Linda Smircich, (1983: 55 - 65) and Edgar 
Schein, (1985 : 1 - 22). At the time, Stablin and Nord, (1985: 22) commented: 
'Probably never before in organisational studies, has an innovative 
area been given so much attention ;0 rapidly ... I 
Smircich (1983 : 57) identified two streams of research that linked the concepts of 
culture and organisation in somewhat different ways: 
i. The 'Application School': 
Regarded culture as a 'system' and like the systems views of 
organisational functioning, regarded culture as a necessary means of 
maintaining organisational balance with its environment; and, 
ii. The 'Root Metaphor' School: 
Viewed culture as something an organisation is - not has, or does. 
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The first school of thought has prompted theorists and researchers to look for a 
correlation between culture and organisational success, (Peters & Waterman, 1982; 
Kanter, 1995). 
Culture research in the latter school has consequently been devoted to investigating its 
nature, in organisational context, rather than its effect upon corporate performance. 
The following are further definitions of culture as seen by other theorists in the field: 
1. A pattern of beliefs and expectations shared by the organisation's 
members. These beliefs and expectations produce norms that powerfully 
shape individual and group behaviour in the organisation. (Schwarz & 
Davies, 1981 : 33); 
2. The common philosophies, ideologies, values, assumptions, perceptions, 
expectations, attitudes and norms which bind a group together. (Kilman 
et al., 1975 : 5); and, 
3. Another means of creating organised activity; by influencing the 
language, norms, folklore, ceremonies and other social practices, that 
communicate the key ideologies, values and beliefs, guiding action. 
(Morgan, 1986 : 135). 
However, Alvesson and Berg, (1992: 48) express a wider perspective: 
' ... culture is as rich as life itself and simply reducing it to a rigid 
framework or precise and absolute definitions, would seriously 
reduce its inborn complexity. ' 
In their book, Corporate Culture and Organisational Symbolism (1992 : 50), they are 
critical of cultural research and theory as it was up to that time, because of what they 
considered to be an absence of empirical research. Nevertheless, these authors cite 
some 2,550 references to culture, in papers and publications, which indicate that the 
culture concept has become well established in organisational development theory and 
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practice. Culture certainly figures prominently in respected organisational change 
models from the 1980s onward. 
A working construct of culture provided by Schein, (1997: 17) is represented 
diagrammatically in Figure 35. It is perhaps in level 3 that pharmacy initially can 
commence change through the rites of practice in the dispensary, shifting more 
responsibility to technicians, then freeing time for the new ritual between pharmacist 
and doctor, placing and maintaining the GP as the lead primary care professional. In 
this way, doctor culture is not challenged and the new pharmacist role is made more 
harmonious with GP self image expectations. 
The underlying explanation is set out by Schein as follows: 
1. Deeply held basic assumptions 
The taken for granted subconscious basis on which behaviour is enacted 
and decision making happens; authority is accepted; the organisation's 
raison d'etre; automatic relationships in the work place; 
2. Values, Beliefs and Attitudes 
Values as moral / ethical issues; expectitions of what should be in terms 
of integrity; beliefs are perceptions of what people think is or is not the 
reality, i.e. 'pay levels effect quality of product.' Attitudes connect 
beliefs and values with feelings - a learned predisposition to respond to a 
stimulus; and, 
3. Artefacts 
Stories, myths, rites, rituals, ceremonies, symbols, which characterise the 
organisation; the most visible aspects of culture; symbolisation of the 
organisation's values. 
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Figure 35 SCHEIN'S LAYERED CONCEPT OF CULTURE 
(Schein, 1997: 17) 
Artefacts & Creations 
The way people dress; language used in work 
place; status symbols; rites or ceremonies; myths 
and stories; taboos. 
Values & Beliefs; Attitudes 
Moral/ethical codes; expectation ofwhBt 
should be. Perceptions of what people 
think is the reality. 
Basic AssumptioDs 
Taken for granted 
beliefs; subconsciously 
held about the 
organisation and its 
policies and human 
relationships. Basis on 
which behaviour is 
enacted. 
1. 
2. 
3. 
Note: Schein's diagrammatic representation of corporate cultw'e, 'basic assumptions' and 'taken for 
granted beliefs being at the heart of employees' perceptions about the way things are done. The 
deeply held basic assumptions and beliefs which are axiomatic in the individual's psyche are 
portrayed by Schein as being at the very core of individual and group culture. Next influential 
are the values, beliefs and attitudes of what people perceive to be their situation in relation to the 
expectations of the organisation. Finally, the visible manifestations of how work culture is 
expressed. These contribute to the 'climate' of the organisation. 
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The deeper layers of culture, basic assumptions; values and beliefs, are cognitive 
elements which, according to Sackman, (1992: 140 - 161) take four different forms, 
which he characterises as follows: 
Dictionary Knowledge 
Assumptions about the 'what' of organisational situations, Le. what is a source 
of status; what constitutes job satisfaction; and what are managerial 
expectations; 
Directory Knowledge 
Assumptions about the causes of departmental I organisational success; about 
influence processes and about how common processes work. They shape the 
way in which people deal with problems; 
Recipe Knowledge 
Accepted prescriptions of how to improve processes at all levels - these can 
express norms and values; includes lessons from the past; and, 
Axiomatic Knowledge 
The most basic assumptions about the nature of things and why they occur; 
assumptions about the nature of people in the w~rk place. 
Dictionary and directory knowledge are held to manifest in the organisation's cultural 
artefacts, (Larwood, 1992: 149 -154). Cognitions that have become widely accepted 
have been described as 'theories in use', 'frames', (Daft & Weik, 1984: 284 - 295) or 
cognitive maps, (Huff & Schwenk, 1990: 89 - 109). To effect change at these levels 
of culture would seem at a glance almost impossible in large compound organisations 
such as pharmacy, as the effort at individual level in all 10,000+ settings would be 
colossal. This is perhaps a pointer to seeking change mechanisms at a simpler level. 
Schein (1997 : 14) goes on to suggest that 'culture', in organisation, should not simply 
be read as a uniform set of behaviours and perceptions held by everyone in the 
workplace. Sub groups and departments may well have entirely different sub-cultures. 
Other researchers support this view, (Sackman, 1992: 140 - 161; Trice & Beyer, 
211 
1993 : 174). The accounts and production departments in manufacturing organisations, 
for example, may well have different cultures; born of different backgrounds, 
professional education and the associated cultures of adjacent environmental contacts. 
The culture factor has, not surprisingly, become associated with organisational 
performance, but Chatman and Jebo, (1994: 522 - 553) argue that it is only safe to 
associate 'strong' culture with success, if one of the culture's strengths is the ability to 
cope with the changing forces of the environment. Luthans, (1993: 12 - 13) believes 
that cultural 'strength' is a function of two factors: 
i. The extent to which all organisation members have the same set of 
values; and, 
ii. The intensity with which the values are held and the resultant degree of 
commitment. 
However, the issue of strong culture being positively related to successful performance 
appears to be unresolved as Kotter and Heskett, (1992: 34) have shown that strong 
culture can also be associated with failure and some weak cultures, in their study, were 
actually successful organisations. In an attempt to shed some light upon the idea of 
'strong' culture being a contributor to success, Christe~sen and Gordon, (1999: 397 -
422) suggest the relationship is to some extent dependent upon the 'environmental fit' 
of the culture and its consequent ability to address the market context, in other words, 
the culture should be strategically appropriate. Kotter and Heskett go on to demonstrate 
that additional factors which may help the correlation between appropriate culture and 
success: 
• the culture in external effect must be one that values and supports the 
legitimate interests of the large stakeholders; and, 
• the culture internally must value excellent leadership from managers at all 
levels in the organisation. 
Their studies showed that over an eleven year period, companies with culture which 
embraced the above perspectives increased revenues by an average of 682% compared 
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with a 166% increase from those which did not. In addition share prices rose by 901 % 
compared with 74% respectively; an impressive comparison. 
Goffee and Jones (1998 : 127) argue in their book, The Character of an Organisation, 
that there is no such thing as one right or best culture for all organisations, but one 
which is synchronous with its environment. Thus culture change and culture 
management become important considerations. The pointer here is suggestive that 
pharmacy, with a culture evolved from history and perhaps entrenched in certain beliefs, 
for example about supervision, needs to develop an adaptive culture to address the 
modern rapidly changing environment. 
Ogbona, (1993: 42 - 53) points out that culture change efforts are unlikely to 
materially affect deeper cultural assumptions and values in the psyche of the individual, 
but that some behavioural change does actually result from culture change interventions. 
This in fact may be all that is needed to reposition the pharmacy profession in primary 
care, with a new role of medicines management. Gilmore et al., (1997: 174 - 189) in a 
study of 530 American companies found that positive culture change effort can improve 
competency, quality, service levels and productivity. They go on to say that climate can 
decline considerably. Climate, in this context, is the manifestation of culture through 
work atmosphere, understanding, perception of work experience and organisational 
context, (Reichers & Schneider, 1990: 42). 
Berk's approach to cultural change is via changed managerial behaviour and thence the 
climate of the organisation, which because of its intimate relationship with culture, 
eventually effects change at a cultural level. Many culture change models appear to be 
derived from Silversweig and Allen's early four stage change process (1975 : 33 - 49): 
1. Analysis of existing culture 
Surveys of all members to acquire comprehensive data; 
2. 'Experiencing' the culture 
Group participation workshops examine existing culture and future 
desired change; 
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3. System installation 
Starts the change process - participation workshops -leaders involved -
modelling of new culture and processes; and, 
4. Ongoing evaluation 
Reviews and checks for 'drift'; reinforces change strategies. 
Involving people at all stages seems to be essential to ensure thorough understanding of 
the change need and its objectives. Hope and Hendry, (1995: 61 -73) pose a relevant 
question, asking if attempts should really be made to change the heart of culture at its 
deep levels, or should more obvious factors be taclded (Le. structures, systems, policies 
and procedures, work climate, artefacts) and then allow the effects to pervade the true 
cultural paradigm on an incremental basis? 
Again, the question arises, with change contemplated for pharmacy, should this latter 
approach be used to deliver the new service and allow culture change from 'supply' to 
service to gradually change over time? This remains to be seen after the field research 
in this study, but would it be a relatively straight forward means of operationally 
engaging in pharmacy practice change? 
5.5.2 Climate 
Climate has already been mentioned in the context of culture as both are intimately 
related and both concepts, in rudimentary origin, can be traced back to research and 
practice in group work, in the 19405, (Lewin; Trist 1951). Climate, according to 
Tagiuri, (1968: 23) can be defmed as: 
' ... a relatively enduring quality of an organisation that is experienced 
by employees and influences their behaviour ... ' 
As Jones and James, (1979 : 201 - 250) have commented ' ... it is the way people 
subjectively describe an organisation to themselves and interpret what they find: 
Schein, (1997: 9) expresses it as: 
214 
' ... the feeling that is conveyed in a group by the physical layout 
and the way in which members of the organisation interact 
with each other, with customers, or other outsiders ... ' 
The term 'relatively enduring', indicates the possibilities of climate change in certain 
circumstances. If climate influences behaviour, then behaviour change becomes a 
possibility through altering organisational climate in some way. Although an 
organisation-wide phenomenon, climate clearly operates in the psyche of the individual 
and is, therefore, according to Glick, (1985: 601 - 616) a multi-level phenomenon and 
is frequently evaluated in this way through 'climate questionnaires', (Litwin and 
Stringer, 1968) and the Business Organisation Climate Survey (BOCS); (Payne & 
Phesey, 1971 : 77 - 98). Climate surveys probe perceptions of organisational members 
in issues such as the following: 
• Relationship of employees with leadership at all levels; 
• Organisational receptivity to new ideas; 
• Authority relationships or how power is used; 
• Reward systems; 
• Social amenity of the work place; and, 
• Effect of human resource management polic~es. 
Warner Burke, (1994: 71 -72) in describing the Burke Litwin Model of organisational 
performance and change, makes the point that both 'climate' and 'culture' should be 
viewed in terms of their interactions with each other, as well as other organisation 
variables. (See Burke Litwin Model, Section 5.4.11). He argues that some 
organisational variables are affected by culture, (transformational issues) and some by 
climate, (transactional issues). Reichers and Schneider, (1990: 5 - 39) in an 
examination of the literature on climate and culture see • ... considerable overlap between 
the two concepts'. Burke, (1994 : 71 - 72) is of the view that culture should not be 
changed by direct effort, but through managerial behaviour, which affects climate. 
Persistent effort in this way will incrementally change culture he argues. Denison, 
(1996 : 619 - 654) likewise supports the view that climate and culture are parts of the 
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same phenomenon and that speculative differentiation of the two has been something of 
a self-fulfilling prophecy. 
Harrison and Shirom, (1994: 264) are of the view that despite overlap in the two 
concepts, there are important differences, which provide the opportunity for influencing 
the deeper issues of culture, through the more superficial aspects, some of which merge 
with 'climate' effects. They see top managers as the creators of climate and the 
employees have perceptions of it, through the factors cited above. Clearly, work related 
perceptions and attitudes are important to organisational performance and indeed 
strategic aspirations. 
Currently (January - March 2002), some perceptions of pharmacists' responsibilities in 
'supervision' of dispensing processes and the sale of 'pharmacy only medicines' may 
obstruct progress in engaging the new role. They do not wish to relinquish the minute-
by-minute mechanistic checking of prescriptions. Letters and articles to the 
Pharmaceutical Journal, between January and November 2002, testify to this fact: 
Hannawain, T. (2002 : 515); Phillips, G. (2002 : 430). 
Those who wish for no change appear not, as yet, to have computed the short, mediwn 
or long term effects on new pharmacist role adoption in medicines management. This 
problem is quite possibly a mixture of cultural and cliID~te effects. 'Culture', bOWld in 
tradition and history, as to how things have always been and 'climate' in the sense of 
perhaps poor organisational receptivity to new ideas, inadequate relationship between 
members and leaders and lack of leadership harmony and strong guidance. 
Rollinson and Broadfield (2002: 601) set out the following scheme of climate 
antecedents and outcomes; together with interactions (Figure 36). Climate, they argue, 
is a result of the organisational structure, work group reporting procedures, tasks, 
rewards and recognition systems, role descriptions and environmental context. These, 
in turn, affect individual motivation, needs, goals and activities. The relevance to 
community pharmacy is plain to see in the changing roles of dispensing staff, procedure 
and task changes and systems adjustment for delivering medicines management. The 
political environment is driving change. 
216 
Figure 36 ORIGINS AND OUTCOMES OF ORGANISATIONAL CLIMATE 
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Note: Author's adaptation ora scheme by Rollinson & Broadtield, (2002: 601). Origins of 'climate' arise both internally and 
as an effect of the environment in which the organisation operates. Hence the two way arrows between the work group 
situation (organisation, context and individual) and the PEST factors of the environment 
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5.5.3 Summary 
Organisational climate then, is conceptualisation by its members of ways in which they 
interact with themselves, their surroundings, managers and leaders. It thus affects 
attitudes and is a basis for at least some of their behaviours, (Schneider, 1983: 53). It 
is further argued by Litwin and Stringer, (1968) that levels of motivation and morale 
are also affected by 'climate'. 
Because of the more superficial nature of climate, as compared with culture, Zohar 
(1980 : 96 - 102) for example, is of the view that sub-climates, at group or team level 
exist and are more pervasive than sub-cultures, because of the potential speed of change 
at relatively superficial levels in certain circumstances. 
If climate, then, is a cognitive effect as Kozlowski and Doherty, (1989: 546 - 553) 
argue, then this could be a means of starting to affect individual mental perspectives on 
behavioural issues, relating to deeper cultural issues, for example, changing a value or 
assumption system to change outlook on customer I patient service. 
So far as the primary care pharmaceutical service is concerned, deeply embedded 
attitudes, assumptions and beliefs, with regard to phannacy's role are even now 
, 
surfacing, (pJ, Anon., 2002 : 515). Letters and articles to the Pharmaceutical Journal 
show a mixture of support for modification to the legal requirements on supervision and 
strong resistance to modification of the interpretation of supervision in any way. 
Similar dissent has been observed by the author, on the PSNC committee and also the 
NPA group within PSNC. History, tradition and some fear, appear to be exerting a 
strong influence in certain quarters and if reflected in large numbers nationally, will 
require effort directed at a culture shift, rather than simply trying to enforce change by 
directive and edict. An approach to culture change, by tackling the simpler issues 
contributing to organisational climate, may well afford the most practical and effective 
way of changing culture in the long term. Operational change in pharmacy, is after all, 
the most urgent issue. 
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Consideration will now be given to some systematic approaches to leadership effort in 
affecting change, dating from the 1940s when such approaches began to emerge. These 
systems attempt to draw together related aspects ofleadership focus (of which culture is 
one) and form a blueprint for addressing organisational problems and a framework of 
addressing change in selected aspects. Most of the developed models date from the 
1970s but use principles established much earlier. 
5.6 LEADERSHIP AND MANAGEMENT THEORY: 
ROLE IN ORGANISATIONAL CHANGE 
5.6.1 Introduction 
In the change models discussed in Chapter 5, 5.5, 'leadership' figures prominently in 
those which comprehensively address the organisational systems, structure and 
infrastructure and totality of the organisation, in inter-relationship with its environment. 
Leadership, although a concept rooted in early history, has become a subject of 
increasing interest in modem management and 'leaders' are recognised as of key 
importance in the performance of their organisations. ~evinson, (1994: 41) has gone 
so far as to say: 
'All organisations are the lengthened shadows of their leaders. 
Sometimes that shadow lasts for generations ... I 
Leaders have a marked effect upon corporate strategy, (Smith & White, 1987: 263 -
280) and in operational terms, can make the difference in an organisation's performance 
between, in extreme terms, success and failure. A continuum of effects between these 
extremes is the ultimate responsibility of the chief executive officer, (Thomas, 1988: 
388 - 400). The world's leading business corporations have made use of the research 
on leadership in order to more successfully appoint individuals who will deliver 
impressive organisational performance, (Hadijian, 1995: 95 - 97). 
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Leadership exists within pharmacy, in the hierarchical sense of having chief officers and 
lead responsibilities in the representative organisations. However. this is not to say that 
leadership, as defined in the following conceptualisations, has been a recognisable 
feature of pharmacy's official leaders in the past few decades. An exception fairly 
recently may be through the RPSGB 'PlANA' document, which unfortunately lacked an 
operational plan and programme of change. The following pages help to expose 
leadership targets of address and methods of role change for the pharmacists in the 
primary health care pharmaceutical service. 
'Leadership', in a modem organisational context has been variously defined as follows: 
i. (YukI, 1989 : 23): ' ... the process through which one member of a group 
influences other group members toward the attainment of specific group 
goals ... '; 
ii. (Jacques & Clement, 1991 : 4): ' ... that process in which one person sets 
the purpose or direction for one or more other persons and gets them to 
move along together with him or her and with each other, in that 
direction with competence andfull commitment ... '; 
, 
iii. (Campbell, 1991 : 3): ' ... actions whic,h focus resources to create 
desirable opportunities ... '; and, 
iv. (Kotter, 1990: 4): ' ... the process of creating a vision for others and 
having the power to translate it into reality and sustain it ... ' 
Leadership, by implication, argues Kotter, (1990: 4) does not produce consistency and 
order, it produces movement through at least three such processes: 
i. It establishes direction, developing a visionfor thefuture and a means of 
getting there; 
ii. It aligns key people, harmoniSing effort towards the objectives; and, 
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iii. It motivates followers to achieve the goals of strategy and movement. 
Leadership then, is regarded as a process, but does not indicate the nature or attributes 
of a leader and in this section of study, both will be addressed, but with greater attention 
to leadership. A defInition of leadership offered by the author of this thesis is as 
follows: 
'Leadership is the ability to create a vision for a group of any size, 
together with the motivation, plan and activity to realise it. ' 
Leadership and the role of leaders is being explored in this chapter to help inform the 
way forward in taking the community pharmacy profession into a new position of 
service and responsibility in primary health care. It is studied on the basis of 
recognising that there are designated leaders and leadership bodies within the 
profession, with current roles and responsibilities in governing, negotiating and 
providing legal, commercial and political advice to members and contractors. These 
traditional roles and activities may however, be inadequate to lead and plan the way 
through change into a new order of service. 
In the magnitude of change contemplated for community pharmacy, transformational, 
. 
within a health care environment, which is itself underg~ing considerable structural and 
motivational change, the profession's leadership will have far reaching responsibility. 
This means responsibility to lead change by both elected leaders at the head of the 
profession and emergent leaders at all levels as the initiative develops. 
The RPSGB will have the pivotal role of change agent, in terms of the legal 
interpretation and reform of 'supervision' relating to dispensary and DTC medicines, 
together with skill mix re-design. The PSNC will need to construct new models of 
remuneration and the NP A will be, by its business systems orientation, responsible for 
re-design of premises amenities for the medicines management cognitive service. The 
Company Chemists' Association will be looking at new role implications for their 
members and taking an overall view on policies to be adopted. 
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The multiples and vertically integrated multiples may be drawn into the role of change 
agents, or indeed change barriers. The gross profit margins on cognitive service are 
dictated by high cost phannacist involvement and thus, much lower than the margin on 
high volume drug purchasing. The new service will remove their competitive 
advantage of purchasing power. Because of this complexity in the internal domain, the 
author arranged a meeting in June 1998 to consider the formation of a 'leadership 
group' to, firstly, achieve 'critical mass' alignment, in commitment to role change and, 
secondly, to hannonise, if possible, aspirations of the various groups. A group was 
formed in July 1998 consisting of the following lead bodies: 
Royal Pharmaceutical Society 
Pharmaceutical Services Negotiating 
Committee 
National Pharmaceutical Association 
Company Chemists' Association 
Co-operative Phannacy Technical Panel 
President; Registrar 
Chairman; Chief Executive 
Chairman; Director 
General Secretary; Director 
Director; Secretary 
Since that time, the group has steered the introduction of a nation wide pilot of the new 
MM service. The structure is as follows: 
Pilot Structure 
• 9 locations in 3 regions (North; Midlands; South); 
• 1 Research Fellow per region; 
• 3 local co-ordinators per region; 
• 43 GP practices; 
• 76 GPs - approximately 3,000 patients; 
• 71 community pharmacies; 
• 91 community phannacists; 
• Universities: Aberdeen; Keele; Nottingham; and, 
• Patients - 2/3 of cohort study group; 1/3 cohort as the control group. 
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The pilot is due to complete in 2003. However successful this may be, it will not 
guarantee the general introduction of the new service. The following issues also need to 
be addressed by the leadership of the profession: 
• Training and education for community phannacists in the new service; 
• Shift of mechanical dispensing workload from pharmacist to technician; 
• Better qualified staff at medicines counter level; 
• Time impact management ofMM, upon GPs and their staff; and, 
• Partnership building between pharmacist I patient and pharmacist I GP. 
The following section, therefore, seeks to study the relevance and activities of 
leadership and leaders in helping to direct and facilitate the change from current to 
future service in primary care pharmacy. It also seeks to identify means of connecting 
the leadership function and responsibilities in this change situation to the grass roots 
profession, in an appropriate manner. 
5.6.2 Leadership -Development of the Concept 
The concept of leadership and existence of leaders has: been evident from early history. 
'Headmanship' or 'chieftanship' in tribal settings and 'command leadership' in warfare, 
or battle situations is a fact of history. So the natural emergence of leadership, or lead 
people, down the centuries has been, it could be said, a natural phenomenon of social 
evolution, situational need and group interaction. Homer's Odyssey (Book iii, line 297), 
for example, mentions the subject and advises leaders to maintain social distance 
between themselves and subordinates: 
' ... the leader, mingling with the vulgar host, is in the common 
mass of matter, ]ost ... ' 
Whether this could be realistically asserted in modem society is debatable. 
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Much later, in the sixteenth century, Machiavelli in his work 'The Prince', teaches 
leadership practices and tactics for the ruler of a Principality and refers to exemplars in 
Kingdoms and Empires. He himself served in Government from 1498 to 1512 and 
learned, it is supposed, the wiles and rules of effective leadership. The book prescribes 
a degree of ruthlessness, manipulation and strong discipline, in precedence over 
collaborative friendly dealing with people, based on strict moral principles (Machiavelli, 
1513 / 1999 : 17): 
•... There is no surer way of keeping possession (of a conquered city) than by 
devastation. Whoever becomes the Master of a city accustomed to freedom, 
and does not destroy it, may expect to be destroyed himself; because when 
there is rebellion, such a city justifies itselfby calling on the name of liberty 
and its ancient institutions never forgotten, despite the passing of time 
and benefits received /rom the new ruler ... ' 
However, he expressed more moderate views on interpersonal competencies relating to 
leadership and examples he gave, have it seems, been the precursors of certain modem 
approaches to leadership. Christie and Geiss, (1970) for example, actually constructed 
a leadership traits scale, in units they called 'Machs', to measure a person's potential in 
leadership ability. The higher the score on this scale, the closer the confonnity to 
Machiavellian principles of resisting social inf1uenc~s and emotional concerns for 
others, to gain compliance to the leader's wishes and focus on the task in hand. 
Conversely, low scores are rated as being susceptible to social and personal relationship 
issues in leadership style and effort (Epstein, 1969: 38 -41). 
The idea that personal traits of a different order could be observed in leaders gained 
some popularity in the early part of the twentieth century and led to a Traits school of 
thought. However, whilst recognising that leaders in certain situations, did exhibit such 
characteristics as strength of character, initiative, sensitivity, it was found that 
identification of a variety of traits found in leaders was not necessarily a predictor of 
successful leadership ability or perfonnance. Other factors were also discovered to 
playa big part, such as situation and particular environmental circumstances. Research 
eventually moved to these latter aspects of detenninant leadership effectiveness. 
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Some twenty years earlier than the work of Christie and Geiss, Fleishman, (1953: 153 
- 158) constructed a two factor theory of leadership behaviour, derived from 
questionnaire results, prior to the main research in the notable Ohio State Leadership 
Studies. He analysed the questionnaire responses of the research and found two primary 
factors, describing group leader approaches, both of which were practised independently 
of each other: 
1. 'Consideration' 
The extent to which some leaders expressed concern for group members' 
welfare. Considerate leaders expressed appreciation for good work; 
strengthened member self-esteem; put member work suggestions into 
operation; sought group approval before going ahead; and, 
2. Initiation of Structure 
The extent to which the leader initiates and structures the work; 
standards and deadlines are imposed. Task orientation rather than 
people, is the focus; the leader does not consult the group but acts on 
own assessment of job requirements. 
This approach to leadership analysis, through identification of leader style, became 
known as the 'style theory of leadership' and wad pursued by other researchers 
investigating the same phenomenon. 
The above ideas on leadership style were further addressed by Blake, et al., (1962: 12 
-15) who took a somewhat different view, that the two approaches were not necessarily 
independent of each other, but could be observed (and practised) in the one leadership 
behaviour. They constructed a scaled grid to assess people's leadership 'style / 
approach mix' , with two axes labelled: 
'Concern for people' 
'Concern for production' 
maximum score 9; and, 
maximum score 9; 
Leaders, they argued could engage both styles of behaviour and with a highest ideal 
score on each axis of the grid (9.9) would show high concern for people as well as 
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production. Thirty years later, Blake and McCanse, (1991 : 29) refined the grid, which 
is shown in Figure 37. 
This approach has been criticised by other researchers, (Larson et aI., 1976: 628 -
641) on the basis that no scientific rigour has been applied to successfully evaluate it 
and that, for example, other influences such as group environment have not been taken 
into account, i.e. situations can change leader behaviour, (Tracey, 1987: 21- 33). 
Figure 37 
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The above researchers worked at company department level, well below corporate 
board and the work is also important to revealing that leadership can take place at lower 
organisational levels not normally thought of in leadership terms. 
Similar work at about the same time as Fleishman's early work and still dealing with the 
style theory of leadership, had recognised the flaw in looking at only two dimensions of 
style and Tannenbaum and Schmidt, (1958: 95 - 102) proposed a continuum of styles, 
based upon the leader being job centred at one extreme, (boss centred as they described 
it) and employee (follower) centred at the other. The Tannenbaum and Schmidt model 
is shown in Figure 38. (Tannenbaum and Schmidt, 1958 : 47) 
Figure 38 TANNENBAUM AND SCHMIDT LEADERSHIP 
STYLE CONTINUUM 
Boss centred leadership ____________ -. . . Follower centred leadership 
Use of authority 
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t 
Leader 
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presents 
tentative 
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subject to 
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presents 
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makes 
decision 
Area of freedom 
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JOINS 
i 
Leader defines 
limits; asks 
group to make 
decision with 
leader as equal 
member 
DELEGATES 
i 
Leader allows 
followers to 
function within 
limits defined 
by leader 
Note: The oblique line of the inner rectangle indicates increasing transition from one style of 
leadership to another, through the stages shown below the rectangle. 
From such early ideas, based initially upon personal traits of the leader and then styles 
of leadership. other theories began to emerge which have been called contingency 
approaches. These were apparently so named because the theorists perceived leadership 
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activity as being contingent upon the contextual circumstance of the operational group 
as well as the style of its leader. 
The first notable of these was that of Fiedler, (1966: 237 - 264) who proposed that 
leadership effectiveness was contingent upon the task structure, leader-member 
relations, leader style and context of the group. His proposition is diagrammatically 
represented as in Figure 39. 
Figure 39 FIEDLER'S CONTINGENCY THEORY OF 
LEADERSHIP VARIABLES 
CONTINGENT CONTEXTUAL 
CIRCUMSTANCES 
Leader-member relations 
Leader power 
Task structure 
" 
LEADER BEHAVIOUR 
STYLE 
'-...-------, ~ FAVOURABLENESS 
OF SITUATION -. 
Positive or negative 
GROUP 
PERFORMANCE 
Note: The three leadership variables, 
delivering group performance are 
described in the three boxes. 
If leader-member relations are good, leadership is fa~i1itated and there are overtones 
here of the 'concern for people' axis of Blake and Mouton's grid. Fiedler's measure of 
leadership style was scaled and measured, from the way in which the leader relates to 
the least preferred co·worker, (LPCW) within the group being led, so that: 
(i) Leaders with high LPCW score, means a positive attitude to the LPCW 
and a social relations orientation to leading the group; and, 
(ii) Leaders with a low LPCW score, points to a negative attitude to the 
LPCWand indicates a task orientated approach by the leader. 
According to Fiedler, leaders in category (i) do best in situations which are not extreme, 
whilst category (ii) do best in extreme situations of favourableness or unfavourableness. 
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This leadership rating is thus a result of personality, which is usually regarded as a 
permanent quality of people and therefore, leader I group incompatibility may also be 
permanent, if personality fit is not present. Fiedler and Mahan, (1976: 247 - 254) went 
on to suggest that in such circumstances the group composition and context could be 
changed if the leader was not to be removed. Fiedler and Garcia, (1987: 49 - 93) 
further suggested how this might be achieved and Table 41 summarises their 
suggestions. 
Table 41 LEADER ACTION TO CHANGE CONTINGENCY VARIABLES 
VARIABLE ACTION 
1. Leader-member relations • Spend wonnal time with group 
• Draft in new members 
• Offer help with aberrancy 
• Engineer new routes of satisfaction 
2. Task structure a). To increase: add detail to the processes 
and create a tighter system 
b). To decrease: increase leader-member joint 
working, reduce detail and 
: 
systems constraints 
-
3. Leader position I power Enhance by raising appearance of being in charge-
formalise instructions; become sole channel of 
communications. 
Diminish by sharing decision making and giving 
more autonomy. 
The approach suggested by 1 and 2(a) may have application at both local and national 
levels in phannacy when the time comes to engage the wider profession in role change. 
Small local study workshops may be a facilitating means, led by selected local 
pharmacists. Leaders at national level cannot easily be changed and some contingency 
variables and their application may be useful tools of facilitation for them to use, such 
as defining clearly new task structures relating to supervision and skill mix, to signal the 
commitment to change. However, Peters et al., (1985: 274 - 285) point out that the 
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above three variables in Table 41 are not the only ones contributing to leader 
effectiveness. Goals of the groups and relationships with other groups, for example, 
could also have a real influence. The goals in pharmacy are enhanced clinical 
knowledge, pharmacist / doctor partnership, a common new role and transformation of 
the profession's place in primary care. A prime goal, involving external groups could 
be the new relationship with GPs and its means of construction. 
At management and supervisory level, these issues appear to be relatively obvious, but 
at strategic level, may be more difficult to apply as autonomy usually increases at higher 
organisational levels and influencing powerful autonomous people may not be easy. 
Especially, this is also the case in autonomously run independent pharmacies and 
leadership bodies. Further, high level roles in the multiples are not usually task 
orientated, but deal with policies and futures. 
However, a number of Fiedler's ideas, such as leader I member relations, may be 
relevant at pharmacy leadership level for planning co-ordinated communications to 
members. Several autonomous leadership bodies are involved and a task orientated 
approach to leading such a group may not be appropriate, although allocating them 
responsibilities for selected task change 'down the line' may be of interest to them. 
Task orientation in this context would be, for example, getting into the detail of the 
programmes for which each individual body would bbcome responsible, then dealing 
with the leader positions and integrating messages to members from each of the lead 
bodies on the following basis shown in Table 42. 
Table 42 MESSAGE SUBJECTS 
BODY MESSAGE SUBJECTS 
RPSGB Education; ethics; law; professional governance 
PSNC NHS remuneration; service development; contractor support 
NPA Business services; legal defence; premises layout 
CCA The political and marketing interests of the members 
CPTP The internal interests of its units relating to the NHS 
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A more 'social' approach using Fiedler's 'context' issues, (i.e. for pharmacy the 
inevitability of change in the NHS) could be emphasising collaboration and integration 
of effort. Collaboration on looking to the future requirements of service roll out, may 
be advisable, then engaging in a dialogue for change with the members, rather than by 
edict and directive. 
Other research, however, does not appear to support Fiedler's theory of leadership 
effectiveness and Isenberg, (1981: 119 - 134) for example, found no correlation 
between Fiedler's model predictions and the actuality of leadership effectiveness within 
the groups in his own communications studies. In other work Rice, (1981 : 1 - 25) also 
could not fmd the predicted relationship between performance and leader type (as 
measured by the LPCW rating) in the expected conditions of Fiedler's model. 
Schriesheim and Hosking, (1978: 496 - 505) further concluded, after a review of 
certain studies which had used the Fiedler model, that 'it really has little empirical 
support ... ' (Schriesheim and Hosking, 1978 : 500). 
On the other side of the argument, Strube and Garcia, (1981 : 307 - 321) in a meta 
analysis of the model, concluded that the model was in fact valid. 
Shortly after Fiedler's work commenced, House, (1971: 321 - 338) proposed that 
leaders are in fact flexible, unlike Fiedler's concept ~f fixed style and change their 
-
approaches to suit circumstance. This idea, first considered by Georgopolous et al., 
(1957 : 345 - 353) has been progressively modified through practical experience and is 
described as path-goal theory'. It is based upon a leader's ability to improve the 
follower's motivation and satisfaction through creating perceived value of the group 
goals and facilitating the path of achievement, (House, 1971 : 324). Fiedler also came 
to a similar revision of his own views and with House regarded supervisionalleadership 
as comprising the setting of clear tasks and roles, support and concern for the 
followers' needs, and agreeable relationships in the work situation, (Fiedler and House, 
1988 : 25 - 42). 
Appropriate leader behaviour (style) is apparently contingent upon two factors inpath. 
goal theory' (of which Fiedler and House were protagonists): 
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• subordinate characteristics; and, 
• environmental factors. 
Diagrammatically these are represented in Figure 40. 
Figure 40 THE PATH-GOAL INTER-RELATIONSHIP 
AS PROPOSED BY HOUSE 
1. LEADER STYLE 
OPTIONS 
• Participative 
• Directive 
• Supportive 
• Achievement Oriented 
2. FOLLOWER 
(SUBORDINATE) 
~CTERJSTICS 
• Task abilities 
• Experience 
• Need for achievement 
• Locus of control 
• Clarity need 
3. ENVIRONMENTAL 
FACI'ORS 
• External influences 
• Character of work 
Contingencies 
Valence of 
Outcomes 
r , 
(Value of outcome as 
perceived by subordinates) 
OUTCOMES 
---I~~ Follower and 
Satisfaction 
• Organisation of group 
• Authority system 
Note: Three sets of variable factors, according to 
House, can lead to motivation of followers, if each 
is managed to best advantage. 
With regard to pharmacy, the lead bodies within their own specialities may well be 
advised to adopt a mix of styles as described in box 1 of the model, in other words, 
directive, supportive and achievement orientated. The RPSGB, with responsibility for 
supervision and skill mix issues, will eventually be engaged in directives, as a legal 
responsibility, but with other lead bodies, can focus upon the rewards of achievement 
through change and support of the transition with training, premises aids and financial 
reward, through negotiation with the DH. 
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Some researchers have found support for the above model, (Szialgi and Sims, 1974: 
622 - 634; Indvik's meta-analysis, 1986: 189 - 192). Others, although not having 
found substantial evidence against the model validity, found that in some studies, not all 
the elements were entirely supported, (Downey et aI., 1976 : 156 - 176). In inter-
people relationships this is not surprising. 
Vroom and Yetton, researchers in the field of management and motivation (1973 : 12-
15), constructed another model of leader effectiveness based on a much narrower focus 
of decision making in leadership. The model originally devised by Vroom and Yetton 
was later modified by Vroom, Yetton and Jago (1978: 151 - 162) by adding another 
option to the 'direction' - 'participation' choices of leaders in group involvement. The 
options continuum is reminiscent of that devised by Tannenbaum and Schmidt (Figure 
37) and sets out the choices which the leader may assess to be most desirable in 
involving the subordinates in the decision process in a given situation. The authors 
argue that situations change the desirability of subordinate involvement. The criteria by 
which the leader may decide on the degree of involvement, is regarded by them as 
twofold: 
1. Does the subject to be decided, affect the whole group or one individual; 
and, 
11. Does the leader give priority to the speed of decision making? 
The four decision trees, which are part of the Vroom model, introduce great complexity 
and time involvement, but generally it seems that the model is well accepted 
scientifically when applied within its narrow focus. 
Another model of leader behaviour in the contingency approach is that designed by 
Hersey and Blanchard, (1974: 23, 26 - 34) based upon subordinates' readiness to 
perform the allotted task(s). 'Readiness' is related to experience, willingness and 
abilities to do the job. Leaders should, they argue, adjust their style according to the 
group's readiness to take responsibility for the task in hand and this may well be 
necessary for community pharmacy, which the field research may hopefully inform. 
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They defme four degrees of readiness: 
RI-Low Followers with low psychological readiness and low 
task related ability. 
R2-LowlModerate Willing but unable, low task related readiness with some 
psychological readiness. 
R3-Moderate/High Unwilling but able, high task readiness, low psychological 
readiness. 
R4-Higb Willing and able, high in task and psychological 
readiness. 
Along with the above follower characterisations they use four leadership styles to inter-
relate with Rl to R4 and so indicate an appropriate leadership style. The four chosen 
leadership styles are: 
Sl-Telling Leadership is high on task orientation, low on relationship 
emphasis. 
-
S2-Selling Leader is high on task and relationship emphasis. 
S3-Participating Leader is low on task orientation (followers decide the 
'how' of things) and high on relationship emphasis. 
S4-Delegating Low task and relationship emphases, followers 
relatively autonomous. 
The contingent factor in this model is the degree of follower readiness and therefore the 
leader requires the ability to accurately discern the circumstances of the followers, vary 
his or her style and cultivate appropriate attributes in the follower group. 
Diagrammatically, the model is represented in Figure 41. 
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Figure 41 
High 
Relationship 
Behaviour 
Low 
HERSEY - BLANCHARD LEADERSmp MODEL 
Style of Leader 
High PARTICIPATING SELLING High Task 
Relationship & S3 S2 & High 
Low Task Relationship 
DELEGATING Low High Task TELLING 
S4 Relationship & & Low SI 
Low Task Relationship 
Low .... ~I-_______ TaskBehavlour ______ -.~ High 
R4 R3 R2 RI 
High Readiness of Subordinates Low 
(Hersey & Blanchard, 1997: 170) 
There is some research which is supportive of the model. (Jacobsen. 1984: 45 and 
Vecchio, 1987: 444 - 451). However other research did not show a positive 
correlation with the predictions of the model, (York & Hastings, 1986: 37 - 47). 
It seems once again that whilst the model has an innate feel of good sense about it and 
contributes to an understanding of leader-follower rela~onships, it cannot be regarded as 
a reliable predictor ofleader style in the given situations. -It can be a useful guide only. 
5.6.3 Transactional and Transformational Leadership 
These two approaches to leadership were initially expressed by Burns, (1978) 
comparing successfu11eadership in two sets of circumstances, i.e. stable situations and 
changing circumstances. In a stable situation it is argued that where the leader can 
discern the expectations and wants of subordinates, he or she can then arrange the 
context of work so that these requirements can be satisfied. Subordinates can then 
satisfactorily engage in transaction with the leader. The leader skill is in determining 
the needs of subordinates and engaging in the appropriate style of leadership. 
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This transactional perspective of leadership appears to depend upon three assumptions 
(Downton, 1973 : 23): 
1. Human behaviour is goal directed and individuals act rationally to 
achieve those goals; 
ii. Behaviours that payoff, will persist; and, 
iii. Norms of reciprocity govern the exchange relationship. 
As Burns put it, (Burns, 1978 : 3) 
' ... transactionalleaders approach/ollowers with an eye to 
exchanging one thing/or another ... ' 
In Section 4, page 227, on organisational change models in this thesis, the Burke Litwin 
model showed the transactional elements which give rise to the climate of the 
organisation, amongst which are, individual needs and values; individual performance; 
individual skills and motivation; management practices; and, systems, policies and 
procedures. These are the aspects of the work place where transactional leadership can 
direct its efforts. Here is where change will be experienced and enacted in pharmacy 
practices, countrywide in engaging the new MM service. Here is where profitable effort 
may be directed in the pharmacy context. The author would argue that this style of 
leadership is required in the role change for pharmacy. 
Transformational leadership, according to Burns' initial work, (1978) involved four 
elements: 
• charismatic leadership 
• inspirational leadership 
• intellectual stimulation 
• individualised attention -
resulting in complete faith in the leader; 
communicating high expectations; 
addressing old problems in new ways; and, 
recognising individuals, not an amorphous 
mass. 
'This construct of transformational leadership was also revealed in clinical work by 
Zaleznik, (1977: 67 - 80) whose research showed leaders attracting strong feelings of 
identity and respect (charisma), sending clear messages of organisational purpose and 
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mission (inspirational leading) and cultivating intensive one-on-one relationships. They 
were more interested in ideas than systems and procedures. 
According to Howell and Frost, (1989: 243 - 269) transformational leaders articulate a 
vision and provide a clear road map to achieve it and Conger, (1991: 31 - 45) sees 
them 'framing' the purpose of their vision, in meaningful and understandable terms for 
the followers, (Conger, 1991 : 44): 
' ... if you, as a leader, can make an appealing dream seem like 
tomorrow's reality, your subordinates will freely 
choose to follow you. ' 
House et aI., (1991 : 243 - 269) in their book on Personality and Charisma in the US 
PreSidency, argue that transformational leaders have high levels of self confidence and a 
high degree of internal strength of character, convinced of their own ideals and beliefs. 
On a purely subjective level, the pharmaceutical profession may well be the sort of 
culture that now needs to generate such leaders. Strong belief in future health and 
importance of the profession in primary health care and a determination to get there 
would seem to be important qualities in leaders who are committed to moving the 
profession on. 
-
Having looked briefly at transformational and transactional perspectives on leadership, 
it again seems to the writer, that perhaps too much of a distinction may have been made 
between the two in the legitimate interests of theory and research. In practice, it seems 
reasonable to suppose that both types of leadership can be practised by some individuals 
and indeed perhaps need to be, in the present circumstance of the change required of 
pharmacy. 
It may be advantageous, in trying to steer the leadership bodies of pharmacy into 
integrated change effort, to place emphasis on the transactional issues already 
mentioned, as the need for change here is almost self evident and in some respects may 
be best treated in the usual style of a professional bureaucracy, i.e. the issue of edicts 
and protocols. Physical amenities processes and systems are relatively easily 
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understood and changed as a matter of professional necessity. The transformation of 
mind-set from supply to cognitive service culture may be the difficult process. 
5.6.4 Leadership Substitutes 
In the discussion so far on leadership and some of the established theories, those 
situations encountered in practice, which apparently do not require leaders, have not 
been mentioned. Kerr and Jermier, (1978: 375 - 403) argue that the circumstance of a 
group may well be enough to provide direction and motivation towards objectives. 
Influences such as those mentioned at the beginning of this thesis, Le. political, 
economic, sociological and technological, may well be powerful and relevant enough to 
drive change in a particular direction. Other internal leadership substitutes are, (Kerr & 
Jermier, 1978.: 378): 
• the presence within the group, of task knowledge; 
• the group individuals' characteristics; and, 
• the organisational culture and framework. 
However, such influences need to be translated into operational dimensions to actually 
, 
effect change and this requires the intervention of the ~temal organisational leaders. 
In such cases, Podsakoff et aI., (1996: 380 - 400) argue that the results are greater than 
conventional leadership. Such contextual circumstances, if positively orientated toward 
achieving objectives, productively engage employee attitudes, task performance and 
role involvement. 
It is difficult to see, however, why such substitute leadership forces could succeed by 
themselves unless the organisational group is autonomous as in perhaps professional 
situations such as 'accountancy' and 'law', but even here, intemalleadership is likely to 
occur even if it is simply opinion leadership. Nevertheless, the concept of leadership 
substitutes is useful in focussing upon the potential of circumstance to facilitate change. 
238 
• 
Once again, this appears to be particularly appropriate to community pharmacy in the 
present circumstance of improving group professional task knowledge plus the external 
drivers of change, for example, government and the competitive forces of the domain. 
The eventual outcomes of leadership substitutes at work in an organisation will, 
according to Tosi, (1982: 403 - 411) vary by organisational level, in any hierarchical 
structure. Modem management approaches using circumstance and task lmowledge 
operate in a more social rather than a formally structured way. However, in the 
community pharmacy situation, use could be made of the drive to change the legal 
framework for supervision. The skill mix issues may be used to effectively lead change 
in pharmacy practice. Once again, opportunities for effecting change present 
themselves through this 'substitute theory' alongside other leadership effort. 
5.6.5 Summary of Leadership Discussion 
The approaches to leadership study were formalised around the beginning of the 
twentieth century and led to successive work on personal traits of the individual, style of 
leading, contingent and contextual effects, and more recently, organisational 
transactional and transformational mechanisms. 
As with many aspects of human qualities and abilities, leadership is complex and it 
could almost be said, elusive. The question has been asked, "are leaders born or are 
they made?" (Kirkpatrick and Locke, 1991 : 58) Or is circumstance and opportunity 
the progenitor of effectiveness in the leader role? Perhaps more importantly in this 
study, what is the place of leadership in the subject of this thesis, the transformation of 
community phannacy? 
Leadership, however it is defmed, does exist within pharmacy as a level of authority but 
what action must it be involved in and initiate to lead pharmacy forward? The glimpse 
of some approaches and models of leadership orientation in this chapter help to cast 
light upon some potential methods of effecting change through leadership activity. 
These will be discussed in the next section together with an examination of the 
relationship between management and leadership. 
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Meanwhile the theories of leadership discussed are summarised in Table 43 together 
with an indication of relevance to pharmacy in the present study. This will help inform 
the following section on management. 
The relevance to pharmacy role change, is suggested in the lower half of Table 43. 
Leadership in pharmacy, in the sense of having representational bodies which liaise 
with other authorities and make decisions for the profession, is compound, as illustrated 
in Chapter 1 : 21. Figure 3. The author's suggested 'relevance' of the models of 
leadership studied is based upon this fact. 
The different bodies, professionally or commercially orientated, will need to take varied 
approaches because of the nature of their responsibilities. The RPSGB for example, 
being responsible for professional and associated legal matters, may be suited to the 
dual approach of the Blake and Mouton model, combining authority-compliance at the 
clinical governance and professional ethics levels, and also the team-management 
approach encouraging profession members to move forward into the new role. Such an 
approach may also help the RPSGB image, in terms of being supportive, as well as 
authoritative. Their grid score on this basis would be maximal. 
On the other hand, the commercial organisations such as NPA and PSNC, may be better 
suited to adopting the Tannenbaum and Schmidt model. deciding with government the 
. 
major issues of new NHS service for pharmacy and going through the process of selling 
the concepts. The members can be consulted and after feedback a 'route map' set out to 
deliver change. The task of facilitating link-up with the medical profession could be 
delegated to thoroughly briefed LPCs. 
The author's recommended model is the Path-Goal approach (page 231. Figure 40 & 
page 241, Table 43, Column 5) for an integrated effort for all the leadership bodies. It 
combines approach options whilst addressing the needs of the members and the 
environmental influences. 
240 
Table 43 THEORIES OF LEADERSHIP: CHARACTERISTICS & RELEVANCE TO PHARMACY 
THEORY TYPE 
.. BRAND I IITYLE 11IEORIES CON'llNGtNCY 1l!EO'''' 
MAIN THEMES 1. BLAKE & I I 
OF INTEREST MOUTON 
2. FLEISHMAN I 3. TANNENBAUM 
2-FACfOR & SCHMIDT 
".FlEDLER 5. PATH-GOAL 6. HERSEY & 
BLANCHARD 
LEADERSHIP 
STYLE 
CONTINGENCY 
ELEMENTS IN EACH 
THEORY,AFFECfING 
LEADERSEUPAPPROACH 
CLASSmCAll0N OF 
STYLE OF LEADERSHIP 
RELEVANCE TO 
PHARMACY - ROLE 
CHANGE 
Focus on people m1l1 
job requirements 
None 
Fixed in two 
dimensions 
People and job 
requirements will 
change in new 
pharmacy role. 
General focus here is 
relevant but limited 
Focus on people QI 
job requirements 
None 
Fixed in one 
dimension 
Not applicable: project 
is too complex for one , 
approach. 
Continuum of varying 
styles 
None 
Varied style with 
circumstance 
Appropriate to new 
pharmacy situation 
requiring different 
approaches at different 
times 
Leader/member 
relations; leader 
power; task structure 
favourableness ofthe 
situation 
As above 
Fixed by the group 
contingencies 
Appropriate because 
of need to develop 
leader-member 
relations and task 
structure situation is 
favourable by 
government assent and 
support 
Supportive; directive, 
participative or 
achievement 
orientation 
Authority system 
group structure 
external forces work 
content 
Variable with 
requirements 
All approaches in this 
model are valid 
through professional 
and legal issues as 
well as need to 
reposition the 
profession in the 
health care delivery 
chain. 
Style tailored to 
member readiness 
degree 
Subordinates degree of 
readiness 
Variable with 
subordinates' 
readiness 
Appropriate in the one 
dimension indicated 
i.e. member readiness 
must be developed as 
part of role and culture 
change. 
7. TRANSFORM-
ATIONAL 
8.TRANSAC-
ACfIONAL 
7. Focus on culture 
strategic intent 
individual and 
organisational 
performance 
8. Focus on systems 
procedures 
process structure 
7. External environs 
culture; individual 
& organisational 
performance 
8. Systems, policies, 
procedures; task 
abilities 
7. Variable at will 
8. Variable at will 
7. Appropriate by 
reason of need for 
culture change and 
strategic intent: new 
organisation 
performance is 
required 
8. New systems; 
procedures & task 
abilities are essential 
in the individual 
j. j. t t j. phllI11ll!CY group. 
I I I t 
These theories hde relevance and should siC comfortably within an appropriate change model fo~ implementation 
Note: The table summarises the key elements of the leadership theories studied, their authors (brand) and suggested relevance to the change proposed in pharmacy. 
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5.6.6 Leadership and Management 
Much, it seems, has been written by researchers and consultants in the field of 
management studies, attempting to distinguish between leadership and management. 
Some twenty years ago, Dagirmanjian, (1981 : 1609) writing in the context of mental 
health service organisation, asserts that leaders serve as managers, by linking the 
organisation with their subordinates. In the same year, Bernhard and Walsh, (1981 : 
22) wrote with regard to the professionalisation of nursing, that leadership involved co-
ordinating activities in two groups, those who seek care and those who give it. It is 
fairly easy to see this latter point in context, as one group (patients) are led into the 
collaborative process of professional encounter. Guidance and at least some motivation 
are important factors in the degree of success achieved. Writing in a more general sense 
on strategy leadership Hosmer, (1982: 47 - 57) comments that leaders manage and 
managers lead. Jaques and Clement (1991 : 21) take that assertion further and assert 
• ... managership and leadership as being not different ... ' However, Kotter in his book, 
'A Force for Change', asserts that • ... leadership and management are not the same 
thing ... ' (Kotter, 1990: 3). 
Clearly, the debate is lively, with varying view points, but what seems to be reasonable 
is that there is overlap in activity and responsibility between the two functions. 
Bernhard's early identification ofleadership functions cis setting of objectives, directing 
-
means of achievement, co-ordinating effort and action planning could be seen as 
management functions also, but perhaps at a lower order. This is similar to Kotter's 
approach (1990: 5) when he views leadership as: 
• ... creating a vision of the future, aligning the appropriate people with 
the objectives and motivating them to achievement by appealing 
to basic human needs, values and emotions. ' 
Management, however, he believes is concerned with: 
• Planning and budgeting Detailing the steps, timetable and 
resources; 
• Organising and stafftng The detail of task organisation; 
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• Controlling & problem solving - Programming, auditing, problem 
address; and, 
• Producing order system & 
structure 
Detailing the framework and 
objective of the task. 
(Kotter, 1990: 6) 
The relationship of leadership and management is summarised by him, in the following 
matrix, as Figure 42. 
Figure 42 
mGH 
REQUIRED 
CHANGE 
LOW 
LEADERSIDP & MANAGEMENT IN THE 
CONTEXT OF CHANGE 
LEADERSHIP LEADERSHIP 
• Considerable • Considerable 
MANAGEMENT MANAGEMENT 
• Minimal • Considerable 
LEADERSmp LEADERSHIP 
: 
• Minimal • Minimal 
MANAGEMENT MANAGEMENT 
• Minimal • Considerable 
LOW ~_____ COMPLEXITY 
OF OPERATION 
______ ~ HIGH 
The point illustrated by him in this matrix is that the impact of leadership and 
management vary with both the complexity of the organisation and the degree of change 
required. Both functions therefore can vary at differing points and degrees of 
organisational transformation or change. 
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Warren Bennis, (1999: 63) wrote: 
' ... the manager administers; the leader innovates; the manager's 
eye is on the bottom line, the leader's on the horizon '" 
The manager maintains; the leader develops. The manager 
asks 'how' and 'when'; the leader asks 'what' and 'why' ... ' 
Capowski, (1994: 23) similarly views management as coming from the head and 
leadership from the heart and lists the qualities of both, as follows; 
The Manager 
The Leader 
Rational, persistent, problem solving, analytical, 
structured, deliberate, stabilising, consulting; and, 
Visionary, passionate, creative, flexible, inspiring, 
innovative, imaginative, experimental, change driving. 
Bryman, (1986: 6) regards management as: 
r '" a preoccupation with the here and now and with goal attainment ... ' 
and Naylor, (1999: 6) defines management as: 
' ... the process of achieving organisational objectives by 
balanCing efficiency, effectiveness and equity ... working 
with and through other people ... ' 
In other words, management deals with operational efficiency and achievement and as 
such requires a degree of planning and programming the daily, weekly and monthly 
work flow and objectives. 
Within the context of this study, the transformation of community pharmacy, good 
management will be an essential requisite of success and prioritisation of effort is one 
very important issue within the management of transition. 
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Such effort includes: 
• Training of phannacists and ancillary staff (TP AS); 
• New quality assurance systems (NQAS); 
• Medication four phase review process and structure (MRPS); 
• Premises facility layout - consultation area (PFLC); 
• Transmission I interchange of data (TID); 
• Communication skills and motivational techniques (CSMT); and, 
• Skill mix - supervision implications (SMSI). 
The recommendation by Adair, (1998; 14) for handling this in a structured way, is by a 
simple matrix of priorities, such as set out in Figure 43. 
Figure 43 
Most 
Important 
IMPORTAN 
Less 
Important 
URGENCY - IMPORTANCE MATRIX FOR 
PRIORITISATION OF TASKS 
Top Priority (1) Medium Priority (2) 
Important & Urgent Important & Less Urgent 
• TPAS • CSMT 
• MRPS • PFLC i 
• SMSI -
Medium Priority (3) Low Priority (4) 
Urgent but Less Important Less Urgent & Less Important 
• NQAS • TID 
Urgent ~.----------------~ Less Urgent 
URGENCY 
Note: The prioritisation in the matrix is the author's assessment of the relative 
importance of the elements of effort described above. 
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Mintzherg, (1971: 97 - 110) in his comprehensive studies and research on 
management in the 1960s, identified the roles that managers regularly fulfil and placed 
these in three categories: 
• Interpersonal; 
• Informational; and, 
• Decisional. 
The categories and roles are set out in Table 44. 
Table 44 MANAGER CATEGORIES, ROLES AND DESCRIPTIONS 
CATEGORY ROLE DESCRIPTION 
Interpersonal Figurebead Embodies authority & formal 
duties (signing documents; receiving 
visitors; committing resources) 
Leader Motivates; sets targets; monitors progress; 
mentors; encourages; disciplines 
Connector Vertical and horizontal communications 
Informational Venue centre Focal point for information 
. Iformal and informal; the 
ma~ of the organisation 
Disseminator Communicates information to 
appropriate organisational targets 
Speaker Source and channel of information 
to appropriate external agencies 
Decisional Intrepreneur An internal entrepreneur giving 
impetus to change and new 
developments 
Disturbance Intervenes to avoid or resolve 
Handlers difficulties and pursue harmony 
Resource Commits capital and personnel in 
Allocator assessed proportions 
Negotiator Internal personnel; external 
suppliers - costs and qualities I 
quantities 
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It is interesting to note, that in Mintzberg's observations, leadership is actually 
identified as one of a manager's interpersonal skills. This tends to support one of the 
earlier propositions in this section, that 'managers lead and leaders manage'. 
(Hosmer, 1982 : 48) 
In practical terms, the role of both manager and leader do interrelate and overlap and 
perhaps the roles become more specific and separate the higher up the organisational 
tree the person is, as there is, in the author's experience, less hour-by-hour transactional 
activity there. 
5.6.7 Summary 
The roles of leadership and management are indispensable in an organisational setting 
and in theoretical terms, perform different functions. In practical terms there is overlap 
between both functions with differences perhaps becoming more obvious at the higher 
and lower levels of the corporate management tree. Management is concerned with 
operational goals which in turn feed into overall corporate strategy. 
The leader and especially the ultimate leader (the chief executive officer) is concerned 
with strategic goals, providing creativity and driving ~hange. Perhaps too much has 
been made of attempting to isolate differences between the two roles but on the other 
hand, it is important that both do perform the responsibilities peculiar to each, whilst 
discharging their amalgam of cross over functions. 
Within the changing environment of the NHS and pharmacy's potential to fulfil a 
different role, there will be clear responsibilities for both management and leadership, in 
order to achieve the repositioning of pharmacy within the health care delivery chain. 
Inspiration and motivation from leaders, coupled with management programmes of 
change will be needed. Table 45 summaries some of the key responsibilities of both 
functions, culled by the author from the study so far. 
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Table 45 A COMPARISON OF MANAGEMENT AND 
LEADERSHIP: KEY RESPONSIBILITIES 
FUNCTION MANAGEMENT ROLE LEADERSHIP ROLE 
ELEMENTS ELEMENTS 
Planning & budgeting To quality; on time; on budget; Envisioning; strategic alliances; 
detailed steps and timetables establishes direction and change 
creating overall strategy to get 
there. Ultimate performance 
responsibility 
Operational Performance Systems & policies creation; Aligns key sub-groups & 
detailed planning and monthly external stakeholders 
budget control 
Controlling & problem solving Minimises deviations from plan. Motivational activity toward the 
Monitors budgets & results vision. Creates human resource 
policy; major resources 
provision 
Creation of processes Hands on management & control Leadership processes in change 
/ audit management; corporate image 
change; culture change; climate 
change 
Primary co-ordinating lob descriptions; chain of Role deSCriptions much less 
mechanisms command; task specifications specified; informal networks and 
t I relationships .. T 
Outcomes Presentability and order : Change and adaptability 
-
Note: The author's summary of management and leadership roles in relation to major corporate 
functions. 
It seems reasonable to suggest at this stage, that the pharmacy leadership bodies should 
concentrate on the issues in the last column of the Table 45, but at the same time giving 
guidance on the systems, operating procedures, processes and task mix for the body of 
the profession at the delivery face. Even the multiples and publicly quoted companies 
will be required to operate within professional guidelines, with quality assured 
processes. In a change programme of the magnitude contemplated, leadership and 
management responsibilities need careful co-ordination, so that the professionals at the 
primary care patient I doctor interface perfonn with efficiency, quality and consistency 
in line with Kotler's core, tangible and augmented aspects of the product; the medicines 
management service. 
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5.7 MOTIVATION 
5.7.1 Introduction 
Although briefly discussed in Chapter 3, in the context of marketing the new pharmacy 
service to doctors (the target market). motivation, in this section, is discussed in 
relationship to the task of motivating pharmacists to move from a supply function to one 
of cognitive service. The subject has also been touched upon in section 5.6, as a 
function of leaders, in bringing their subordinates to a future desired position in 
company or organisational performance. Here, in the MM project, the pharmacist 
population will need assistance I encouragement to move into a different order of 
service. 
It is important, therefore, to consider other approaches to motivation, alongside 
Maslow's early ideas. Motivation has been defmed as follows, (Huczinski and 
Buchanan, 1991 : 64): 
' ... a decision maldngprocess through which the individual 
chooses desired outcomes and sets in motion 
the behaviours for acquiring:them .. • 
In every day parlance, people are spoken of, from time-to-time, as well motivated or 
sometimes de-motivated and in organisational theory, high motivation is perceived as 
being one important determinant of good performance, (Kanfer, 1990: 75 - 170). 
Hence organisations have sought ways of motivating work forces to deliver best quality; 
best output; and, best attendance, to name but a few organisational hwnan resource 
objectives. 
In addition to Maslow's early ideas, a number of other approaches have been developed 
by researchers and these are discussed in the following pages. If change can he 
facilitated for phannacists through established motivational techniques, then the willing 
collaboration with the change process and objectives may be accomplished. If so, then 
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the involvement and commitment which results, could in turn, become a secondary 
change driver helping to increase the momentum of change. 
S.7.2 Theories of Motivation and Comment 
Motivation, it seems, is generally interpreted in two broad ways: 
i. As the mental process which leads people to pursue certain objectives 
and the link they consciously make between the objectives and the 
behaviour which they decide will help to achieve them. In this context it 
has been defined as; 
"The internal psychological drives of the individual. giving rise to 
activity which seeks to initiate. direct and terminate behaviour. II 
(Landy & Becker, 1987 : 1 - 38); and, 
ii. As the social processes that people use in seeking to change the 
behaviour of others, i.e. by the cultural norms of societal expectation 
and their valued perceptions, e.g. 'wealth is admired', 'social position is 
admired'; 'hard work should lead to success'; 'achievement is 
satisfying'. In this context it has been defined as: 
"Managerial activity to encourage specified results from others in the 
organisational environment . .. 
(Tosi, et. aI., 2000 : 127 - 129) 
The common element in the above two concepts is the goal(s) or objective(s) that 
people consciously recognise as part of their existence. This is not to imply that all 
4 
people then actively pursue such goals, but if it is recognised that general societal and 
work goals do exist, then it may be possible to show people a route and reward of 
achievement. 
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Briefly restating the potential in Maslow's theory in an organisational context for 
phannacy: 
Esteem Needs 
Self Actualisation Needs 
May be partly fulfilled by positive work-results 
feed back, through patient satisfaction surveys, 
doctor satisfaction surveys and in cultural terms, 
moving up the health care delivery chain to greater 
profile and recognition; and, 
May be fulfilled by equipping pharmacists who've 
been in the dispensing contract for a long time, 
with new clinical knowledge I interpersonal skills 
to discharge the new role - achieves 'consultant' 
status in medicines management. Transforms 
pharmacy into a clinical service. 
Maslow's approach is classified as a content theory, because it consists of a proposed 
package of inherent needs, to explaining motivation in a social context, rather than an 
organisational setting. 
However, alternative approaches have been developed by other workers and researchers 
in the field of motivation. These appear to fall into two categories: 
• Theories known as process theories, seeking to explain the routes by which 
people can be motivated by others to undertake some course of action; and, 
• Theories know as content theories. seeking to explain the individual's internal 
psychological factors that initiate and sustain pursuit of certain objectives. 
It seems to be recognised, however. that each group of theories contains elements of the 
other, as some human drives are learned by socialisation with peer groups which 
reinforce certain ideals and objectives of the particular culture. Examples of these two 
groups of theories are discussed in the following section. 
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5.7.3 Process Theories 
Reinforcement Theory 
Reinforcement theory, as discussed by Allyon & Azrin, (1965 : 357 - 383) appears to 
have been used successfully in industry and depends upon the particular approach taken 
to sustain good effort, or to discourage undesirable practice in the work place. Positive 
reinforcement is found to increase the probability of repeated good practice, as is 
negative reinforcement. 
An example of the latter, in relationship to the proposed new pharmacy role, might be 
the removal of certain barriers to change. One of these, for example, could be the 
present full work load of the phannacist, leaving no time for additional responsibilities. 
This could be resolved by taking away the barrier through delegating some of the 
present pharmacist activities to technicians. Similarly, positive reinforcement could be 
by adding incentive, through designing and implementing a new more fulfilling and 
better remunerated contract. Other elements of reinforcement theory are: 
• Punishment - which can deter bad practice but have unpredictable side effects, 
such as resentment in other staff, by implied peer group pressure (e.g. statutory 
committee judgements); and, 
• Extinction - removal of benefits, if only average performance is delivered. In 
pharmacy, this could be, for example, removal of the 'period-of-treatment-fee', 
if phannacist influence on excess doctor prescribing proves ineffectual. 
Reluctance in moving into a new cognitive service by community pharmacists could 
result in reduction of dispensing fees and part of the 'global sum' removed to fund other 
suppliers of the medicines management service. Reinforcement approaches to change, 
if managed well, could be an effective lever of change into the new role. 
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Expectancy Theory 
At about the same time as Maslow, another American psychologist, E.C. Tolman 
argued that human behaviour was determined by the goals people have (either emergent 
or actively decided) and the personal activity they perceived as being necessary to 
achieve them. (This is as indicated in item (i), page 249). Georgopoulos et. al., (1957: 
345 - 353) applied this concept in the work situation, in what they described as a path 
goal approach, to work productivity. This latter activity was seen by them as a 
function of the individual's goals (as delivered by management) and required 
behaviours (paths) to achieve them. 
The benefits of being able to set goals and constructively help with the means of 
achieving them (for example, introduction of more efficient systems and procedures) 
made this theory attractive to management. In phannacy the position will be similar as 
new systems are introduced and this could still tie in with Maslow's approach, (self 
esteem / actualisation) in constructing the goals, which would additionally include 
doctor and patient satisfaction and improved clinical outcomes. As new contract 
proposals are a real possibility in 2003, this new service could be based, not upon global 
sums, which divide a fIxed fmancial return, but item of service payments, which 
multiply individuals' rewards. The Georgopoulos approach has become known as 
expectancy theory because of the expectations people develop from set objectives and 
routes of achievement. It is thus classified as a process theory. 
In 1964 a researcher named Vroom, also developed such a theory, which he formalised 
on mathematical lines. This rested upon a number of assumptions (Vroom, 1964 : 8 -
28): 
• People pursue desirable outcomes; 
• People place subjective values on these outcomes (called valence, V) and 
exercise preference; 
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• People have a view about the likelihood of achieving these outcomes by good 
performance. Expressed mathematically as a probability this can be between 0 
and 1. This is known as instrumentality (I); and, 
• People further have an expectation that effort will result in good performance. 
Expectancy (E) can also be measured in probability terms, i.e. from 0 (no 
possibility) to 1 (certainty). 
Vroom further argued that behaviour can have a number of outcomes and so the 
alternatives have to be summed up if expressed mathematically: 
F (force of motivation) = L (V x I x E) 
Clearly, if one of the components on the right hand side of the equation is zero, then F = 
zero. This apparently is why the equation cannot be expressed in a summational way: 
F=l:(V+I+E) 
If the probability of becoming a world marathon champion is zero, it matters little that E 
or V is high; the outcome is still zero. The probability of arriving at the desired 
, 
outcome of the medicines management pilot trials is, on t;xperience and evidence so far, 
very good and the possibilities for Vroom's equation being fulfilled positively, are good 
as V is indicated by the DH as being positive. (Although not called V by them). 
Vroom's ideas appear to be usable in the pharmacy context through leadership 
communications emphasising the value of medicines management outcomes through, 
for example, Maslow's concepts as well as fmancial rewards and also delivering a route 
map to achieving the outcome (Author's leadership defInition, p.220). Job design is 
involved, in this particular approach, because of the potential need to free up time for 
the pharmacist to perform new roles. In this respect, re-design of the pharmacist's job, 
which is what medicines management does, could be looked upon as job enrichment 
and emancipation from a routine and sometimes boring process of re-Iabelling 
medicines and mechanically processing an FPl O. 
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The work experience of the dispensing process could certainly be enhanced by fonnally 
adding other elements of patient care to it, for example, identification of adverse drug 
reactions, drug interactions, side effects and issuing fonnalised reports to the doctor of 
such effects for eradication. This may give better job satisfaction, but would it re-
position pharmacy within primary health care? In the view of the author it would not, 
simply because there is minimal patient involvement and adverse drug reactions could 
equally easily be identified by the doctor, health visitor, social worker or nurse. 
However, such modest fonnalised additions to the dispensing process, could perhaps be 
regarded as preliminary incremental change to the standard dispensing process and 
therefore the beginning of general movement in the overall change process toward 
medicines management. 
Goal Setting Theory 
This is another 'process' approach to motivation based upon the proposition that 
necessary desirable goals are pursued by individuals if they are clearly set out. Such 
goals give or reinforce a person's workplace raison d'etre. Locke et aI., (1981 : 125-
152) showed that specific goals set for a range of personnel (laboratory, production, 
marketing and students) achieved consistently higher perfonnance than those simply 
~.trying to do their best'. In this context, information sharing and participation in 
setting goals is important, as is feedback on progress. Further, a sense of self 
confidence or competence related to which is self esteem (Maslow), is a strongly related 
factor. In further research into this route of motivation it was found that managers with 
high self esteem worked harder toward performance goals than those with low self 
esteem (Carroll & Tosi, 1973 : 235 -237; Locke, 1997: 375 - 412). 
Goal setting in the proposed new community pharmacy service could revolve around 
clinical governance and patient outcomes measured by health gain and quality of life 
improvement. 
255 
Equity Theory 
This relates to the perception of personnel, as they evaluate fairness of treatment. 
Adams, a social psychologist, (1963: 422 • 436) proposed a 'social' approach to 
motivation, based upon interpersonal comparisons, such as mentioned above, which 
were made by people in the course of their work. This rests upon the proposition of 
perceived fairness and is known as equity theory. In essence this regards people as 
being aware of and concerned with, comparative treatment of themselves and related 
groups with similar jobs. They engage in comparisons based upon their own evaluation 
of what inputs were being made, to attract observed rewards. They are said to compare 
their own ratio of input to returns, with the same ratio in the comparator group or 
individual. When these ratios are about the same then treatment is judged to be fair. 
Greenberg in 1989 I 90 conducted studies in the effects of perceived pay inequities in 
three different production plants of the same company during an economic down turn in 
trade, in two of them. (Greenberg and Stone, 1992: 76) 
PLANT BUSINESS SITUATION EMPLOYER ACTION 
Plant 1 poor economic results pay was reduced by 15% 
Phase 1 Plant 2 poor economic results pay was reduced by 15% 
Plant 3 stagnant economic pay kept static 
conditions & perfonnance 
Plant 1 employees given thorough theft rates marginally 
explanation of the reasons and increased (of tools and 
need to preserve employment; equipment) 
management showed sympathy 
and regrets 
Phase 2 Plant 2 employees given minimum theft rates dramatically 
explanation and no sympathy increased (of tools and 
from management equipment) 
Plant 3 employees given brief explanation theft rates unchanged (of 
of static conditions which meant tools and equipment) 
no increase 
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The results were predicted by Greenberg with accuracy before implementation. After 
the recession the effects returned to normal when pay increases were re-instated. This 
and other studies, (e.g. Bretz & Thomas, 1992) have shown that perceptions of 
inequity produce de-motivation and negative consequences. Equity theory thus has a 
contribution to make to understanding motivation in the work situation and the 
consequences of negative contextual factors. 
5.7.4 Content Theories 
Maslow's theory has already been considered and other theories based upon 'needs' of 
the individual followed his proposals. The basic premise recognised by all such 
researchers was that people will generally respond to innate or perceived needs by 
trying to satisfy them. 
Achievement Power Theory 
Two decades after Maslow, McClelland (1965 : 321 - 323) developed an 'achievement 
power I theory in which he described motives as: 
' ... ajJectively toned. associated networks arranged in a hierarchy 
of strength and importance peculiar to the individual... I 
The three basic motives he described were: 
• The need for achievement - the extent to which success is important; 
• The need for power the need to exercise influence over others; and, 
• The need for affiliation - the need for recognition in connected groups. 
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This differs from Maslow's theory in that the 'hierarchy' varies from individual to 
individual and one of the above three aspects may be dominant for anyone person. 
All three elements could relate to pharmacy and be motivational inducements to 
promote change by: 
i. Demonstrating the achievement potential via medicines management by 
elevating the pharmacist's importance in primary health care; 
11. Demonstrating the power potential in being a decision maker in patient 
medication selection and adjustment; and, 
iii. Demonstrating the prestige affiliation with the prime decision maker (the 
OP) in patient medication, in a potentially competitive situation. 
This theory could be used for background marketing communications 'theme-ing', in 
promotional literature and messages (conferences). 
Job Enrichment Theory 
. 
This is founded upon the proposition that the nature of the work undertaken has an 
effect upon motivation. This approach has been studied by researchers, such as 
Herzberg, (1959), Lawler, (1973) and Macoby, (1988) and it is said that changing the 
design of a job can determine intrinsic and extrinsic rewards. 
Intrinsic rewards are those valued outcomes which the individual pursues (self 
actualisation; esteem; achievement) and extrinsic are those contrived by others, 
(prestige titles; symbols; trappings of authority; bonuses linked to performance). A so 
called job 'characteristics model', generically describing methods of job enrichment, 
was constructed by Hackman et. aI., (1975: 62) and links the: 
• Characteristics of jobs, with ... 
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• The individual's experience of these characteristics, with ... 
• Resultant outcomes 
Again, desire for personal growth and fulfilment and self actualisation present 
themselves as variants within each individual and motivation will consequently vary. 
Of special interest in the context of primary care pharmacy is the heart of the model 
which splits any job into five dimensions. 
1. 
2. 
3. 
4. 
5. 
Skill variety Extent to which the job uses different skills 
and abilities; 
Task identity Extent to which the job encompasses a 
complete piece of work; 
Task significance Extent to which the job affects other 
organisation members; 
Autonomy Extent of individual freedom; and, 
Feedback Extent to which performance excellence is 
related back to the individual. 
The whole model is diagrammatically set out in Figure 144, on the next page, (Hackman 
et aI., 1975 : 62). 
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Note: The model shows how the elements under 'core job dimensions' are fed and enhanced by the 
implementation concepts to deliver enriched psychological states and better work outcomes. 
Pharmacy Implications 
The motivational possibilities in this model, so far as primary care pharmacy is 
concerned appear to revolve around: 
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Skill variety Equip phannacists with a comprehensive clinical and 
communication abilities. 
Client relationships Equip phannacists with interpersonal skills for GP / patient 
Autonomy 
interaction. 
Build the actualisation potential in carefully structured 
communications to pharmacists from leadership. Support 
independence and authority to make decisions. 
Personal & work Resulting from confidence in knowledge, skills and ability in 
outcomes medicines management, patient feedback and influence with 
the doctor. 
These factors again reference back to Maslow's construct of innate needs together with 
marketing communications copy, which should theme around self esteem and self 
actualisation in the professional forum. 
At about the same period as Hackman's work, another researcher in the USA, 
(Herzberg, 1968 : 53 - 62) was investigating a different approach to organisational 
motivation encompassing not only motivating influences but also de-motivating 
circumstances which obstructed motivating factors from' being fully effective. 
The de-motivational influences he called hygiene factors and included such items as 
poor working environment, low pay, poor professional relationships and poor staff 
benefits. However, his research indicated that whilst such factors were an impediment 
to positive motivational activity, removal of them did not constitute a motivating force 
themselves. They simply allow other motivational effort to proceed unimpeded. 
The task of leader or manager is therefore to see that both issues are properly addressed. 
Within community pharmacy the implications are likely to include an equitable 
remuneration reward system to justify the substantially increased effort required from 
community pharmacy in medicines management. Consistent comments to the author at 
seminars and conferences since the tennination of the cost-plus contract, indicate 
dissatisfaction even with the present remuneration package for dispensing. 
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A comment from a seminar in Swansea (35 pharmacists) illustrates a common attitude: 
' ... the way the DH has retained all its own advantages from the old cost-plus 
contract and removed all of ours, shows what they think of us ... ' 
(Swansea: Medicines Management Seminar, 23.04.02) 
The comment received murmurs of support in the group and no dissent. 
The general working environment for pharmacists. is on the other hand, largely a matter 
of self selection in the independent sector and good in the multiples who have additional 
benefits for employee pharmacists, such as career development, pension schemes, bonus 
schemes and training packages. It could be argued that the multiples are driven to 
compete with each other on such benefits because of an adverse supply position for 
pharmacist labour. Their employment terms are therefore arguably at least what the 
market minimally expects. In the forty five years experience of the author within the 
profession, the independent sector dissatisfaction has focused around perceived 
inadequate reward from the NHS contract compared with other professionals and their 
respective contracts. It should be said, however, that little research appears to have 
been done, by the PSNC on comparative, measured rdponsibilities I rewards, with the 
other NHS health care professions. Career patterns within the multiples do, 
understandably, involve a different assessment process, which takes into account 
commercial management responsibilities as well as professional pharmacy 
qualifications and obligations. 
Herzberg's motivational factors included: 
• Interesting and meaningful work content; 
• Sense of achievement; 
• Recognition; 
• Responsibility; and, 
• Personal growth and advancement. 
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Herein is potential attractiveness in medicines management, which arguably has the 
potential to deliver all of the above desirable elements of motivation. 
In practical tenus, in the pharmacy work situation, such 'hygiene I factors as Herzberg 
conceptualised, could ensure: 
• Adequate bench space for efficient systematic dispensing, ready for increased 
technician responsibility; 
• Adequate consultation facility for the new pharmacist / patient interface; 
• Non-stressful workload quotas for each member of staff; 
• Adequately trained support staff; and, 
• Pleasant phannacy layout. 
In a new demanding service, such as medicines management, the working conditions 
need to be right. properly rewarded and patient friendly; in order to engage commitment 
and sustained dedication to the role. There are high expectations for beneficial 
outcomes to the DH, the tax payer, the patient, the pharmacist and the doctor, as 
indicated to the author in a conversation with the Chief Pharmacist DH, in May 2002. It 
follows, therefore, that the profession's leadership have a duty to create the right 
motivational circumstances in discussion with the DH, to achieve the benefits for the 
major stakeholders. 
5.7.5 A Content & Process Theory Combined 
A more comprehensive model of motivation, borrowing elements of content and 
process theories and containing some of Maslow's elements was constructed by Porter 
and Lawler (1968 : 165). 
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The elements of the model are set out below: 
Factor 1 
Factor 2 
Factor 3 
Factor 4 
Factor 5 
Factor 6 
Intrinsic Rewards 
Extrinsic Rewards 
[
Perceived value of 
the rewards 
[
'Performance - -
Reward' probability 
is clear 
[
'Effort -Performance'-
probability is assured 
[
Perception of role 
demands 
[
Task abilities 
required 
Factor 7 [perceived equity 
rewards 
Originating with the person or job itself 
(self esteem; actualisation; job interest / 
variety) 
Arising externally from third parties. 
(praise, recognition, promotion, pay, 
bonuses, etc.) 
Is value commensurate withjob input & 
value? Is it seen to be worth pursuing? 
The perfonnance delivered has every 
chance of achieving the rewards 
Effort to performance relationship to 
be credible and achievable 
Role to be credible and perceived as 
such ! 
Within the competence of the worker and 
perceived as such 
Rewards stand up to comparison with 
similar reward systems 
This model is diagrammatically summarised in Figure 45. 
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Figure 45 PORTER AND LAWLER MODEL OF MOTIVATION (After Porter - Lawler, 1968: 165) 
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5.7.6 Section Summary 
The purpose of visiting the issue of motivation has been to explore some elements of 
potential address in moving community pharmacists from supply to cognitive service. 
Several issues emerge as potential areas of detailed consideration in encouraging 
pharmacists to shift into a new order of health care: 
• A potential to take account of Maslow's concepts of self actualisation and 
esteem. Greater professional fulfilment should be experienced in cognitive 
service; 
• The assurance of commensurate rewards based upon equity and comparative 
rewards in related professions; 
• The professionals' belief that quality performance will deliver those rewards; 
• Equipping the profession with task ability, to give confidence in role discharge 
and enjoyment of the new activity; 
• Good communications from leadership in setting out a clear route by which role 
change can be achieved and enjoyed; and, 
• Visible recognition and praise for those who systematically move into the new 
service - extrinsic rewards. 
Motivation, on the evidence examined, appears to be a subject which will continue to 
unfold and new principles and techniques discovered, but there is enough solid 
foundation on which to build a programme of leadership effort for moving the 
profession forward. Much however, may depend upon the sincerity of the Department 
of Health in wanting to employ in greater depth, the qualifications and expertise of the 
pharmacist, whilst being committed to creating rewards perceived as equitable and 
achievable. 
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5.8 CHAPTER SUMMARY 
Organisational development in a general sense, has been a feature of society since early 
history. Societal evolution, driven by environmental effects such as war, famine and 
survival needs, together with individual and group belief systems, such as religion and 
mysticism, have all played a part in developing more formal structures and cultures in 
all walks ofHfe. 
In the late nineteenth and twentieth centuries more specific attention was directed 
toward organisational development in the work place. Lewin and rrist's research into 
group behaviour in the first half of the twentieth century, heralded the emergence of 
formalised models of change, from further research and consultancy in the field of 
management. 
Twelve such models have been examined here in the search for an appropriate model of 
effecting change in primary care pharmacy within its NHS responsibilities. The issues 
for pharmacy are complex but identifiable and thus capable of address. For this reason 
a change model has now been suggested by the author for application in pharmacy. 
The Burke Litwin Model of Organisational Performance and Change has been chosen, 
because of its comprehensive address in principle and de,tail of the transformational and 
transactional aspects of the order of change required in pharmacy. An identified 
weakness of the model is its lack of specific address of the organisation'S technical 
resources. However, this is not a weakness in the present application because it does 
deal with: 
• 'task and individual capability'; and, 
• 'individual needs and values'. 
Herein lies the technical expertise within pharmacy, its professional knowledge base. 
It contains all the elements requiring address in the proposed service change for 
pharmacy. 
267 
Motivation of the leadership bodies and phannacists themselves remains of key 
importance in sustaining momentum for change and preventing strategic drift. 
Pharmacy currently has a unique opportunity for a bigger role in an expanding health 
care environment and failure to grasp it may result in a decline in role into that of a 
highly qualified technician, whilst other health professionals seize the option. 
An outline examination of the motivational triggers and processes has indicated a 
number of potential ways of engaging the profession in commitment to change and the 
field research may give further clues on how these may be applied in the practical 
situation of community pharmacy. 
Leadership targets and means of intervention have been explored and found to be useful 
in indicating both its role and relationship with the organisational management function. 
Leadership has a major role to play, which if mishandled, may well have to preside over 
a fragmented disorganised market situation. This would in turn send the wrong signals 
to the major stakeholders, who have so far supported the strategy of change; namely the 
doctors' national General Practice Committee and the Department of Health. 
Table 46 sets out the elements, or levers of change, in the Burke Litwin model and their 
suggested relevance to the present phannacy position. The table also indicates potential 
marketing effort to be applied through each of the l~vers, in helping to initiate and 
sustain change. Marketing and change techniques are thus brought together by the 
author, illustrating how the two disciplines can be uniquely used to bring about change 
in the pharmacist's role in primary care. 
The following field research will help to steer the way forward and indicate where and 
how the theoretical research may be used. The results of this are set out in the following 
chapters. 
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Table 46 
LEVER 
1. LEADERSH1P 
2. STRATEGIC 
INTENT 
3. CULTURE 
4. TASK AND 
INDIVIDUAL 
CAPABILITY 
5. INDIVIDUAL 
NEEDS AND 
VALUES 
6. SYSTEMS AND 
POUCIESJ 
PROCEDURE 
7. BUSINESS 
PROGRESS & 
STRUCTURE 
8. MANAGEMENT 
PRACTICES I 
STYLE 
9. WORK GROUP 
CLIMATE 
10. MOTIVATION 
BURKE-LITWIN CHANGE LEVERS: RELEVANCE TO 
PHARMACY: SUGGESTED MARKETING APPLICATION 
RELEVANCE MARKETING EFFORT 
Compound disparate leadership requires constant PSNC MM group to plan programme of 
effort to deliver congruent messages and integrate workshops to brief on change management and 
activity in leading pharmacist/pharmacy change. agree individual contributions. (Relationship I 
collaboration theme). 
To reposition pharmacy in primary care and Series of professional journal articles on necessity 
sustain competitive advantage. of change plus its benefits. 
Historically programmed attitudes, some of which Message content very important; discorntirm 
may impede progress. Culture shift required pasts interpretation of supervision; confirm safety 
(Lewin & Trist's work). of new proposition; have lead figures confirm. 
Journals and in-house letters and periodicals used 
.. 
for media campaign consistent and regular . 
New skills and knowledge required for MM. Publish in journals f periodicals the availability of 
Involves pharmacists, technicians, counter raining packages; means of access and time f cost 
medicines staff. Key to a new pharmacy image . nvolvement of options. 
and position in health care. 
Self esteem; self actuaiisation; equity of rewards; A series of articles to a national programme. with 
belief that effort will deliver performance and the ocal LPC collaboration and monitoring schemes. 
rewards. 
New IT links with GP and PPA. Exception ~sence of message effectiveness is the right 
reporting to minimise work. psychology and repetition. Benefits of MM to be 
~pecified and the utilities of those benefits (Ch. 
~ .2) clarified related to the needs and wants of 
Re-engineer dispensing work process; greater pharmacist contractors (Ch. 4.4). 
technician responsibility and checking. Quality 
assured process and audit scheme. deally a dedicated section in the Pharmaceutical 
~ournal, until the profession move is tinally under 
Pharmacist f Doctor; Pharmacist I Patient !way 
interfaces to re-design; psychology very important 
to sustain cultural needs ofbotb. .. 
: 
The group is pharmacist, tcchnician and OTC Consider similar uniforms and new livCl)' for 
medicines stalI A new collaborative atmosphere consultation area I dispensary - a major image 
is required in integrating NHS + OTC medicines- change to be visible to public and DH. Again 
part of MM. publicise in PJ, C + D, NPA internal supplement 
Motivation engineered through the means explored All pharmacy media involved; web sites ofPSNC, 
in Ch. 5.7. RPSGB. NP A and cross referenced in the 
professional press. Message content once again 
consistent with needs I wants of pharmacists and 
e-"pressed as benefits. 
Note: The above table is the author's view of where and what marketing effort can be applied in the context of the Burke-
Litwin model of organisational performance and change. 
ABBREVIATIONS: 
CD 
MM 
NIlS 
NPA 
OTC 
Chemist & Druggist 
Medicines Management 
National Health Service 
National Pharmaceutical Association 
Over The Counter medicine 
PJ 
PPA 
PSNC 
RPSGB 
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Pharmaceuticalloumal 
Prescription Pricing Authority 
Pharmaceutical Services Negotiating Committee 
Royal Pharmaceutical Society 
CHAPTER 6 
RESEARCH RESULTS ANALYSIS 
PHASE 1 
6.1 INTRODUCTION 
The elements of research in this phase (Chapter 3 : 44 - 48) have been described in the 
method. 
6.2 Key Informant Interviews; and, 
6.3 National Focus Groups. 
This chapter now brings together the results of phase 1 of the primary research and 
relates this to the previous chapters on marketing and change effort. 
6.2 KEY INFORMANT INTERVIEWS 
(Appendices 11a, 11b lIe, pages 434 - 438) 
The content analysis, (Appendix ltc, page 438) is summarised in Table 47 abstracting 
the key issues from individual interviews. A commentary follows after the last sheet of 
Table 47. All interviews were cordial and constructive and have exposed a number of 
issues, which will be borne in mind when analysing the GP national focus group results 
and the results of the postal survey to GPs. Common themes will be abstracted from 
each and used to inform a change progranune for repositioning community pharmacy 
within primary care, with reference to the key stakeholder, the GP. 
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Table 47 
KEY 
INFORMANT 
QUESTION 
Ql 
Arc there any 
aspects of patient 
treatment which may 
be suitable for new 
pharmacist 
involvement? 
Q2 
What do you 
anticipate will be GP 
reaction to a new 
structured 
relationship with 
community 
~harmacists? 
Q3 
Do you foresee 
problems with such 
collaboration? 
Q4 
How could such 
problems be 
addressed? 
ADR 
mc 
DI 
FPIO 
GP 
GPC 
KEY INFORMANT QUESTION I RESPONSE MATRIX : DISTILLATION OF COMMENTS 
A B C D E 
Compliance. Rationalise Pharmacists to deal Drug waste Fonnalised advice to 
ADRIDI reporting or prescribing. with minor ailments. reduction. GPs on drug inter-
correction. Don't add drugs to Biggest issue is Patients to be relationships. 
Explain to the deal with side effects patient compliance encouraged to follow Patient information 
patient the - change the basic with treatment instructions. on their medicine. 
medication. drugs. Explain the XS brand Reduction in brand 
Monitor side effects. Reduce: costs by medicine's benefits. prescribing can be usage. 
Target disease your price: reduced. 
groups for the above. knowledge:. 
Mixed; some: will Younger doctors will New doctors will Mixed but Govt OK in time, if their 
welcome; some will agree - older feel like it but older may pressure will help. funds are not 
oppose. threatened. give trouble. They will groan threatened. 
It needs selling - Some will employ Overall it could about the work. Some will be 
benefits shown. pharmsinGP reduce: the doctor's Some will feel resistant but are 
practice. workload. threatened. under Govt pressure 
for efficiency. 
Yes,which Yes-a plan for Yes; mainly the link Not if you plan weU. Handling the volume 
pharmacies with introduction up with information A problem could be of work. 
whichGPs. essential. exchange and with the paperwork. Making your input 
Reporting WorkloadofGP. follow- up. GP time: Systems to be effective. 
procedures. Patient confusion is a touchy subject. efficient. Doctor must act on 
Quality markers. with who is .- Keep things simple your advice: - how? 
responsible for what. \ 
Focus group Through discussion Needs series of As I said - plan Get Govt. research 
discussions with withGPs. discussions. thoroughly. backing if possible. 
GPIPharms. LMClLPCto Benefits should be Discuss with GPC Design best systems 
PCG coulli facilitalc_ L collaborate. 
Adverse: Drug Reaction 
Community Health Council 
Drug Interaction 
NBS Prescription Form 
General Practitioner 
General Practitioner Committee 
emphasised. 
HA 
HAPA 
IT 
LMC 
LPC 
OTC 
andPCGs. to minimise volume. 
Health Authority 
Health Authority Phannaceutical Advisor 
Information Technology 
Local Medical Committee: 
Local Pharmaceutical Committee 
Over The Counter medicines 
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F G 
Patient Clinics for such as 
understanding of asthma patients -
drugs. how to maximise 
Reduction in waste their drugs. 
prescribing. Checks for ADRs. 
Identify side effects. Motivate: the: patients 
Harmonise treatment to comply with 
periods for each treatments. 
drug. 
Older GPs have seen Will welcome if 
more and more there is no increase 
people encroaching in work and their 
on their territory; fund is not 
may be resistant. threatened. OK if 
Young doctors may tasks agreed. 
be OK. 
Matching the GP Keeping the 
practices with the paperwork down. 
pharmacies. Ensuring follow 
Patient continuity through of your 
with same phannacy input. 
confusion over Measuring the 
which pharm sees benefits you bring. 
whichGP. 
You must work out a Jointly with GPs; get 
good system. joint solutions. 
Maybe HAPA could Develop good IT 
help. systems. 
PC Patient Compliance: 
PCG Primary Care Group 
PCf Primary Care Trust 
Pbarm(s) Pharmacist(s) 
RCGP Royal College of General Practitioners 
XS Excess 
H 
Monitoring drug 
response. 
Compliance clinics. 
Advice to GPs on 
minimising drugs 
interaction. 
Checking the: 
response to a 
changed drug. 
Good-if the 
elements are right. 
But it creates a lot of 
work. 
Suspicious if not 
well sold. 
Persuading the GPs 
that it is worthwhile. 
Proving the benefits. 
Getting the , 
organisation right. 
A joint GP I Pharms 
study of the 
prospect. 
A number of pilots. 
Table 47 
KEY 
INFORMANT 
QUESTION 
QS 
What in your view, 
would be conducive 
to a new pharmacist 
involvement in 
patient care: 
a) for doctor 
b) for patient? 
Q6 
How could a more 
structured operation 
be developed 
between pharmacist 
and doctor? 
ADR 
CDC 
DI 
FPIO 
GP 
GPC 
cont. KEY INFORMANT QUESTION I RESPONSE MATRIX: DISTILLATION OF COMMENTS 
A B C D E F G 
J 
a) a) a) a) a) a) a) 
Confidentiality. GP confidence in the GPC support. HA support and co- A recognisably good Dr. to be assured of An LPC study of the 
Pharmacy premises pharmacist. Your RCGP support. ordination. training package for Pharm ability and GP and patient needs 
not suitable; need service presented as Good liaison between LMC with major pharmacists in your report systems. byLPCand a 
better facilities. good support for the pro! Bodies for role in facilitation. complete new role Pharm support of all proposition put to 
Pharms running an doctor, not a MEDICINE and Good GPIPharm proposition. Dr. therapeutic LMC. 
efficient system. replacement. PHARMACY. series of workshops. A clear sign of decisions. Pharm. Ability to be 
GPlPharm. local teamwork. assured. 
goodwill. 
b) b) b) b) b) b) b) 
Confidentiality. Good pharmacy Full explanation to Good facility in A clear procedure A ritual which gives A ritual that implies 
Simple non facilities. patients. pharmacy to give which shows the maximum patient a joint initiative of 
threatening Good patient Collaboration with patients confidence. Dr/Pharm team understanding and GP and pharm. 
approaches to manner. patient organisations - A good review effort. support in helping A familiar report 
patient. Good follow through good patient perception routine. Professional facility compliance. form like a FPIO. 
Encouragement for of decisions. ofGP/Pharm Patient knowledge in pharmacy. Occasional Dr. &. Relaxed atmosphere 
the patient on long collaboration. that Dr. is directing pharm meeting with and some privacy. 
term treatment. affairs. Jlatient. 
HA. raJ, LMC, It should be 'top Workshops to agree Outside help may be HA can facilitate a A group of GPs &. LMCILPC should 
LPC need to agree a down' and assisted approach. needed- series of focus Pharms should meet discuss and agree 
programme ofeffurt. by 'bottom up' Working groups to agree consultants. groups to define the to discuss and define both protocols and 
initiatives. systems. HA can assist with operational the intervention and role content. 
LPC should initiate Pilots to try out- systems via PCGs I requirements. tasks. Then design 
Government support PSNClGMSC LMCILPC 'close liaison. Per and practices - HA can give steer on Needs ofGPs can be paperwork to fit 
would be likely- RPSGBJRCGP Start by linking GPs a study should be patient 'needs' defined then build requirements. 
would help to plus local initiatives with the closest conducted after address. LMCILPC the system. Consider exceptions 
facilitate. PCGIPCT with HAs - these pharmacies for trials. requirements are to work closely. Joint university Med only for drug 
especially should be probably currently defined. &. Pbarm schools change: exception 
involved. the best route. could provide reports are time 
seminars&. efficient. GPs would 
workshops. welcome. 
-
~--- ... --
Health Authority PC Patient Compliance Adverse Drug Reaction 
Community Health Council 
Drug Interaction 
HA 
HAPA 
IT 
LMC 
Ll'C 
OTe 
Health Authority Pharmaceutical Advisor 
Information Technology 
I'CG Primary Care Group 
rer Primary Care Trust 
Pharm(s) Pbarmacist(s) NHS Prescription Form 
General Practitioner 
General Practitioner Committee 
Local Medical Committee 
Local Pharmaceutical Committee 
Over The Counter medicines 
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RCGP Royal College of General Practitioners 
XS Excess 
II 
a) 
Flexibility on 
location - GP 
surgery or pharmacy. 
Joint agreed routine I 
for patient interview ! 
&.GPlPharm 
meetings. 
b) 
User friendly format 
and minimise the 
questions; focus on 
main issues. 
Encourage relaxed 
procedure. 
Interviews at quiet 
times in31harma<:y. 
HA and LMC can 
assist redeveloping 
an admin system. 
Keep it simple and 
start thinking IT 
connections. 
Consider Dr J pharrn. 
team building 
initiative. 
Confidential IT 
exchange of key 
medicines records 
between Dr./pharm. 
Table 47 
KEY 
INFORMANT 
QUESTION 
Q7 
Where should a new 
pharmacist role be 
located? 
Q8 
In a new pharmacist 
role along the lines 
we have discussed, 
are there any aspects 
you feel should be 
omitted? 
Q9 
Would you like to be 
involved in 
developing a new 
role for pharmacists 
in partnership with 
GPs? 
QIO 
Would you be 
willing to comment 
on some aspects of 
this research? 
ADR 
CUC 
DI 
FPIO 
GP 
GPC 
coot. KEY INFORMANT QUESTION I RESPONSE MATRIX ; DISTILLATION OF COMMENTS 
A B C D E 
The pharmacy. Pharmcy - but will Pharmacy is best Leave choice to Pharmacy is only 
In some cases the need flexibility for where the patient if necessary; place where 
surgery. some elderly and prescription is but prefer pharmacy OTCINHS conflict 
Pharmacists may housebound dispensed. where OTC can be oftrcatment can be 
need a little more checked as it checked. 
professionalisation. happens when 
patient is buying. 
Diagnostic issues- Don't always shift No, but develop In developing cost No, but try to reduce 
that is Dr's job. But from brand to effective measures savings don't drugs wastage by 
add official reporting generic. Sometimes for compliance. sacrifice quality. limiting the periods 
ofADRs. the sustained release This is a major issue. Keep prejudice out of supplied 
Avoid at present, brands are better Much drug wastage of drug selection. quantities. 
therapeutic than old generics. is created by non-
substitution. compliance. 
Maybe issues I could Would be interested I could give advice Depends upon HA I think HA would 
help in - quality in pilot and on some issues. view but I think yes. say yes and I 
issues and the like. development work. certainly would. 
Keep me informed 
please. 
--
Unofficially yes. Yes. Probably yes. Time Yes. Yes. if confidential. 
Politically sensitive. 
Mustbc 
confidential. 
Adverse Drug Reaction 
Community Health Council 
Drug Interaction 
NIlS Prescription Form 
General Practitioner 
General Practitioner Committee 
is the factor. 
HA 
IIAPA 
IT 
LMC 
LPC 
OTC 
... -
--
Health Authority 
Health Authority Pharmaceutical Advisor 
Information Technology 
Local Medical Committee 
Local Pharmaceutical Committee 
Over The Counter medicines 
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---
F G 
Pharmacy if IT link At surgery, but good 
systems arc good IT may change my 
enough. view. 
Could be a need in Surgery location 
some cases for keeps it a truly 
locating in surgery- medical matter. 
difficult family 
circumstances. 
Try to develop better Don't major on 
compliance; therapeutic 
motivation of substitution. 
patients is essential. Brand to generic 
Be careful with shifts OK most of 
family problems. the time. 
Yes. Yes, it would be 
ideal here. We could 
work through it 
together. 
Yes. If time permits. 
-- - --
PC Patient Compliance 
PCG Primary Care Group 
PCf Primary Care Trust 
Pbarm(s) Pharmacist(s) 
RCGP Royal College of General Practitioners 
XS Excess 
H 
At pharmacy if 
patient registration 
can be arranged -
gives good 
consistency. 
Patients could view 
other dosage forms 
here if necessary. 
No, but keep the 
I process as simple as 
possible. Keep away 
from medicines 
selection in fust 
instance. 
Certainly. Let me 
know how you 
propose proceeding. 
See me at the time -
possibly yes. 
-- ---
6.2.1 SUMMARY AND BRIEF COMMENT 
(KEY INFORMANTS' RESPONSES) 
The main themes emerging from the eight key informants are: 
• Patient non-compliance with medicines regimens is a major concern in these 
informants' perceptions. It was raised specifically in responses to Questions 1,5, 
8 (and obliquely throughout discussions). (A, C, F, G, H) 
• Doctor autonomy and lead role were also implied as important to the doctors. 
This theme recurred in responses to Questions 2,5, 7 and 8. (A, B, C, D, F, G) 
• Implications of the new pharmacist role being 'threatening' emerged from 
responses to Questions 2 and 5. (B, C, D, E, F, H) 
• Message source and sponsorship may be important in helping avoid this. 
Respected sources, in persuading GPs to adopt the new practice, could be a key 
consideration in leading the GPs into change. GPs themselves, despite any 
reassurances given to them, may be apprehensive about deeper pharmacist 
involvement with their patients. Lead figures in their own profession, with 
positive encouragement messages, could be a ke~ factor in the change process; 
Questions 4 and 6. (A, B, D, E, G, H) 
• GP workload was cited by four informants as being a potential barrier to progress. 
If medicines management imposes a bigger workload on doctors, it could be 
slowed down, or rejected as a new service from pharmacists; Questions 2 and 3. 
(B, C, D, E, G, H) 
• Joint development of the project (with GPs and pharmacists), was suggested and 
also the need for a team relationship. Good persuasive communications to doctors 
is clearly signalled, together with team workshops facilitated by the PCT. 
Questions 4, 5, 6. (A, B, C, D, E, P, G, H) 
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• Potential doctor age related barriers were raised by three informants; Question 2. 
(B, C, F) 
• Pharmacy facilities need to be appropriate for patient confidentiality, confidence 
and recognition that the new pharmacist role is a joint structure; Questions Sa and 
5b. (A, B, D, E, F, G) 
A proper consideration of marketing philosophy and principles, its tools and channels of 
application, should take account of cultural sensitivities, particularly self esteem and 
doctor autonomy in the health professional hierarchy. Barriers to progress, such as 
perceived extra workload and age related resistance, will need address through the 
tangible product, (Chapter 4) and tailored communications process and content 
(Chapter 4). The overall positive views of the key informants may be because of their 
in-depth knowledge of the changing nature of the NHS and the desirability of each 
professional making a full contribution to patient care, as indicated in the Government 
White Papers on the 'New NHS'. None overtly voiced knowledge of prejudice among 
GPs, but some comment may imply an assumption that the GP should be seen as the 
lead professional in the new service, not least by the patient. These views relate to 
Garvin's dimensions of quality (Chapter 4 : 75 - Table 15) in product design and the 
relationship is set out in the following table: 
Table 48 KEY INFORMANT RESPONSES TO QUESTION S MAPPED TO 
GARVIN'S DIMENSIONS OF QUALITY 
DIMENSION (Bold Type) 
KEY THEME (Light type) 
Service PerformaDt:e 
Confidenc:c in pbannacist 
Proprietary Pndi_ 
Confidentiality 
PremiJcs adaptatiOll 
Clear sign of leam working 
Durability 
Run an efficient system X 
Reli.biIity 
Good liaison inter-
ProfessionaI\y 
Aestbetic 
Present as support for doctor 
- not competition 
A 
x 
x 
X 
B 
x 
KEY INFORMANT RESPONSE 
C D E F G H 
x x x 
X X X 
X X x 
X x 
Note: The crosses indicate mention by the respective key informant, of issues caused by the 'DIMENSIONS' 
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6.2 NATIONAL FOCUS GROUP 
6.3.1 MEDICO·PHARMACEUTICAL LEADERSHIP FOCUS GROUP 
(Appendices 13A, 13B, 13e, 13D,pages 466 - 484) 
The complete focus group discussion content analysis is set out in Appendix 13D and 
the key themes are summarised as follows: 
• Non-compliance by the patient with the regimen, again emerges as a major 
issue. There was repeated return to this issue. (Questions 1, 2, 5, 8, 9 
responses); 
• Doctor self esteem and autonomy are important implications (responses to 
Questions 2, 8, 9, to); 
• Resistance to increased workload could be a major barrier if the medicines 
management product is not properly constructed. (Questions 2, 3, 5, 9, 10 
responses); and, 
• The desirability of doctor I pharmacist collaboration underpinned the doctor 
responses (Questions 1,2,3, 5, 6, 7); 
6.3.2 SUMMARY - MEDICO-PHARMACEUTICAL LEADERSIllP 
FOCUS GROUP 
There was clear indication, by body language and repeated return to compliance issues, 
at certain points in the discussion, that some responsibilities for patient care are 
considered by OP leaders as the preserve of the OP (as indicated in Questions 2 and 10) 
(Appendix 130). Here is an opportunity to design the product offering accordingly, by 
retaining doctor leadership in the medicines management process. The tangible and 
augmented product features can be constructed to accommodate and enhance the appeal 
to doctor culture (Chapter 4), for example, locating clinical decision discussions at the 
OP surgery, chaired by the doctor and disease areas of address, prioritised by the doctor. 
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Overall, there was a high degree of similarity with the essential themes of the Key 
Informant responses to some questions (Table 49), even though the questions 
themselves were not identical; e.g. compliance is a major issue; workload; spirit of 
collaboration; and whilst no overt hint of being threatened emerged, Dr B (Question 8) 
wanted measurable results that both doctor and pharmacist would look at. The other 
GPs present, by nods of agreement, emphasised this point. The underlying cultural 
perspectives of the GP in the work situation may account for this. All medical members 
of the national focus group were practising GPs. 
However, no mention was made by participants of the focus group about the possibility 
of age related GP resistance, or a need to sell the new pharmacy role to the medical 
profession. This may be due to the medical leadership knowledge of the need for 
cultural change in primary care, engineered by Government documents and White 
Papers, (1997- 2002) emphasising peiformance, clinical excellence, and 'partnership' 
between the health professions. 
The comparative views of the GP key informants and focus groups, are set out in Table 
49, together with the suggested marketing implications of both. 
6.3.3 PHARMACY MEDICINES MANAGEMENT LEADERSHIP 
FOCUS GROUP 
(Appendices 12A, 12B, 12C, pages 446 - 465) 
The complete group content analysis is set out in Appendix 12C (page 465) and the key 
themes are as follows: 
• Special training for MM will be required; 
• Outcomes for beneficiaries (GPs & patients) very important; 
• GP/pharmacist teamwork is essential- pilots advised; and, 
• Pharmacy and medicalleadersbip collaboration essential. 
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Columns 2, 3 and 4 of Table 50 show a positive response to the prospect of medicines 
management and recognition of the need for collaboration internally and externally at 
leadership levels. Piloting the service was considered essential, as was joint ownership 
of the whole introductory process. Allocation of specific responsibilities for each lead 
body in pharmacy was assumed from cues in the comments and collaboration in the 
group (Appendix 12B, items 5, 6). This turned out to be the case as evidenced by 
fonnation of the leadership group. A summary of key issues and areas of agreement is 
set out in Table 50 and the sub-committees are as set out in Appendices 4 to 9, (pages 
421-432). 
6.3.4 SUMMARY 
Table 49 draws together the themes expressed by key informants and the medico-
phannaceutical focus group. The key marketing elements which could address these 
themes have been abstracted from the literature research on marketing, (Chapter 4 : 64 
- 84; 111 - 114; 122 - 127) and cross matched in the matrix, showing potential links. 
Marketing activity through the listed elements should be constructed around the cells 
marked with an asterisk under the column header. On this basis, the expertise of 
relationship marketing, emphasising for example, service quality, through consonant 
messages from opinion leaders supporting the doctor le~d health care position, would be 
applied to underpinning the existing GP support for medico-pharmaceutical 
collaboration. Similarly, design of the new service and its promotion ('product design') 
would use the tangible and augmented product aspect to portray the new service as 
doctor led, quality assured and guaranteed through clinical governance (Kotler & 
Clarke, Figure 8, page 68). Likewise the remaining themes at the head of the table are 
addressed using appropriate elements of the marketing process and marked in the table 
cells as the author's concept of the appropriate link up. 
Table SO (page 281) summarises in matrix layout, the individual contributions of the 
phannacy focus group under the main heads of discussion at the top of the table. It 
contains pointers to targets of change activity in moving to a new role. (Chapter 5 : 
199 - Figure 33) such as: 
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• Leadership activity importance; 
• Tasks and individual capability; 
• Individual, team & organisation performance; and, 
• Strategic Intent. 
This means that the profession's leaders have a grasp of the problems and commitment 
to engage in a formalised change process, requiring specified activity to start and 
maintain change momentum. If the pharmacy profession leadership is able to co-
ordinate a sustained effort addressing the above issues, together with those revealed by 
the postal surveys, then at least some of the elements of the Burke-Litwin model of 
change can begin to be applied, i.e. Leadership role, Strategic Intent, Individual 
performance, (Chapter 5 : 199) These three are transformational, which are most 
important in the context of the change order which is transformational. (Chapter 5 : 
198). 
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Table 49 MEDICO-PHARMACEUTICAL LEADERSHIP FOCUS GROUP I KEY INFORMANT RESPONSE COMPARISON SUMMARIES: 
KEY THEMES WITH ASSOCIATED MARKETING IMPLICATIONS 
Support for 
ASSOCIATED med/pharm 
MARKETING collaboration 
ISSUES 
FG KI 
./ / 
Relationship 
marketinl!: 
Relationship 
manaeement • • 
Service qualitY * * 
Consonant message * * 
Communications 
Process and content 
()Pinion leadership • * 
Message source + 
soonsorshil> * • 
Marketin! mix 
Product desiin 
• Core 
• Tan2iblc 
• AIWDcnted * * 
Promotion 
People 
Physical evidence 
Process 
Key: FG 
KI 
./ 
* * 
* * 
Focus Group 
Key Informant 
Majority View 
Resistance to 
increascd GP 
worldoad 
FG KI 
/ ./ 
• * 
* * 
* * 
* • 
o 
• 
# 
KEY RESPONSE THEMES 
Medicines Implied Pilot trials as 
compliance doctor self suggested 
by patient esteem I way forward 
autonomy 
FG KI FG KI FG Kl 
./ ./ / / ./ ./ 
• * • * 
* * 
• * * * 
* * * * 
* * 
* • 
* * 
--
* * • * 
--
No view given 
Suggested main marketing link 
Minor resistance 
Sponsorship Pharmacist 
suggested to potential 
facilitate role recognised 
FG Kl FO KI 
# ./ ./ / 
* • 
• • 
* 
• 
* * 
* * 
Age related Need to sell Lorationof 
GP proposition service in the 
resistance to is recognised pharmacy 
change 
recol!:Dised 
FO Kl FG Kl FG Kl 
0 ./ 0 ./ 0 jN 
* 
• 
• * 
* * • 
• 
* 
* 
* 
* * 
* 
Limit on 
items of 
pharmacist 
input to new 
role 
FO Kl 
0 ./ 
• 
* 
* 
Note: The asterisks in the matrix. denote the author's view of the relevant aspect of marketing applicable to the particular key response themes. The marketing issues in the 
far left column, discussed in Chapter 4, are the author's view of which elements of marketing are involved. The column headings are the subjects raised by key 
informants and the Medico-Pharmaceutical leadership focus group. 
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TABLE SO 
SUBJECT 
INFORMANT 
A 
B 
C 
D 
E 
F 
G 
H 
CODE 
MATRIX ABSTRACT OF THE PHARMACY MEDICINES MANAGEMENT 
LEADERSHIP FOCUS GROUP 
HELD AT RPSGB ON THURSDAY 4th JUNE 1999, 1.00 pm 
KEY VIEWS: RPSGB, PSNC, NPA & OTHERS 
1 1 3 
" 
5 6 
Pharmacist Dodor& Introducing Communications Focus Group Crilieal Mass 
Ability Pharmacist tbe Service to Stakeholders Collaboration Achieved 
Partnersbip into Practice & Ownersblp 
Training is Pilots are the MeetwithGP 
required; in way forward. leaders soonest. 
agreement with Consider Inform ·N 
" F'sviews outcomes for pharmacists as PSNC benefit soon as possible 
Many could do Start early with Outcomes for Agreed with A 
this role. schools of doctors, and F; asked 
Some will pharmacy in patients and about preparatory 
"" 
.., 
never do it building good any other work RPSGB 
communication beneficiary are 
skills with important 
doctors 
Pharmacists Pharmacists Team work is Agreed with F 
have good have good necessary; 
.., 
skills inter- interpersonal pharmacist and ..,,, 
person: will skills. Inter- or Not applicable 
adapt to MM profession but committed 
very quickly collaboration 
necessary 
Impressed with Agreed with Connect the Use joint research 
H's point and H'scomment p£ofessions via group as base for 
referred to RPSGBhas theNHSnet communication. ..,.., v 
RPSGB skills courses. Start within the RPSGB 
courses Produced a pharmacy 
booklet profession 
MMrequires Locums as well Team work is Agreed with F 
life long should be essential 
learning. The trained- ·N 
" place is the response to H's RPSGB community point, i.c. GP + 
pharmacy pharmacist 
partnership : 
Special Do not have Examples of InformGP 
training will be access to all pilot work leaders soonest. 
required- medical given from Usc Crown 
"" 
..J 
courses are information of Aberdeen Report as a Not essential 
available' patients - very possible basis to critical mass 
imp9rtant but important 
Experience in Interpersonal Agreed with F 
repeat script skills are very 
..,.., .., trials shows important 
pharmacists NPA 
can build 
abilities 
Impresscd with Doctor and Integrate the Should initiate at -J -J 
skills already pharmacist pharmacist into CbieCExcc level, 
in this area collaboration I primary care Health Authority. Ownership Not applicable 
now being communication team. Focus Also primary care committed at but committed 
used by is urgent. Have on the patient directors local level 
pharmacists we any plans? service 
A - Baumber C - Dutton E - Hawksworth G· McCreedy MM - Medicines Management 
B - ClII'Phy D-Ferguson F-Mackie H-S-'Pencer 
RPSGB .. Royal Pharmaceutical Society_of Great Britain 
Note: The abovc matrix summarises six major themes of the group discussion and the contributions of each member (A-H). 
The double ticks indicate both 'collaboration' and 'ownership' commitment by each contributor (body). Singlc ticks, 
fmal column mean the organisation named has committed and accepts responsibility for action in columns I, 2, 3 or 4 as 
appropriate. 
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CHAPTER SEVEN 
RESEARCH RESULTS, ANALYSIS AND COMMENTARY 
POSTAL SURVEY QUESTIONNAIRES 
PHASE 2 
7.1 INTRODUCTION 
The field research postal surveys in this study (Chapter 3 : 51) are geared to exposing 
GPs' and pharmacists' attitudes, needs and wants, with respect to the new role for 
community pharmacy, i.e. medicines management, in partnership with doctor and 
patient. 
It has further attempted to reveal potential barriers to change within both professions 
and indicate targets for change effort through modem marketing and management 
techniques. From these studies and analyses, a communications strategy will be 
suggested for pharmacists and GPs and an outline change template set out for 
community pharmacy in moving both professions toward the new collaborative service, 
as stated above. The following sections examine the results of the field postal surveys 
and their relevance to this thesis, which is: 
<t... that there are barriers to repOSitioning community pharmacy in 
the primary health care chain, resident within the medical and 
pharmaceutical professions and that these can be systematically 
addressed by original research and a novel application of modern 
management techniques. " 
(Chapter 2: 37) 
Results of the postal surveys will also be related to issues arising from the key 
informant andfocus group work (Chapter 6 : 270 - 277). 
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PHASE 2 FIELD RESEARCH 
PART] 
POSTAL SURVEY QUESTIONAIRE ANALYSIS: GPs 
7.2 SURVEY RETURNS 
Of the 1000 surveys posted to randomly selected GP practices in England and Wales in 
November 2002, not all were returned: 
4 - were returned blank; 
3 - were unusable; 
37 - were not deliverable; and, 
540 - were useable. 
Giving a 54% response rate. 
This figure (540) in turn, represents a 5.79% sample of the total population of GP 
practices in England and Wales (Statistical Bulletin, 2000 - 2001 : Table 10). The raw 
data has been set out in Appendix 18 (page 489) for reference and the interpreted data 
set out in the body of the thesis. 
Unfortunately nothing is known of non-respondents, which if for example, lie mainly in 
one particular size of practice, would skew the result land reduce sample relevance to 
the whole population. However, a sample return of 540 gives useful information, 
which if interpreted with care, will give a useful indication of GP views on the subjects 
addressed by the survey. 
The survey was mailed twice, the second time four weeks after the rust mailing, in an 
attempt to maximise returns. Anecdotal views from three GPs in Newcastle serving on 
doctor representative committees, (Gateshead; Newcastle; and Sunderland) all regarded 
a 54% response rate as very good. Response rates quoted by them as being 'normal' 
were 10 to 15% for postal surveys from sources external to their own profession. 
In this instance, there was a general practitioner as one signatory to the research and 
perhaps this has led to a higher response rate. The following charts and tables help 
interpret the survey returns, together with comment accompanying. 
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7.3 SURVEY RESULTS: ANALYSIS BY QUESTION 
7.3.1 Analysis of Question 1 a & 1 b : Group Practice Sizes 
'Please state the number of doctors in your practice. Of these, how many are 
partners?' 
Purpose - To determine the difference in status, if any, of practice members and form a 
base which can be used for relating to other issues in the questionnaire. 
Result - The sample response profile of practice group sizes approximates to that of the 
total population (DR : General and PMS Statistics, Table 10) (Figure 46) 
Figure 46 BAR CHART SHOWING SAMPLE RETURNS FOR GROUP 
PRACTICE SIZES TOGETHER WITH CORRESPONDING POPULATION 
PERCENTAGES OF PRACTICE SIZE (n=536) 
600 
soo 
400 
Number orGP 300 
Respondents 
200 
100 
o 
POPULATION PERCENTAGES 
(DH : General &. PMS Statistics. 2002) 
I I 
8.9% 41.1% 38.6% 11.4% 
248 : 
t'f6:3"/o} 18S -
r-- (34.5%) 
r--
S7 46 
rtJ.IM.%)- t- \,,:-60/0} 
n r=1 
1-4 S·7 8+ 
Categorle. of Response 
No. 01 GP'.ln Respondents Practices 
Comment - It is interesting to note that all practice sizes, grouped as above, show 
similar perception of patient health care expectations having increased over recent 
years, (Question 17) as shown in Table 51. The x2 test on Table 51 gives a Chi square 
value of 4.006 and a p value of 0.261 i.e. > 0.05. A Somers Delta test gives a d value of 
-0.027 and a p value of 0.165. Both show no association between practice size and 
perception of patient expectations of health care. 
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Table 51 GROUP PRACTICE SIZES COMPARED WITH GP PERCEPTION OF PATIENT 
EXPECI'ATIONS OF HEALTH CARE OVER RECENT YEARS (0=539) 
PRACTICE SIZE GP PERCEPTION OF PATIENT EXPECTATIONS OF HEALTH CARE RELATED TO 
(GPs) PRACTICE SIZE 
Greatly Increased Somewhat Increased Combined % 
Si"gle 36 (63.2%) 14 (24.60/0) 87.8% 
2-4 136 (64.2%) 59 (27.8%) 92.0% 
5-7 125 (67.6%) 51 (27.6%) 95.2% 
8+ 55 (67.9%) 20 (24.7%) 92.6% 
Markedly different is the group practice size related to the desirability of doctor / 
pharmacist collaboration, as set out in Question II, 'Government seem to be 
encouraging pharmacist / GP collaboration on aspects of medication review. Do you 
agree with this approach?' This comparison is illustrated in the following table: 
Table 52 GROUP PRACTICE SIZE COMPARED WITH DOCTOR VIEW OF 'GP-
PHARMACIST COLLABORATION' (0=539) 
PRACTICE SlZE (GPs) GP AGREEMENT WITH PHARMACIST - GP COLLA BORA TlON ON MEDICINES 
1 MANAGEMENT 
Strongly Agree 2 Agree J Combined % 4 
Single 9 (16.1%) 20 (3S.7%) 52.7% 
2-4 29 (13.6%) 132 (62.0%) 7S.6% 
5-7 34 (18.4%) 109 (58.9%) 17.3% 
8+ 18 (22.2%) 54 (66.7%) 88.9% 
Here, there is increasing general agreement to the proposition with increasing size of 
practice (column 4). Speculatively this may be associated with larger drugs budgeting 
responsibility in the larger practices and greater awareness of the difficulties of 
thoroughly managing medication review processes for large numbers of patients. 
Medicines management services are now a government requirement of all peTs by 
April 2004 (Pharmacy in the Future, 2000 : 15). A Chi square test on Table 52 gives a 
X2 value of 25.184 and a p value of 0.005 showing an association between practice size 
and OP views of OP I pharmacist collaboration. A Somers Delta test gives a d value of 
0.124 and a p value of 0.005 confirming the association. 
Pharmacy should keep in mind that, if the population of single handed practices is of a 
similar view to this sample, it may require a more supportive and empathetic approach, 
when seeking to build a collaborative relationship with pharmacy. 
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7.3.2 Analysis of Question 2 : Practice Dispensing Status 
lIs your practice a dispensing practice? ' 
The null hypothesis for Question 2 comparisons with Questions 8, 11 and 19, is that 
there is no difference in the dispensing doctor (DO) and non-dispensing doctor (NDD) 
responses. 
Purpose - Because of traditional competition between GP and pharmacist in rural / 
fringe urban areas, this question seeks to detennine the views of dispensing doctor 
respondents. These can then be constructively related to dispensing doctors' responses 
in other parts of the questionnaire, to determine any barriers or prejudice. 
Result - Response shows a 13.4% response from dispensing doctors. This approximates 
to that of the total population of dispensing doctors = 14.0% (DH: General and PMS 
Statistics, Table 5). The random sample is therefore encouragingly similar in 
dispensing doctor percentage compared with the population and other OP responses are 
a little high at 86.6%. (Figure 47) 
Figure 47 BAR CHART SHOWING SAMPLE PROPORTION OF DISPENSING 
AND NON- DISPENSING PRACTICE RESPONSES (n=538) 
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Comment - This question was posed because of the potential sensitivity of the rural 
competition for dispensing rights between pharmacists and doctors, (Chapter 1 : 11) 
which may require a different approach to collaboration building in medicines 
management. The following questions have been selected to investigate potential 
differences in response from dispensing doctors: 
Q8 would you like a pharmacist to work with you in the future? ' 
Qll do you agree with pharmacist / GP collaboration in medicines 
management? • 
Q19 t ... do you agree that patient perception of your service could be enhanced by a 
pharmacist medicines review service directed by you?' 
and the results are illustrated in Table 53. 
Table 53 COMPARISON BETWEEN DISPENSING AND NON-DISPENSING GP 
RESPONSES TO Q8, Ql1 & Q19 
Question GPs-TotaJ Response Cat~ 
Number Numbers & Full Time Regular Part Periodically Never 
Types Time 
1 1 3 
360D 1 4 16 15 
Q8 (2.8%) (11.1%) : (44.4%) (41.7%) 
(n =232) 
196NDO 8 58 109 21 
(4.1%) (29.6%) (55.6%) (10.7%) 
Strongly Agree Neither Disagree Strongly 
Agree Agree nor Disagree 
Disagree 
Qll 1 2 3 4 
(n =- 537) 71 DD 3 38 24 3 3 
(4.2%) (53.5%) (33.8%) (4.2%) (4.2%) 
466NDD 87 277 85 13 4 
(18.7%) (59.4%) (18.2%) (2.8%) (0.9%) 
Q19 71 DO 2 31 24 12 2 
(n =537) (2.8%) (43.7%) (33.8%) (16.9%) (2.8%) 
466NDD 38 269 124 31 4 
(8.2%) (57.7%) (26.6%) (6.7%) (0.9%) 
CODE: DD .. Dispensing Doctors 
NDD - NOD Dispensini: Doctors 
GP -Dodor 
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The three questions (Questions 8, 11, 19) are about GP attitude to future working 
together with phannacists and the effect this may have upon improved patient 
perception of the collaborative partnership in medicines management. The percentage 
of affinnative responses in Questions 8, 11 and 19 is higher in all questions, from non· 
dispensing doctors, (combining columns 1 and 2 in Questions 11 and 19). 
Chi square tests on all three comparisons show: 
Question 2 cf. Question 8, Xl = 23.5; p < 0.005 
Question 2 cf. Question 11, Xl = 13.78; P < 0.005 
Question 2 cf. Question 19, Xl = 9.984; p < 0.002 
The null hypothesis is rejected in all three cases. There is thus an association between 
GP dispensing I non-dispensing status and their respective responses to these questions. 
However, a substantial proportion of dispensing doctors (58.3%) do want a pharmacist 
to work with them in future, (columns 1, 2, 3 Question 8) which, if reflected in the 
whole population, is an encouraging base to work from in bringing the two professions 
together in rural and fringe urban areas. A similar percentage (57.7%) also agree that 
'collaboration' is the right approach, (columns 1,2 Question 11) but only 46.5% think 
that such collaboration would enhance patient perception of their service, (columns 1,2 
Question 19). 
The sub-group responses for dispensing doctors are small but can be generalised. The 
total group of 71 dispensing GPs does give an indication of what might be expected in 
the wider population of this group and it would be judicious to plan an empathetic 
marketing communications programme in attempting to build collaboration between 
dispensing doctors and pharmacists. 
Potential Barriers to Change - A proportion of dispensing doctors perhaps through 
competitive sensitivities for dispensing rights with pharmacists; also other uncommitted 
and antagonistic non dispensing respondents in Questions 8, 11 and 19. 
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7.3.3 Analysis of Question 3 : Practice Size By Patient List 
'Approximately how many patients are in your practice? ' 
Purpose - Confmnation of workload. 
Result - Response shows similar percentages of respondents from the 2000 to 9,999 
patient volume levels, with substantially different percentage responses below and 
above these levels. (Figure 48) 
Figure 48 SAMPLE DISTRIBUTION OF PRACTICE SIZES 
BY PATIENT NUMBER (0=527) 
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Catel:ories or Response 
Practice Size by Patient Numbers 
Comment - Distribution of practice size measured by patient number proportionately 
follows distribution of number of GPs per practice. 
Potential Barriers to Change - The workload issue needs address in the 
communication and marketing programme to present medicines management as work 
reducing I shared, rather than increasing the administration. 
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7.3.4 Analysis a/Question 4: Doctor Ages 
'Please tick the age groups you all come within. ' 
The null hypothesis for Question 4 comparison with Question 11 is that there is no age 
related difference in willingness to collaborate with pharmacists. 
Purpose - To investigate relationship of attitude with age and determine any resultant 
need for 'approach change' to building collaboration with GPs / pharmacists. 
Result - The age spread of respondent returns approximates to a normal distribution. 
(Figure 49) 
Figure 49 AGE GROUPS OF SAMPLE RESPONDENTS COMPARED WITH 'AGREE' 
CATEGORIES IN QUESTION 11 (n= 526 accounting for 1147 age categories) 
600T----------------------------------
500+----------------------------------
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MW+-------~~--~~~--~L----------
NumberofGP 
Respondents 300 +--------r.,...,=,.........j 
200 +--------1 
20-29yrs 30-39yrs .. O .... 9yrs SO-59yrs 60+yrs 
Age Groups In Years & Corresponding Strongly 
Agree/Agree Categories combined from Q11 
[J Age Groups 
[J Proportion of Age Group 
agreeing with question 11 
Note: The percentage of eacb group is calculated on the total number oC ages reported, l.e. 1147 
Question 11 Comparison 
'Do you agree with GP I pharmacist collaboration on medicines management? I 
Comment - The highest percentage agreement is in the youngest GP group (90%) and 
progressively reduces as age increases, but is still high percentage support in all age 
groups. All proportions of the groups agreeing with collaboration are good bases on 
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which to build a new partnership between GPs and pharmacists. However, when age 
groups are compared with one of the key elements of Question 12 (12.5 'choice of 
medicines') the percentage 'agreeing' more steeply declines with increasing age. (Table 
54) 
Question 12 Comparison 
'Which of the following items do you think a pharmacist could assist you with? ' 
Item 12.5 'Choice o/medicines' 
Table 54 AGE BANDS COMPARED WITH GP RESPONSE TO QUESTION 12.5 
- 'Choosing The Medication' 
QUESTION 4 AGE BANDS 
20-29 30-39 40-49 50-59 60+ 
No.ofGPs 32 143 170 130 28 
Responding 
(n = 503) 
0/0 Response 55.2% 48.8% 46.6% 43.6% 35.0% 
Agreeing to 12.5 
Overall, Question 12.5 gets to the heart of the traditional GP role; selection of 
appropriate medicine for the patient's illness. This may be an indication of 
unwillingness to be challenged as the original selecto:r of medication for the patient's 
condition. As the age increases, so does the resistance to allowing the pharmacist to 
become involved in the choice of medication. This may be as a result of older traditions 
being more fIrmly preserved by the older GPs (Chapter 1 : 11). The Chi square test 
on this comparison shows: X2 = 20.646; p < O.OOS. The null hypothesis is rejected and 
there is an association between GP age and willingness to collaborate with pharmacists. 
Potential Barriers to Change - Cultural mindset, in older GPs, may see selection of 
suitable medication for the patient as the doctor's right and thus may be a barrier to 
change (Chapter S, Section S). The less positive percentages of respondents to 
Questions 11 and 12 which increase with age increase need careful consideration. 
Communications should be tailored to positive benefIts and recognition of GP leading 
position. 
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7.3.5 Analysis of Question 5 : GP Contact with Pharmacist 
'Broadly, how would you describe the frequency with which you contact a dispensing 
pharmacist? I 
The null hypothesis for Question 5 comparison with Question 11 is that there is no 
difference in the GPs' willingness to collaborate with pharmacists related to their 
frequency of contact. 
Purpose - A basis for comparison with other responses showing potential effect of 
contact on relationship, if any. 
Result - A positively skewed distribution of responses with the majority of doctors 
having contact with a pharmacist. (Figure 50) 
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Comment - At one extreme, a very small percentage of doctors never contact a 
pharmacist (1.3%) and 15.2% have rare contact. There is, however, 'very often' to 
'periodic' contact in 83.3% of the sample, which again, if reflected in the whole 
population may be a good base on which to build a more structured and systematic 
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contact on a regular basis. There do not appear to be any major barriers to progress 
indicated here. 
When this response is compared with the Question 11 responses on, the 'desirability of 
collaboration with pharmacists on medication reviews', the following picture emerges 
as shown in Table 55. For this comparison the 'strongly agree' and 'agree' categories 
have been combined as have the 'disagree' and 'strongly disagree' categories in 
Question 11. The full response to Question 11 is set out under Question 11 analysis. 
Question J J Comparison with Question 5 
'Do you agree with pharmacist / GP collaboration in aspects of medication review?' 
Table 55 FREQUENCY OF GP CONTACT WITH A PHARMACIST COMPARED WITH 
DESIRE TO COLLABORATE ON MEDICATION REVIEW 
GP Frequency or Contact Qtl- Desire for Collaboration (n -539) 
with a Pharmacist (n .. Strongly Agree and Agree Vneertain Disagree & Strongly 
538) Combined Disagree Combined 
1 2 3 
Very Often 43 6 3 
(52) (82.7%) (I1.S%) (S.7%) 
Often 145 23 S 
(173) (83.8%) (13.3%) (2.9%) 
Periodically 169 49 6 
(224) (75.4%) (21.9%) (2.7%) 
Rarely 46 28 - 8 
(82) (56.1%) (34.l%) (9.8%) 
Never 3 3 1 
(7) (42.9%) (42.9%) (14.3%) 
4 
Looking at the 'frequency of contact ' (column 1) and 'desire for collaboration ' (column 
2), agreement with the Question 11 proposition of collaboration increases with 
increasing routine contact of the GP with the pharmacist. A positive relationship 
appears to be related to frequency of contact. The Chi square test on this comparison 
shows: 
X2 = 28.613; P < 0.005. The null hypothesis is rejected and there is an association 
between frequency of GP / pharmacist contact and willingness to collaborate. 
Potential Barriers to Change - Continued lack of routine contact. 
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7.3.6 Analysis of Question 6: Current GP / Pharmacist Collaboration 
'Do you have a pharmacist work/or you in the practice?' 
Purpose - To determine who currently has pharmacist support and by implication who 
is still to require support; thence the potential magnitude of the change programme, for 
those practices with rare or no pharmacist contact at present. 
Result - The majority of OPs do not have regular work undertaken by a pharmacist. 
(Figure 51) 
Figure 51 CURRENT FREQUENCY OF GP I PHARMACIST WORKING TOGETHER (n=538) 
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Comment - 36.7% of respondent practices have pharmacist help, on a full time or 
periodic basis, and 63% have rare or no contact. If applied to the population of OP 
practices in England and Wales (9,334) this means an opportunity for regular 
collaboration in at least 5,880 practices; a worthwhile objective. (NHS Statistics 
Bulletin 2000 - 2002) 
The manpower requirements from pharmacists is substantial. The skill mix issue 
assumes greater importance. A marketing and change programme would in theory 
require targeting initially at those practices not receiving help (an open market) and at 
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least the same number of pharmacist dispensing contractors (at least one such pharmacy 
will be currently serving each GP practice in terms of the present dispensing service). 
The next question. Question 7. further indicates that 83.4% of the 344 GP sample 
receiving assistance currently, do so from other than dispensing pharmacists and so the 
ultimate potential market is larger than the 5,880 GP practices mentioned above if some 
of the other pharmacist help can be displaced. 
Potential Barriers to Change - The rare and nil contact situation currently experienced 
by 63% of GP practices, where the reasons for little contact are not fully understood. 
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7.3.7 An Analysis of Question 7: Sources of Pharmacist Assistance to GPs 
'What is the source of your pharmacist help? • 
Purpose - To determine the competition to dispensing pharmacists and thus the nature 
of the barriers to entry into this segment of the market. 
Result - The majority of pharmacist help is supplied by the peTs which could 
constitute a real threat if the trend continues. This would be described in Porter's terms 
(Figure 4, page 37) as threat of new entrants into the MM market. (Figure 52) 
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The apparent discrepancy between Q6 aggregate of pharmacists working for doctors (290) and 
"sources of htlp" in this question maybe the frequent changes in sources of help from time to time 
(several boxes ticked by some respondents, in Q7). 
Comment - Dispensing pharmacists provide 16.6% of the OP current pharmaceutical 
assistance. This may serve a two-fold purpose: 
i. To act as a mentoring group for other pharmacy contractors wishing to 
undertake medicines management. 
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ii. To form an experience base from which to cull useful information to 
facilitate change elsewhere. 
Potential Barriers to Change - The competitor help being given to 83.4% of the 
proportion of the respondents to Question 6, who do receive pharmacist help, which if 
reflected in the population is a substantial segment of the market. 
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7.3.8 Analysis of Question 8 : Intentions Of GPs Who Have No Current 
Pharmacist Help 
'If you answered 'never' to Question 6, would you like a pharmacist to work for you in 
the future?' (Question 6 = 'Do you have a pharmacist work for you in the practice? ') 
Purpose - To ascertain the proportion of GPs who currently would like phannacist 
assistance but do not have it and the desired frequency of such support. 
Result - The majority of respondents not currently receiving help, would like to have 
this at various frequencies. (Figure 53) 
Figure 53 PROPORTION OF CPs WITHOUT PHARMACIST ASSISTANCE 
(Q6) WHO WOULD UKE THIS IN FUTURE (n=233) 
150 
140 
130 
120 
110 
100 
90 
Number or 80 
Respondents 70 
60 
SO 
40 
30 
20 
10 
o 
197 (84,5%) 
1_"0 Codes: !5.4%) 
(;2 
(')6.6%).-
J-
I-
9 I"-
-t);9%r- l"-
f 1 l-
Fr RPT 
r--
p 
~6 , 
(1),:1'70) 
t-_r- ~ 
t--
t--
N 
Categories or RelpoDst 
Desire ror Pharmacists Help 
Fr Full time 
RPT Regnlar part time 
P Ptriodic:ally 
N Never 
_. 
Comment - Of the 248 respondents to Question 6 not currently receiving pharmacist 
help, only 233 answered this question (Question 8) and of those who answered 'never' 
in Question 6, 41.6% were dispensing doctors. This again points to the sensitivities 
exposed in Questio~ '2 and emphasises the need for careful address of the dispensing 
doctor and dispensing phannacist relationship. From an analysis of returned 
questionnaires the 'never' group above, are all dispensing doctors. 
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However, 84.5% of respondents do want pharmacist help. This has positive 
implications for medico-pharmaceutical collaboration in MM. 
Potential Barriers to Change - The attitude that led to decline of the offer of 
pharmacist support, plus a dispensing doctor negative component. Further research 
needs undertaking on the dispensing doctor antipathy, to seek a more specific role of 
collaboration. 
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7.3.9 Question 9: Doctor Awareness Of Medication Problems 
'Please indicate the frequency with which )lou encounter the following medicines 
problems with patients (8 items specified). ' 
Purpose - To ascertain awareness of medicines problems and to see if such awareness 
relates to other attitudinal responses to the questionnaire; to determine most popular 
items selected by GPs with a view to incorporating these in a core product of medicines 
management (Chapter 4: 67, 68); to determine one aspect of potential pressure upon the 
GP to achieve better patient outcomes. 
Result - All specified problems are encountered at VarIOUS frequencies by all 
respondents. (Table 56) 
Table 56 NUMBER AND SAMPLE FREQUENCY WITH WHICH DOCTORS 
ENCOUNTER MEDICINES PROBLEMS WITH PATIENTS (n - 539) 
NVMBER& Very Often Often Periodically Never 
FREQUENCY 
CATEGORY 
I I 
MEDICINES PROBLEMS 
1. Troublesome side I 57 227 J 248 4 
effects 
284(52.7%) 
2. Drug interactions I 13 lOa I 402 IS 
12lJ22.4%) : 
3. Adverse drug I 12 51 I - 4SS IS reactions 
69(12.8%) 
4. Patient I 71 240 J 226 2 non-compliance 
311 (51.7%) 
S. Poor response to I 36 201 J 298 4 treatment 
237 (44%) 
6. Elderly patient 
I 69 
208 I 
2SS 7 
confusion 
271 (51.4%) 
7. Food and drug 
I 
2 41 I 
414 82 
interactions 
43 (8%) 
8. NHS & OTe drug 
interactions L 3 
37 I 401 7S 
40(7.4%) 
Comment - There was 100% multiple response to this question. Recognition of these 
effects is widespread. All but two specified problems are encountered, at some 
frequency by at least 97% of respondents. The two exceptions are NHS I OTC 
interactions and food / drug interactions. The latter two are recognised relatively rarely. 
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Perhaps this is because patients themselves are unaware of those interactions and so do 
not report them to the GP. The GPs may also be unaware of these problems. 
Equally interesting is that the highest recognition of problems lies in the area of patient 
compliance (item 4, 57.7% very often / often; item 6, very often / often) and thus 
perhaps a non-threatening area for pharmacist intervention, from the doctor's viewpoint. 
This could become a major component of the new 'core product' - medicines 
management (Chapter 4 : 67, 68). Improved compliance would benefit the patient, the 
tax payer and the doctor, in improved health, reduced waste and better health outcome 
respectively. 
Potential Barriers to Change - None apparent. 
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7.3.10 Analysis of Question 10: Doctor Awareness of Medication Problems 
in the 'Elderly' 
'Please indicate what you believe to be the incidence of the following potential 
problems, elderly patients may have with medicines. ' 
Purpose - To reinforce the focus of the doctor's attention on medicines problems in the 
largest consumer group of NHS medication. To ascertain recognition of specified 
problems in this group; to determine areas that may be suitable for incorporating into 
the medicines management 'core and / or tangible product' (Chapter 4 : 67. 68); to 
expose opportunities for non adversarial collaboration with the GP. 
Result - The specified potential problems are recognised by high percentages of 
respondents. (Table 57) 
Table 57 FREQUENCY WITH WHICH DOCTORS ENCOUNTER 
MEDICINES PROBLEMS IN THE ELDERLY (0 - 53S) 
NUMBER & Very Often Often Periodically 
FREQUENCY OF 
ENCOUNTER 
MEDICINES 
PROBLEMS 
1. Capsule I tablet size , 26 193 312, 
99% 
2. Calendar packs I 21 135 336, 
92% 
3. Frequency of dose , 70 303 161, 
99% 
4. Multiplicity of drugs , 214 270 51J 
100% 
5. Remembering to I 153 290 92J 
take the medication 
100% 
6. Medication taste III 70 385 
87% 
7. Other 
Never 
4 
43 
2 
1 
0 
70 
Comment - There is high recognition of all items as problems and in the often / very 
often / periodically categories, items 3, 4 and 5 figure most prominently. These are 
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again compliance issues confIrming the result in Question 9. Once again a non doctor-
threatening issue suitable for pharmacy support. 
Potential Barriers to Change - None apparent but caution should be exercised in the 
approach to item 3 (frequency of dose) by the phannacist and this issue not portrayed as 
a doctor inability to address. 
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7.3.11 Question 11: GP Attitudes to Government Policy on Collaboration 
'Government seem to be encouraging pharmacist I GP collaboration on aspects of 
medication review. Do you agree with this approach? ' 
Purpose - To achieve a plain view of doctor attitudes to official collaboration with 
pharmacists; to relate the responses to other questionnaire items; to give a measure of 
the difficulty / ease of promoting the new GP / pharmacist partnership concept in 
medicines management. 
Result - A high percentage of respondents agree with collaboration. (Figure 54) 
Figure S4 GP VIEWS OF COLLABORATION WITH PHARMACISTS ON 
ASPECTS OF MEDICATION REVIEW (0=539) 
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Comment - An encouraging 75.5% strongly agree or agree the proposition. However 
effort will require targeting at the uncertain, disagree and strongly disagree groups, 
although the latter two are small (3% and 1.3% respectively). 
Potential Barriers to Change - 24.3% of respondents who are uncommitted or against 
GP / pharmacist collaboration. 57.7% of dispensing doctor respondents (71) 'strongly 
agreed' or 'agreed' and 33.8% were uncertain. 8.4% 'disagreed' or 'strongly 
disagreed'. (Table 52) Clearly a proportion of dispensing doctors favour collaboration 
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and it may be possible to build the MM service with like minded doctors in the 
population. If so, then these in turn could become role models or mentors for the 
reluctant or 'anti' members of the dispensing doctor sector. 
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7.3.12 Analysis of Question 12 : GP Selection Of Suggested Items For 
Pharmacist Assistance 
'lfyou ticked any boxfrom 11.1 to 11.3, which of the following items do you think a 
pharmacist could assist you with? (Please tick all appropriate boxes). ' 
Purpose - To determine if any of the 'uncertain' respondents to question 11 would be 
prepared to speculatively give an opinion on potential help; to see if 12.5 and 12.10 
were regarded less favourably than other items of help, as these could be regarded as 
direct challenges to the GP competence and threatening from a pharmacist intervention. 
These two items are part of established GP territory. 
Result - A favourable response to all items but diminishing approval for 12.5 and 12.10. 
(Figure 55) 
Figure S5 ITEMS A PHARMACIST COULD ASSIST YOU Wlm (n=536) 
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I--
t-
12.10 
228 
r-
-12.S 
Comment - The bar chart has been arranged to show in order, the 'most' to 'least' 
popular of these items with which pharmacists can help, as specified in the question. 
The three most popular items are non-threatening to the doctors' position as decision 
maker in the health care hierarchy. The two least popular items could be seen as 
threatening to the doctor's authority in drug selection for patients. However, 42.5% of 
respondents do wish assistance with these items. Again this may be a good base on 
which to build approaches to the other 57.5%. 
Of the uncertain group in Question 11, all completed Question 12, with the same 
emphasis on top and bottom 2, 'most' and 'least' popular items nominated for 
pharmacist help. 'Patient compliance' again rates highly for pharmacist assistance. 
Potential Barriers to Change - Implied from 12.5 and 12.10, doctor ego I culture 
threat, in being challenged on correct selection of medicines for the patient's illness at 
the correct dose level (Chapter 1 : 10). 
As medicines management is very much about the selection of appropriate medicines 
and dosage levels, a suggested strategy for dealing with potential doctor sensitivity on 
these issues, is as follows: 
i. Construct the first marketing package for :MM, excluding the above two 
issues. Thus the introductory new inter-professional collaboration package, 
is OP culture protective and non-threatening. 
ii. When the first package is agreed, (via the GPC and LMCs) it should be 
implemented and then effort put into building OP confidence in remaining 
the clinical lead in the team. 
iii. When the relationship between GP and pharmacist is developed, (perhaps 
within one year) the pharmacist can then introduce the additional concept of 
contributing to selection of initial treatment and dosage. A diplomatic 
vehicle could be the need to observe the NICE guidelines for addressing 
disease treatment in a structured way. Achievement of the quality markers, 
which will form part of a new OP contract, thus receive the assistance of a 
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'friendly pharmacist' acting to the instructions of the GP. Furthermore, 
offering alternatives for initial treatment can be suggested in the guise of 
seeking cost minimisation and helping practice budgets. 
The PCT advisers can be encouraged by the LPCs to continually emphasise with the 
PCT Boards the need to pursue the NICE guidelines, as well as use the dispensing 
pharmacists to support the GP in this drive. 
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7.3.13 Analysis of Question 13: Objections To Collahoration (Derived From Q 11.4; 
11.5) 
'If you ticked boxes 11.4 or 11.5 in Question 11 please outline your reason here. • 
Question 11 'Government seem to be encouraging pharmacist / GP collaboration on 
aspects of medication review. Do you agree with this approach? I 
Purpose ~ To attempt to determine reasons for opposition to QUestion 11 proposition; to 
thereby indicate a means of approach to these people. 
Results - Increased workload and professional sensitivities are apparent in this result. 
(Table 58) 
Table 58 SPECIFIC REASONS FOR DISAGREEING OR STRONGLY DISAGREEING 
QUESTION 11 PROPOSITION OF COLLABORATION (n=18) 
AUTHOR RESPONSE IN DETAIL 
CATEGORISATION OF 
RESPONSES 
Privacy & 1. Lack of confidentiality of pharmacy; 2. pharmaCist not clinically 
Confidentiality qualified; 3. pharmacy lacks privacy; 4. such collaboration will not reduce 
1 demand on GP 
The Responsibility oUhe 5. Doctor can judge necessity of patient review; 6. patient problems should 
GP be taken straight back to surgery; 
:% 7. pharmacists are not doctors, "I prescribe. I am responsible." 8. "We 
monitor all the above issues and make the decisions ourselves." 9. "1 am an 
expert in general prescribing. worldng on behalf of my patient"; 10. a 
collaborative approach may lead t~ uncertainty and confusion of the 
patient. 
CPs See no Benefit 11. No need; 12. not convinced collaboration leads to better prescriptions 
3 for patients; 13. no knowledge of government encouragement to 
collaborate. 14. The bureaucracy would be stifling and feedback from 
patients would be deafenin~ 
CPs See Themselves as 15. Clinical application of drugs and theoretical knowledge are two 
Already Well Organised different approaches. 16. "We prescribe from limited formulary; we 
4 review prescribing with our nurse practitioner. 17. Pharmacist would have 
to be based in surgery to be of any use - easier to do ourselves. 18. 
Already enough interference by NICE and PCT prescribing advisers. 
ResponsibiIity_ is sim~y_ dUQ!icated." 
Abbreviations: NICE National Institute of Clinical Excellence 
PCT Primary Care Trust 
Total Re~onses 18 
Comment - These individual comments begin to expose some real and perceived 
objections by doctors to pharmacist involvement with their own traditional roles and 
must be taken into account in the marketing campaign to bring the professions together 
in collaboration on medicines management. Item little '14' is again a reflection of 
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views already exposed by key informants. Workload is a real issue and some of the 
views exposed here may well be held also by doctors who do want pharmacist help. 
Potential Barriers to Change - Cultural mindsets on whose territory belongs to who; 
concern about pharmacy facilities inadequacy; pressures of time, bureaucracy and 
workload. All must be addressed in the final product design, the presentation of 
'medicines management. ' 
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7.3.14 Analysis of Question14: Desired Frequency of Pharmacist Involvement with 
Patient Review 
'If a pharmacist worked with you to undertake a patient review of those medication 
issues agreed by you, how frequently should this be done for those on long term 
medication? ' 
Purpose - To obtain measures of doctor perception of desired frequency of review 
requirement; to obtain a proxy for doctor view of potential added workload and scarcity 
of time. 
Result - The most favoured review periods are four monthly and six monthly. (Figure 
56) 
Figure 56 GP PREFERRED PATIENT REVIEW FREQUENCY (0,.513) 
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Comment - A small proportion of GPs (8.6%) want one or two-monthly reviews. This 
may be because they know that new patients are constantly going onto long tenn 
therapy which may need change early in treatment. Wastage of drugs could be reduced 
by issuing smaller initial quantities; this group may indicate a few astute cost-conscious 
doctors. 
A much higher percentage would like quarterly review (31.7%) and 3.9% seek a four 
monthly period. Interestingly, a much higher percentage (55.7%) prefer a six or twelve 
311 
monthly programme. Whilst there may be a genuine clinical basis for this in the minds 
of these respondents, time pressures may also be a factor and again workload 
implications may be involved. The subject does require further research. 
Potential Barriers to Change - Possible time constraints on OP; increased workload 
aversion and detennination to minimise additional administration. Nevertheless reviews 
are an accepted proposition for 513 respondents, (100%) albeit for differing frequencies. 
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7.3.15 Analysis of Question 15: Formalisation Of GP / Pharmacist Collaboration 
'Do you feel the pharmacist should become a formal part of the doctor's team 
addressing selected items agreed by you? ' 
Purpose - To ascertain from a direct question, the degree of GP commitment to formal 
collaboration between pharmacist and doctor. This question effectively links Questions 
8 and 11 to the ultimate recognition of 'partnership.' 
i.e. Q8' Would you like a pharmacist to work with you in the future?' 
Qll ',., do you agree with pharmacist / GP collaboration? ' 
(Question 8 and Question 11 responses exposed as percentages only, for the purpose of 
comparison and using the 'yes' and 'no' categories only). 
Results - More than half the respondents agree with formalising the GP / pharmacist 
team relationship. (Figure 57) 
Figure 57 GP RESPONSES TO PROPOSAL OF FORMALISING COLLABORATION WITH 
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Comment - The results to Question IS show lower commitment to formalising the 
levels of collaboration already agreed in Question 8 and the commitment expressed in 
Question 11. The percentages are the important figures. Similarly the anti-
formalisation group in Question 15 is higher. (Question 8 'no' category only refers to 
the balance of Question 6). 
This question begins to get to the heart of the issue of 'visible involvement' and degree 
to which the GP is prepared to accept recognition of partnership with patient 
medication. 
Potential Barriers to Change - Limited GP commitment to pharmacist formal 
membership of the doctor's team in the patient care process through participation in 
joint medicines management. 
It may be that doctor ego is involved and the esteem needs postulated by Maslow are 
being threatened, (Chapter 4 : 97, 98) by higher profile recognition of the pharmacist. 
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7.3.16 Analysis 0/ Question 16: Doctor Views On Importance 0/ Patient Perception 
O/Quality 
The quality of patient care in general practice may be very good, even though the 
patient may not be aware of that quality. How important is the patient's own 
perception of that quality?' 
Purpose - To detennine GP awareness of importance of patient perception of quality of 
care by the GP; to explore potential in the responses for presenting the pharmacist as a 
complimentary element to the doctor's own quality of care, in Question 19. 
To link with Questions 17 and 18, building up to Question 19, to again explore an 
opportunity for presenting the pharmacist as a complimentary addition to the doctor's 
own image in the eye of the patient and not a threat. 
Result - There is wide recognition of the importance of patient perception of quality of 
care. (Figure 58) 
Figure S8 GP PERCEPTIONS OF PATIENT AWARENESS OF QUALITY OF CARE (0=537) 
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Comment - 95% of respondents considered patient perception of quality of care to be 
important or relatively important. This is very useful to promoting pharmacist / OP 
collaboration if the links to quality can be made, with the additional pharmacist help 
role and presented as a non-threatening addition. 
Potential Barriers to Change - None, other than potentially in a small percentage of 
OPs. 
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7.3.17 Analysis of Question 17: Doctor Views On Patient Expectations Of Health 
Care 
'Quality of care and clinical excellence are recurrent themes in the White Papers. 
What is your perception of patient expectations of health care over recent years? ' 
Purpose - To detennine GP awareness of any change in degree of patient expectations 
over recent years. To determine whether patient expectations could be used as a route 
to presenting once again, the pharmacist as relief pressure on GP performance, which 
may be increasing through patient knowledge of what to expect in terms of health care. 
Result - A large majority of GPs recognise increased patient expectations of health care. 
(Figure 59) 
Figure 59 DOCTOR VIEWS OF PATIENT PERCEPTIONS OF HEALTH CARE (0=539) 
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Comment - 92.7% of respondents recognise increased patient expectations of health 
care over recent years. This could therefore be a useful1ever of proposed change, in 
marketing the new pharmacist collaboration in medicines management, i.e. present 
pharmacist involvement as a solution to potential increased pressure. 
Potential Barriers to Change - None. Facilitating change through patient pressure 
may be a possibility. 
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7.3.18 Analysis of Question 18: Doctor Perspective on Patient Motivation 
'Patient's perception of quality of care may be a factor in their commitment to the 
therapy. Do you agree?' 
Purpose - Another build up to Question 19 and a possible lever of change in engaging 
pharmacist / GP collaboration. 'Ibis may also strengthen the case for a pharmacist role 
in patient compliance. 'Ibis question uses a non-threatening but important issue to 
explore again, the possibility of pharmacist involvement in patient medication problem 
solving. 
Result - A large majority. of GPs agree with the proposition. (Figure 60) 
Figure 60 DOCTOR VIEWS ON IMPORTANCE OF PATIENTS' PERCEPTION OF 
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Comment - 85.2% of respondents agree that patient perception of quality of care may 
be a factor in their commitment to therapy. Commitment to therapy is an important 
component of patient compliance which doctors see as an area for pharmacist 
intervention. 'Ibis is potentially an indicator for the possibility of being able to 
construct an appropriate product offering welcomed by doctors as a non-threatening 
issue (Chapter 4 : 16). 
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Potential Barriers to Change - None substantive, but the 'undecided' require 
marketing address and some persuasive benefits outlining to them, for engaging patient 
commitment to comply with the doctor's treatments. This could also be presented as a 
work reducing input from the phannacist, through achieving better patient outcomes in 
patient compliance. 
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7.3.19 Analysis of Question 19: Doctor Opinions On Potential Pharmacist Impact On 
Their Image 
'Patient perception of your overall service could be enhanced by a pharmacist 
medication review service, directed by you. Do you agree? ' 
Purpose - To get a straight forward answer to a key question having led the doctor 
respondents into focussing on related issues in Questions 17 and 18, which gives an 
indication of the value GPs place upon the new phannacist intervention. 
Result - A majority of GPs agree the position. (Figure 61) 
Figure 61 DOcrOR OPINION ON ENHANCEMENT OF MEDICAL SERVICE 
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Comment - The respondent component in agreement with this proposition is 63.4% 
which is somewhat higher than those who believe the pharmacist should become a 
formal part of the doctor's team (54.5%). This is encouraging but there again appears to 
be some reluctance to recognise the potential beneficial impact of phannacist 
involvement in the eyes of the patient. Is third party recognition of the pharmacist an 
ego threat? A counter view could be that there is only a small percentage of 
respondents, (9.1 %) who disagree with the proposition. Is this the ego speaking and 
inferring that GP image could not be improved by phannacist assistance? All 
respondents in this latter group are dispensing doctors. 
Potential Barriers to Change - A threat to the doctor's ego? Potential lack of 
recognition of the importance of the phannacist in the health care delivery process; 
potential fear of rising importance of the pharmacist? Although the doctor is being 
asked for a patient view, it is in reality, partly at least, the doctor's own view. A prime 
target for persuasion is the uncommitted group, through reassuring communications and 
dialogue. 
The pharmacist should be presented as a supportive addition to the doctor's team, 
enhancing the doctor's own image of quality service in patient overall health care. 
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7.3.20 Analysis of Question 20: Practice Location 
<Please indicate in which of the following locations your practice is based' 
Purpose - An approximate internal validation of the figure respondents gave to 
Question 2 ~th respect to dispensing doctor numbers. 'Is your practice a dispensing 
practice?' 
A basis for further research, relating location of doctors to other question responses in 
the current research, i.e. Questions 8, 11, 15, 19. 
Result - Rural GP respondents comprise 14.7% of respondents. (Figure 62) 
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Comment - There is an approximate consistency between this result and that in 
Question 2 which gave dispensing practices as 71 out of sample of 528, (13.45%). This 
Question 20 sample response gives 89 rural practices out of 526 respondents which 
equals 16.7% and not all of these will be dispensing doctors; nor do all rural GPs 
dispense. Also some dispensing practices will be in fringe suburban areas. 
Potential Barriers to Change - Potentially dispensing doctors. Other comment has 
been made on this potential problem under Question 2. 
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A summary of the GP survey returns (Table 59) and implications follows. After 
analysis of the phannacy postal survey a consolidation (Table 63) of GP and phannacist 
survey returns link-ups, brings the two surveys together. 
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Table 59 DOCTOR POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE 
WITH ASSOCIATED MOTIVATIONAL & MARKETING IMPUCATIONS 
1. SURVEY QUESTION NO. & 2. E..,{POSED BARRIERS 3. SUGGESTED MOTIVATIONAL 4. COMMUNICATIONS; MARKETING; 
CONTENT POSTAL SURVEY 2.1 2.2 IMPLICATIONS & NEEDS FOR GPs IMPLICATIONS 
Kl FG 
Q1a:b. PII:lb"t: state th.: number of doctors Singld handed practic.:sldSS inclined Possibld fdar of workload increasing or as II OPs who are 1.:88 intdfo:l>idd, or not intdfdOied in 
in your practice; Of these, how many are to want conaboration with - - singl.: practitiondf, being in the hands of a collaboration with pharmacists, need to be ofti:red 
partners? dispensing pharmaciJ.is. pharmacist, without GP peer support. N.:ed to attractive bendits, framed in an ego & culturally 
cf. Q 11 preserve OP: supportive package, i.e. via the Augmented & 
Tangible Product (Ch. 4: 67) Face to tace 
QZ. Is your practice II dispensing practice? Dispensing doctors IdSS inclined to S.:lf dOi.:em; s.:lf actualisation; (Ch. 4 :905) & presentations by pharmacists. The 
cf. Q8, Ql1, Q19 want to: promote OP cultural valu.:s Sheth/NewmanlGross theory of V alue Categori.:s 
a. Have a pharmacist work with are important here (Ch. 4 :102, Table 18) 
them in future (Q8) Psychological safety needs also n.:ed supporting; especiallythd 'emotional', '.:pist.mUc' and 
b. Collaborate with pharmacists Wsign appropriat .. approach to SIOrvic" (product) 'conditional valu.:s '. 
on MM (Ql1) or to ... introduction, which is ego dc:fensive (Ch. 4 : 106, Promotional communications should be in 
c. See that a pharmacist could Table 19) p.:rsuasive message and structure (Ch. 4 : 113) 
enhanCd patient perception of sdeking to engage cognitive, effective and 
their service by working with conative components ofGP perception (Ch. 4 : 
them (Q19) 114} 
(Tradition of competing with 
pharmacists for right to dispense) 
Q3. How many patients are in your Single handed doctors need special - - Q3. Communications copy: Portray the new MM 
practice? address. (ref. QI) Workload" service as time saving not time consuming -
rdeasllS GP time for important disease 
diagnosis/managementJreviews 
Q4. Pl_ tick age groups you all come As age increasell, 80 does .J - Same comments as above Q4. Communications messag.:s to be ego 
within. cf. Ql2 unwi11ingndSS to see the pharmacist supportive; non-threatening; culturally supportive 
be party to choosing the patient's of traditional valUell, remembered by older OPs 
medication (ret: QIZ) (the l.:ad profllSBiolllll.) 
--
Q5. Broadly, how wouW you describe the Jnfr.:quent contact with a' pharmacist - - Pharmacist contact with UP may be approached Relationship ITUU"kding will be important in 
fn:quency with which you contact a ill related to lack of d.:sire for through satisfying doctor needs in the devdoping engaging those GPs who only have 'periodic' Ill" 
dispensing pluumacist1 (cf. Q II) collaboration (ref. Qll). Less new NHS. These are partly likely to lie in the 'rare' contact with dil.-pensing pharmacists. Local 
current contact .... less desire to area of quality prllScribing. driven by pr.:ssure workshops with OPs and pharmaci:.'ts could 
collaborate. from NICE. Certain payments to GPs depend become one mc:ans of developing a good intdf· 
upon hitting the PCT Quality Markers professional rapport by settingjoint objectives in 
thc:oretical patient medication problems of a non-
critical nature e. g. reduction of side effects in the 
elderly patient 
-- -
. - .. t: .... r' r ~ "-" ...... W'oo .... .- irol"~ _ _ _ .... t:_" • 
___ !. ___ t __ 
.... 11. .. ....... "- .. ' _t ,_h 
Abbrniations: l\lM = Medicines Management NICE = National !n:,iitut" of Clinical E=:1l..nce per = Prinwy Care Trru.i 
Furthdf explanation of this table is on page 3Z8, connection ofChaptdf" (th,:ory) and sw""')" r",,-ults of doctor needs, wants. 
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Table 59 DOCTOR POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE 
WITH ASSOCIATED MOTIVATIONAL & MARKETING IMPUCATIONS 
1. SURVEY QUESTION NO. &. 2. E.,{POSED BARRIERS l. SUGGESTED MOTIVATIONAL 4. COMMUNICATIONS; MARKETING; 
CONTENT POSTAL SURVEY 2.1 l.2 IMPUCATIONS &. NEEDS FOR GPs IMPUCATIONS 
Kl FG 
Q6. Do you have a pharmacist work for Only 36.8% ofGPs have a fuU time 
- -
Create a GP 'wunt' from pres.mting the DH Ot"the 36.8% (198) only 57 OPs receive such help 
you in the practice" or periodic pharmacu.t working with driven need tOr high quality OP prescribing and from dispensing pharmacists ie. 10.6%. However, 
them. Lack of relationship basis on patient care; also the growing requirem.mt t"or 197 would like help in the future (36.6%). 
which to build for 63.2% GP~ crn,t effective prescribing which the pharmaci~ 
can address for the OP . Thoughtful cOllbtruction of the product offering, 
focusing the core product upon non-cont.mtious 
issues initially and demo~ating effectiveness in 
Q7. What is the source of your pharmacist 83.4% of doctors who do have Negative reinforcem.mt (Ch. S : 251) small pilot exercises by selected OP practices or 
help? pharmacist help acquire it from - - PCTs - should provide encouragement to GPs to 
competing sources to di>'peIlSing engage the service. 
pharmacu.ts. 
As the outcomes are se.m to be beneticial, 
Q8. Would you like a pharmaci~ to work The 'NEVER' group: all dispensing 
..J Present dispensing pharmacu.t as added value contid,>Rce in the new collaborative relationship tOr you in the future? doctors (DDs) - through real time int"",entions in OTClNHS drug should build. This str,,"giliening of partnership 
inll:ractions &. fOod I drug interactions (Ch. 4 : approach should in turn lead to other more 
96). Positive reinforcement (Ch. 5 : 251) s,,"sitive issues (medicines selection &. sub-
therapeutic dose levels - Q 12) at I~ being 
Q9. PIl:ase indicate the frequency with NONE: AIl specified problems were Resolution of these problems in whole or part can discussed or more acceptably, naturally entering 
",Nch you encounter the following e:sperienced by aU respond~nts. - - be achieved by p\uumaci..t intervention. A sense discussions at practic.o meetings. 
medicines problems with pati~. of GP accomplishment as dt:scribed by Rokeach 
&. Vinson et aI (Ch. 4: 101) may thus be The Tangibl" &. Augmt>n1ed Product (Ch. 4 : 67 -
QI0. Pleas" indicate what you believe to NONE: All re..'POndents recognised achieved. Motivation through a more satisfied 72) should be addressed through its: 
be the incidence oflbe following potentia1 incidence oftlle specified problems patient. (Self esteem; Maslow) • Utilities &. Benefits segmentation 
problenJS, elderly patients may have with except in two categories. • Risk reduction 
medicines. • Packaging; styling; branding 
24.3% of respondents who are Motivation through clarit)ing government policy 
(to support doctor ego) 
QU. Government seem to be encouraging 
..J ..J • Quality &. warranty &. follow up pharmacist I GP collaboration on aspects of uncertain or disagree. -- for GPB re th" partnerships in pati""t care, service (Garvin Ch. 4 : 75, Table 13) 
medication review. Do you agree with this 
, 
llIIlphasising chang" necessity and shared benefit 
approach? for GP I pharmacist. Thus, positive outcomes in pati.mt perception will 
QU. If you ticked any box from 11.1 to 12.5 &. 12.10 indicate Op, feel 
..J (Vroom - E:.-pectancy theory) 
reinforce doctor image as improver, leader and 
-
carer in developing improved patic:nt ."",ice. GP 
11.3, which ofthc following items do you threatened - culture I ag~ rel.!.ted. Major on nOlHlensitive areas in cOllbtructing contidc:nce can be encouraged over time, on 
think a pharmac~ could assist you with? benefits to OPB' package. sensitive issues. 
-
_. ... .~ 
. - . ..--....... '" 
............. . ~.' - . _ .... -_. ~. • ". I.. 
Abbrnfations: 1\I~1 = M..wcines Managem.mt NIlS = National Health S.:rvice (Drugs) OTe = Over the Counter (Drugs) 
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Table 59 DOCTOR POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE 
WITH ASSOCIATED MOTIVATIONAL & MARKETING IMPLICATIONS 
1. SURVEY QUESTION NO. & 2. EXPOSED BARRIERS 3. SUGGESTED MOTIVATIONAL .... COMMUNICATIONS; MARKETING; 
CONTENT POSTAL SURVEY 1.1 1.1 IMPLICATIONS & NEEDS FOR GPs IMPLICATIONS 
K1 FG 
QU. ffyou ticked boxes 11.4 or 11.5 in Cultural mindsets on which territory Ot:sign MM service around cultural values (Ch. 4 The reasons given indicate th.: n.:ed to build OP 
Qll, pleas.: indicat.: your reason here. belongs to whom. -J -J : 101) and sel.:ct value categori.:s supportive of confidence in the pharmacu,1 ability and non-
patient benefit - ht:l1ce doctOl1l satisl:iiction & threatening nature of the MM intervt:l1tion. 
QU. ff a pharmaci>.1 worked with you to Time COI\b1raints and inCl'ellSed doctors benefit outcomes(Ch. ... : 102, Table 18). Kotler's tangible product in particular (Ch. 4: 61) 
undertake a patit:l1t review of those workload. -J -J McCh,lland's achiewment-power motivational requires carcfulassembly to reinforc .. the 'quality' 
medication issues agl".:ed by you, how theory, (Ch. 5 : 256) of the pharmacist intervention. 
frequently should this be don.: for those on 
long term medication'? The delivery oftlle product (MM) in doctor 
interface mode (as distinct from th" pati"nt 
interfac" phas,,) should be tailored to a practice 
specific frtlquency, but overall in time saving 
intent, not time eli.-pcnsiw. 
Ql5. Do you f.:el the pharmacu,1 should Only 54.5% said yes. 45.5% may -J 
" 
Thoory ofreasonoo action model (Ch. ... : 109, This issu.: can btl allowed to increm.:ntally 
btlcome a formal part of the doctor's team, btl reluctant to have pharmacy Fig 11) clearly d"fmes the outcom.:s and values dewlop rather than through aggnossive promotion. 
addressing selected items agreed by you? officially recognised. Ego issue'? of the btlnefits. Establish by pilots the harmony The soft sell approach built up as the 
betw.:en belie& and actual experience (Ch. 4 : OP Ipharmacist relationship lkvelopll. 
110). 
-
Ql6. The quality of plltient care for NONE 
- -
Maslow's 'safety' needs require address to Q16, Q17 & Ql8 indicat.: OP awareness of 
general practice may be very good, even l'CIIS>'llre doctor as head of 'team' - psychological patiomt importance::, botll for medication outcomes 
though the patient may not be aware of that comfort. and patient expectations. 
quality. How important is the patient's 
own perception of that quality? Reinforce th.:sc positive responses by use of the Opinion m.:ssage source and opinion leadership 
patient as thll ultimate beneticiary and thus a (Ch. 4 : 126) may btl built into marbting 
Q17. ~-ofcareandclirucal NONE 
- -
rout.: to achieving tlte quality markers' targ"ts of communications by enlisting the spokesman for 
exeoollcnce are:: recurrent themes in the each PCT/OP practice. patient organisations and their high profile 
White Papers. What is your perception of -- medica1advisers in r"inforcing the message 
patit:l1l expectations of health care over 
. 
contllnt that MM collaboration and partnership is 
recent years? Emphasis on n.:eds of OPs to be recognistld by crucial to improving primary care treatment for 
DHINICE as quality prescribers. patients. 
Q18. Patient's percq>tion of quality of care None subt.1a.ntive; but the undecided 
" " may be a factor in their commituumt to need address. McCMland's achievement-power/motivational Promotional channels Gournals, direct mail & in-
therapy. Do you agl".:e? - theory (Ch. 5 : 2S6) house ntlWSpilpers) should periodically carry 
articles in which external spokesmt:l1 figure 
prominently, in support of the DtlW proposed 
rdationship (partnership building) between 
pharmacists and OPs. 
-- ---
.- .. , .~ 
--
... . 19-- ..... .- ... ......... ~ ... -- . - ...... -_ .. .' .... L 
Abbrnlations: l\1M = Mlldicines Managemt:l1l NICE = National Institut.: of Clinical EXCellt:l1ce per = Primary Care TI1b1 
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Table 59 DOCTOR POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE 
WITH ASSOCIATED MOTIVATIONAL & MARKETING IMPLICATIONS 
1. SURVEY QUESTION NO. & Z. E.,{POSED BARRIERS 3. SUGGESTED MOTIVATIONAL 4. COMMUNICATIONS; MARKETING; 
CONTENT POSTAL SURVEY 2.1 2.2 IMPUCATIONS & NEEDS FOR GPa IMPUCATIONS 
Kl FG 
Q19. Patient perception of your overall 36.6% uruL:cidlld 01' 'anti'. Doctor The positive base 01'63.4% resporulmts is Ii Q12.5; Q15, QI9 retl..ctGP attitudes on 
service could be enhanced by a pharmacist ego barrier? ct: Q I S V V sound majority on which to ofti:r a non- important issues. 'Ego defence' (Ch. 4 : 106, 
medication review service dir..cted by you. thr~tening. doctor supporting service, which is Table 19) is one explanation. All communications 
Do you agree" tailored to enhancing the doctor's image. - face to face; written and published - would 
Maslow's self e~1l)em need should be Ii targo:t of benefit from portraying to patients and the health 
rnarkt:ting communications psychology. (Porter- professions, the new MM intervmtion, as GP led 
Lawler motivational model. factors 1,2,3 related and directed 
to 'Quality Markers' reo practice budgets.) 
Q20. Please indicate in which of the Potentially ~1"'Il8ing doctors. 
- -
fol1owin~ locations your practice is baslld. cf. Q2. 01I. 08. 019 
_. .. .. -. . .... . ... -'" 
- - ----- - .-
.•. • _0' • - - .- - _ .. 
'" --
Abbre\'iations: 1\11\1 = Medicines Management NICE = National Iru.'titute for Clinical Excellence PCT = Primary Care Trust 
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7.4 DOCTOR SURVEY SUMMARY 
Table 59 is the summary of the postal survey results and exposed barriers to phannacist 
role change from doctors and indicates alongside these the same, or similar issues, 
raised by key informants andfoeus group. Columns 3 and 4 summarise the author's 
concept of the motivational implications for GPs, as well as the marketing approaches 
that would be best pursued to encourage doctor participation in the new partnership 
service of medicines management. This brings together the results of the literature 
research ftndings in Chapter 4, relating to the marketing and presentation of any product 
(service) through its core, tangible and augmented benefits, (Chapter 4 : 68) and field 
research results. The table also marks the place of relationship marketing, marketing 
communications, opinion message source and advertising channels. 
The potential barriers to progress, in introducing medicines management, are in degree 
rather than absolute terms: 
• Lack of GP time; 
• Age related antipathy (as age increases); 
• Lack of existing routine contact with pharmacists (58.1 %); 
• Current competitor entrenchment within the GP practice (36.8%); 
• Those who do not wish to collaborate (15.5%); and, 
• Cultural mindsets on territorial rights (47 - 57%) with respect to professional 
cultural sensitivities. 
Facilitating issues, as discovered in the general analysis are: 
• Respondents who do wish to collaborate (75%); 
• Respondents who have identified eight issues for collaboration (61 -75%); 
• Very high percentage of respondents who see patient expectations of health care 
increasing (92.7%); and, 
• High percentage of respondents who see the pharmacist as an enhancement to 
their service image (63.4%). 
If the above barriers and facilitating factors are reflected in the whole population, the 
facilitating issues can be used to address the barriers by creating initial collaboration 
with the collaborative segment of GPs. These practices may then be used as role model 
/ mentors for more reluctant colleagues. 
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PHASE 2 FIELD RESEARCH 
PARTII 
POSTAL SURVEY QUESTIONNAIRE ANALYSIS 
INDEPENDENT DISPENSING PHARMACISTS 
7.S SURVEY RETURNS 
Of the 750 surveys posted to randomly selected independent pharmacies in England 
and Wales, in November 2002 not all were returned: 
Giving a 
7 - were returned blank; 
3 - were unusable; 
14 - were not deliverable; 
55 - materialised as multiples; and, 
403 - were usable. 
53.7% response rate. 
This figure (403) in turn represents a marginally lower percentage return than in the GP 
survey and 7.4% of independent pharmacies in England and Wales. (Statistical 
Bulletin, 2001 : 1) 
Nothing is known of non respondents (46.3%) and therefore the results are interpreted 
with caution. 
Nevertheless a return of 403 respondents constitutes a useful sample size and will give 
an indication of independent pharmacists' views on the range of issues covered by the 
survey questions. 
The survey was mailed twice, the second time four weeks after the first mailing, in an 
attempt to maximise returns. Other researchers have achieved similar percentage 
returns, (Jones, I.F. & Booth, T.G. 1975 : 150 - 153, Vol. 215 - 56%; Smith, A.J. 1994 
- 53.5%; Brown et aI., 1996 : 854 - 858, Vol. 257 - 61.4%). The response for this 
thesis was judged to be reasonably good and should give a useful view of general 
independent pharmacy opinion on the subject matter. 
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7.6 POSTAL SURVEY ANALYSIS BY QUESTION 
7.6.1 Analysis of Questions 1 and 2: Gender And Position 
Question 1 - 'What gender are you? ' 
Question 2 - 'What position do you hold? ' 
Purpose - These two questions are to ascertain the proportion of each sex responding to 
the survey and to use for comparison with later questions, if necessary, to investigate 
potential differences of views based upon male I female perspectives. 
Result - A large majority of respondents were the owners of the pharmacy and 80% of 
all respondents were male. (Figure 63) 
Figure 63 NUMBER, STATUS AND SEX OF RESPONDENTS (0=397) 
IDMale C Fcmalcl 
400~--------------------------~====----~ 
300+-------------------------------------
No. of 200 
RespoDdeDts 
OWNER 
4 5 
(1%{1 .3%) 
MANAGER ASSISTANT 
PHARMACIST 
RespoDse Categories 
Status 
18 
(4.5°A,) 
OTHER 
Comment - The proportion of female respondents in all categories is small and renders 
generalisation inappropriate. It may, nevertheless, be interesting on a qualitative basis 
to see if any marked differences do exist with respect to certain issues. These will be 
dealt with under selected questions following. The ' other' category consisted solely of 
'partners' and 'superintendent pharmacists.' 
Potential Barriers to Change - None apparent. 
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7.6.2 Analysis of Question 3: Size Of Organisation Represented 
'How many pharmacies are in your group?' 
Purpose - To ascertain the spread of independent pharmacist respondents in terms of 
organisational size, to discover whether size may affect possible approaches to change. 
Result The majority response was from single pharmacies followed by groups of two 
to four. (Figure 64) 
Figure 64 SIZE OF RESPONDENT ORGANISATIONS (n - 395) 
400 
300 
Number of 200 
Respondents 
100 
o 
238 
(60.3%) 
r-
-
-
1 
103 
(26.1%) 
35 
19 (8.9%) (4.8%) n r-J 
2-4 ~-7 8+ 
C.te&ories orRespoose 
No orrhannacie.ln Repoadeau' Group. 
Comment - Those respondents with more than one branch may need support on 
handling intemal group change, one route of which may be the employment of extra 
pharmacist (s) to move around the groups' associated doctors and pharmacy bases. 
Groups may well initially be the best potential for introducing the service. 
Potential Barriers to Change - Potential workload on single contractors. 
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7.6.3 Analysis of Question 4: Ages And Linkages 
'What age group are you in?' 
The null hypothesis for Question 4 comparison with Questions 11 and 19 is that there is 
no age related difference in responses to these questions. 
Purpose - To act as potential basis for attitude difference, for example in 
Question 11 ' ... how satisfied. .. pharmacist skills being used in present contract? ' 
QueStion 19 ' ... desire to undertake Medicines Management (MM). 
Result - Overall response pattern resembles a normal distribution across the age groups. 
The percentages of all age groups expressing dissatisfaction, varies between 37% and 
71 %. (Figure 65) 
Figure 6S AGE GROUPS COMPARED WITH PHARMACIST DISSA TISFACTlON WITH 
SKILL USE (n = 396) 
72.4%<5Oyrs 
100 I I I I 
90 
80 
(24.4%) 84 
_ r-j-<.u I-%)}- ------
70 58 
60 
Number of SO Respoodeots 
40 
30 
20 
10 
0 
-t-_____ ....;4:u-9 _ 1 1_ HJ.4.6% C Total respondents per Group I 
40 (12.3%) ~ r , CProportion DissatisliedIVery Dissatisfied I 
l: ' rio 4 f- _ 
- 1= I7.l I-"-J-"-!IS-°------
18 III {~' IOJ ll., (7%) 
(4.5%) ( Iii. ~) I2J. Ii· 1~·.,1--:(::5[1~.-:· ,by.7") '::r-=--(~41~;.""")--8---
all. ~i (~~_) li~I-~I- I~ -I~~v.J n . (2%) 3 
l4!1'ro.t:.1 1''0' Ie, 'if - \ I" (i6:t%) n (37.5%) 
n 1'\i~1 I~ I~ liP;'; \~ ';:. 1- 'l;i~; l H 
(10.1%) 
Under 25<30 30<35 35<40 40<45 45<50 50<5S 55<60 60<65 65+ 
25 
Categories of Respoose 
Age Groups & Dissat1sfactioo witb Skills Usaee 
Comment - There does not seem to be a consistent dissatisfaction ratio with use of 
present skills, which is related to age. Lowest percentages dissatisfaction are expressed 
by the groups: 25 < 30 - 49% 
55 < 60 - 43.4% 
35 <40 - 43% 
65+ - 37.5% 
45 < 50 - 49% 
The Chi square test gave an x2 value of 12.75 and a p value of 0.121 and this result is 
therefore not significant. The null hypothesis is sustained. A Somers Delta test gave d 
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as -0.039 and pas 0.244 confinning no association between age and dissatisfaction with 
skills use. 
Potential Barriers to Change - With the five exceptions listed above, plus the four age 
groups with above 50% dissatisfied, there is still a large base on which to build 
dissatisfaction I disconfmnation of the present contracts (Lewin's cultural shift Chapter 
5 : 171) preparatory to moving to a different contract and culture. The next chart 
compares age groups with desire to undertake medicines management. 
Figure 66 AGE GROUPS COMPARED WIm DESIRE TO UNDERTAKE MM (0 = 394) 
100 
90 
80 
70 
60 
Number of 50 Respondents 
40 
30 
20 
10 
0 
1------:8:-74- t-::==- 'l'htalltsp011llentnm group 
Under 25<30 30<35 35<40 40<45 45<50 50<55 55<60 60<65 65+ 
25 
Categories of Response . 
(62%) 
Comment - Again the sub groups are small but a high proportion of all age categories 
would like to undertake medicines management. The lower positive responses to 
medicines management are in age groups: 50 < 55 - 69% in favour, 60 < 65 - 75% in 
favour 65+ - 62% in favour. The 30 < 35 age group is again a highly positive group (as 
Question 11). Overall, the proportion is very positive (above 80%) in all other groups. 
A Somers delta test gave a d value of -0.54 and p value of 0.05 which is not less than 
0.05. A Chi square test gave X2 as 9.696 and p value of 0.287 confirming no 
association between age and desire to undertake MM. The Somers test, however, shows 
how close the result is to there being an association. 
Potential Barriers to Change - The percentages uncommitted and against undertaking 
medicines management (see Questions 11 and 19 discussion). 
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7.6.4 Analysis of Question 5: Dispensing Activity 
'On average, how many prescriptions are dispensed in your pharmacy each month? ' 
Purpose - To gain a picture of work load of respondents and possible relationship of 
work load to other issues in this questionnaire. 
Result - Prescriptions dispensed range from less than 1,000 to 11,000 plus with 70% 
revealed as below 7,000 items per month. (Figure 67) 
Figure 67 PRESCRIPTION VOLUME DISPENSED IN RESPONDENTS' 
PHARMACIES EACH MONTH (n = 388) 
400T-----------------------------------------------
300,-----------------------------------------------
Number of %00 
RtspoDdeDts 
70% 30% 
+---------+1-1 -------\-
100,-------~~~~~~n_----------------------------
5 12 9 10 
<1006 1006· %000· 3000- 4000. 5000· 6000- 7000· 8000. 9000· 10000·11000+ 
1999 %999 3999 4999 5999 6999 7999 8999 9999 10999 
Catelories ofRespclDse 
Prescription Bauds (Mouthly Averale) 
Comment - The majority response band are around the national average (5000 items 
per month: PSNC Internal Statistics, 2002). 
Potential Barriers to Change - None at this stage. 
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7.6.5 Analysis of Question 6: NHS / OTC Balance of Business 
'Approximately what percentage of your total turnover is generated by NBS receipts? ' 
Purpose - To gain a measure of dependency on NHS services and thus potential interest 
in expanding that aspect of the total business / health service. 
Result - More than 95% of respondents have 50% to 90% dependency upon NHS 
receipts. (Figure 68) 
Figure 68 NHS RECEIPTS AS PERCENT AGE OF TOTAL TURNOVER 
FROM EACH RESPONDENT (0 ... 370) 
400 
300 
Number of 100 
R\!spond\!nts 
100 
o 
4.65% 95.35% 
.1 I 1 I 
128 
102 ro-
58 50 
4 4 2 6 
16 1] Il 0 r, 
<10% 1040% 20<30% 30<40% 40<50% 50<60% 60<70% 70<80% 80<90'~ 90%+ 
Catecories of Response 
NIlS receipts as % of Total Turnover 
Comment - Only 4.65% of the independent profession are not dependent upon NHS 
receipts for their turnover. The NHS contract is therefore of crucial importance to over 
95% of contractors. Any improvement in service return is therefore likely to be of 
interest as may be the route to acquiring that increased return. Equally the cost and 
effort of achieving that increase will also be relevant to contractors. Construction of the 
medicines management product and its valuation is a key issue, together with its 
marketing. 
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Potential Barriers to Change - There may be an inverse relationship between 
workload in dispensing and take up of the new medicines management role so that the 
4.65% have more time and desire to go for the extra work and compensation. Question 
20 helps clarify the picture and will be related to Question 6 under Question 19 analysis. 
336 
7.6.6 Analysis of Question 7: Location of Respondents 
'What is the location of your pharmacy? I 
Purpose - To see whether, for example, rural pharmacies are different in attitude to the 
medicines management role from their city / town counterparts. 
Result - All categories of response were returned, with the dominant number lying 
within suburban distances. (Figure 69) 
Figure 69 LOCATION OF RESPONDENTS (0 - 392) 
400~---------------------- -------------------
300~-------~2~37~-----------------------------------
(68.7%) 
Number of 200 +-----1 
Respoadeats 
CityrroWll Suburbu 
Centre 
Rund Other 
Cate&orie. or Response 
Loeations 
Comment - The vast majority of respondents are suburban which reflects the national 
distribution as polled from PSNC statistics. (PSNC Internal Statistics, 2002) 
Potential Barriers to Change - None at this stage. 
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7.6.7 Analysis of Question 8: Staffing Levels - Dispensing 
'How many dispensing assistants do you employ? ' 
Purpose - To detennine support in human resource tenns, for the dispensing function. 
Result - Dispensing assistance varies between zero and five or more full or part time 
assistance. (Figure 70) 
No. of 
Figure 70 NUMBERS OF PHARMACISTS EMPLOYING FULL 
TIME AND PART TIME DISPENSERS (n = 319) 
o Full lime 
!aPart lime 
400+-----------------------------~====~~ 
300+--------------------------------------
Respondents 200 +--------------------------
100 +-..",....,..",..----1 
o 2 3 4 5+ 
Response Categories 
No. orFfIPT Dispensers Employed 
Comment - To be read in conjunction with Question 5. All pharmacies with no 
dispensing assistance lie within the prescription bands below 2,000 items per month. 
All respondents employing one fuJI or part time assistant lie in the 2,001 to 4,999 range. 
Potential Barriers to Change - To be detennined on cross tabulation with Question 5. 
A much more detailed analysis needs to be done on manpower and workload 
relationships for planning any expansion of cognitive service. This will be undertaken 
within the next twelve months. 
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7.6.8 A nalysis of Question 9: Dispensing Assistants Qualifications 
'How many of your dispensing assistants have a technician certificate?' 
The null hypothesis for Question 9 is that the proportions of full time and part time 
technicians with a certificate in the population is the same. 
Purpose - To determine the general level of competency in dispensing support staff; to 
thereby gain a view of the amount of work required to bring other staff up to an 
officially recognised level of competence and thereby assist in assessing whether 
dispensing work could be realistically delegated from pharmacist to support staff. 
Gives a measure of time resource, which may be released for pharmacist transfer of the 
role to cognitive service. 
Result A large proportion of full time technicians are certificated (68%) but only 50% 
of part time dispensing assistants. (Figure 71) 
Figure 71 PERCENTAGES OF FULL AND PART TIME DISPENSJNG 
ASSISTANTS WITH TECHNICIAN CERTIFICATES 
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Comment - For the pharmacist to move from largely mechanistic dispensing into 
COgnitive medicines management, dispensing staff will need to be formally trained, to 
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take more responsibility for the quality dispensing process. This will take time (2 years 
for NVQ 3; 1 year for NVQ 2). With several competing professionals for medicines 
management, this is a matter requiring urgent address. A time barrier, if protracted, 
could lose the medicines management role for dispensing contractors. 
The Chi square test gave a p value of 0.005. The null hypothesis is therefore rejected 
and this result would occur by chance only 5 times in 10,000. 
Some pharmacist respondents to this questionnaire (19%) are not convinced that even 
fully trained technicians would solve the problem of pharmacist time availability. This 
is illustrated by pharmacist responses to Question 24. Question 23 shows that 53.4% of 
respondents consider that currently they do not have time to undertake the MM Role. 
(Figure 72) 
Question 23 'Assuming your present workload remains the same, do you believe you 
currently have time to undertake the medicines management service?' 
Figure 72 TIME AVAILABILITY TO UNDERTAKE NEW ROLE 
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Question 24 'If you answered 'no' or 'not sure' in Question 23 could some of your work 
load be delegated to other staff if they were folly trained? ' 
Figure 73 WORK DELEGATION TO TRAINED STAFF (n == 320) 
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19% of all respondents to Question 23, therefore are not convinced that better qualified 
support staff are the answer. If the same percentage is reflected in the total population, 
there are certain implications: 
• This percentage of independent dispensing pharmacists may never take up the 
new role, even though many of them wish to (Question 19, 80%); 
• It may be possible to persuade a proportion of them otherwise; 
• Independent pharmacists in the same district may be amenable to joining forces 
and acquiring extra pharmacists to engage the new role for them on a rotational 
basis each month - or other alternating time periods. Thus the service would 
still be based in a community pharmacy; 
• An effect of the latter strategy may be to encourage, in time, the original 
dispensing pharmacists to engage in the role themselves; 
• If 19% of the independent dispensing contractors were to opt out of new service 
pick up, then the opportunity - even encouragement - would be there for the 
potential competitors identified in Chapter 1 to take up the role; and, 
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• This may in tum, prompt the DH to reallocate a portion of the present 'global 
SlUll' to the new service providers through the peTs. 
Lack of time resource is clearly a serious matter, requiring constructive address and this 
will be dealt with in the next chapter on conclusions and recommendations. 
Potential Barriers to Change - Limited pharmacist time resource; pharmacist 
perception of 'trained staff' as not the solution. 
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7.6.9 Analysis of Question 10 and Question 11: Contractor Satisfaction - Extra 
Pharmacist Support And Skills Use 
Question 10 
'How many pharmacists regularly work with you in the pharmacy? (Not locums) J 
Question 11 
'How satisfied are you that the pharmacists' skills are being fully used in the present 
contract?' 
Purpose - To assist with Question 12 in determining levels of satisfaction / 
dissatisfaction with the current status of community pharmacy NHS work and related 
factors for potential use in role change. 
Results - Question 10 response rate was low at only 55.5% of all surveys returned. 
Lack of extra pharmacist help is apparent in 70% of those returns. (Figure 74) 
Figure 74 HOW MANY PHARMACISTS REGULARLARY WORK WITH YOU IN THE 
PHARMACY: FULL AND PART TIME (0 = 300) 
CFulllime 
E!JPart time 
400+---------------------------~---------
300+--------------------------------------
No. of 
Respondents 200 
100 
o 
215 209 
(71.7%) (70%) 
o 
23 6 
(7.7%) 1 (2%) 
(0.3%) 0 0 
2 3 4 5+ 
Response Categories 
No. of Additional Pbarmacists Working with RespondenQ 
343 
Comment - Question 10. Almost three quarters of respondents have neither full nor 
part time phannacist help (71.7% and 70% respectively). Of the remainder 26.9% have 
one to three additional full time pharmacists in attendance and 30.4% have extra part 
time phannacists. Figure 75 shows respondents' views on skills use, Question 11. 
Figure 75 RESPONDENT SATISFACTION WITH SKILLS USE (n == 399) 
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When this response is compared with Question 10 breakdown of respondents who have 
full time pharmacist assistance the following picture e~erges. (Table 60) 
Table 60 PHARMACIES STAFFED WITH ONE OR MORE FULL TIME PHARMACISTS 
AND SATISFACTION WITH SKILLS USE 
(Question 11 n = 295) 
l. 2. 3. 4. s. 
QIO No. of Em a Full No. of Respondents to Very Satisfied + Neither Satisfied nor Very Dissatisfied + 
rime Pharmacists Q 11 (Totals in each Satisfied Combined Dissatisfied Dissatisfied Combined 
Employed Group) 
0 21S 39 65 110 
(72.5%) (18.3%) (30.4%) (S1.4%) 
1 73 16 21 36 
(24.7% (22%) (28.8%) (49.4%) 
2 7 2 2 0 
(2.4%) (28.6%) (28.6%) (42.9%) 
3 1 0 0 0 
(0.33%) 
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The sub groups are small at the 2 and 3 extra pharmacist levels and generalisation is not 
possible. However, the sample shows increasing satisfaction with skills use, as the 
number of pharmacists employed increases (column 3). It may be that the higher 
volwnes of prescriptions dispensed, in generating increasingly high 'reimbursement 
profit' are partly, at least, responsible for that satisfaction. Conversely, the greatest 
dissatisfaction expressed, increases as pharmacist levels drop (again in the lower 
prescription volume pharmacies). Perhaps this is because low prescription volumes 
give low patient contact, low reimbursement profit and little opportunity under the 
present contract to enter cognitive service I gain remuneration. 
Potential Barriers to Change - Time and pharmacist resource shortage at lower 
prescription volume levels; the apathy partly implied in column 4 from the neither 
satisfied nor dissatisfied. 
A facilitating force for change may be the psychological 'dissatisfaction' levels, 
creating one of the suggested conditions assisting any change process, (Lewin, Schein, 
Chapter 5 : 172). This dissatisfaction level is again. strongly indicated by responses to 
the next question. 
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7.6.10 Analysis of Question 12: Contractor Satisfaction With Remuneration 
'How satisfied are you with current remuneration levels in the NHS contract? ' 
Purpose - To investigate another element of satisfaction I dissatisfaction for potential 
use in effecting role change. 
Result - There is a predominant dissatisfaction with remuneration. (Figure 76) 
Figure 76 SATISFACTlONWIm REMUNERATION (n =41)1) 
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Comment - Here again in Question 12, is confirmation of strong dissatisfaction with 
NHS remuneration; 84.2% being dissatisfied or very dissatisfied with their position in 
financial returns. There was no relationship with any particular size of pharmacy (in 
dispensing volume terms) in responses to the question. (In Dr Alan Smith's thesis, 
1994, a postal survey to all categories of dispensing pharmacies - independent and 
multiples - returned 82 - 92% of the sample of 362 as being dissatisfied with 
remuneration). 
Potential Barriers to Change - Perhaps, inferential dissatisfaction with the paymaster 
(the DII) and antipathy to collaboration with a perceived mean employer. Facilitating 
pressure to change may be a new role offering better remuneration prospects and 
satisfaction. (Lewin; Schein, Chapter 5 : 172) 
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7.6.11 Analysis olQuestion 13: Pharmacist / GP Relationship 
'How do you rate your present relationship with GPs? ' 
Purpose - To indicate potential relationship barriers to collaboration in a new role. 
Result - A high proportion of respondents believe their relationship with GPs to be 
positive. (Figure 77) 
Figure 77 RATING OF PHARMACIST I GP RELATIONSHIP 
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Comment - From a pharmacist view point, relationships with 74% of respondents and 
their GPs are 'very satisfactory' or 'satisfactory' and 10.3% 'very unsatisfactory' or 
'unsatisfactory'. This is a good base on which to build collaboration around a closer OP 
relationship in cognitive service and therefore an important facilitating factor in a 
change process. 
Potential Barriers to Change - Those unsatisfactory situations (10.3%), which if 
reflected in the total population of aps / pharmacists, need specific address. Minorities, 
if useable, can be very effective influences - positive or negative. 
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7.6.12 Analysis of Question 14: Pharmacist Views On Patient Response To Greater 
Pharmacist Involvement With Their Medication 
'What do you assess would be the view of patients on greater pharmacist involvement 
with management of their NBS medicines?' 
Purpose - To determine potential pharmacist positive or negative attitude to the 
prospect of greater interpersonal relationship with the patient. 
Result A very high positive response to this question from almost the whole survey 
return (98.5%). A large majority see patient response as positive. (Figure 78) 
Figure 78 PHARMACIST PERCEPTION OF PATIENTS' RESPONSE TO 
INCREASED PHARMACIST INVOLVEMENT (0 - 397) 
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Comment - Again, this is a very positive response in terms of the pharmacist's 
perception of how a patient may respond to a different sort of relationship with the 
pharmacist. 88.6% see the patient view as likely to be welcome. New service design 
therefore, through medicines management is not likely to hold apprehension for the 
pharmacist on the basis of potential patient antipathy. Nevertheless, service design for 
the new role should take account of the possibility of patient apprehension and build the 
interpersonal skills of the pharmacist, ready to deal with any such patient sensitivity. 
Potential Barriers to Change - Potentially mistaken pharmacist expectations of 
patient response; inadequate interpersonal skills to deal with this. 
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7.6.13 Analysis of Question 15: Pharmacist Perception Of Doctor Response To 
Greater Pharmacist Involvement With Medication Management 
'What do you assess would be the attitude of your local doctors to greater pharmacist 
involvement with patient medication management?' 
The null hypothesis for Question 15 is that there will be no difference in the categories 
of phannacists' perceptions of doctor attitudes to pharmacist involvement in patient 
medication management. 
Purpose - To determine potential apprehension and thus barrier, to closer pharmacist I 
GP collaboration on what could be regarded as a threatening issue for the doctor. 
Result A much lower positive response than to Question 14. A majority still see doctor 
attitude as positive. (Figure 79) 
Figure 79 PHARMACIST PERCEPTION OF GP VIEWS ON PHARMACIST 
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Comment - Here there is a marked difference in the pharmacist's perception of how the 
doctor, as distinct from the patient, might view the proposition in the question. The 
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percentage of 'very welcome / welcome' has dropped from 95% in Question 14 to 
61.3% or 352 down to 243 positive respondents - a reduction of31 %. 
The Chi square test gave a p value of 0.005. The null hypothesis is therefore rejected 
and the sample result could only occur by chance 5 times in 1,000. 
Likewise, the 'unwelcome / very unwelcome' responses have risen by 1,120%. Whilst 
the numbers are small, this still indicates a substantial difference in how pharmacists 
view patient and doctor possible responses to the proposition. 
Potential Barriers to Change - Pharmacist relatively more uncertain of positive 
doctor response; consequently more negative mindset in approaching change. 
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7.6.14 Analysis of Question 16: Knowledge Of The New Role 
'Are you aware of the Government backed PSNC medicines management proposals for 
community pharmacy?' 
Purpose - To reveal how much information on community phannacy's potential future 
has been absorbed by dispensing contractors. 
Result - Detailed awareness of MM is almost non-existent. A high proportion of the 
sample returns (99.5%) gave responses to this question; these approximately follow the 
pattern of a normal distribution. (Figure 80) 
Figure 80 RESPONDENT AWARENESS OF PSNC PROPOSALS (n - 401) 
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Comment - The responses show that there is little detailed knowledge of the PSNC 
medicines management proposals, which in principle have been accepted by the DH and 
are currently being piloted in England and Wales. This indicates a need for an effective 
communications programme to contractors, giving: 
• Details of the 'core', 'tangible' and 'augmented'scheme; 
• Its implications for relationships with primary care, doctors and other health 
workers; 
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• Details of human resource and facilities requirements; 
• Details of knowledge and skills requirements for those who undertake the 
service; and, 
• Routes of entry and means of partnership building with GPs. 
On the positive side of the survey result, 77.6% of respondents have some knowledge of 
the 'medicines management' concept on which can be built the above communications 
programme. There is, however, a failure of leadership to properly inform the target 
market of change, the dispensing contractor, of the MM proposals. 
Potential Barriers to Change - Complexity of infonnation to be imparted and time to 
absorb. 
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7.6.15 Question 17: Perceptions of Doctor 'Needs' in Medicines Management 
Collaboration With Pharmacists 
'In this new professional relationship between doctor and pharmacist, how would you 
rate the potential importance of the following factors? Please circle each of your 
choices on a scale of '0-5' (0 = not important; 5 = most important). 
Note: The four phases of medicines management were outlined in the introduction section of the 
questionnaire together with its definition. (Appendix 10) 
Purpose - To gain a measure of the level of pharmacist insight into the potential effect 
of medicines management, on the cultural and professional mindset of the doctor; to 
thereby assist the construction of a communications and marketing programme for 
introduction of the new service. 
Result - A high response rate within the total returns showing recognition of GP needs. 
(Table 61) 
Table 61 PHARMACIST RANKING OF SIX FACTORS, 
POTENTIALLY IMPORTANT TO DOCTORS' 
CULTURAL I PROFESSIONAL NEEDS (n .. 401) 
Ranking by Not Important ~ost Important 
Likert Scale 
RANKING 
Factor 0 1 1 . 3 4 5 
oeNeed Number ofre~onses in each of the six categories above 
Doctor's need to feel non-
threatened by pharmacist 7 8 23 50 1133 1801 
involvement 1 78% 
Doctor's need to be 
recognised as the lead 9 8 26 73 [134 151 
health care professional 2 
71% 
Doctor's need to be the 
fmal decision maker on 10 7 27 54 [125 1771 
medicines regimen 3 
75.5% 
Doctor's need to have 
confidence in the 1 2 1 14 1103 2801 
pharmacist's abilities 4 95.5% 
Doctor's need to be sure of 
COnfidentiality in all 3 4 4 31 llO3 2561 
matters 5 89.S% 
Doctor's need to have 
confidence in the pharmacy 3 3 9 75 [131 179J 
facilities for confidential 
consultation 6 77.5% 
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Comment - More than 70% of all respondents have ranked the specific list of all doctor 
'needs' at the 4-5 level, recognising the importance of these cultural and professional 
issues in the context of medicines management. This awareness of potential 
sensitivities, if reflected in the whole population is a sound basis from which to 
construct a culturally empathetic communications and marketing programme for the 
introduction of the full medicines management service. Pharmacists further recognise, 
by the largest majority, the importance of 'pharmacist abilities', (factor 4) as a potential 
requirement of the doctor 'need' in any such service. Linked with the responses to 
Question 19, which show 80% of pharmacists wishing to undertake the new role, this is 
also a key motivational basis for making progress in additional training commitment for 
medicines management via dispensing pharmacists. 
'Confidentiality' is the next most highly ranked need element (89.5%) which includes 
information confidentiality as well as privacy of pharmacist I patient interchanges at 
consultations. Again, premises amenities need constructing for patient comfort, relaxed 
atmosphere and confidential discussion (Chapter 4: 81; Figure 9). 
Third most importantly ranked doctor need, is ' ... to feel non-threatened by pharmacist 
involvement' (78%). This elemen~ relates back to Maslow's 'hierarchy of needs' 
(Chapter 4 : 98; Figure 10) 'esteem' and self actualisation' and again is a key 
consideration in marketing communications theming. 
Potential Barriers to Change - None obvious. It is encouraging to find that in 
pharmacists' perceptions, the 'doctor need issues' presented to them, are recognised, 
highly ranked and form a sound basis on which to package the new service in an 
empathetic framework. This should help doctor collaboration and willingness to begin 
sharing responsibility for patient medication. Even if it transpired that doctors 
themselves were not overly sensitive about the issues, an empathetic approach to GPs, 
based upon address of these factors would still be recommended for the service 
package, (Schein, Chapter 4 : 10; Rokeach, Chapter 4 : 101 - 102) which underpin the 
overall service benefits. 
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7. 6.16 Analysis of Question 18: Pharmacist Task Ahilities 
'How would you describe your present ability to undertake the medicines management 
(MM)role? 
Purpose - To measure the magnitude of training requirements to undertake medicines 
management and determine the population of respondents who are ready now; expose 
potential educational / training differences and barriers to progress. 
Result - This shows a large majority of the respondents to be unable, at present, to 
undertake MM. (Figure 81) 
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Comment - The positive aspect of this result is that although only 11.3% of respondents 
consider themselves able to undertake the role now, 71.9% consider that they would be 
able to do so with suitable training. This represents an opportunity for the profession to 
design training packages with appropriate content, to facilitate uptake of the medicines 
management service (Ref. Questions 19,21). 
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Potential Barriers to Change - The training required of such a large number of 
dispensing pharmacists, i.e. 88.7% if all are requested, in a new contract, to undertake 
the new service. 
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7.6.17 Analysis olQuestion 19: Desire To Undertake Medicines Management 
'Would you personally wish to undertake the new medicines management service if 
remuneration is acceptable?' 
Purpose - To determine the existing commitment to undertaking the new role, given the 
stated proviso; to link this response with those of Questions 17, 18, 20, 21, 22. 
Result A high proportion of the sample wish to undertake MM. (Figure 82) 
Figure 82 PHARMACIST COMMITMENT TO MEDICINES MANAGEMENT (n ... 401) 
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Comment - Question 17 showed strong awareness of perceived doctor needs; Question 
18 exposed requirement for training to be substantial. This question declares a large 
majority (80.8%) of respondents to be in favour of taking up the new role, with 16.2% 
still to be persuaded and only 3% against. There is thus, some understanding of the 
doctor's position (needs) in this new pharmacist role; acceptance of pharmacist training 
needs; and a fIrm declaration of desire to get into medicines management, given that 
remuneration is acceptable. 
These positive indications that dispensing community pharmacists do want to extend 
their role into cognitive service. 
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Potential Barriers to Cbange .. The nature and time commitment to training; those 'not 
sure' and 'no' who may fear erosion of their dispensing focus or for other reasons wish 
to stay with the present service. These, in percentage terms constitute 19.2% of 
respondents which approximates to 18.3% of respondents (Question 11) who are 
satisfied that the pharmacists' skills are currently being fully used anyway. Again, this 
represents an opportunity for invasion by threat of entrants, e.g. nurses; peT 
pharmaceutical advisers. 
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7.6.18 Analysis of Question 20: Antipathy To Competing Professionals For 
Medicines Management 
'In the following list (8 options) who do you feel should not take up the service? Please 
tick appropriate boxes. ' 
Purpose - A measure of the strength of feeling, as to who actually should be the 
deliverer of medicines management, in the context of Questions 18 and 19; another 
proxy for potential commitment and motivation; a measure of 'competitive intenf. 
Result - There is a clear declaration of who should not undertake the MM role. 354 
respondents made in total, 1149 choices. (Figure 83) 
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Comment - One interesting feature of this response is the 10.2% who do not wish 
dispensing contractors to undertake medicines management. This is three times the 
number who said 'no'to Question 19. These responses all come from those in the 'not 
sure' category of Question 19 and so appear to have firmed up a view after being 
focussed on alternatives in this question, to dispensing contractors. 
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Equally interesting is the 75.7% of respondents who do not feel that nurses should be 
involved. This is the highest 'anti' vote of all the alternatives, next to which is the 
doctor at 53.1%. Freelance phannacists are almost as unpopular as the doctor. On 
querying why this could be, with Gateshead and South Tyneside LPC, the reason given 
was: 
' .. . peripatetic pharmacists make changes doing deals with 
drug companies that disadvantage contractors ... ' 
' ... their prescribing advice and changes to approved practice 
formularies leave us with dead stock .. ' 
These answers cannot be generalised, but perhaps give a hint as to the reasons for 
peripatetic unpopularity. 
Potential Barriers to Change - The responses to this question indicate a facilitating 
force for change into cognitive service, pushing dispensing pharmacists towards 
engaging medicines management. The potential competitive entrants may thus 
constitute one of Lewin's disconfirmation factors (Lewin; Schein, Chapter 5 : 172) 
However, some of the competitive options are already providing some medication 
review services and with further development could become a growing barrier to 
dispensing pharmacist entry into the medicines management service (Chapter 1 : 29, 
Figure 4). 
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7.6.19 Analysis olQuestion 21: Training Preferences 
'If you require training to undertake the new role, what subjects among the following 
list would you select? Please tick all appropriate boxes. I 
Purpose - To obtain a measure of respondents perception of what is required for 
medicines management knowledge; to assist in formulation of training programmes. 
Result - The response indicates awareness of weaknesses in respondent knowledge base 
required for MM. 390 respondents exercised in total 1,438 choices for training 
requirements. (Figure 84) 
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Comment - The two leading preferred subjects are 'clinical pharmacology I and 
'disease management I which are not surprising choices. What is surprising is that the 
lowest popUlarity is attracted by 'interpersonal skills'. There may be a number of 
reasons for this, of which three possibles are: 
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• Some pharmacists have no knowledge of it as a formalised subject and cannot 
make a judgement; 
• Pharmacists believe they already have sufficient skills; and, 
• Pharmacists don't see medicines management as other than technical address of 
drugs and diseases (perhaps partly reflected in their two top choices of preferred 
subject learning). 
The three top choices are technical subjects, well known in the treatment of disease 
field. The three bottom choices are subjects without in-depth pharmaceutical address in 
traditional training and education. Perhaps there is little knowledge of their application. 
Potential Barriers to Change - Possible lack of knowledge of the importance of the 
three subjects least popular of the specified list; (interpersonal skills; drug economics; 
motivation techniques) the training / education hurdle of the three most popular choices 
- clinical pharmacology, disease management; patho-physiology. 
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7.6.20 Analysis of Question 22: Preferred Training Options 
'In the following list of training (P D) options, which one would be your preferred 
training route? 
Purpose - To establish preferences, so as to facilitate the move into further professional 
development for dispensing contractors. 
Result - Clear views are expressed on all options on a very personal basis. 357 
respondents exercised only 382 choices in total. (Figure 85) 
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Comment - Daytime lectures are preferred by 46.5% of respondents with the next most 
preferred route being distance learning (24.1 %). The latter being further supported by 
those who would like seminars to supplement the distance learning (16%). Web based 
learning is not popular in either of the variants offered (5.6% and 1.7%). Evening 
lectures fair a little better at 13.2%. The above results are not surprising bearing in 
mind the detailed concentrated daily work of the dispensing pharmacist and its tiring 
effects. Nevertheless, all options have some support and training packages could be 
prepared accordingly. 
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Potential Barriers to Change - Time available to study. This would need very careful 
reflection to provide the right amenity in the most time and cost efficient way so as to 
maximise enthusiasm and uptake. 
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7.6.21 Analysis olQuestion 23: Workload Implications 
'Assuming your present workload remains the same, do you believe you currently have 
time to undertake the medicines management course? ' 
Purpose - To establish respondents' views on time availability for additional cognitive 
service; to link with Questions 9 and 24, relating to technician qualifications (and hence 
ability to handle more responsibility); to consequently identify and change management 
action required. 
Result - This shows lack of time to undertake MM by a large majority if the present 
workload remains the same. (Figure 86) 
Figure 86 TIME AVAILABILITY TO UNDERTAKE MEDICINES 
MANAGEMENT (n - 399) 
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Comment - A relatively small percentage of respondents think they currently have time 
to undertake medicines management. This is a serious situation if reflected in the total 
population as there is: 
• A community pharmacy shortage of pharmacists, not likely to be corrected for 
several years (pSNC projections: internal document January 2003); 
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• An active competitive range of professionals in the market place, already 
expanding their services (Chapter 1 : 24, Figure 9); and, 
• Lack of time resource to undertake the new role; shortage of pharmacist 
manpower in the short to medium term. 
Question 17, elicited strong awareness of doctor needs (71.0%); 
Question 18, exposed a large majority requiring training for MM (78.2%); 
Question 19, showed a large majority wishing to undertake MM (80.8%); 
Question 20, revealed widespread antipathy to other professionals undertaking MM 
(89.8%); and, 
Question 23, shows a lack of belief that there is time to undertake MM (80.2%). 
This shows dispensing pharmacists' desire to move into a new role; substantial barriers 
to progress; competitive force for change (antipathy to other professionals); and, 
appreciation of the potential for GP sensitivities (needs). All these issues require 
careful consideration in formulating a programme for change of role. 
Potential Barriers to Change - These issues, together with the implications in 
Question 9 will be dealt with more fully under Question 24 following. 
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7.6.22 Analysis of Question 24: Potential Resolution Of The Problem Of The 
Scarcity Of Pharmacist Time, Blocking New Role Take Up 
'If you answered 'no' or 'not sure' in the previous question, could some of your 
workload be delegated to other staff, if they were fully trained? ' 
Purpose - To establish whether a relatively simple solution would be acceptable to 
respondents; to detennine by implication, respondent views on 'other staff potential. 
Result A majority of phannacists believe delegation of work is the answer to the 
scarcity oftime problem. (Figure 87) 
Figure 87 POTENTIAL WORK DELEGATION TO OTHER STAFF (0 = 320) 
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Comment - On the positive side, 51.2% of respondents to this question (41.1% of 
respondents to original Question 23) do believe they can delegate some workload. The 
'not sure' and 'no' groups (156) constitute 39% of the original responses to Question 23 
(399) and are not convinced at this time, that they can delegate any present workload to 
other staff. If reflected by the total population, this is a seriously restrictive factor in 
gaining quick uptake of medicines management. 
The implications of the answers, 'not sure' and 'no', raise a number of potential 
problems: 
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• This segment of the total population may never take up the new role even 
though many actually do wish to (Question 19 - 80%); 
• This in turn may prompt the DH to remove money from the global sum for 
dispensing and reallocate to practitioners of medicines management; and, 
• Other competitor professionals, will have an 'open' market to target for 
themselves, making later entry by dispensing pharmacists very difficult. 
However, a positive approach to marketing the benefits of the new service and benefit 
of workload reallocation to trained dispensing technicians, may be able to convert a 
proportion of the 'not sure I no I group quite quickly and use the change momentum to 
encourage others to so do. Other possibilities could include: 
• The LPCs (now LRCs) employing pharmacists to work for selected groups of 
local dispensing pharmacists on a rotational basis, e.g. 1 pharmacist per 6 
pharmacies working 1 Yz days at each and repeating fortnightly. 
(This would save the complexity of 'consortia' becoming an employer, with all the 
attendant corporate set up costs and some pharmacies wishing to drop out or 
alternatively have more time allocated to them). 
, 
• Groups of independent pharmacies actually goin~ down the corporate consortia 
route and employing their own pharmacists - rather than those of the LRC. 
In suggesting extra pharmacists employed as above does imply obtaining manpower 
from sources other than community pharmacy, e.g. the hospital service, which would in 
turn create greater shortages there. 
Roles such as the above are effectively 'tied peripatetics' but would be different from 
the current group of peripatetics, as they would be based in pharmacies not surgeries. 
Potential Barriers to Change - Antipathy to workload delegation; lack of pharmacist 
time resource. This is a serious matter requiring positive and creative address and will 
be dealt with in the next and fmal chapter on conclusions and recommendations. 
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7.6.23 Analysis 0/ Question 25: Satisfaction With Current Contract 
'Do you think it is time/or an entirely new pharmacy contract?' 
Purpose - To obtain a measure by proxy, of the potential willingness to change the 
current basis of the NHS dispensing contract toward more cognitive service. 
Result - A clear majority say yes but a substantial minority say 'not sure' or 'no'. 
(Figure 88) 
Figure 88 RESPONDENT ATTITUDE TO CHANGE OF CONTRACT (n = 394) 
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Comment - A high percentage (60.7%) do want a new contract; 11.4% definitely do not 
and 27.9% are not sure. The 11.4% who don't want a new contract are largely those 
who also do not want dispensing pharmacists to undertake medicines management 
(Question 20 -10.2%). 
The 'not sures' are also largely those who do not believe they have the time for 
medicines management (Question 23 - 26.8%) and to a marginally lesser extent those 
who are 'not sure' about delegating to other staff (Question 24 - 25%). 
It appears that there are two broad groups of dispensing pharmacist who are not fully 
committed to moving into medicines management: 
370 
1. Those who believe they have no time and cannot delegate workload; and, 
2. Those who are set against moving out of the current dispensing contract. This 
group appear to be operating from an individual perspective of preference for the 
status quo and are not related to particular age or prescription volume categories. 
Nor is there a difference related to the numbers of technicians or extra 
pharmacists employed. It appears to be a particular attitude of mind opposed to 
change. 
Potential Barriers to Change - The mind set that doesn't want change; the undecided. 
This is a strange result in view of the 80.8% response rate to Question 19 who do wish 
to undertake medicines management which will certainly require a different contractual 
framework than the simple dispensing contract of the present. 
It may be that the term 'entirely new contract' used in the question has implications for 
some, that the very foundations of stability in the present contract will depart leaving 
them with the unknown. An unknown remuneration package for unknown new services 
may be one motivational force driving this result which would relate in some measure 
to the responses in Question 16 where 20.4% were not ~ware of the 'PSNC Government 
backed medicines management proposals' and 54.4% were only aware 'in outline '. 
Perhaps linking responses to Question 16 and Question 24, the further barrier to change 
is lack of clarity in the future vision of the pharmacy service (Chapter 1 : 21). 
A summary of the phannacist survey returns and implications follows, after which a 
consolidation table (Table 62) of OP and pharmacist survey returns link-ups, brings the 
two surveys together. 
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Table 62 PHARMACIST POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE WITH 
ASSOCIATED MOTIVATIONAL & MARKETING IMPLICATIONS 
I. SURVEY QUESTION NO. & 
CONTENf 
POSTAL SURVEY 
12. EXPOSED BARRIERS 13. SUGGESTED MOTIVATIONAL 12.1 IMPLICATIONS & NEEDS FOR 
FG PHARMACISTS 
Ql. What gender are you? J 
Q2" What position do you hold? 
Q3. How many pharmacies are in your 
group? 
Q4. What age group are you in? (ct: QI9 
- who wishes to do MM?) 
QS. On average, how many preSCriPtiJ are dispensed in your pharmacy each month? 06. Approx. what % of your total turn-over is generated by NHS scripts? 
ct: Q23 .•. do you believe you actually have 
time to do MM?) 
Q7. What is the location of your 
pharmacy? 
Q8. How many dispensing assistants d~ 
you employ? 
09. How many of your dispensing 
assistants have a technician's certificate? 
ct: Q24 could some of your workload be 
delegated? 
QI0. How many phannacists regularly 
wort with you in the pharmacy? 
None apparent 
19.4% were unsure or did not 
want to do MM in the 50+ age 
groups. 
Workload and time constraints 
gO.2% said 'no' or 'not sure' 
Rural pharmacist/and 
dispensing doctor antipathy. 
32% IT dispensers havc, not" 
50"/0 PT dispensers have not 
Delegation restrictions. 
..J 
70+% havc no extra pharmacist. I ..J 
MM will require delegation of 
work. 
Workload and time constraints. 
Subsequent analysis failed to expose 
response differences based on these 3 
attributes. Different approaches not 
required at this time . 
Negative reinforcement (Ch 5: 251) may 
come from change engaged by peer groups. 
Porter-Lawler model could be useful also -
(Ch S : 262) elements 1-7. 
Herzberg Two factor motivational 
approach. (Ch 5 : 260) Also negative 
reinforcement theory. 
Facilitation required - approach to 
pharmslGPs based upon the Hackman et 
aI., motivational model (client relationship 
aspects) 
AsQ5&Q6 
AsQ5&Q6 
Note: Where the same or associated barrier was exposed in the Focus Group (FG) research. this is shown in column 2.1 by a tick M 
AbbrniatioDs: DH 
FG 
IT 
LPC 
= Departmcot ofHeatth 
= Focus Group (Pharmacy) 
= Full Twc 
= Local Pharmaceutical Committee 
MM 
PT 
- Medicines Management 
= PartTime 
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4. MARKETING; COMMUNICATIONS; IMPUCATIONS 
Uniform approach to promotion, irrespective of gender, position or 
group size. (In independent sector) 
Marketing 'copy' to reflect benefits using the Porter-Lawler factors 
as framework of major underpinning guides (factors 1,2,3, S, 7) 
Professional journal articles, arguing need for urgent address of 
skill mix and training options for pharmacists. - Reinforce by 
guidance to LPCs on engaging their electorate. 
Present as complimentary benefits eradicating the previously 
competitive nature of relationship between rural GP and 
pharmacists. Patient is major beneficiary. 
Supportive guidance literature on dispensing assistants' training 
courses to NVQ Levels 2 & 3. 
Engage if possible. message sponsorship from DH. 
As Q5. Marketing themes promoting skill mix. 
Table 61 PHARMACIST POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE WITH 
ASSOCIATED MOTIVATIONAL & MARKETING IMPLICATIONS 
1. SURVEY QUESTION NO. & 
CONTENT 
Qll. How satisfied are you that the 
pharmacists' skills are being fully used in 
the present contract? 
Q12. How satisfied are you with current 
remuneration levels in the NHS contract? 
Q13. How do you rate your present 
relationship with GPs? 
Q14. What do you assess would be the 
view of patients on greater pharmacist 
in\lol\lement with management of their 
NHS medicines? 
Q15. What do you assess could be the 
attitude of your local doctors to greater 
pharmacist invol\lement with patient 
medication management? 
POSTAL SURVEY 
12. EXPOSEDBARRIERS 13. SUGGESTED MOTIVATIONAL /2.1 IMPLICA nONS & NEEDS FOR 
FG PHARMACISTS 
53% were dissatisfied. 
Only 18.3% were satisfied - a 
facilitating influence. 
84.2% were dissatisfied - a 
facilitating influence. 
74% rated as very satisfactory I...J 
or satisfactory - a facilitating 
measure; but 26% are unsure or 
have unsatisfactory relationship. 
The latter is a significant barrier 
if reflected nationally. 
88.6% view it as likely to be 
welcome - a facilitating force. 
Potential barrier: pharmacists 
may be mistaken. 
Lewin's disconfirming technique for 
driving change can exploit this 
dissatisfaction (Ch 5 : 171, 172; Fig 19; 
Hackman et aI. t 5 ; 259) 
As above - but caution with possible 
Rebound component in form of resentment 
against DH paymaster . 
• Relationship between a large proportion of GPslpharmacists appear positive. For MM 
to engage, this firm base needs developing 
- a positive force for change 
(ScheinlIsabeUa +' S : 172; Fig 19) 
As above for Q 13 
• Lower percentage positive view 
here-61.3%. OlIeralla.gooif 
sign of positive thinking but 
38.7% are more negative - a 
barrier to overcome. 
...J I Disconfirming information on present 
contract to be reinforced (Lewin I Schein) 
using QII. QI2 responses & consequent 
need to change to achieve satisfaction I 
rewards. Porter Lawler model useful in 
planning the moti\lational communications. 
Note: Where the same or associated barrier was exposed in the Focus Group (FG) research, this is shown in column 2.1 by a tick ('I) 
Abbreviations: FG 
MM 
= Focus Group (Pharmacy) 
= Medicines Management 
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4. MARKETING; COMMUNICATIONS; IMPLICATIONS 
Product benefits to pharmacists to be promoted (core, tangible. 
augmented) together with the benefits to GPs and patients. 
Message based upon new route into job fulfilment & higher profile 
in primary care. Outline disadvantages of remaining with status 
quo. (Ch 4: 67) 
Relationship Marketing - based upon mutual product benefit and 
self actual ising outcomes. Service to be presented as supportive of 
GP lead position in health care & confidence built so as not to 
threaten doctor culture (Ch 4: 84) 
Engage opinion sponsorship and message leadership from patient 
organisations to reinforce what pharmacists instinctively beJie\lc 
(i.e. 88.6%) about patient relationships (Ch 4 : 126 ) 
Cite beliefs of 61.3% of colleagues reo doctor response together 
with views of the GP National Focus Group. Cite survey views of 
GPs on elements ofMM which they are agreeable to receiving 
assistance on (Third party evidence Ch 4: (27) 
Table 62 PHARMACIST POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE WITH 
ASSOCIATED MOTIVATIONAL & MARKETING IMPLICATIONS 
I. SURVEY QUESTION NO. & 2. EXPOSED BARRIERS 
CONTENT 
POSTAL SURVEY 
Q16. Are you aware of the Government Little detailed knowledge 
backed PSNC medicines management (23.2%). Thus little grasp of 
proposals for community pharmacy? the 'knowledge needs'. 
Q17. In the new professional relationship No obvious barriers in the 
between doctor and pharmacist, how would responses. A strong facilitating 
you rate the potential importance of the factor in change would be the 
following factors (6 given)? strong grasp of the doctors' 
needs in a new role. 
Also pharmacists recognise the 
doctors' need to have 
confidence in the pharmacists' 
abilities and facilities. 
Q18. How would you describe your 88.7"10 of respondents not yet 
present ability to undertake the MM role? able to undertake the new role 
at present 
Q19. Would you personally wish to 19.2% not sure or don't want to 
undertake this new MM service if enter new role. However 80.8% 
remuneration is acceptable? do. 
QlO. Who do you feel should not be the Firm views expressed: 
deliverer of MM? Please tick all Anti nurse 75.7"10 
appropriate boxes. Anti doctors 53.1% 
.. 
---
.. ••• 0 
-
_. 
AbbreviatioDs: FG 
~L'\t 
.pos' 
= Focus Group (pharmacy) 
= Medicines Management 
J. SUGGESTED MOTIVATIONAL 4. MARKETING; COMMUNICATIONS; IMPLICATIONS 
2.1 IMPLICATIONS & NEEDS FOR 
FG PHARMACISTS 
Promote staff actualisation and self esteem, Marketing of the concept is a real requirement; communications 
delivered by new place in primary care need polishing and a programme for informing dispensing 
through the new role (Maslow Ch 4 : 97; pharmacists needs constructing. 
Fig 10) McClelland (Ch 5: 256) 
Again, a good base for arguing the 'softly, The promotion of the MM concept to pharmacists, should 
softly' approach to engaging doctors and emphasise the gains to be made by taking full account of the 
encouraging the pharmacist to proceed with doctors' cultural practice of leading the primary health care team 
confidence. Job enrichment theory; and having reciprocal confidence in the pharmacist. The 
(Herzberg Ch S : 260) psychology of the message is crucial (Ch 4 : 126) 
" 
Impart self confidence & esteem by good Communications: 
training package based upon response to Provide clear routes of support through training & menloring 
Q21 & Q22. Vroom I Yetton model (Ch S schemes, derived from PSNC pilot trials; pursue possibility of day 
: 252). Use self actualisation; csteem; self release and distance learning plus seminars. 
image (Ch 4 : 98 - Harr6, Tajfel et a1.) 'Reinforcement' copy, confirming the positive beliefs patient I GP I 
Group identity; group culture (Schein : Ch pharmacist, winlwinlwin benefits enumerated. 
4 : 99). Emphasise 'need' for dispensing 
pharmacists to equip themselves for MM 
role without delay. As Q19 with addition of community pharmacist competitive 
(Ch 4 : 93 Wells & Punsky defInition) advantage i.c. NIlS IOTC interventions in real time. 
(Ch 5 : 251 reinforcement theory-
elements 1 & 2). 
--
_ .. 
.. . , ~ p 'y (oJ) 
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Table 62 PHARMACIST POSTAL SURVEY RESPONSES SUMMARY - POTENTIAL BARRIERS TO CHANGE WITH 
ASSOCIATED MOTIVATIONAL & MARKETING IMPLICATIONS 
1. SURVEY QVESTION NO. & 2. EXPOSED BARRIERS 3. SUGGESTED MOTlVATIONAL 4. MARKETING; COMMUNICATIONS; IMPUCATIONS 
CONTENT 2.1 IMPUCATIONS & NEEDS FOR 
POSTAL SURVEY FG PHARMACISTS 
Q21. If you require training to undertake Clear needs and, in this case, As Q18. Equip with training packages - As Ql8 - communications providing solutions to concerns; via 
the new role, what subjects among the barriers to role uptake are: ...J strengthen self confidence. Target the need LPC, and direct to contractors by professional journals. Set out 
following list, would you select? knowledge deficiency in a for achievement and affiliation sources of training packages with alternatives. Copy to point out 
number of subjects principally: (McClelland Ch 4 : 98). rewards in terms of self actualisation & new important place in 
Oinical pharmacology (84.1%) Hackman et al.job characteristics model primary care. 
and Disease management (Ch 5 : 259) 
(82.3%) 
Q22. In the following list of training The least popular option i.c. Training packages to be offered in most Copy to offer a range of options, at launch of desire to market the 
options, which ~ would be your preferred web based packages & evening popular routes i.e. daytime lectures and new service, but major on availability of the most popular, taking 
training route? lectures. distance learning (70.6%) as Q21. account of day release implications. 
Q23. Assuming your present workload 53.4% who said 'no' + 26.8% Taking the Ql9, 80.8% who do wish to do Communications: As Q6 and disconfirm possibility of remaining 
remains the same, do you believe you who said 'not sure' -lack of MM, the 'path' to this goal, should be with present contract Emphasise new service benefits in 
currently have time to undertake the time resource (79.8% total 320) prepared carefully and the route made as pharmacist I GP I patient terms. 
medicines management service? easy as possible (Ch 5 : 252 - Tolman; 
Geolgopoulos 'Path-Goal Theory') 
Q24. If you answered '00' or 'not sure' in 48.8% of the 79.8% (156) said Job enrichment model of motivation, Promotional platform of the new service to portray benefits of 
the previous question, could some of your '110' or 'not sure'. This is 39"1o...J Hackman et al., combined staffskills greater competence of ancillary staff - easier workload for 
workload be delegated to other staff, if they of all respondents to the realignment pharmacist; more efficient patient service - consequent greater 
were fully trained? questionnaire. attraction of patients to the pharmacy; patient/pharmacist 
relationships strengthened; allegiance strengthened 
Q2S. Do you think it is time for an entirely 60.7% said 'yes' but 11.4% said New contract with underpinning principles Benefits of change to be clearly set out in practical effects; higher 
new pharmacy contract? '110' and 27.9% were not sure. from Maslow & McOclland. value service attracts higher recognition or potential rewards. 
The latter two groups are 
potential barriers to change. _. 
_. ......... • ~ .... •• ...... _ IY'I_" _I .. I. ! .... I .. o.t I. 
Abbrrviations: FG 
l\IM 
= Focus Group (pharmacy) 
= Medicines Management 
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Pharmacist Postal Sunrey Summary 
Table 62 summarises the postal survey results and exposes barriers to role change from 
pharmacists and indicates alongside these, the same or similar issues raised by the 
national focus group. Columns 3 and 4 set out the author's concept of the motivational 
and needs implications for pharmacists, as well as suggested marketing approaches that 
would be best pursued to encourage pharmacists into the new service of medicines 
management. 
This table also brings together the results of the literature research findings in Chapter 4, 
relating to the marketing and presentation of a new product (service) through its core, 
tangible and augmented benefits, (Chapter 4 : 68) and field research results. 
Relationship marketing, oplfllon sponsorship and the psychology of tailored 
communications to members is emphasised. The potential barriers to progress are: 
• Lack of pharmacist time for the additional work (80.2% of respondents); 
• Age related antipathy (as age increases) (19.4% in 50+ age group); 
• Reluctance to delegate present workload (39% of respondents); 
• Rural pharmacist / dispensing doctor antipathy; 
• High percentage of 'unqualified' technicians (50% part time, 32% full time); 
and, 
-
• Inability to undertake medicines management (88.7% of respondents). 
Facilitating issues, as discussed in the general analysis were: 
• Good relationship with GPs (74% of respondents); 
• Positive view of patient response to MM (88.6% of respondents); 
• Positive view ofOP response to MM (61.3% of respondents); 
• Respondents do not wish various other professionals to undertake MM (89.8%); 
• Respondents' dissatisfaction with remuneration in present contract (84.2%); and, 
• Respondents' desire to undertake MM (80.8%). 
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If the above barriers and facilitating factors are reflected in the whole population, the 
facilitating issues can be used to address the barriers by creating disconfmnation of the 
current position and indicating better rewards for a new service using the Lewin-Schein 
theory, (Chapter 5 : 172, Figure 19). This leads to the fmal swrunary table (Table 63) 
showing barriers and link ups for the professions of medicine and phannacy. 
377 
Table 63 SUMMARY - POSTAL SURVEYS DOCTORS & PHARMACISTS 
BARRIERS AND FACILITATORS TO CHANGE: 
KEY RESPONSE CROSS LINK-UPS 
DocrOR SURVEY QUESTIONS & 
RESPONSES 
EXPOSED BARRIERS & 
FACILITATORS 
Ql Please state the number of doctors in 
yOUI' practice. 
a/these, how many are partners? 
Barriers: None 
Facilitators: None 
Comment: As practice size increases so 
does agreement with collaboration with 
pharmacists. 
Ql Is your practice a dispensing practice: 
Barriers: Dispensing doctors: 
Q8 Less desire to work with p'cists 
Q 11 Less agreement with collaboration in 
medicines management 
Q19 Less agreement that pharmacists 
could improve patient perception of the 
GPs'service. 
Facilitators: The high proportions ofGPs 
who gave positive responses to Q8, 11, 19 
(see under those questions). 
QJ Approximately how many patients are 
in your practice? 
Barriers: Potential workload needs 
address 
Facilitators: Worldoad reduction of GP 
by the pharmacist 
Q4 Please tick the age groups you all 
come within. 
Bamers: With increasing age there is 
less willingness to have p' cists selecting 
initial patient medication & less 
willingness to collaborate. 
Facilitators: Large % of GPs who do 
want collaboration. 
Q5 Broadly, how would you descrihe the 
frequency with which you contact a 
dispensing pharmacist? 
Barriers: Lack of routine contact (c£ 
Qll) 
Facilitators: Greater routine contact 
corresponds with greater desire for 
collaboration (Q11). 
Q6 Do you hove a pharmacist workJor 
you in the practice? 
Barriers: Low incidence of pharmacist 
work in GP practice. 
Facilitators: 37% of respondents who 
have pharmacist help in the practice -
~otential mentors I role models. 
KEY RESPONSE LINK-UPS 
Link-up 1 
GP Ql High proportion ofGPs 
favouring pharmacist I GP 
collaboration. 
P QlJ High proportion of 
p' cists claim good relationship 
with GPs - even in rural areas. 
P QlS High proportion of 
p' cists believe GP attitudes to 
collaboration would be positive. 
A good basic mutual empathy 
exists 
Link-up 2 
GP Q3, 14 Scarcity of time 
resource 
PO', %3, 24 Scarcity of time 
resource 
Link-up 3 
GP Q4 Increased age shows 
greatCT reluctance to involve 
pharmacists with GP traditional 
roles. 
P Q4, 19 Higher age groups 
marginally more reluctant to 
undertake medicines 
management 
PHARMACIST SURVEY QUESTIONS & 
RESPONSES 
EXPOSED BARRIERS & FACILITATORS 
Ql What gender are you? 
Ql What position do you hold? 
Barriers: None 
Facilitators: None 
Comment: Basic attributes which may have 
implications in relationship to other responses. 
Q3 How many pharmaCies are in )lour group? 
As Ql & Q2 note workload implications in 
single contractors (60.3%) o(respondents. 
Q4 What age group are you in? 
Barriers: None specifically related to age. 
Facilitators: Dissatisfaction overall with 
remuneration of present contract - 84.2% (Q12) 
QS On average, how many prescriptions are 
dispensed in ),our pharmacy each month? 
Barriers: Workload in high dispensing 
pharmacies with only one pharmacist and 
minimal technicians. 
Facilitators: Very low volume dispensing 
pharmacies (20%). 
06 Approximately what % of you,. total turnover 
is generated by NHS receipts? 
Barriers: As QS 
Facilitators: As QS 
Q7 What is the Iocatioll o/)Jour pharmacy? 
87.6% in town/city centre/suburban 
18.S% rura1 
Barriers: Rural pharmacist/dispensing doctor 
potential antipathy. 
Facilitators: Majority of pharmacists arc where 
ml\iority of doctors are. 
Q8 How many dispensing assistants do you 
employ? 
Barriers: 
Facilitators: 
Q9 How many a/your dispensing assistants 
haw a technician', certificate? 
Barriers: Limited pharmacist time resource 
with limited quality support 
Facilitators: 68% respondents with qualified 
assistants (full time) & part time. 
Note: These arc the author's representation of identified link-up issues where both GPs and pharmacists have similar problems 
or synergistic views on subjects raised in surveys. 
CODE: GP 
MM 
P 
P'dst 
- General Medical Practitioner 
.. Medicines Management 
- Pharmacist 
.. Pharmacist 
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Table 63 cont. SUMMARY - POSTAL SURVEYS DOCTORS & PHARMACISTS 
BARRIERS AND FACILITATORS TO CHANGE: 
KEY RESPONSE CROSS LINK-UPS 
DOcrOR SURVEY QUESTIONS & KEY RESPONSE PHARMACIST SURVEY QUESTIONS & 
RESPONSES LINK-UPS RESPONSES 
EXPOSED BARRffiRS & FACILITATORS EXPOSED BARRIERS & FACILITATORS 
Q7 What ill the 1I0urce o/your pharmacist help? QIO How many pharmacists regularly work with 
Barrier: Competitor entrenchment in the new you in the pharmacy? 
dispensing pharmacist role {medicines Qll How satisfied are you that the pharmacists' 
management elements}. Link-up" skills are beingfully used in the present contract? 
Facilitator: 16.6% dispensing pharmacists GP Q7 PharmacistlGP Barrier: cf. Q5 present workload ofp'cists not 
working with doctors i.e. role models; . COllaboration works. conducive to time intensive medicines management 
exemplars; mentors. PQ18 Only 11.3% Facilitator: 53% dissatisfied with use of 
dispensing pharmacists pharmacist skills. 38.3 % undecided - PQtential for 
Q8 Q you answered 'never' to Q6 would you able to do full medicines marketing effort 
like a pharmacist to work with you In the future? management 
Barrier: Dispensing & other GP mindset P Q16 Only 19% know QIl How satisfied are you with current 
{15.S%}. ofMM scheme in detail. remuneration levels In the present contract? 
Facilitator: Of those who said never in Q6 Barrier: None 
84.5% want pharmacist help in future (some Facilitator: 84.2% dissatisfaction with the present 
dispensing GPs included). contract. 
Q9 Please indicate frequency with which you Q13 How do Jlou rate your present relationship 
encounter the/ollowingproblems (8). with Gl's? 
Barriers: None apparent Barrier: Minority (10.3%) who see their 
Facilitator: Recognition of patient problems relationship as unsatisfactory. 
which are not effectively addressed. Facilitator: 74% rate it as satisfactory - a good 
QI0 Please indicate what you believe to be the 
PQsitive outlook by a large majority. 
incidence of the following potential problems, Ql" What do you assess would be the view 0/ 
elderly patients may have with medicines. patients on greater pharmacist Involvement with 
Barrier: None apparent. management of their NHS medicines? 
Facilitator: Recognition of medication Barrier: lfthey are wrong. 
problems - focus for pharmacist solutions. Facilitator: Good positive outlook (88.6%). 
LInk-up 5 
Ql1 Government seem to be encouraging GP Ql1 Collaboration Q15 What do you assess would be the attitude 0/ 
pharmacist/OP col/aboration 011 aspects of with pharmacists your local doctors to greater pharmacist 
medication review. Do you agree with this welcome {7S.S%}. involvement with patient medication management? 
approach? P Q15 Pharmacist Barrier: A much lower proportion of respondents 
Barrier: None substantial. expectation of doctor who sec doctor response as welcome {61.3%}. 
Facilitator: 75.5% agree - fertile market place. views on collaboration Facilitator: The 61.3% who positively view doctor 
is good (61.3%). resp0!lse. 
Qll 1IYou ticked boxes 11.1 to JJ.3lnprevious P Q19 80.82% wish to 
question, which of the follOWing Items do you doMM Q16 Are )IOU oware o/the government backed 
think a pharmacist could assist you with? PSNC medicines management proposals? 
Barrier: Least attractive iterns to GP, sub- Barrier: Not as such but not sufficiently well 
therapeutic dose levels; choice of medicines. known. Publicity inadequate. 
CHAllENGES TO TIm GP CORE ROLE. Facilitator: 17.6% 'know oC it'. 
Facilitator: Six other items, very well 
supPQrted - could become core of new service 
offering. 
Note: These are the author's representation of identified link-up issues where both GPs and pharmacists have similar problems 
or synergistic views on subjects raised in surveys. 
CODE: GP 
MM 
P 
- General Medical Practitioner 
- Medicines Management 
- Pharmacist 
P'cist - Pharmacist 
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Table 63 cont. SUMMARY - POSTAL SURVEYS DOcrORS & PHARMACISTS 
BARRIERS AND FACILITATORS TO CHANGE: 
KEY RESPONSE CROSS LINK-UPS 
DocrOR SURVEY QUESTIONS & KEY RESPONSE PHARMACIST SURVEY QUESTIONS & 
RESPONSES LINK-UPS RESPONSES 
EXPOSED BARRIERS & FACILITATORS EXPOSED BARRIERS & FACILITATORS 
Q13 If)lou ticked boxes 11.4 or I I.S please Q17 In this new professional relationship between 
outline )lour reason here. doctor and pharmaCist, how would)lOu rate the 
Barriers: potential Importance ofrhefollowingfactors? (Six 
• Lack of privacy & confidentiality given) 
• 'It is GP's responsibility' Barriers: None obvious. 
• 'Bureaucracy would be stifling' Facilitators: Strong awareness of the 
• 'Already enough interference from psychological 'needs' ofGPs. A good sympathetic 
NICE' position, from which to engage change. 
Facilitators: None. Q18 How would)lou describe )lOUT present ability 
Q14 If a pharmacist worked with )IOU to Link-up 6 to undertake the medicines management role 
undertake a patient review of those medication GP Q14 Time scarcity. (MM)? 
issues agreed by )IOu, how frequently should this P Q23, 24 Lack of time. Barriers: Only 11.3% able now; the substantial 
be done for those on long term medication? training programme to equip pharmacists, 
55.7% preferred over six-monthly. Facilitators: 72% who are confident that they can 
Barriers: Scarcity oftime. do it with appropriate training. 
Facilitators: 44.2% said four monthly or less. Q19 Would )Iou personally wish to undertake this Good base to work with but pharmacist reviews 
are acceptable. new MM service (fremuneration isacceptahle? 
Barriers: The time and intensity of the required 
Q15 Do youfeel the pharmacist should become Link-up 7 training. 
a/ormal part of the doctor's team addressing GP Q15 Formal Facilitators: 80.8% said yes. A positive attitude 
selected Items agreed by )Iou? recognition of basis for change. 
Barriers: 45.4% 'uncertain' or '00', pharmacist agreed by 
Facilitators: 54.5% said 'yes'. 54.5%. Q20 In the/allowing list (8 options) who do)lOu 
P Q17 Pharmacists feel should not take up the new service? 
Q16 The quality 0/ patient care in general aware of doctors' needs Barriers: None. 
practice may be very good even though the of recognition as the Facilitators: Recognition of real competition to 
patient may not be aware o/that quality. How lead in health care. deprive pharmacists of a major new role (dispensing 
important is the patient', own perception a/that P Q19 80.8% wish to contractors). 
quality? do medicines 
Barriers: None. management Q:zt ({you require training to undertake the new 
Fuilitators: 95% of respondents in the P Q20 Dispensing role, what subjects among the following list, would 
aflll1llative, pharmacists feel others )IOU select? 
should not Barriers: None but the effort required and time 
Q17 Quality of care and clinical excellence are commitment 
recurrent theme! in the White Papers. What is Facilitators: A thoughtful response and 
)lOur perception o/patient expectatiOns o/health recognition of the main requirements. 
care over recent years? Q22 In the/oIlowlng list o/training options which Barriers: 92.7% respondents saw an increase. 
No barriers. one would be )lour preferred training route? 
Facilitators: This is a facilitating issue. Barriers: Probably time at night. Day time 
lectures preferred. 
Q18 Patients 'perception of quality of care may Facilitators: Willingness to exercise choice. 
be a/actor In their commitment to the therapy. 
Do )IOU agree? 
Barriers: None. 
Facilitators: 85.2% who a!!Tee. 
Note: These are the author's representation of identified link-up issues where both GPs and pharmacists have similar problems 
or synergistic views on subjects raised in surveys. 
CODE: GP 
MM 
P 
P'clst 
'" General Medical Practitioner 
- Medicines Management 
- Pharmacist 
- Pharmacist 
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Table 63 cont. SUMMARY - POSTAL SURVEYS DOCTORS & PHARMACISTS 
BARRIERS AND FACILITATORS TO CHANGE: 
KEY RESPONSE CROSS LINK-UPS 
DOcrOR SURVEY QUESTIONS &: KEY RESPONSE PHARMACIST SURVEY QUESTIONS & 
RESPONSES LINK-UPS RESPONSES 
EXPOSED BARRIERS & FACILITATORS EXPOSED BARRIERS & FACILITATORS 
Q19 Patient perception of your overall service Link-up 8 Q2J Assuming your present workload remains the 
could be enhanced by a pharmacist review GP Q19 Favourable same, do you believe ;you currently have time to 
service, directed by you. .. Do you agree? GP view of pharmacist undertake the medicines management service? 
Barriers: 36.6% disagree or arc uncommitted - involvcment - 63.4% Barriers: Lack oftimc (53.4% 'nos', 26.8% 'not 
an age threat? respondents. sure'. 
Facilitators: 63.4% agree - positive indication P Q15 Pharmacists Facilitators: Some willing to shed workload 
for good relationship building. judgc GPs to be (S1.2% - Q24). 
favourable to 
Q20 Please indicate in which of the following pharmacist help (61.3%) Q24 grau an~ered 'no'/ 'not sure' in Q23 could 
locations your practice is based. some o/your workload be delegated? 
Barriers: Rural 14.7% c£ Q2 - 13.4% Barrier.: 48.8% 'not surc' /'no'. 
dispensing doctors. Facilitators: S 1.2% 'yes'. 
Facilitators: Not Applicable. 
Q25 Do you think It is time for an entirely new 
pharmacy contract? 
Barriers: 39.3% 'not sure' /'no'. 
Facilitators: 60.7"/0 who said 'yes' - fertile ground 
for persuasion to rolc change. 
Note: These arc the author's representation of identified link-up issues where both GPs and pharmacists have similar problems 
or synergistic views on subjects raised in surveys. 
CODE: GP 
MM 
P 
P'eist 
= General Medical Practitioner 
.. Medicines Management 
- Pharmacist 
- Pharmacist 
This chart brings together the GP and pharmacist responses to the random postal 
surveys and indicates, in the central column, those issues which could be mutually 
beneficial or are mutually problematic. 
Such factors can be used in an empathetic way to each profession by using them in 
marketing communications to show some of the benefits of collaboration. Reassurance 
that each profession has similar views or problems and indeed aspirations (e.g, GPQ19 : 
PQ15) would be positive reinforcement of 'collaborative' proposals, generating 
mutually beneficial working outcomes in the future. 
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CHAPTERB 
SUMMARY AND DISCUSSION 
This flnal chapter is set out in eleven sections and sub-sections as follows: 
8.1 Introduction 
8.2 Literature Research 
8.2.1 Part I, Marketing 
8.2.2 Part 2, Organisational Change 
8.3 Field Research 
8.3.1 Key Informants 
8.3.2 Focus Group: General Practitioners 
8.3.3 Focus Group: Pharmacy 
8.3.4 Postal Surveys - General 
8.3.5 Postal Survey - General Practitioners 
8.3.6 Postal Survey -Independent Dispensing Pharmacists 
8.1 INTRODUCTION 
This thesis, occasioned by the author's interest and involvement in developing the 
dispensing pharmacist's role, has created a unique approach to effecting change in 
primary care pharmacy, which necessitates some change in primary care medical 
practice. 
Change necessity has been signalled to the pharmacy profession from offlcial sources 
over a period of some twenty years, arguably starting with the Minister for Social 
Services in 1981, Dr Gerrard Vaughan, (Chapter 1 : 11). Redundancy of traditional 
skills and radical redesign of the NHS, especially within the term of the present 
Government, now necessitates positive movement into a new cognitive service. To 
engage in the role change envisaged (partnership in medicines management) will of 
necessity impact upon the GP's role, with which the pharmacist must interact. 
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This research summary and discussion deals with the results, implications and further 
suggestions for research arising from the work undertaken in this study, 
8.2 LITERATURE RESEARCH 
8.2.1 Part 1, Marketing 
The history of 'marketing' was briefly outlined to contextualise its place and role in 
general society. Then, specific aspects of marketing practice were theoretically applied 
to the problem of effecting change in the working relationship between GPs and 
pharmacists in primary care, taking account of the doctor's traditional lead in patient 
illness treatment. 
A number of marketing authorities and practitioners were consulted through the 
literature in an investigation of, the marketing mix, relationship marketing and health 
care marketing. The nature of the target market's needs, wants, attitudes and 
motivation was studied, together with product design, communications and message 
content (Chapter 4 : 59 - 129). 
Based upon these considerations a number of models i were constructed by the author 
addressing the following problems: 
• Creation of competitive advantage (Chapter 1 : 29) for dispensing pharmacists 
against threat of entry and substitute (Chapter 4 : 82, Figure 9); 
• Hannonisation of the behavioural connections between pharmacists and doctors 
in primary care and integrating marketing activity (Chapter 4 : 134, Table 23); 
• Targeting of GPs with suitable marketing activity via selected routes, to assist 
acceptance of pharmacy's new role of medicines management (Chapter 4 : 135, 
Table 24); and, 
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• Design of appropriate marketing approaches to dispensing pharmacists, in 
encouraging role change into cognitive service and recommending the 
communicating channels (Chapter 4 : 136, Table 25). 
From a theoretical viewpoint, persuasive communications, in a marketing. context, 
involves consideration of the target audience in terms of its potential involvement or 
passivity with the service I product promotional messages, (Chapter 4 : 113-118, 
Figures 13 & 14) and achievement of audience response. Design of mechanisms to 
achieve feedback, as in action research, will be important here, (Chapter 4 : 120, 122 
& Figure 15) as is opinion leadership in reinforcing the message (Chapter 4 : 126). 
These are key issues in communicating with both professions, in the change initiative, 
to achieve ownership of the new role and conceptual partnership between 'medicine' 
and 'pharmacy'. 
Marketing, its instruments of application, techniques and psychology have an important 
role to play in the presentation of the new proposition to the target audiences, i.e. 
medical and pharmaceutical practitioners in primary care. Careful formulation of the 
service / product, in its 'core', 'tangible' and 'augmented' aspects, is crucial to its 
potential attractiveness, (Chapter 4 : 67 - 73, Figure 8) and success to both doctors and 
pharmacists. Garvin's dimensions of quality, (Chapter 4 : 75, Table 15) applied in the 
context of the new pharmacy service are likely to be appealing aspects of service to the 
doctor. The 'product' in essence should be designed from the doctor's perspective, 
being culturally acceptable in values, (Chapter 5 : 209) and offering desirable benefits 
fulfilling the 'needs' of the medical profession in primary care. Thus, according to 
Maslow's content theory of motivation, doctors have reasons to welcome the new 
pharmacy service. They may also see it as complimentary rather than confrontational, in 
relationship to their currently perceived place in primary care and patient perception of 
who is responsible for what. 
A legitimate question is, 
"Could change be achieved without the application of 
marketing expertise and principles?" 
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If, as Baker maintains, (Chapter 4 : 60) 'marketing came into being with the first barter 
exchange ... ' then marketing processes can hardly be avoided and with normal 
discursive interchange, the process of role change could be taken forward. It is also 
likely, that sensible people at leadership level in medicine and pharmacy would speak in 
reasonable terms to each other, observing the normal courtesies and sensitivities, being 
as persuasive as possible. 
However, it could be argued that a more planned, efficient and thorough approach to the 
medical profession, with better prospect of success, could only be achieved by an in-
depth awareness of the formalised methods and techniques of persuasion. Marketing 
practice could certainly have existed in Baker's concept of its origins, but formalised 
marketing theory, research and structured practice has arrived relatively recently 
(Chapter 4: 61). It has undoubtedly therefore developed much more sophistication and 
learned a great deal more about the psychology of human behaviour in consumer mode. 
It is the author's view therefore, that a systematic programmed approach to role change, 
has a far better prospect of success and in a given time frame, than simple well meaning 
approaches of a somewhat haphazard nature. This latter approach has happened in the 
past, with mediocre results (e.g. 'PlANA' - General Introduction, xiv). 
Following the literature research on marketing, the problem of organisational change 
management was addressed. 
8.2.2 Part 2, Organisational Change 
Once again the approach was through a discussion, the history of 'organisational 
development,' which was summarised to identify important early research still used 
today in effecting change oI1" an organisational scale. It is apparent that whilst 
organisational structures can be changed relatively easily, individual commitment to 
change and change of working culture is considerably more complex (Chapter 5: 137-
267) 
A consideration of the general change drivers in society, from which organisational 
change is also derived, was undertaken alongside internal change forces. From this, a 
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matrix of 'effects' and 'implications' was constructed against the external P.E.S.T. 
change drivers, (Chapter 5 : 150, Table 28) to expose objectives and activity judged 
necessary by the author to effect change in community pharmacy. 
The implications for PSNC and community pharmacy were: 
• The professional input and reward relationships required reformulation and 
presented to the DH in new more effective ways, based upon market research; 
• Strategic alliances with patient organisations were indicated for greater impact 
with government; accompanied by researched evidence of patient needs and 
wants; and, 
• 'People ability' to be matched to tasks, is a necessity for; 
- effective negotiation (national and local); 
- delivery of new cognitive clinical service; 
- managing interpersonal GP/patient relationship with the pharmacist; and, 
- reallocation ofNHS duties from pharmacist to technician to free up time 
resource. 
The 'strategic capability' of the PSNC was examined, (Chapter 5 : 151 - 161), 
comparing its present (recently restructured by the author) capability with that prior to 
June 2000. The comparison shows (Chapter 5 : 153, Table 27) a more analytical 
address of the core functions of the PSNC and integrated effort toward the strategic 
objectives, instead of each sub-committee running an independent agenda. 'Strategy' is 
an important element of the Burke Litwin model of change. A resource audit was then 
speculatively undertaken by the author following a SWOT analysis completed by 
Gateshead I South Tyneside LPC and Sunderland LPC. Here the crucial issues of 
importance for community pharmacy were: 
• Renewal of clinical knowledge to a new standard for MM; 
• Renewal of image as a professional health care resource with 'qualified' staff; 
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• Renewal of pharmacy facilities to engage the new MM role; and, 
• Renewal of negotiating skills and presentational structure at national and local 
levels. 
The process of analysis was then completed in a further 'solutions matrix' (Chapter 5 : 
161, Table 30) to give an outline of strategies to be engaged in managing the 
'weaknesses' and 'strengths' position together with the 'opportunities' and 'threats'. 
The change drivers, strategic capability and suggested appropriate action were thus 
addressed from a theoretical standpoint relating to overcoming barriers to role change in 
pharmacy. 
Twelve specific models of change were then studied, to enable selection of an 
appropriate model, by which to guide change effort in community pharmacy. After 
summary and comparative analysis (Chapter 5 : 204, Table 37) the 'Burke-Litwin' 
model was selected for application to community pharmacy change because of its 
'transactional' and 'transformational' perspectives and focus on change of systems and 
people. It does not deal with 'systems congruence', which would be important in a 
large organisation containing many different systems. The independent community 
pharmacy sector comprises many 'small' units (pharmacies), which scale-wise rely 
much less on systems congruence. Although the technical resource of the organisation 
, 
is not addressed in this model, 'task and individual cal!ability I and 'individual needs 
and values I are. Herein lie the technical resources of the pharmacy, i.e. pharmacists and 
technicians equipped with new knowledge, supported by I.T. Overall, therefore. this 
model is recommended for use alongside suitable marketing techniques to engineer 
change. 
A general consideration of organisational climate, the visible manifestation of culture, 
and culture itself, was undertaken and related to pharmacy in particular. This indicated 
that initially at least, attention may best be given to climate, being the simpler of the two 
issues to address. In doing so, cultural change from being largely a supply service, to a 
cognitive service with attendant changes in mind set can be encouraged. 
Such changes could include: 
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• Premises adjustments, giving a more comprehensive consultation facility, 
accommodating three to four people, (one pharmacist plus patient and up to two 
relatives / carers); 
• The livery presentation of the whole medicines I surgical area to reflect a more 
clinical image and professional service; 
• The signage by which these areas are to be easily recognised; and, 
• The ritual by which patients I customers are received into these areas. 
In this way, the physical layout of premises sends messages to staff as well as patients, 
that a new approach has arrived. Thus, the simpler aspects of culture manifestation Le. 
physical layout and the 'way in which staff interact with each other and patients / 
customers' (Schein, Chapter 5: 210) begin a change in outlook or attitude. 
'Climate' is also a component of the Burke-Litwin change model. Accompanying such 
change may be a discreet notice in the window, outlining the consultation services 
available and ultimately, for example: 
'Full medicines review service, giving yo~ the best results 
from NBS & OTe treatments - FREE 
ASKINSIDE' 
The foregoing change imperative implies leadership involvement and this subject was 
studied in the context of organisational direction and change. A nwnber of models of 
leadership were examined and value found in several to guide leadership activity, 
(Chapter 5 : 241, Table 41). Path-Goal theory seems particularly appropriate to 
pharmacy because of its flexibility in leader styles, which are likely to be advantageous 
in the complex organisational units of the community pharmacy sector (Chapter 5 : 231 
- 232). In this respect, the goals for community pharmacy should be clearly articulated 
(full implementation ofMM) through repeated messages in the pharmacy journals (Page 
136, Table 26). Accompanying these messages should be a list of educational packages 
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and their sources, and the means of accessing them. It will be leadership's job to also 
communicate with the LPCs who will in turn, co-ordinate local activity in the planning 
of premises' amenities and act as a mentor for local pharmacists. 
Differences and complimentary aspects of leadership and management were explored 
and compared, (Chapter 5 : 248, Table 43) and both functions were found to be 
essential to the process of change management in community pharmacy (Chapter 5 : 
246). 'Leadership' and 'management' are once again elements of address in the 'Burke-
Litwin' model of organisational performance and change. The complex leadership 
structure of pharmacy will need to allocate its own responsibilities to avoid confusion of 
messages and create complementary themes with common direction of change 
destination, i.e. cognitive medicines management service. 
In seeking to lead community pharmacy into a new role, it was clear that some 
motivational effort would be required in creating a desire and commitment to move into 
a new order of service. To this end, a study of motivation theory was undertaken, to 
investigate different approaches to engaging certain human behaviours in an 
organisational setting. 
Work dating from the 1940s in England and the USA was reviewed, together with a 
nwnber of more recent models of motivational effort, all dependent to some extent, 
upon that early research. Promising avenues of motivational effort, are Hackman's job 
characteristics model and that of Porter and Lawler, revolving around task abilities, 
meaningfulness of the work and perceived value of the rewards of undertaking that 
work, (Chapter 5: 260,265, Figures 44, 45). 
Consideration of marketing and change management principles, elements and methods, 
from a theoretical point of view, has revealed approaches from both disciplines, which 
can help facilitate change in the role of community pharmacy. 
The elements or levers of organisational change, their relevance to this study and 
suggested avenues of marketing efforts, targeted toward engaging those levers, were 
brought together by the author in Table 46 (Chapter 6: 269) as a general schemat of the 
organisational development marketing interface. Specific issues, relating to 'barriers' 
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and 'facilitators' of change, exposed by the field research are now considered in the 
following sections related to the theoretical research. 
8.3 FIELD RESEARCH 
8.3.1 Key Informants (Appendices lIA, lIB, 11 C, pages 434 - 445) 
The results of these semi-structured, purposive interviews conducted by the author and 
relating to the medical profession, were to 'gain special insights and interpretations of 
some underlying issues in doctor attitudes to collaboration with pharmacists,' (Chapter 
3 : 44). From the results, abstracted and then charted out as a matrix, (Chapter 6: 271 -
273, Table 47) a number of relevant themes emerged giving signposts as to what may: 
• Be acceptable approaches to promoting GP I pharmacist collaboration 
(supporting doctor lead role); 
• Be important to avoid inadvertently creating barriers to partnership (time 
consuming interventions); 
• Give GPs' confidence in the proposed new ph~acy service (clinical premises 
facilities); 
• Encourage GPs' interest (authoritative 'message source' and 'opinion 
leadership'); 
• Engage joint ownership of the proposal (joint pilot work); and, 
• Be non-threatening to GPs' own role (address of patient compliance). 
(Chapter 6 : 273, Q8) 
390 
These important observations of highly qualified and experienced professionals in the 
health care field were recorded and compared with themes arising from the national 
focus group ofleading OPs on the national representative body, the OPC. 
8.3.2 National Focus Group - General Practitioners (Appendices 13A, 13B, 13C, 
l3D, pages 461 - 484) 
From this group, a number of key themes also emerged, some of which coincided with 
those raised by the key informants (Chapter 6 : 280, Table 49). 
These were: 
• Patient non-compliance is a major concern and non-sensitive in terms of 
phannacists potentially encroaching upon OP core cultural perception of their 
responsibilities; 
• Doctor self esteem and autonomy are important; 
• Increased workload is a disincentive to additional service; and, 
• Doctor-pharmacist collaboration is supported at national level. 
However, therapeutic and clinical decisions are held to be the preserve of the doctor, as 
in some of the key informant interviews (Q8, A & G, Chapter 6: 273). 
Both focus group and key informant analysis point to service design, in such a way as to 
be supportive of doctor culture and majoring on issues which are patient beneficial 
without implying doctor inadequacy. 
The results of both key informants and focus group were consolidated in Table 49 (page 
280). The comparison was then cross related to 'relationship marketing', 'the 
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marketing mix' and 'marketing communications', giving an indication of the type and 
target of effort required (Chapter 6 : 280, Table 49). 
8.3.3 National Focus Group - Pharmacy (Appendices 12A, 12B, 12C, pages 446 -
465) 
The group discussed the potential of medicines management, as a new role for 
pharmacy and as a means of repositioning the profession in primary care. Role change 
was agreed as necessary and the individual leadership bodies represented at the group 
agreed their own specific roles in taking the prospect forward. 
Judged to be of key importance (Chapter 6: 281, Table SO) were: 
• Suitable training for dispensing pharmacists; 
• The support of the OP leaders is essential; 
• Piloting of the new service is essential for testing the service itself and doctor I 
pharmacist working relationships; 
• Pharmacist locums must be brought into the scheme; 
• Interpersonal skills must be of good standard; and, 
• Suitable communications with OPs in primary care must be developed. 
The overall summary of these points is set out in Chapter 6 : 281, Table SO, which 
informs certain change management activity, as summarised in the Burke-Litwin model 
of organisational performance and change, (Chapter 5 : 199). 
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Communication to stakeholders was generally acknowledged to be of crucial 
importance and in this respect, marketing has a specialised role in managing message 
content, message source and sponsorship (Chapter 4 : 113 - 118, 126) along with the 
media channels to be used. In the case of a health care profession, in this instance 
pharmacy, professional journals should be used for a series of infonnative articles, 
charting out the route into medicines management service, as well as the means of 
achieving a suitable professional standard of clinical ability to deliver the intervention. 
Trade publications can supplement this effort, as well as 'in-house' leadership body 
letters (Chapter 4 : 136, Table 26). Other promotional activity is also summarised in 
this table. 
8.3.4 Postal Surveys - General (Chapter 7: 282) 
Some limitations of postal survey questionnaires have already been examined, (Chapter 
3 : 52, Table 9) and whilst response rates for both the doctor and pharmacist surveys 
achieved around the 50% level, non-respondents remain a problem. They could 
conceivably have introduced bias in pharmacy returns, for example through 'active 
disinterest', being so against changing the traditional comfort zone of dispensing, they 
may have set aside the questionnaire in irritation. 
Equally, it is not known whether either doctor or pharmacist returns, contain a 
proportion of composite views, i.e. some questionnaires may have been completed by 
small groups of people, thereby embodying several different perspectives on one fonn. 
Conversely, it could be argued that those who do complete and return questionnaires, do 
so, simply because they enjoy the mental exercise, but without real commitment to the 
answers. They may also feel a pressure to say the 'right things', if the social context of 
the day is pushing toward a new 'correct' way of approaching, as in this study, public 
service, i.e. through partnerships of collaboration. This could conceivably be the case in 
the doctor survey, seeing that the signatories were a doctor and two pharmacists 
'observing' their responses. This may conceptually equate to the Hawthorne effect 
mentioned earlier in the thesis, (Chapter 5 : 140). 
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It perhaps should also be recognised that psychological thought patterns leading to 
decisions or attitude formation, are not usually expressed in either thought or word as, 
'strongly agreeing', 'agreeing', 'neither agreeing nor disagreeing' and so on. Such 
categories, however, do impose a net expression of opinion or attitude and reduce 
interpretive bias in the researcher. Having said all this, much successful marketing 
involving billions of pounds worth of profitable product I service sales worldwide is 
launched from postal survey research encapsulated in such categorisation. Results and 
deductions from the surveys in this research are, therefore, interpreted with caution and 
used on the basis that if sample results are reflected in the total populations, then certain 
marketing and change activity is recommended, using the principles and techniques 
exposed in this research. 
8.3.5 Postal Survey - General Practitioners (Chapter 7: 283) 
The survey returns of the random national sample of GPs have produced interesting 
results, exposing both barriers to change, in relationship to the new pharmacy role and 
also substantial facilitating issues. 
The survey-exposed barriers, as partially indicated in the key informant and focus group 
work, were time constraints (Chapter 7 : 312, Q 14), some age related antipathy toward 
certain potential pharmacist involvement, (Chapter 7 : 290, Q4), therapeutic choice and 
sub-therapeutic dose identification (Chapter 7: 306, Figure 55 - 12.10 and 12.5) and 
workload (Chapter 7 : 289 Q3) Insensitive challenge of the doctors' own role is to be 
avoided and focus on non-confrontational issues in medication management should be 
pursued. 
Few dispensing pharmacists work in the GP practices at present, (16.6%) and the more 
frequent the present routine contact between GP and pharmacist, the more positive is the 
GP over future collaboration. Introduction of the new role, (which involves closer 
collaboration between the two professions) is supported by 75.5% of GPs (Chapter 7 ; 
304 Ql1) but only 54.5% think the pharmacist should become a formal part of the 
doctor's team, (Chapter 7 : 313 QI5). This may be an ego effect, as postulated in the 
discussion on Maslow's needs theory, (Chapter 4: 97) and a perceived threat to doctor 
394 
autonomy and primacy in the health care hierarchy. Whether this is so or not, the 
medicines management service promotional presentation, should take account of this 
possibility and marketing communications copy should clearly recognise the OP as lead 
clinician and final decision maker. 
Medication problems are recognised by all respondents (specifically those problems 
listed in the survey) and by implication, ideally need resolving. Doctors (77%) 
recognise that pharmacists could assist with this, especially in food / drug interactions, 
NHS / OTC drug interactions and patient compliance. Support for the general 
proposition declines specifically with those issues that challenge the doctor's right to be 
the decision maker, in traditional GP responsibilities, i.e. choice of drug; choice of dose 
level; selection of brand versus generic, (Chapter 7: 290 Q4). The percentage of OPs, 
who regard a pharmacist medication review service as an enhancement to their overall 
service, in the eyes of the patient, is 63.4%, (Chapter 7 : 320 QI9). This is a sound 
base upon which to build introduction of the new pharmacist role and by peer 
sponsorship, become an inducement to the remainder of their colleagues who are not yet 
convinced. 
To assist this process, PCT seminars could be a route of sponsorship of this approach 
and the benefits measured throughout the PCT. 
Special attention will need to be paid in promoting the new service to rural and 
suburban dispensing doctors, who may feel doubly challenged, as they compete for 
dispensing rights already and may feel uncomfortable in opening up their patient 
records to adjacent pharmacists. Support for collaboration with pharmacists, from 
dispensing doctors is 58% compared with 78% of non-dispensing doctors, (Chapter 7 : 
287, Table 53). Nevertheless, 58% is a positive base upon which to build a new 
relationship with this sector of general medical practice and should not be approached in 
a negative way. The overall marketing approach has been discussed in the literature 
research and field research summary, (Chapter 4: 82, 126, 134). 
Because support for the MM proposition at the medico-pharmaceutical focus group was 
good, it may be possible for both bodies to endorse a programme of 'collaborative 
facilitation', bringing the professions together at grass roots, to address patient care 
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through medication management. Results from the national pilot trials on medicines 
management, should help clarify interpersonal issues between OP and pharmacist, and 
patient and pharmacist. 
A mentoring scheme could be evolved from these pilot participants leading willing 
members of both professions into the new relationship. 
The messages from the OP Key Informants, Focus Group and Postal Survey are 
complimentary and positive in overall acceptance of a new role for pharmacy, in 
helping manage the patient's medication. However, some dangerous barriers do exist, 
which if not effectively addressed could undergo metamorphosis into a complete block 
on dispensing pharmacist role development. 
These are: 
• The established pharmacist assistance to GPs is largely (83%) from other than 
dispensing pharmacists who have made better progress into cognitive service 
(Chapter 7 : 296, Q7); 
• Cultural challenges to the doctors' lead role in choice of patient medication, is 
resisted and increases as age of respondents increases (Chapter 7 : 291, Q4 v 
QI2); 
• Potential increased workload involved in medicines management (Chapter 6 : 
271, Q2, Q3; Chapter 7: 289) and lack of time (Chapter 7: 311. QI4); 
• Current lack of contact between some GPs and pharmacists (Chapter 7 : 292); 
• Single handed GPs potentially short of time (8% nationally, 10% of sample) 
(Chapter 7 : 284); and, 
• Dispensing doctor antipathy (Chapter 7: 287, Q2). 
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For these reasons the programme of change in phannacy's role, must, in its marketing 
approach to GPs, emphasise medicines management as time saving, (and construct the 
service to be so) and doctor supporting, (not challenging) using the 'more-satisfied-
patient' as a work reducer and doctor image enhancer, (Chapter 7 : 315 - 318, Q19 
response especially). 
Applied as a marketing strategy across the board, this pharmaceutical platform should 
accommodate those GPs who may be uncertain about the new pharmacy service, or 
those who feel threatened or apprehensive about increased workload. Presented well, 
the new service benefits should help to outweigh any temporary 'set-up' problems and 
encourage wider doctor acceptance. 
Although barriers to progress do exist within the medical profession, there are strong 
facilitating messages which, if carefully managed, could overcome much resistance. 
From the GP postal survey response, the factors which may facilitate progress of the 
new pharmacy role are substantial. All survey questions relating to future collaboration 
with pharmacists, (Q8, Qll, Q15, Q19) show that there is an encouraging percentage 
of respondents, positively disposed toward working with a pharmacist (84.5%; 75%; 
54.5%; 63.4% respectively). 
The external pressures upon the primary care medical profession are also facilitating 
forces for change, (Government White and Green Papers, Chapter 1 : 12) and will in 
turn help a medical role transition from sole decision maker in patient medication to one 
of collaborative effort with the pharmacist. This makes it even more important for 
pharmacy to engage in empathetic discourse and communications with doctors, 
recognising cultural sensitivities relating to a traditional medical lead and authority in 
patient care (Chapter 4 : 125, 126). 
Carefully constructed marketing plans with the right presentation of the product, 
(Chapter 4 : 67) careful address of doctor needs and wants, (Chapter 4 : 95) and 
persuasive communications, (Chapter 4 ; 113) are clearly prerequisites of smooth, time 
efficient transition of the pharmacists' role together with committed doctor support. 
The problems within pharmacy will now be examined in the light of the field research. 
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8.3.6 Postal Survey -Independent Dispensing Pharmacists (Chapter 7: 329) 
The respondents to this survey have expressed very interesting attitudes, needs and 
wants. There are substantial barriers to change within the phannacy profession, 
arguably more so than in the medical profession. The nature of the problems are, 
however, somewhat different, although one outstandingly, is identical; the lack of time 
in which to discharge substantial additional responsibilities. Only 19.8% of respondents 
claimed to have time to undertake the new role and 53.4% said they definitely had not; 
26.8% were not sure (Chapter 7 : 366, Q23). Moreover, only 51.2% of those who did 
not have time argued that some of their current workload could be delegated to other 
staff (Chapter 7 : 368, Q24). Extrapolated to the full population of independent 
dispensing pharmacists this would equate to 27% of independent contractors in England 
and Wales. Further research into this group is advised to determine the nature of the 
workload problem and at least one proposed solution, which might be a shared 
phannacist with similar contractors, proportionately paid for by the participants. 
However, other major barriers also exist: 
I. The majority of contractors cannot currently provide the service due to lack of 
knowledge. Training is required for 88.7% of respondents which would be a 
major task for such a proportion of the total pophiation (Chapter 7 : 356, QI8). 
2. Only 68% of full time and 50% of part time dispensing assistants have formal 
qualifications. Workload delegation, such as prescription accuracy checking, 
could not easily be actioned at this stage (Chapter 7 : 339, Q9). 
The basic motivation for independent pharmacists to engage in the new role, is likely to 
be a net balance of forces for and against. If the skill mix I manpower situation is not 
managed to deliver extra time, then no amount of incentive will be able to help the 
movement into medicines management. Applying Vroom's equation, (Chapter 5 : 253) 
then: 
F (force of motivation) = L (V x I x E) 
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If'!' (the perceived likelihood of achieving outcomes) is in this instance, zero, without 
the time or manpower, then Vroom would predict that motivation would be absent. 
Real address of these issues must be undertaken to have any success of transforming the 
profession's role. 
There may however, be an interim stage. It may be possible to construct as a first step, 
a simplified additional process to the present dispensing operation, which would lead 
ultimately to full medicines management. It would require fonnal acceptance by the 
DR and medical stakeholders (Chapter 1 : 34, Figure 5) and a proper system of 
implementation, which would by agreement be acted upon. 
Such an incremental but definite move could be delivered by undertaking for the 
chronically ill, within specified disease categories to begin with, the following services: 
• Dose rationalisation; 
• Dose alignment; 
• Pre-agreed brand to generic shift; 
• Reduction of 'pm' quantities by half; and, 
• Maintenance dose correction for specified diseases (e.g. proton pump inhibitors 
to reduce levels of non required additional medication or ACE inhibitors 
increased from the starter dose to maintenance level. 
Such a scheme would be managed by pre-printed fonns, with 'tick boxes' to indicate 
the task completed or to be reviewed by the medical practice. 
This could be agreed as part of a new national contract, for an enhanced fee structure 
and full medicines management, incrementally introduced as locally commissioned 
services by those who could provide them. A period could then be set during which the 
majority of the profession would complete training and skill mix re-distribution, after 
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which full medicines management could become part of a second stage national 
contract; i.e. Phase 1 national contract attracts one fee structure; Phase 2 national 
contract attracts an extra fee structure. 
Alternatively, a second phase could be specified by a 'NICE' agreed package, so that 
postal code variation in service availability is minimised and then PCTs commission 
this locally, funded through the PCT budget, as pharmacists become ready to engage the 
service. Target service take up, could for example, be set at 65% of the dispensing 
profession in full service, (phases I and II) within three years and a further 20% within 
another two years. 
Such interim stages would: 
• Send a positive message to the major stakeholders, especially the DH and 
medical profession, that pharmacy's change in role is a commitment with a 
timetable; 
• Allow time for training in the full medicines management service; 
• Provide a comfort zone for pharmacists and doctors, in engaging in formalised 
, 
collaboration, without confrontational issues creatJng barriers to change; and, 
• Build the phannaco-medical relationship and with it, GP confidence that their 
position in health care is secure. 
More complex issues such as choice of therapeutic route and I or substitution, may thus 
be allowed to filter into the joint approach to patient medicines management, when a 
secure relationship has been established. 
Once again, on the positive side of things, there are a number of major forces exposed 
by the research, potentially assisting the proposed transition from relatively simple 
dispensing supply, to cognitive service. These are: 
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• Government pressure to change the pharmacist contribution to primary care 
(Chapter 1 : 2); 
• The desire of respondents to undertake medicines management (80.8% - Chapter 
7: 358); 
• The desire of respondents, that alternative professionals to themselves should 
not undertake this service (Chapter 7 : 360); 
• A large majority think it is time for a new contract (60.7% - Chapter 7: 370); 
• A large majority recognise doctors' psychological needs in having a non-
confrontational relationship with the pharmacist (Chapter 7: 370); and, 
• A majority believe that the GP will welcome the new pharmacist role proposed 
(Chapter 7 : 350). 
Given that the profession's leadership are able to: 
• Provide the training courses to bring dispensinr contractors up to the required 
level of knowledge and ability; 
• Resolve the skill mix issues around the dispensing process and release 
pharmacist time; and, 
• Construct a new framework of systematic collaboration between GPs and 
pharmacists, 
Then the barriers to progress can be overcome and a new order of pharmaceutical 
service programmed in, over a planned timescale. Those contractors who may be 
reluctant to move out of their traditional comfort zone, will in all likelihood, be pulled 
by a majority of those who do wish to change into the new service. 
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CHAPTER 9 
CONCLUSIONS AND FURTHER RESEARCH 
9.1 INTRODUCTION 
The thesis of this work is that: 
' ... There are cultural, professional and operational barriers to repositioning 
the community pharmacy dispensing service in the primary health care 
delivery chain - through a new role of medicines management - resident 
within the medical and pharmaceutical professions; and that these can be 
systematically addressed by Qriginal research and a novel application of 
modern management techniques. ' 
(Chapter 2 : 36) 
This thesis is sustained by the findings of the field research and by the management 
issues exposed in the literature research. 
The hypotheses under investigation are: 
i. The attitudes of general medical practitioners are such that they will resent 
invasion into their traditional area of responsibility for patient medication 
and constitute a barrier to change (Chapter 3 : 42); and, 
ii. The attitudes of independent dispensing pharmacists are such that they will 
wish to remain in the traditional dispensing role. 
Both hypotheses are not sustained. Both professions are willing to move into a 
synergistic role in managing patient medication, but there are substantial barriers to 
achieving the role change. Now that this research has been completed the following 
facts are revealed. 
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9.2 SUMMARY 
The barriers are of a cultural, professional and operational nature, which according to 
the research findings can be systematically addressed, by the application of modem 
marketing and change management principles, processes and techniques of application. 
The main research fmdings from the respondent information sources and postal surveys 
are set out below: 
9.2.1 Doctors 
i. General medical practitioners, by a large majority (75%), support 
collaboration with pharmacists on patient medication; a professional attitude; 
ii. A large proportion, (92.7%) recognise increased patient expectations in 
health care; a professional assessment; 
iii. A large proportion, (63.4%) see a pharmacist medication review service as a 
potential enhancement to their overall service; a cultural perspective; and, 
iv. A large proportion of GPs, (84.5%) who d~ not have a pharmacist working 
for them currently would like such help in future; an operational need. 
These are powerful facilitating factors in moving the dispensing pharmacist into new 
cognitive service. However: 
v. 83.4% of GPs currently receiving pharmacist assistance do so from sources 
other than dispensing pharmacists; an operational barrier potentially 
growing; 
vi. 45% of GPs do not yet see the pharmacist becoming a formal part of the 
doctor's team; a cultural effect with possible operational considerations; 
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vii. Traditional core doctor responsibilities for choice of patient medication and 
dosage level are seen by fewer GPs, (42.55 and 52%) as issues for 
pharmacist involvement; a cultural effect which increases with increased 
doctor age; 
viii. Adverse time and workload consequences of the new service are 
disincentives to GP involvement; an operational effect; and, 
ix. Only 57.7% of dispensing doctor respondents support collaboration, a much 
lower percentage than non-dispensing GPs and thus a potentially more 
difficult sector to engage in change. 
The overall message from these responses is that the new proposed pharmacy service is 
welcome, given that it does not overtly threaten the culturally perceived rights of the 
doctor to be the arbiter of patient medication regimens. Within the primary care 
dispensing pharmacist profession the following information was revealed from the 
respondent postal survey. 
9.2.2 Pharmacists 
i. A large majority of respondents (80.8%) wish to undertake medicines 
management if remuneration is acceptable; a professional consideration; 
ii. A large majority believe doctors and patients would view this service 
favourably (61.3% and 88.6% respectively); a cultural perspective; 
iii. A large majority believe they have a good relationship with GPs (74%); an 
operational perspective; 
iv. A collective large majority do not wish various other professionals to 
undertake medicines management (89.8%); an operational and cultural 
effect; and, 
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v. A large majority are dissatisfied with remuneration for the present contract 
(84.2%); a professional attitude. 
These are all potentially facilitating issues, encouraging a move into a more satisfactory 
service and reward system. 
However: 
vi. 80.2% of respondents believed there was not time to undertake the new 
medicines management role; an operational consideration; 
vii. 88.7% require further training to undertake the new role; a professional 
requirement; 
viii. Delegation of present workload is not supported by 39% of respondents; a 
cultural view; and, 
ix. Of the numbers of technicians employed by respondents, 50% of part time 
staff had no technician certificate; 32% of full time staff had no certificate; 
an operational requirement for the future. 
9.2.3 Aims and Objectives of the Thesis 
The overall aim was to expose those issues which may impede or facilitate the 
development of a new operational partnership between doctor and phannacist, in 
managing patient medication and to examine the potential of marketing as a means of 
effecting change at the medico-pharmaceutical interface in primary care. 
This has been done in the field and literature research and the specific objectives have 
been fulfilled: 
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1. Identification of barriers to pharmacy change within the medical and 
pharmaceutical professions, together with any facilitating factors which may 
assist change; 
ii. Identification of some of the key attitudes, needs and wants of medical and 
pharmacy stakeholders in the new pharmacy role; 
iii. Development of suitable marketing approaches which may address the 
medical stakeholders' key attitudes, needs and wants; 
iv. Evaluation of the role of leadership in repositioning the profession in 
primary care; and, 
v. Inform a communications strategy to both professions, in initiating and 
delivering change for pharmacy. 
Although barriers have been exposed in both practical and conceptual dimensions 
within the medical profession (e.g. increased workload; cultural threat) these are 
counterbalanced with positive GP perceptions of their potential use of community 
pharmacy in a new role. Suggested elements of medicines management were well 
received, but challenge to the doctor's right of therapeutic selection and dose choice 
were much less so. The majority of respondents welcomed pharmacist / GP 
collaboration in specified issues, but time consuming systems should be minimised or 
avoided altogether. Dispensing doctors need special address to downplay competitive 
outcomes, whilst still building a collaborative relationship, which from the research, 
appears to be a real possibility. 
Provided the potential barriers to collaboration are sensitively and constructively 
managed, the facilitating issues emerging from the research give pharmacy a major 
opportunity to move into a new partnership of patient care with the GP. 
The barriers to repositioning community pharmacy, existing within pharmacy itself, are 
more substantial in practical terms. Conceptually a large majority of respondents wish 
to engage in medicines management. They see both patient and doctor prospective 
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responses to the new phannacy service very positively and do not wish competitor 
professionals to take up this role. However, lack of time is a major impediment to 
installing the new service, as is current ability to deliver the clinical expertise. Provided 
these barriers can be overcome then pharmacy also is able to move forward. 
These matters require urgent address, if competitors are to be prevented from blocking 
the expansion of the potential cognitive resource within the present dispensing service. 
Leadership has a responsibility in providing the means and motivation to achieve the 
vision of a new role and place in primary care for dispensing contractors. 
9.3 NEXT STEPS 
From a consideration of the literature and field research, an outline programme of 
change, leading to engagement of the new MM role by independent primary care 
dispensing pharmacists, is suggested in Table 64. It encompasses: 
• Leadership activity; 
• Key external stakeholder management; 
• Internal stakeholder preparation; 
• The Burke-Litwin change levers; 
• New Service configuration; and, 
• A suggested timetable. 
The suggested timetable is geared to the negotiation, currently underway, for a new 
community pharmacy contract initially discussed with the Minister of State for Health 
at the presentation of the new MM service in 1998. The author's discussions with the 
DH, in July 2003, indicate that the new contract is likely to contain some basic elements 
of MM, as suggested by the author in this thesis, with a later phase to include full 
medicines management. This would create some time in which to train pharmacists, but 
would not prevent competitor professionals (e.g. from peTs) from continuing to enter 
the new service. 
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It is therefore very important that a programme of role change is implemented without 
delay. Although this suggested plan is for independents, pharmacists employed by the 
'multiples' could benefit from ail or parts of it. The multiples also have a choice to 
make, i.e. stay with the current service or move into cognitive MM-based patient care, 
which the DH is now offering to phannacy. Table 64 outlines the change programme 
elements. 
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TABLE 64 OUTLINE PROGRAMME OF CHANGE FOR INDEPENDENT PRIMARY CARE DISPNESING PHARMACISTS 
ACfNITY 
1. Leadership Role: 
• Create phased service specification and 
configuration; 
• Promote the need for role change; its 
benefits; avoidance of delay; 
• Timetable the process; 
• Ensure availability of training courses 
and alternative routes. (pharmacists and 
Technicians); 
• Set out new protocols of supervision and 
skill-mix guidelines; and, 
• Initiate and maintain dialogue with key 
stakeholders and with pre-determined 
objectives. 
2. Key External Stakeholder Management 
• 
• 
• 
GPC and DR to be regularly briefed by 
face-ta-face meetings and pre-arranged 
agendas; 
Joint interim supportive announcements 
to be made in the pharmaceutical media; 
and, 
Patient organisations to be regularly 
briefed. 
-
= Department ofRealth 
= Ditto 
ACfIONED BY; AND BURKE-LIlWIN LEVER OF PURPOSE TARGET 
ROUTE CHANGE DATE 
RPSGB;PSNC LEADERSHIP. To define the new service; create barriers to December 
BUSINESS PROCESSES I entry for competitors; to support GP culture. 2003 STRUCTURE. Liaise with DR. CULTURE. 
Ongoing 
Spoken and written word; STRATEGIC INTENT; To create movement of minds; disconfirm from October 
journals, seminars and MOTIVATION. present situation and create desire to change. 2003 
conferences by region. STRATEGIC INTENT. By October 
INDIVIDUAL TEAM AND To govern change by milestone objectives. 2003 
ORGANISATIONAL 
PERFORMANCE. To equip pharmacists with knowledge and By January 
TASK AND INDIVIDUAL skills to deliver the new service; to create the 2004 
CAPABIUfY. time resource for pharmacists; to reassure GPs By April 
EXTERNAL ENVIRONMENT. 
that patient care is safe in pharmacists' hands. 2004 
Started 
To build support for the new MM role and January 2003 
establish dispensing pharmacists as preferred -continues 
source of supply. 
RPSGB;PSNC 
EXTERNAL ENVIRONMENT. Started 
GPC; DR; PSNC; To establish opinion leadership and message August 2002 
RPSGB. -- sponsorship, assisting motivation of -continues 
. pharmacists and GPs. MOTIVATION OF 
RESPECIlVE January 2004 
CONS1TIUENCIES. DO. 
PSNC; Face-to-face STRA TEGlC INTENT; EXTERNAL ENVIRONMENT. Started 
meetings. DO. January 2002 
continues 
NP A = National Pharmaceutical Association 
PMRs = Patient Medication Records 
RPSGB = Royal Pharmaceutical Society Great 
Britain 
Abbreviations: DH 
DO 
GPC = General Practice Committee PSNC = Pharmaceutical Services Negotiating Committee WWW = World Wide Web 
409 
r 
I 
I 
TABLE 64 cont. OUTLINE PROGRAMME OF CHANGE FOR INDEPENDENT PRIMARY CARE DISPNESING PHARMACISTS 
ACTIVITY 
3. Internal Stakeholder Preparation 
• Dispensing pharmacists to regularly 
receive information on new contract 
elements and phasing; 
• To be informed of training packages, 
sources and costs; 
• To be given blueprints for new premises 
facilities and work processing systems 
(new skill mix responsibilities and 
patient interview protocols); and, 
• To have available mentoring schemes 
and LPC support. 
4. New Service Configuration 
• 
• 
• 
• 
• 
The patient-pharmacist interface to be 
protocol driven with possible 
algorithmic guidance; 
Paper driven to commence, then IT 
linked to PMRs; and, 
Systematic review process with pre-
determined elements. 
The GP-pharmacist interface to be styled 
as doctor led with collaborative 
pharmacist assistance. 
Suitable articles prepared for medical 
and pharmaceutical communications. 
~ Department of Health 
= Ditto 
ACTIONED BY; AND BURKE-LITWIN PURPOSE TARGET 
ROUTE LEVER OF CHANGE DATE 
RPSGB;PSNC 
PSNC letters to LPCs and MANAGEMENT PRACTICES To perpetuate motivation, emphasise Start January 
on WWW to contractors; AND STYLE. professional benefits. 2004 
TASK AND INDIVIDUAL LPCs to be given CAPABIUfY; INDIVIDUAL To generate confidence, remove psychological Start January 
templates of support for NEEDS AND VALUES. barriers and give purpose for new role. 2004 
contractors by PSNC; 
NP A to propose SYSTEMS POUCIES AND To provide the organisational knowledge and October 2003 STRUCTURES; premises/facilities plans; BUSll{ESSPROCESSESAND time resource for new role implementation. 
and, STRUCTURE. 
PSNC to provide MANAGEMENT PRACTICES 
AND STYLE. To provide security and confidence to enter May 2004 guidance packages on new service, with back up help. 
how to support 
contractors. 
PSNC;RPSGB ~TURE;BUSll{ESS To minimise patient apprehension, maximise May 2004 PROCESS AND STRUCTURE. patient comfort and ensure universal quality of 
Journal articles and service. 
RPSGB branch seminars; 
PSNC/LPC seminars. SYSTEMS POUCIES AND To facilitate recording, reduce time July 2004 STRUCTURES. Joint IT committeeNPA, involvement and guide patient as well as 
PSNC, RPSGB' pharmacist, for repeat encounters. 
RPSGB;PSNC 
Mailed to community 
pharmacies. ~TURE. To support GP culture; use the pharmacists' January 2004 
understanding ofGP needs; and, 
PSNC,RPSGB 
Professional journals and To encourage doctors to participate. 
intemalletters. 
NP A = National Pharmaceutical AssociatIon 
PMRs = Patient Medication Records 
RPSGB = Royal Pharmaceutical Society Great 
Britain 
Abbreviations: DR 
DO 
GPC = General Practice Committee PSNC = Pharmaceutical Services Negotiating Committee WWW = World Wide Web 
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The outline programme of change set out in Table 64 now needs to be considered in 
detail and work apportioned between the leadership bodies. It will be presented by the 
author in the next leadership group meeting in early October 2003, for this purpose and 
if possible a timetable agreed. 
From the research conducted in this thesis, it is apparent that a realistic opportunity 
exists for the independent sector of primary care dispensing pharmacy to transform its 
role. It remains to be seen whether adequate progress can be made in time to prevent 
competing professionals from supplanting this role. 
The thesis and its contents are the original work of the author, researched from the 
recognised bodies of literature and using standard methods of field research, applied to 
an original plan of work. 
9.4 FURTHER RESEARCH 
Suggested areas of further research arising from this work are: 
1. Research into building the collaborative partnership between dispensing doctors 
and rural pharmacists; 
2. Research into patient motivation to comply with treatment; and the pharmacist 
/ doctor link in that process; 
3. Research into the patient consultation amenity provided by dispensing 
phannacists, for future development of the service - the IT aid; algorithms; inter 
communication psychology; 
4. Research into GP / pharmacist relationship development and reapportionment of 
responsibilities as medicines management develops (toward a point where, for 
example, doctor diagnoses, pharmacist prescribes); and, 
5. The issue of obstruction to delegation of pharmacist workload to other staff. 
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Such studies will generally assist continuous development of primary care service to 
patients and specifically pharmacists' continual development of professional 
contribution to that health care process. 
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APPENDIX 1 
(Ref. Chapter 1 : Page 2) 
PEST ANALYSIS - COMMUNITY PHARMACY 
POLITICO - LEGAL ISSUES 
• Government legislation on limitation of contract has increased the equity value of 
individual and group community pharmacy business. 
• Government perception of community pharmacy contribution to health care, as 
mainly counting and pouring, has limited government views of the value of the 
profession's service. 
• Government restructuring of the National Health Service into Primary Care Groups I 
Primary Care Trusts, has placed all doctors in a cost conscious environment. 
Pharmacist expertise being welcomed by GPs to assist in control of prescribing 
costs (Hansard: Nov 23, 1999: 468). Inter-professional partnerships encouraged. 
• Requirement in Law of pharmacist supervision -of medicines sales, restricts 
pharmacist domicillary work. 
• Pharmacist requirement to supervise dispensing activity gives similar effect. 
• Creation of benchmarking performance and clinical audit of GPs (,NICE') by 1999 
White Paper drives quality improvement in primary health care - potential for 
pharmacist input in medicines management. 
• New annual patient survey of health care views, introduced by 1997 White Paper -
patient empowerment by active voice. 
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• Government edict has effectively devolved budgets for primary care expenditure to 
Health Action Zones and Primary Care Trusts when they form. (Not dispensing 
remuneration) 
• Possibility of pharmacists prescribing, signalled by Secretary of State for Health in 
1999. 
• Government sponsored 'Walk in Centres' created by Government in 1999 - staffed 
by nurses - potential competition for pharmacists in health advice and possibly 
medicines supply. 
• NBS Direct, introduced by Government (staffed by nurses) in 1999; more 
competition for health education from the nursing profession; but potential for 
pharmacy as the fourth disposition. 
• Continued encouragement by Health Minister for pharmacist role in medicines 
management. Pilot trials agreed May 2000. 
ECONOMIC INFLUENCES 
• EU devolvement of health care spending to member states gives UK Government 
flexibility in allocating resource. 
• Global sum remuneration for community pharmacy restricted to inflation increase 
only, year on year, since 1993. (Inflation is measured by RPI). True inflation for 
pharmacy is consistently ahead of the retail price index, because of the additional 
rise in drug costs. 
• Global sum for pharmacy has, therefore, diminished in real terms. Profit surplus for 
reinvestment in pharmaceutical service is either non-existent or much diminished at 
independent pharmacy sector level, dependent upon size of pharmacy dispensary. 
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• Foreign competition entering the UK market (phoenix and GEHE) have pushed 
other vertically integrated UK indigenous companies into re-entering another 
expansion phase to block the competition. The independent sector is thus 
diminishing, down from 70.4% in 1990 to 55% in 2000 (PPA Statistics Bulletin, 
1998 and RPSGB Register, 1999) and still declining. 
• This movement in pharmacy ownership must restructure the national representative 
committees in favour of the multiples being in a majority, in due course. This, in 
tum, means real risk of contract limitation terminating, (possibly within three to 
five years) as the multiples, e.g. Superdrug, have never been comfortable with 
restricted expansion. Pharmacy equity values will then drop. 
• Resale price maintenance on medicines is now removed despite a new pharmacy 
group (eIP AG) being formed to fight the prospect, now instigated by the Office of 
Fair Trading (1998). CIPAG failed in it mission during 2001. 
• In the current phase of the economic trade cycle (recovery) the pressure for 
competition in all markets is the order of the day and is further encouraged by anti-
monopoly ED legislation. (The competition laws). 
• A new pharmacy price negotiation scheme for brand~d drug suppliers, introduced in 
1999 and price regulation for generics introduced in 2000, now means reduced 
profit margins for independents and multiples alike, further pressure upon the 
viability of the independent and increased propensity to sell out to multiples. Equity 
values may begin to fall. 
SOCIO CULTURAL EFFECTS 
• Stress related illness is increasing, (Statistics Bulletin, 1999) - increased pressure 
on drugs budget NHS by increased prescribing of tranquilizers. 
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• Government emphasis in society on health promotion; increased number of leisure 
centres / gymnasia; Government sponsored initiatives in dietary importance and 
healthy lifestyles. Health promotion role for pharmacy is increasingly important. 
• Public involvement in health service quality, annual patient survey proposed 
(Government White Paper: 'The New NHS - Modern, Dependable: 1997); may be 
an opportunity for pharmacists to form strategic alliances with patient organisations 
to build new cases for extra services to special groups, i.e. CHD, diabetic patients, 
etc. 
• lllicit drug abuse still increasing; methadone scheme development? Other 
approaches? 
• NHS medicines compliance still a problem (RPSGB / MSD Joint Project 1996 : 3 -
12) and related to drug waste on a grand scale; a major element of medicines 
management? 
• Public awareness of quality of care issues through television current affairs 
programmes and DH constant publicity on the subject. Further pressure upon 
stretched resources of independent communi7 pharmacy through clinical 
governance. Aid or barrier to medicines management? 
• Connection of whole popUlation to world wide web a real possibility through touch 
screen television; future communications with patients in their own homes greatly 
facilitated. Who will staff terminals at the GP end of the line? - Practice nurses? 
Further potential for pharmacy terminals and patient compliance / communication 
issues? 
• Nation wide drive to life-long learning - may have beneficial effect upon public's 
attitudes to medicines over a period of time. 
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TECHNOLOGY EFFECTS 
• 'IT' installed in every phannacy in UK and every medical practice - facilitates 
collaboration inter-professionally, when 'IT' links developed. 
• Potential for rapid communication in patient medication information, between 
pharmacists and GPs. 
• The virtual prescription is a reality and electronic prescriptions only a few years 
away (by 2005) - strong potential for redistribution of prescription volume and 
renewed viability of all phannacies - may be resisted by multiples as script volume 
is lost. 
• Potential for more sophisticated compliance aids and containers at reasonable cost 
for large scale use - especially the chronically ill. Perhaps increased potential for 
compliance assistance through television linked to the internet, triggered by 
pharmacy input for registered patients (signal transmission). 
• Potential for nation wide on-screen system and structure for review of patient 
medication in the phannacy by phannacists; more than an algorithm. It could also a 
, 
training aid and upgrade of review system, wi~ latest drug information and 
evidence based advice. 
• Doctor I phannacist conferencing a future possibility (1 OP practice + several 
pharmacists) in consolidating the periodic review of medication for each group of 
patients (e.g. CHD, asthma, etc.). 
• Potential to extend the last concept to Internet patient compliance clinics, for 
specific disease groups, at regular pre-agreed intervals, when all individuals 
(phannacist I doctor I patients) hold a 'virtual' get together to discuss the disease 
and its prognosis and medication review. Patients would assemble in a room with a 
facilitator and television screen, receiving selected advice (live) from consultants, 
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pharmacists, doctors, in different locations, joining the clinics at pre-determined 
times. 
• PRODIGY or MIQUEST IT systems to place more expertise in the hands of 
doctors? Is this a threat to pharmacy or an opportunity to add the medicines 
management initiative at pharmacy level with the patient? 
SUMMARY 
The above analysis, conducted under four main headings, gives an indication of 
dynamic environmental forces which pose threat and opportunity for community 
pharmacy, in its present form and structure. These issues will be used in the body of 
this thesis to illustrate and indicate ways of using the market environment to take the 
profession forward into a new order of service. 
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Patient Care through Medicines Management* APPENDIX 2 
Frunily Nrune: ................................................................ . 
Forename: .................................................................... . 
Address: ...................................................................... . 
Date of Birth: I I (Insert name o/prescriber below) 
DearDr .................................................................... . 
The current review of this patient's medication prompts the following observations: 
·Pharmacist management of medication on an ongoing basis helps to maximise the benefit and minimise /he 
risk from prescribed medicines by ensuring: the full understanding by the patient of the way in which the 
medicine i! to be used, and the need for concordance with the recommended treatm'ent; the laJe and 
appropriate choice and combination of medicinel, and structured collaboration with the prescriber. 
Pharmacist's signature Date: 
BLANKSHIRE H.A. 
N.E. PharmacistP6414 
The Phannacy 
Well Street 
Blanktown 
Tel: 01476592020 
For office use only ~.--. - ] 
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lDisease Category; Monitored Dosage System .. YesINol Recommend 
CHD/stroke Asthma Mental Diabetes GI tract Stoma 
Current medication Compliance Problems 
I I 
. I 
.. · .. ·· .. ········· ...... ······· .. ······ .. t················· .. ·~ ....................... . 2 !i i 
.. .. ········ .... ·· .. ···· .. ···············t··············· .. ··.,. ...................... . 
3 I I 
I ; 
4
·· .. ················· .. · .. ···············1········ .. ···· ...... 1" •••••••••••••••••..•..• 
I I 
...................... " ........................................................ ~ ........................................ i. ............................................ .. 
5 i I 
.......................................... i. ••••••••••••••••••••• 1 ........................ . 
6 I I 
r·········t .....................•............... _ .... l... ..•.••• 
Drug No: 1 .... ~ .... l ... ~ .... ..II ... ~ ..... l .. ~ .... l .. : .... l .... ~ .. ..! 
a) Side effect I toxicity \1 ......... + .......... ········+ .. ········i········+·_· .. ···! 
:~ ~~:~::action 1:::::::::::1::::::·:::: ·::::::::::1::::=:::::\.::=::=t::=j 
d) Sub-optimal dose i.·.·····.·l·· .. ·······I· .. ·· .... ··~··· .. ····I··· .. ······!· ..... _.1 
e) Unpalatable dosage form \ .......... l··········.'I·· .. ····~····· .. ···-!-·········l...· .. ··-! 
f) Disease I drug incompatibility I ........... ~ ........... ····· .. ··+··········1··· .. ····1l......_·1 
g) Food incompatibility 1 .. ·······+·········· ···········t···········r.' ._ •. - I··········i 
h) Drug avoidance j ........... ; ...................... i ...... · .... ··· __ ·t· .. ··_··j 
i) Medication asynchronised ~ .......... { ........... ·········l·······+· .... ··+·· .. ··i 
j) Potential generic substitution j ......... + ....... + ........ t········· .\ ........ +._, 
k) Possible reduction in items IL..····+······· ..... ·········t···········j··· .. ··· .. .,_ .. ···, 
•........... 1.. ......... 1... ........ 1.. ........ 1 •• __ 1._._ .. 1 
Notes: 
Patient sought advice on: Prescribed medication 0 O.t.c. medicine 0 Condition 0 
Lifestyle 0 Concordance 0 Palliative care 0 Other 0 
I consent to the information and advice contained on this form being made 
available to other members of the health care team: 
Signature of Patient (or representative) Date: I I 
APPENDIX3 
(Ref. Chapter 1 : Page 18) 
OUTLINE NETWORK ANALYSIS OF ACTIVITY REQUIRED TO 
CHANGE COMMUNITY PHARMACY FROM SUPPLY ROLE TO 
COGNITIVE SERVICE IN MEDICINES MANAGEMENT. 
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APPENDIX 4 
(Ref. Chapter 1 : Page 22) 
GROUPl 
CHAIR:RPSGB EDUCATION I TRAINING I ETHICAL 
Objective: 
Comments: 
* 
* 
* 
To ensure that pharmacists have the knowledge and 
ability to apply that knowledge to help people gain 
maximum therapeutic benefit and encounter minimum 
untoward side effects from medication which is 
appropriate for their treatment, in the pursuit of self 
regulation and lifelong learning. 
Knowledge, skills and culture are developed to enable 
-
community phannacists to discharge effectively the role of 
managing medicinal therapy. 
Skills in the learning methods can be applied according to the 
principles specified by the working group and establish best 
practice by giving learning providers a specification for desired 
outcomes. 
Key events and systems for a suitable change process are 
identified, to be certain that the learning (attitude, knowledge and 
skills) is achieved, and to build in ways of reviewing that learning 
and monitoring progress. 
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* 
• 
• 
Account is also taken of the need to work with and I or 
influence the learning of other professions. 
The approach reinforces, and helps pharmacists to meet their 
requirements of the code of ethics and professional standards. 
Aspects of clinical governance relevant to medicines 
management will also be part of this group's remit. 
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GROUP 2 
CHAIR:PSNC 
Objective: 
Comment: * 
'" 
'" 
APPENDIX 5 
(Ref. Chapter 1 : Page 22) 
COMMUNICATION/MEDICO-
PHARMACEUTICAL TEAM BUILDING 
Using the outline stakeholder analysis in the PSNC 
document this committee will identify and engage the 
major stakeholders 0/ the new role, hy appropriate 
communication techniques, and enlist their support in 
delivering a success/ul new role/or pharmacy. 
In conducting its work this committee will make best use 
of existing resources such as PR consultants, political 
consultants and other organisations as deemed necessary 
for the different target 'publics'. 
The committee will develop an outline communications 
programme for each target group setting out: the 
selection of media / means of promoting successful 
ownership of the new role implementation and suggested 
frequency of contact. 
The group will take account of the internal resources of 
each member constituency such as the major professional 
journals, regular organisational mailings (NP A 
Supplement, PSNC News, etc.) and such bodies as the 
RPSGB branches, LPCs and NPA branches. 
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GROUP 3 
CHAIR: 
Mission: 
APPENDIX 6 
(Ref. Chapter 1 : Page 22) 
PHARMACY PRACTICE RESEARCH GROUP: 
COMMISSIONING PROJECTS 
This committee will develop and present to the leadership group 
for approval satisfactory model(s) of service for the medicines 
management role. The models will use 'Action Research', as 
the developmental process in pilot style, so that by the end of the 
chosen period, a developed intervention is ready for a larger 
scale roll out 
Comment: ... In conducting its work for this project, the group will 
engage internal resourtes and external expertise in 
defining and structuring the interventions and suggesting 
a tight time scale. 
... Funding will be sought in collaboration with the 
leadership group for several pilots on a regional basis, 
taking account of new HAZ and peG structures. Careful 
work with these bodies will facilitate adoption of the new 
service within the revised structure of the New NIlS. 
This committee will also make recommendations to the 
leadership group on best approach to the overall 
intervention, i.e. should the pilots all be similar, or 
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* 
* 
* 
* 
differentiated for example by disease group? The 
leadership group currently favours a generalist approach. 
Perfonnance measures will also be developed, as well as 
statistically valid processes for generalisation, at 
completion. 
This group will liaise closely with the communications 
group in engaging the team building component of each 
medico-phannaceutical collaborative project. 
It will also be the responsibility of this group to suggest 
methods of project funding and to collaborate with the 
leadership group in approaching suitable sources. 
Proposed models of service and pilot locations together 
with perfonnance measures will be submitted to the 
leadership group prior to action. 
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APPENDIX 7 
(Ref. Chapter 1 : Page 22) 
GROUP 4 
CHAIR: NPA REPEAT DISPENSING DEVELOPMENT 
Objective: To develop an action plan including: key tasks, time scales and 
funding to rollout repeat dispensing across the whole of 
England and Wales in line with the time scale dictated by 
negotiations with the NBS Executive. To submit this action 
plan to the Medication Management Group for approvaL To 
manage and monitor the implementation of the approved action 
plan. 
Comments: * To ensure that the platform created by repeat dispensing is 
a suitable base from which medicines management can be 
developed. 
* Establishment of the 'FPIO' as a central document in 
medicines management is a crucial factor in securing the 
new role for community pharmacists already in contract to 
the NHS. This document, instead of simply being an 
order for medicines, becomes Q contract for patient care, 
triggering for the chronically ill, a medic3tion review. 
* Developing pharmacist familiarity with increased 
responsibility is judged by the leadership group to be an 
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• 
* 
important prelude to the transformation of the 
pharmacist's place in primary care . 
Progressing acceptance and roll out of repeat dispensing 
services, may also be used as a relatively user friendly 
way of engaging the medical profession in a collaborative 
exercise and building confidence between the two 
professions. 
Continued excellence in extending this service will make 
a big contribution to the successful introduction of 
medicines management. 
• Liaison between this group and the PPRG will establish 
means of collaboration in the commissioning project roll 
out. 
427 
APPENDIX 8 
(Ref. Chapter 1 : Page 22) 
GROUPS 
CHAIR: CCAI 
CPTP PREMISES J IMAGE CHANGE 
Objective: This group will develop concepts for in-pharmacy 
transformation o/facilities and image, in such a way as to: 
• encourage patient participation in the new service 
• facilitate and encourage pharmacist engagement in the new 
role 
• generate confidence in the: medical profession through a 
thoroughly professional new intervention in primary care by 
the pharmacist. 
Comments: ... Successful transfonnation of the professional side of 
pharmacy, through its image with the public is one of the 
most powerful influences in successful modern 
relationship marketing and will build public confidence 
in the community profession. 
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'" 
.,. 
... 
... 
... 
... 
... 
Infonnation technology as well as consultation facilities 
will be a key consideration in this work, both for records 
and intercommunication with the medical profession . 
The area where the medicines management activity occurs 
should be within the pharmacy counter I dispensary area 
(Le. where there is immediate access to the pharmacist). 
The area should be uncluttered, clean, warm, welcoming, 
professional and with no barriers to entry . 
The area should be quiet and information in the form of 
leaflets and I or videos and books should be available. 
There should be ready availability of trained support staff, 
easy access to the pharmacist and easy access to the area 
itself. There is no need for separate consulting rooms, at 
this stage. 
Only pharmacy merchandise should be available in the 
pharmacy counter I dispensary area and in the consulting 
area itself. Little, if any, merchandise should be 
promoted. It is recommended that health promotion I 
health education information should be available, together 
with compliance aids and equipment to support, for 
example, the demonstration of inhalers, etc., together with 
appropriate diagnostic equipment necessary for patient 
monitoring, e.g. peak flow meters, cholesterol testing and 
blood pressure monitoring. 
There is a need to provide seating, particularly for elderly 
patients and there should be some worktop provision. 
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* 
* 
* 
* 
* 
Cash taking facilities within the consultation I quiet area 
can detract from the professional image. It is, however, 
recognised that it is not possible to remove these facilities 
in all small pharmacies. 
The area itself needs to be within the pharmacy counter I 
dispensary area so that the pharmacist will still be able to 
be in control of activities within the professional area, and 
the area needs to be discreetly located and obviously apart 
from the main customer traffic flows so that patients I 
customers cannot inadvertently walk into it. 
The area should be able to accommodate more than just 
two people, particularly when children will require to be 
accompanied by a parent and possibly a minimum of 40 
square feet will be required. 
It is recognised that it will be necessary to generate 
sufficient income from this space to cover the potential 
lost sales opportunity. 
There should be appropriate signage outside the 
pharmacy, within the pharmacy and also at lover the 
consultation area. 
• Consideration will be given to the appropriate location of 
IT equipment within the pharmacy I counter dispensary 
area. 
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APPENDIX 9 
(Ref. Chapter 1 : Page 22) 
WORKING GROUP GUIDELINES 
1. GENERAL - EACH GROUP WILL: 
1.1 Construct an outline programme of proposed work with milestone objectives and 
submit to the leadership group for approval I amendment. Each working group 
will progressively agree a timetable of delivery of objectives with the leadership 
group. Working groups should also set out a reporting programme indicating 
how the work of the group will be reviewed and monitored, taking into account 
quality objectives, a time plan and milestones. 
1.2 Meeting frequency is at the discretion of each working group. 
1.3 Adopt the partnerships of patient care as the overall guide document. 
1.4 Submit minutes of their meetings to leadership group one week or thereabouts 
after the meeting. Members of the working groups will be kept appraised of the 
progress of other groups by the Leadership Group. Minutes of the working 
groups will be considered by the Leadership Group to ensure that the working 
group's activity is co-ordinated and there is no overlap. 
I.S Refer items of all proposed expenditure for operational proposals to leadership 
group for approval. 
1.6 A verbal report on each working group will be made at the Leadership Group 
meeting by the appropriate lead organisation. 
1.7 The chairman and secretary of the leadership group may be ex officio members 
of the sub-committees and will attend on an infrequent ad hoc basis. 
431 
1.8 Each constituent members. hip of the groups will be responsible for its own 
expenses and meeting facilities. 
1.9 It will accomplish this with a timetable progressively agreed within the 
leadership group. 
NB. Progress of each group will be reviewed by the leadership group and matters 
for joint collaboration and interests relayed on to other sub groups for action. 
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APPENDIX 10 
(Ref. Chapter 1 : Page 16) 
MEDICINES MANAGEMENT- PHASES 
Note: The medicines management process, has hitherto been conceptualised as a cyclical four phase 
process, i.e. 
• Review of the patient's prescription; 
• Consultation with the patient; 
• Recommendations to the patient's GP; and, 
• Implementation and review. 
The phases of medicines management, in an operational setting have been regarded as 
falling into four distinct procedures as outlined in the note above. However, with 
experience of operating a scheme in Oateshead on Tyne, it has become clear that a fifth 
process is desirable as a formalised part of the complete service. 
This is a pre-phase, to the review of the patient's prescription, in a fully developed 
Partnership of care, between patient, doctor and phannacist. That phase is a review of 
the patient's illness I condition as being currently treated. This is to contextualise the 
medication, so that accurate recommendations can be made, i.e. it should be known for 
example, what a particular diuretic is being used for; is it simple diuresis, congestive 
heart failure or hypertension? The full cyclical phases of developed medicines 
management would thus be: 
• Review of current patient medical condition; 
• Review of current medication; 
• Patient consultation with pharmacist; 
• Pharmacist recommendations to OP; and, 
• Agreed implementation and cyclical review. 
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APPENDIX llA 
(Ref. Chapter 3 : Page 45) 
KEY INFORMANTS - CODES 
CODE 
Professor Sir Michael Rawlins BSe MD FRCP (Ed.) PRCP (Lond.) FFPM A 
Chairman: National Institute of Clincical Excellence 
Professor Colin Bradshaw MB CbB FRCP FRCGP 
Visiting Professor of Health & Social Science & Education 
University of North umbria & General Practitioner, South Tyneside 
Dr. G. Rae MB BS 
Chairman, North Tyne Medical Committee and General Practitioner 
Dr. K. Megson BA MB BS MRCGP DRCOG 
Secretary, South Tyne Medical Committee and General Practitioner 
Dr. B. Posner MB BS 
Secretary, Sunderland Medical Committee and General Practitioner (Retd.) 
Dr. M. Stewart BSc MBA PhD 
Director of Professional Services, Durham Health Authority 
Dr. I. Spencer MB BS 
Director of Primary Care, Newcastle & North Tyne Health Authority 
Dr. D.M. Fleming OBE, MB CbB PhD FRCGP 
Royal College of General Practitioners and General Practitioner, Binningham 
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APPENDIX lIB 
(Ref. Chapter 3 : Page 45) 
FRAMEWORK OF INTERVIEWS - KEY INFORMANTS 
Technique flexible, semi-structured 
Introduction brief and based upon Government White Papers 
Thank you for helping with my research. The purpose of this work is to explore some 
issues which may be involved with closer medical I pharmaceutical collaboration in 
primary care. As you know, recent Government White Papers are supportive of the 
primary health care professionals working closely together and this discussion simply 
seeks to obtain your views on these matters. 
Question 1 
Are there any aspects of patient treatment which may be suitable for a new pharmacist 
involvement? 
Question 2 
What do you feel will be the general reaction of GPs to a new structured relationship 
with community pharmacists? 
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Question) 
Do you see any particular problems arising with a proposition to bring the medical and 
pharmaceutical professions more closely together? 
Question" (for those who see problems) 
How, in your view, may these problems be addressed? 
Question 5 
What, in your view, would be conducive to a new pharmacy involvement with patient 
care: 
(a) For the patient? 
(b) For the doctor? 
Question 6 
How could a more structured operation be developed between the doctor and 
pharmacist? 
Question 7 
Where should a new pharmacist role be located? 
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Question 8 
If a new role for pharmacists along the lines we have discussed was proposed, are there 
any aspects you feel should be omitted from such a proposition, i.e. which may be 
regarded as unattractive? 
Question 9 
Would you like to be involved in developing a new role for pharmacists in a new 
'partnership' with GPs? 
Question 10 
May I refer back to you for comment when this research nears completion? 
Many thanks for your help in the consideration of the way forward for pharmacy. I will 
refer back to you with some results, for any comment you wish to make. 
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ADR 
CRC 
Dl 
GP 
GPC 
HA 
HAPA 
IT 
Introduction 
APPENDIX llC 
(Ref. Chapter 3 :Page 47) 
RESEARCH RESULTS ANALYSIS 
• 
KEY INFORMANTS 
KEY INFORMANT INTERVIEWS 
CONTENT ANALYSIS 
ABBREVIATIONS 
Adverse Drug Reactions 
Community Health Council 
Drug Interaction 
General Practitioner 
General Practitioner Committee 
Health Authority 
Health Authority I 
Pharmaceutical Adviser 
Information Technology 
LMC 
LPC 
OTC 
PC 
peG 
PCf 
RCGP 
Local Medical Committee 
Local Pharmaceutical Committee 
Over the Counter medicines 
Patient Compliance 
Primary Care Group 
Primary Care Trust 
Royal College of General 
Practitioners 
The Key Informant interviews are discussed under each of the questions asked in the 
semi-structured interviews. The dominant themes have thus been extracted and 
exceptions reported where they are considered significant. Additionally, where 
responses under particular questions also relate to responses under other questions, these 
are mentioned to help establish consistency / inconsistency in attitudes and beliefs of the 
• 
respondents. 
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Questions 
Question 1 Are there any aspects of patient treatments which you feel may be 
suitable for a new involvement by the pharmacist? 
The interesting overall aspect of the responses here is the unanimity of 
assent, that there were tasks, which these highly qualified doctors 
perceived as the domain of the pharmacist. No respondent stated, or 
implied, that such issues were the sole realm of the doctor. As to why 
this is, could be pursued in further question and comment, in final 
feedback of results to the key informants. 
Equally interestingly, the suggestions from all were medicines based and 
of these five (62%) related to patient compliance with the medicines 
regimens. As respondent C put it: 
' ... 1 have done some research on patient compliance... and figures 
collected by me vary, between 34% and 60% of patients not taking their 
medicines regularly or correctly ... ' 
A similar number of respondents iemphasised rationalisation of 
prescribing within the practice (5 = 62%) as suitable for pharmacist 
involvement. The implication, according to respondent A, was that 
doctors are conscious of inconsistencies of prescribing practice. 
Three respondents mentioned drug cost reduction and shifting branded 
drugs to generics, which are related issues, (Q8: D, E confirm this 
issue). 
Only one informant, at this stage (respondent A) mentioned premises 
deficiencies in pharmacies. This translates in his terms, into lack of 
confidentiality for patients and could form a major consideration in the 
total product offering. 
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Key Themes -
Exception 
Recognition of pharmacist potential 
Patient compliance problems 
Could reduce doctor workload 
Question 2 What do you anticipate will be GP reaction to a new structured 
relationship with community pharmaCists? 
Six respondents, (75%) felt sure that reaction would be mixed and three, 
(37%) judged age difference, (young voId doctors) to be a significant 
factor. 
Respondent A was keenly aware that the new pharmacist proposition 
would need selling ... and benefits shown. This is a clear indication of the 
need to consider not only the new product, but the presentation 
(packaging) and communication issues involved in the target market 
needs and motivation. 
Key Themes -
Exception 
Age related doctor resistance (self esteem?) 
Potential workload barrier to change 
Need to sell the new proposal 
Question 3 Do you see any particular problems with a proposition to bring the 
medical and pharmaceutical professions more closely together? 
The problems mentioned, developed mainly around the operational 
difficulties in sustaining a formalised relationship. The systems and 
paperwork implications were mentioned by six of the eight informants, 
(75%) and five, (62%) mentioned the volume, time and paperwork 
involved - all matters of resource. The total product offering needs to 
address these issues effectively, because even if the product could be 
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successfully introduced without such consideration, in practice these 
aspects may become serious disincentives to continue the scheme. The 
product could thus fail, post market introduction. It is significant that 
respondent D felt that problems could be avoided by ... planning well. 
This is one of the first elements in Kotler's definition of marketing, 
(Chapter 4). 
Key Themes -
Exception 
Potential workload and organisational barriers to 
change 
Need to sell the idea 
Question 4 How, in your view, may these problems be addressed? 
Six, (75%) of the eight informants favoured a joint GP / Pharmacist 
approach by preparatory discussions, (the beginning of relationship 
building) and five, (62%) suggested facilitation by one or more of the 
NHS bodies, (pCG / HA / LMC / LPC). This, in effect, is sponsorship 
in communications, (Chapter 4) and will be used at the appropriate 
stage. 
Key Themes -
Exception 
Collaboration inter-professionally 
Official sponsorship: Government bodies 
Need to sell benefits 
Question 5 What, in your view, would be conducive to a new pharmacy involvement 
with patient care? 
(a) For the doctor? 
(b) For the patient? 
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For the doctor a number of requirements emerged, some of which reflect 
or relate to Garvin's dimensions of quality in product design, (Table 13, 
page 64). These included premises facilities, teamwork, doctor support 
by pharmacist and official leadership. 
The doctor's perception of the factors which may assist patient 
participation in the new pharmacist role, were confidentiality of 
encounter with the pharmacist in the pharmacy and reflection of the joint 
doctor / pharmacist nature of the new service to the patient, (75% of 
respondents C, D, E, F, G). There is a hint here of the needs of the 
doctor to be satisfied, in terms of esteem and actualisalion (Chapter 4). 
Key Themes - Confidentiality of service 
Official sponsorship: Government bodies 
Doctor self esteem 
Question 6 How could a more structured operation be developed between doctor 
and pharmacist? 
The unanimous theme here was that of ~ponsorship / opinion leadership 
through the structure of the NHS, (pCGs, HAs, LMC / LPCs) and lead 
organisations of the professions (GPC / PSNC). Top down, bottom up 
effort was suggested by respondent B. The leadership level, of the 
Burke-Litwin change model, is assuming importance as a target of 
marketing effort, in encouraging change. as discussed in Chapter S. 
Workshops, focus groups and systems development are indicated by six 
respondents, (75%). 
Key Themes - Official sponsorship / leadership 
Collaboration inter-professionally 
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Question 7 Where should a new pharmacist role be located? 
Seven respondents were fIrmly in favour of the pharmacy, (87%), but 
one said the surgery, unless IT links were good enough to allow a 
pharmacy based service. Interestingly, respondent A indicated in his 
reply that ~ .. a little more professionalisation may be required in all 
pharmacies ... ' When questioned further, this turned out to mean a 
premises confidential facility and an agreed protocol for interfacing with 
the patient. This supports the overall response in Question 5, to factors 
which may be conducive to the new pharmacy service. 
Key Themes - Location of product in the pharmacy 
Exception At GP surgery: doctor self esteem 
Question 8 In a new pharmacist role along the lines we have discussed, are there 
any aspects you feel should be omitted? 
Two elements of the responses seem to be particularly signifIcant. 
Infonnants A and C suggested that therapeutic substitution of drugs is an 
issue for later, (as opposed to a launch: topic). They indicated that the 
decision to change the patient's drugs must lie with the doctor, even 
when current medication is failing. Further questioning exposed the 
view, that pharmacist involvement here would be likely to be perceived 
by GPs as a threat to their core role. The rationale underlying Maslow's 
Hierarchy of Needs again emerges as a concept to be considered 
carefully, with regard to self actualisation and esteem. Otherwise, 
respondents did not raise any major items to be omitted. A system to 
ensure reduction in wastage was mentioned twice. 
Key Themes - Avoid therapeutic substitution 
Doctor autonomy: self esteem 
Reduction of drug wastage 
Patient compliance 
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Question 9 Would you like to be involved in developing a new role for pharmacists 
in partnership with GPs? 
All respondents were interested in becoming involved, given that certain 
political sensitivities would need to be recognised and addressed. 
Key Themes - Unanimous assent, given time and sensitivity 
Question 10 Wouldyou be willing to comment upon some aspects of this research? 
Summary 
Again, all respondents were positive, but two again emphasised the 
politically sensitive nature of their positions. 
Key Themes - Unanimous assent, given confidentiality I 
sensitivity 
The potential sensitivities mentioned in response to questions 9 and 10 
may be in themselves, some indication of tensions between the two 
professions. 
The overall result of the key informant interviews was positive and constructive, with 
respondents recognising certain appropriate tasks for the pharmacist. All these elements 
are present in the core product offering. 
Prominent, was patient compliance and workload considerations, the latter of which 
were perceived to be a potential barrier to GP acceptance, as was the older GP. The 
scheme would need selling, in the view of two respondents. 
Collaboration and the usefulness of sponsorship emerged as suggestions for taking the 
process forward. 
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An indication of underlying doctor self esteem emerged in questions 5, 7 and 8 and it 
will therefore be advisable to ensure that product packaging and the communications 
message, support this possibility in consonant copy. 
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APPENDIX 12A 
(Ref. Chapter 3 : Page 48) 
MEDICINES MANAGEMENT FOCUS GROUP: STEERING CUES 
SEMI STRUCTURED FORMAT - FREE RANGING DISCUSSION 
. 
. A.M. Tweedie Chair 
Secretariat PSNC General Secretary 
Introduction Content 
Medicines management as a new role for community pharmacy; repositioning 
community pharmacy in primary care; communications with stakeholders; education I 
training,' interprofessional relationships; the way forward 
Rationale and Objectives 
The leadership of the phannaceutical profession is co~plex with several autonomous 
bodies with nominally different responsibilities. Political drivers create overlap and 
sometimes disparate views and conflict. The overall purposes of this group were: 
• To begin to generate joint ownership of changing the profession's future; 
• To encourage the 'leaders' to begin to relax in joint efforts and discussion; 
• To allow mind sets to begin to see clear individual responsibilities in taking the 
medicines management issue forward and avoid duplication; and, 
• To achieve 'critical mass' of commitment at leadership level; 
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The specific overt objectives were: 
• To gain group views of current dispensing pharmacist abilities to undertake 
medicines management; 
• To ascertain group views on any educational and training requirements for 
dispensing pharmacists; 
• To gain, if possible, unanimity on ways of taking the initiative and the 
profession forward; 
• To achieve an agreed group view on communications to the stakeholders; and, 
• To agree, if possible, on immediate next steps (to avoid loss of momentwn), if 
group agreement and approval of the initiative was achieved. 
Meeting Flow 
The meeting was conducted on informal lines to encourage open debate and expression 
of views. Straying conversation was permitted, if the stray subject was relevant to the 
topic in hand. Intervention by the chainnan was minimised to encourage the nature of 
freely expressed group discussion. It is sometimes the case that the most important 
issues arise and underlying views emerge, tangentially, to what is perceived to be the 
central issue of the main agenda. 
Summary 
The report of the group is by abstract and matrix of group member contributions 
shOwing the response of the group members and indicating the effect upon group 
collaboration and future potential. 
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APPENDIX 12B 
(Ref. Chapter 3 : Page 48) 
REPORT OF THE PHARMACY MEDICINES MANAGEMENT 
LEADERSHIP FOCUS GROUP HELD AT THE RPSGB ON 
THURSDAY 4th JUNE 1999 AT 1.00 pm 
Present: 
Mr. N. Baumber 
Mr. S. Williams 
Mr. P. Curphy 
Mr. J. Ferguson 
Ms. C. McCreedy 
Dr. I. Spencer 
CHAIR: 
NHSE 
NPA 
PSNC 
RPSGB 
) PSNC Medicine Dr. G. Hawksworth ) Community 
) Management Prof. C. Mackie ) Pharmacist 
Group Practitioners 
)RPSGB Ms. C. Dutton ) Pharmaceutical 
) ) Adviser 
)NPA Mr. S.R. Axon ) 
Mr.M.King ) PSNC Staff-
)NHSE Mrs. B. Parsons ) Secretariat 
Mr. A.M. Tweedie 
National Health Service Executive 
National Phannaceutical Association 
Pharmaceutical Services Negotiating Committee 
Royal Pharmaceutical Society of Great Britain 
1. INTRODUCTION 
The Chainnan introduced the purpose of the meeting, which was to discuss in nn open 
and relaxed way, the future potential of medicines management, as a new role for 
community pharmacy and a means of repositioning the profession in primary care. It 
was hoped that the group would also explore some of the issues associated with the 
proposition and express views on such topics as communications within and external to 
the profession, education and training and inter-professional relationships. He further 
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explained that his role was simply to steer the group and clarify, where necessary, any 
subjects where guidance was needed at times, during discussion. All members had been 
pre-supplied with the new medicines management booklet which had been prepared by 
a working group, chaired by the Chairman of this focus group. The session was 
conducted on informal conversational lines. 
Steering cues for the group were: 
i. Community pharmacists' ability to undertake the new role and any 
educational / training requirements / facilities. 
ii. The way forward. 
iii. Outcomes beneficial to stakeholders. 
iv. Communications. 
Recording of comment was undertaken by the secretariat and abstracted, with the 
Chairman's help, as a written account, with specific quotations where felt to be helpful. 
2. PHARMACISTS' ABILITY TO UNDERTAKE THE NEW 
ROLE - EDUCATION I TRAINING 
CHAIR: 
'This section of our discussion relates to dispensing pharmacists' present 
ability to operate a medicines management scheme. Can we discuss this 
subject andjlag up those issues wefeel are important?' 
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Mr. Ferguson asked: 
'Have any apprehensions been expressed within the survey which has 
been carried out in the north east of England, about the ability of 
community pharmacists to carry out the role of medicines management. I 
The Chairman replied that the apprehensions expressed mainly related to their 
professional ability regarding clinical knowledge and their ability to influence general 
practitioners. However, a majority of respondents had indicated willingness to 
undertake the medicines management role, given that they would receive training. 
Professor Mackie: 
'I'm sure that special training will be required for many pharmacists. 
The course at Aberdeen University... and from other universities, would 
equip pharmacists to undertake the new clinical role involved in 
medicines management. ' 
On being questioned by Mr. Baumber, she responded that those taking part already in 
such courses did not come from any particular age group, but covered a fairly wide 
spectrum of experience. She indicated that, in her view, the Aberdeen course was more 
rigorous than many of the courses available. 
The main characteristics of the Aberdeen course summarised by Professor Mackie were: 
• Distance learning 
• Modular format of 15 hours per module 
• Six modules in total for community pharmacy 
• A period of placement within GP practices 
• Cost of the order of £2,000 
In addition to the cost of the course, participants need to provide for attendance 
at Aberdeen for three weeks. 
450 
The course could then be converted to an MSc at a cost of a further £500. 
Professor Mackie agreed to send details of the course to the Chairman. 
Mr. Curpby asked: 
'Does medicine management start from the assumption that there is to be 
a massive amount of training and that every pharmacist will provide the 
medicine management service?' 
His feeling was that currently many pharmacists could undertake the role, but others 
would never be able to provide the role due to lack of expertise. He asked whether 
these points would be covered in pilot trials. Mr Tweedie replied that research 
conducted in the northern NHS region (his MBA dissertation 1997) indicated that all 
pharmacists could undertake the role, given adequate training. This was irrespective of 
age groups. However, as the project rolled out, interest should help stimulate 
commitment amongst all contractors, who may not wish to be left behind. 
Ms. McCreedy referred to the experience of the National Pharmaceutical Association 
with pilot trials of some of the elements of medicines management and indicated that 
other basic experience was being built at local level. ! She suggested that in devising 
pilots, an examination should take place of what is currently known, to avoid the 
necessity of: 
' ... reinventing the wheel. It is important to work upon specific skills, 
including those of an inter-personal nature. ' 
Ms. Dutton indicated that health authorities were working on some aspects of 
medicines management, such as prescribing advice, and that her experience, and that of 
other pharmaceutical advisers, was that general practitioners are very keen to use 
Pharmacists. She also said: 
'In my experience, pharmaCists have good inter-personal skms, and will 
quickJy adapt to medicines management. ' 
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She noted that the PSNC working party report had made very sparse mention of other 
professions - in particular, nurses and hospital phannacists. She felt that there was a 
need to make use of all local expertise, in appropriate ways. 
Mr. Ferguson referred to the government health improvement programme: 
'I'm pretty sure the new NBS structure will produce a huge demand for 
prescribing support... when Primary Care Groups begin to operate ... 
there'll be a 'demand pull' for pharmacist expertise. ' 
Professor Mackie indicated that she disagreed with much of the implication of what 
had been said with regard to community pharmacists' lack of clinical ability: 
'... many pharmacists are already providing some clinical service, as far 
as they can, but they flel they don't have suffiCient access to the 
information required, as well asfacilit;es. to provide a complete service. ' 
In this respect, she criticised the definition of 'dispensing' set down by the Royal 
Pharmaceutical Society of Great Britain, saying: 
'The profession has to start from the ass~mption that community 
pharmacists are clinical pharmacists,· that clinical practice should take 
place across the whole of the spectrum of pharmacy activity. ' 
Unfortunately, in her experience: 
'Some pharmacists provide services at only one end of that spectrum. ' 
(She did not relate the RPSGB definition of 'dispensing'.) 
She also disagreed with what had been said within the profession, in the past, about the 
core skill being 'dispensing', She considered the core expertise to be the clinical skills, 
rather than the mechanical or commercial skills, of a retail pharmacy operation. 
Pharmacy, she said, was concerned with applied therapeutics. 
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Dr. Hawksworth welcomed the PSNC working party report produced under Mr 
Tweedie's chairmanship. 
'It sets out the way that pharmacy practice should be undertaken. .. this is 
the way it operates in my pharmacy ... I am interested in patient care; not 
just dispensing. ' 
'One can't just provide a training course and expect a pharmacist to be 
immediately allowed to practice. Other support systems need to be in 
place ... medicines management requires a life-long learning process. ' 
She also stressed the importance of the service being provided within the community 
and from the community pharmacy, rather than peripatetics. 
Dr. Spencer, (HA Medical Director, Newcastle and North Tyne) during his time 
working for the NHSE, had learned what pharmacy could offer in terms of a range of 
skills which could be provided from the site where services are available to patients. He 
said: 
'As far as health authorities are concerned, it's not so much a cost 
argument, as one of getting the maximum value jar money. ' 
He felt that one of the main barriers was that of communication between doctors and 
Pharmacists, brought about by the lack of recognition of the community pharmacist as 
an integral member of the Primary Health Care Team. He said: 
'This should be addressed as a matter of some urgency ... do you have 
plans to address this problem?' 
Mr. Curphy: 
'We need to start a dialogue with heads of schools of pharmacy for a 
built in baseline, with regard to the need to encourage undergraduates 
well ahead of the need to communicate with GPs.. Discussions should 
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also take place with the Education Division of the RPSGB, to encourage 
practising pharmacists to make an effort to build good rapport with the 
local GP.' 
Mr. Ferguson regarding Dr. Spencer's point about 'skills" referred to the range of 
courses available through the RPSGB and passed across a booklet on this to the 
Chairman. 
Dr. Hawksworth was fmnly of the view that the medicines management service should 
be encouraged, without pharmacists being put off by either major cost, or major 
examinations. She also pointed to the problems that exist where a medicines 
management service would be provided in a pharmacy and the pharmacist owner was 
absent. She felt, therefore: 
'locum pharmacists must also be targeted for the provision of the 
service, and given some training. ' 
SUMMARY 
The Chairman summarised this part of the discussion b~ saying that there appeared to 
be general agreement that there was a need for a structured programme of education and 
training for community pharmacists, as defined at present, and that this was a major 
issue on which the RPSGB would undoubtedly be able to give guidance and oversee I 
co-ordinate the various options. 
'Clearly, the operating relationship between doctors and pharmacists 
needs careful priority address, as suggested by Dr. Spencer. This can 
either be a major facilitation of the proposed new service, or indeed a 
major barrier to progress. ' 
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3. THEWAYFORWARD 
CHAIR: 
'We have looked at some of the issues involved in preparing the 
professionfor this role. What do you feel is the best way of taking things 
forward?' 
The meeting then turned to a general discussion relating to bringing pharmacists and 
doctors together. 
Mr. Curphy opened the discussion by asking: 
'How far are we prepared to go with the detail of any pilot work? For 
example, are we talking about taking blood pressure readings or 
samples? If so, what action should the pharmacist be prepared to take -
to refer to the GP, or to be more proactive in changing dosages? , 
Ms. Dutton expanded on this point by asking: 
'Will the pharmacist takefull charge or responsi~ilityfor the care of the 
patient?' 
CHAIR: 
'That is not what is envisaged at present. We need to bear in mind the 
role of the doctor. • 
Professor Mackie took up the issue saying: 
'It is easy to 'cherry-pick' the simpler items of medicines management 
and devise protocols for them. The danger of this is that others could 
also do it, such as nurses; blood pressure monitoring is a very good 
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example. However, if blood pressure monitoring leads to the changing 
of drug regimens, this would be a task which the pharmacist alone would 
be properly fittedfor ... but it's not takingfull charge of the patient. ' 
She envisaged a movement to self-management by patients, together with the 
pharmacist's support, as the pharmacist had an advantage over all other health 
professionals, due to the knowledge of the interactions of drugs, both NHS and ore, 
and multiple disease states. 
Dr. Hawksworth considered that the management of medicine should be linked to an 
ongoing monitoring process within the pharmacy. Dr. Spencer pointed to the 
importance of the service being patient-focused. He made the point: 
'A Primary Care Group is an administrative group, but the pharmacist 
should be an integral part of the Primary Health Care Team. It is 
important to distinguish between Primary Care Groups, on the one hand, 
and the service provided through the Primary Health Care Team, on the 
other. ' 
Ms. McCreedy raised the issue of the definition of 'Medicines Management' by saying 
that the PSNC definition clearly included prescribing sJpport, whereas the NPA felt that 
the definition within the PSNC's document was more akin to pharmaceutical care. The 
Chairman indicated that this was an issue that would need to be examined again by the 
Group and agreement reached on a universally acceptable definition. He asked: 
'Is it your view that on this issue, in particular, the profession should 
speak with one voice? ' 
A discussion then took place with regard to terminology, in particular: 
• medicine management 
• compliance 
• pharmaceutical care 
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Different members favoured different expressions and the matter was left for further 
discussion. 
Mr. Curphy stated: 
'Terminology will be a matter to be resolved through the Joint Steering 
Group when it meets. ' 
4. OUTCOMES BENEFICIAL TO STAKEHOLDERS 
CHAIR: 
'Perhaps we could now move on to another important issue; what 
outcomes of medicines management do you feel are important to the 
stakeholders? ' 
(No guidance was given on who the stakeholders may be; views were left to emerge) 
The meeting then turned to the discussion of outcomes. Mr. Curphy felt that these 
were key to the whole process and that, ultimately, the p~yment to pharmacy contractors 
would solely depend on outcomes: 
'We should be looking at outcomes for patients, doctors and any other 
beneficiary we can think of ' 
(The indication here was that a range of stakeholders needed to be identified) 
Ms. Dutton asked how these outcomes might be defined and suggested that it would be 
necessary to have appropriate 'proxies'. The following suggestions were made: 
• the impact of services on drugs budget (Mr. Baumber) 
• reduced admissions to secondary care (Mr. Ferguson) 
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• patient and users' views, such as doctors and nurses (Dr. Hawksworth) 
• surrogate markets (Ms. Dutton) 
As regards the patient I user views, Ms. Dutton said: 
'It's very important that this should include satisfied professions, 
satisfied users and a good financial outcome. Important stakeholders 
would be, for example: 
• Pharmacists themselves 
• Patients and Patient's Organisations 
• Doctors 
• The Department 
• Health Authorities. 
Professor Mackie referred to the importance of clinical outcomes for the patients and 
mentioned 'bandolier'. She went on to outline this research project which had been 
undertaken within her University, where the NHS drug and OTC treatment of patients 
was examined and, where appropriate, reference was made to the patient's GP. In this 
particular study, follow-ups were made a year later to confirm the clinical outcome. 
The project had involved a control group, which was also. documented. 
Patients within the project were on four or more drugs and the referral rate was 84% on 
clinical grounds. The GP rejection rate of pharmacist recommendations was only 3%. 
On average three problems per patient were noted. Professor Mackie indicated that they 
would shortly be publishing the research, which had been put to the Scottish Office and 
had been well received. She undertook to let the Chairman have the detailed 
information. 
Some discussion, triggered by Mr. Ferguson, then took place with regru-d to the cost of 
pilots. Professor Mackie outlined the cost of the pilot carried out in conjunction with 
the Scottish Office. 
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In brief: 
• 30 community pharmacists had been trained at a cost of £46,000; 
• the training involved 40 hours clinical phannacy (problem based); 
• private study time commitment was 30 hours over 10 weeks; 
• the protocol included time within a GP practice over a period of 3 - 6 
months; and, 
• £20,000 was being made available to progress this project. 
She cited an important point that had come out of this project, was the need for full 
relevant patient information being made available to the pharmacist and the value of an 
IT link was also identified for the future. 
Mr. Curpby asked: 
'Will it be possible to undertake medicines management without the ful1 
patient information? ' 
A discussion then took place where various views were expressed: 
• formulary advice could be given without specific patient input (Ms. Dutton); 
• prescribing advice could also be given without patient records being 
involved (Mr. Ferguson); 
• review of patient medication cannot be realistically undertaken without 
patient illness history and / or full medication record (Mr. Bawnber); and, 
• Mr. Williams, likewise, confirmed that concordance issues and identification 
of side effects could not be identified without patient collaboration. 
Dr. Hawksworth felt, however, that it was a prerequisite for an effective system, that 
teamwork should operate, there should be a full patient profile and ideally, an IT link. 
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Ms. Dutton referred to teamwork being very relevant to health improvement 
programmes, which might provide an opportunity to expand upon medicines 
management and to encompass health promotion. 
Mr. Ferguson said: 
'This again emphasises the importance of pharmacists being connected 
to the NHS net, through which a more comprehensive approach can be 
made. ' 
Dr. Hawksworth expressed some reservations, based on time involvement of both 
pharmacist and staff. 
Mr. Curphy agreed, saying; 
'Technician responsibilities will undoubtedly be on the agenda again, 
won'/ they? The onerous supervision requirements of the pharmacist 
need to be examined ' 
CHAIR: 
Dr. Spencer: 
'Ian (Dr. Spencer) what is your view of the role of the health 
authority in the new pharmacy initiative?' 
'I think health authorities will be very positive in trying to move towards 
your new role, but currently the situation is in a state offluxfor funding. 
Most of the available finance c~mes to the health authority through the 
general medical services budget and some health authorities have 
facilitators in this area. Funding opportunities will arise if peGs arc 
organised and accordingly, provided that those doctors at 'grass roots' 
are convinced of the need a/the service and the benefits it brings. • 
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(In his Authority that benefit was already being used and recognised.) 
'ft is really a matter for good promotion of the service by your 
profession. ' 
Professor Mackie referred to the needs assessment of patients and that this should be 
proactive by the GP transmitting relevant information to the pharmacist through an IT 
system. This process, she felt, should be based upon specific groups of patients and 
conditions, which would automatically qualify for the new intervention. This would be 
a 'fIrst stage' in the overall process and assist in producing the best outcome. 
Turning to the selection of those who might be included in the trials, Mr Curphy 
suggested that the service may have to grow by starting with those who currently 
provided elements of medicines management. There would thus be a 'cascade' roll out 
programme which would also be in line with the uptake of new educational programmes 
for the service. 
Dr. Hawksworth referred to the need for service in all areas, including those where 
there is, perhaps, only a single phannacist and a single OP. It was generally agreed that 
flexibility was necessary in the selection of trialists for any pilot research: 
' ... I think this should be a country-wide service with all pharmacists able 
to take part ... ' 
s. COMMUNICATIONS 
CHAIR: 
'We have talked through some of the issues in engaging the profession in 
a new medicines management service. Who should we talk to ahout this, 
to progress the initiative and keep the stakeholders informed' 
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Dr. Spencer: 
'It is important that communication should be initiated at Chief 
Executive level with the HAs. I 
He pointed out that arrangements apply at regional level for meetings between Chief 
Executives. Meetings with Directors of Primary Care and Directors of Public Health 
would also be important, to explain the initiative and enlist their support. 
There could also be follow up meetings, where the detailed issues need to be picked up 
and structures laid down. This would involve groups with specialist input. 
Mr. Ferguson referred to the relevance of the Society's Steering Group on Research, of 
which the Chairman of the Medicines Management Working Group is a member. The 
Chairman agreed that this group could have a pivotal role in co-ordinating pilot work, as 
all the major phannaceutical bodies were represented on it. This would form a strong 
integrated link in a unified effort throughout the profession: 
'However, promotion of this self initiative itselfwould need to come from 
additional sources. Who might these be? I 
-
Professor Mackie raised the issue of the possibility of a suggestion being made in the 
Crown Report relating to review of prescribing, which would be very relevant to 
medicines management and Mr Ferguson said that this would be extremely helpful. 
If the communication process is to be effective, it was generally agreed by everyone that 
GP leaders would need to be informed as soon as possible of the profession's views and 
enlisted in promoting the service. 
Mr. Baumber reported that steps had already been taken by the PSNC in this respect 
and were of a preliminary nature, through a brief discussion with the GMSC. However, 
a full focus group meeting with the GMSC was in the process of being nrrnnged by the 
Chairman, when a thorough discussion would be conducted. 
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6. NEXT STAGES 
CHAIR: 
'Is there anything else we should do? I 
Mr. Baumber responded by saying that: 
'Our own members (community pharmacists) should be brought into the 
picture as soon as possible and kept informed of progress. In this way, 
interest can be generated at an early stage and people encouraged to 
prepare their knowledge base, through training courses and local 
initiatives in elements of medicines management, such as prescribing 
advice. I 
Mr. Curphy agreed and asked if any preparatory work had been done to look at a 
communications programme. 
CHAIR: 
i 
'Some work on a communications programme ~has been done by the 
medicines management working group. What are your views on the 
formalisation of a programme. What do you all feel? ' 
There was general agreement that a proper programme should be organised and Mr. 
King suggested a special booklet be prepared for circulation to some of the 
stakeholders: 
we need something that describes the process of medicines 
management as well as its purpose ... a small booklet of some sort ... ' 
The Chainnan thanked the members for committing their time and interest in attending 
the Focus Group and for the comments which had all been very constructive and 
463 
helpful. He said the next stage was to set up a steering group for the project and that 
this should be arranged following a meeting between representatives of the PSNC, the 
RPSGB and the NPA. 
The Chairman invited all participants to write in with any further comments or 
suggestions, following reflective thought on the discussions which had taken place. 
The group was closed at 4.15 p.m. 
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APPENDIX 12C 
(Ref. Chapter 3 : Page 48) 
lJfATRIXABSTRACT OF NATIONAL PHARMACY MEDICINES 
MANAGEMENT LEADERSHIP FOCUS GROUP HELDAT RPSGB ON 
THURSDAY.fh JUNE 1999,1.00 PM 
KEY VIEWS: RPSGB, PSNC, NPA & OTHERS 
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APPENDIX 13B 
(Ref. Chapter 3 : Page 48) 
MEDICO-PHARMACEUTICAL LEADERSHIP FOCUS GROUP 
14th January 1999 at 4.00 p.m. 
MEMBERSHIP 
Medical 
Dr. John Chisholm (Chairman GPC) 
Dr. George Rae (Chainnan Practice Sub· Committee) 
Dr. Hamish Meldrum (Chainnan Rural Sub· Committee) 
Pharmaceutical 
Mr. W.Dove 
Mr. R. Carrington 
Mr. A.M. Tweedie 
Mr. S.R. Axon 
(Chainnan PSNC) 
(Chairman Co-op Phannacy Technical Panel) 
(Chairman PSNC Strategy Sub-Committee) 
(Secretary) 
FORMAT - SEMI· STRUCTURED 
CODE 
B 
A 
C 
F 
D 
E 
Background delivered by A.M. Tweedie: Origins of Proposed Phannacy New Role 
• Minister of State for Social Services 1981 (Dr. Vaughn) 
• Government White Papers 1984 - 1988 
• The growing complexity of medicines 
• The new M. Phann. degree for entry to Pharmacy 
• White Paper 1997 emphasising partnerships in primary care 
• Widespread collaboration already on ad hoc projects locally 
• Elements of core service handed around on sheets 
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Question 1 
What is our general view of the sort of service doctors may see pharmacists fulfilling in 
the near future, bearing in mind recent Government policy on health care? 
Question 2 
What inter-professional relationship issues, do we see as being important in new 
collaborative work between our two professions? 
Question 3 
What do we feel are the resource implications for future collaborative work such as 
described in our introduction? 
Question 4 
If doctors and pharmacists do engage in a new service together, what do we see as the 
main issues to be addressed, not already mentioned? 
QuestionS 
How do we feel progress could be made toward such joint goals as may be agreed? 
Question 6 
Do we feel that, if a joint proposition could be achieved, then a proposal could be taken 
to the Secretary of State for Health: 
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a) separately? 
b) jointly? 
Question 7 
What may be the difficulties for Government in: 
a) a separate approach? 
b) ajoint approach? 
Question 8 
Do we see any education I training issues inherent in such a proposition for joint 
working of the two professions? 
Question 9 
If a new role for pharmacy was agreed, what outcomes would our medical colleagues 
see as being crucial? 
Question 10 
How may we progress matters from here? 
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APPENDIX 13C 
(Ref. Chapter 3 : Page 48) 
MEDICO-PHARMACEUTICAL LEADERSHIP FOCUS GROUP 
14th January 1999 at 4.00 p.m. 
ABSTRACTED 
Abbreviations 
GP General Practitioner (Medical) 
PCG Primary Care Group 
GPC General Practitioner Committee 
RCGP Royal College of General Practitioners 
MEMBERSHIP 
Medical 
Dr. John Chisholm (Chainnan OPC) 
Dr. George Rae (Chairman Practice Sub-Committee) 
Dr. Hamish Meldrum (Chainnan Rural Sub-Committee) 
Pharmaceutical 
Mr. W.Dove 
Mr. R. Carrington 
Mr. A.M. Tweedie 
Mr. S.R. Axon 
(Chairman PSNC) 
(Chairman Co-op PharmacY Technical Panel) 
(Chainnan PSNC Strategy Sub-Committee) 
(Secretary) 
FORMAT-SEMI STRUCTURED: NOTES 
CODE 
B 
A 
C 
F 
D 
E 
Background delivered by A.M. Tweedie: Origins of Proposed Pharmacy New Role 
• Minister of State for Social Services 1981 (Dr. Vaughn) 
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• Government White Papers 1984 -1988 
• The growing complexity of medicines 
• The new M. Pharm. degree for entry to Pharmacy 
• White Paper 1997 emphasising partnerships in primary care 
• Widespread collaboration already on ad hoc projects locally 
• Elements of core service handed around on sheets 
Purpose of Meeting: 
To explore views on future collaboration based on the proposed core service. 
The following questions were asked by Mr. A.M. Tweedie 
Question 1 What is our general view of the sort of service doctors may see 
pharmacists fulfilling in the near future, bearing in mind recent 
Government policy on health care? 
Dr.B: 
Dr. A: 
Mr.D: 
Dr.B: 
I think there is an awful lot of collaboration out there already with all 
sorts of schemes. I think usually that we receive help on formulary work 
and general advice on generics usage. ";'hat do you think George? 
I think that's right lohn and in my 'practice my local pharmacist does 
quite a bit of work on compliance ... but unofficially, I believe. We don't 
have a system of formal collaboration. 
Do you come across such issues as adverse drug effects or iatrogenic 
reactions? 
All the time, I'm afraid the pharmacist usually rings me and keeps me 
right. 
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Dr. C: I think I'm mainly concerned with compliance issues, but we don't seem 
to have any systematic way of looking at this. Perhaps what is needed 
really is a more formal system to record problem areas. 
Mr. Tweedie: Looking at the collaboration which already exists, do you feel that there 
Dr.B: 
is now a case to perhaps formalise some of this into a systematic review 
of medicines effects, particularly say, for the chronically ill whose 
prognosis often changes? 
I think that must be right, certainly the way health care is now going with 
a more structured approach. The peGs certainly need advice right now 
on all sorts of issues, ranging from economic drug usage, to perhaps a 
more formal approach to specific disease treatment... after all, we in 
general practice are going to be required to collaborate with other 
members of our profession in adjacent practices ... that needs bringing 
together somehow. 
Question 2 What inter-professional relationship issues, do we see as being 
important in new collaborative work between our two professions? 
Dr. A: 
Dr.B: 
I think one of the main issues here is proper agreement about the way 
any new collaborative effort will work. How would reporting be 
organised between doctor and pharmacist? And who would set the 
agenda? 
Yes, we would need to look carefully at the issues involved ... what we 
don't want is a lot of extra paperwork to clog up the system. I think the 
main point really is agreeing what your new proposals would involve and 
then prioritising them for each practice. Each practice will have its own 
view on priority diseases and care needs to be exercised not to try to 
impose some sort of rigid view ... 
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Dr.C: 
Mr.E: 
Dr. A: 
Dr.C: 
Mr.E: 
Dr. A: 
Mr.F: 
Dr.B: 
Yes, it would be important to get agreement from each practice on what 
the priorities are. A different focus may need to be taken at different 
times of the year. 
Do you mean by that, reviewing a range of diseases in sequence? 
Yes, I think so. It would also depend, I suppose, on the government's 
priorities. They have targeted a number of diseases to be addressed to 
bring better results. There'd probably need to be a core service tweaked 
for local needs. 
We would need to sit down together to look at the troublesome issues 
involved in all medication. You know the sort of thing ... side effects, 
drug reactions, and., of course, the old issue of compliance. How would 
you do all this anyway? It sounds like a lot of time and effort. 
(Question 3) This really leads us into the problem of resources doesn't 
it? I was going to ask what you felt might be the resources involved at 
your end, for a collaborative project such as the one we described at the 
beginning of the meeting? 
Yes, I agree with Hamish. We don't all want to be buried in paper that 
never gets looked at. How would you see this being handled? 
I think what we had in mind was interviewing patients individually and 
only recording the problems rather than the nonn. We could consolidate 
such reports and deal with special patients at a practice meeting ... what 
do you think? 
It's obviously something we need to think about. .. that is, if we could get 
through the Committee. We all realise the need for good prescribing ..• 
and drugs are becoming more complex... and the alternatives keep 
increasing. I think we would want to see probably a fully worked 
proposal for trying some of the ideas out and see if we could get 
something going. (Question 4) We probably need a proper trial with 
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some idea of the paperwork and some means of review so that we all 
made best use of time. As we have said, surgeries are getting busier and 
the workload increases.... How many practices are you thinking about? 
(Question 5) 
Mr. Tweedie: We think that for this to be meaningful we should look at a spread of 
practices across the country, perhaps picking samples of urban and rural 
practice and also maybe specialised health centres as well as inner cities. 
Could this be arranged, say through the ReGP? 
Dr.B: That's quite a good idea ... and certainly there will be people within the 
network who already work with pharmacists from time to time ... should 
we do that or would you? 
Mr. Tweedie: Perhaps we could do that together and in preparation I could visit the 
RCGP to explore some possibilities and outline the service we have in 
mind. 
Dr. A: I have one or two contacts there, Allen and I can have a chat with you 
back north ... maybe you could give me a ring and we could meet. As a 
matter of fact, I wrote a short paper on pharmacist I OP collaboration and 
I could let you have that as well ... 
Question 6 Do we feel that, if a joint proposition could be achieved, then a proposal 
could be taken to the Secretary o/State/or Health: 
Dr.C: 
a) Separately? 
b) Jointly? 
We'd need to give that some thought. There are a few things on the 
general health agenda right now and if we're not careful some confusion 
may arise. Perhaps this is a subject we could discuss when we are a little 
further forward with our discussions on some joint collaboration? 
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Dr.B: Yes, the 'round table' meeting called by the Secretary of State last 
September, suggested that phannacist prescribing is also on the agenda. 
Where does your proposal fit in with this? The GPC is not likely to be 
entirely negative about this, but I cannot predict the outcome of the 
Crown Report which will enJarge this debate. I think we have a positive 
feeling overall with what you are saying today - there are many 
constructive examples of collaboration in practice already and the Glaxo 
Innovation A ward comes to mind, when we submitted joint examples of 
collaboration to them. 
Mr. Tweedie: Thank you. That gives us a steer of what may lie ahead and I wonder if 
you perhaps see any difficulties for Government at this stage in going for 
a separate or joint approach to them? (Question 7) 
Dr.B: I think: we could probably jointly see the Department on the project you 
have in mind, but as far as remuneration goes, I think we would need to 
keep that separate. 
Question 8 Do we see any educational I training issues inherent in such a 
proposition/or jOint working o/the two professions? 
Dr. A: The new sort of formal link up with the two professions you're 
proposing will certainly need some briefing and training in getting OP 
practices to work with community pharmacists ... but I think educational 
requirements will be minimal on our side. You people will know what 
sort of extra educational training you require and as long as we are 
assured that you are fully able to the new job, that's all we need. 
Dr.B: We need to be careful to do things in close collaboration if such a service 
becomes a real proposition nationally. I think the local medical 
committees and pharmaceutical committees need to work much closer 
together. 
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Mr. Tweedie: Yes, I agree. When we get into the nitty gritty of medicines management 
as we see it, I think we would expect the doctors to set out appropriate 
protocols and parameters to link the two professions on an ongoing basis. 
There shouldn't be any problems here at all. The way we see it, the 
doctor will become director of a new service which will give him much 
greater support in medicines selection and review, and, of course, the 
patient will get greater benefit out of their treatments. 
Dr. A: There's no question about it ... the sort of stuff you are talking about ... if 
it can be targeted at compliance issues, as well as side effects and the 
like, will make a big contribution to patient response. I reckon between 
30 - 50% of patients don't take their medicine correctly. I can see, 
however. that access to medical records may be a problem. Maybe more 
than education and training, we need things like relationship building and 
trust. .. 
Mr. Tweedie: Thank you and if we could perhaps pick up that theme of relationship 
and trust in this question ... 
Question 9 If a new role for pharmacy was agrJed, what outcomes would our 
medical colleagues see as being crucial? 
Dr.B: 
Dr.C: 
I think fairly obviously we would want to see measurable results ... on the 
items we would both agree to look at. This could be at this level and 
local issues agreed with the peGs. 
We need to look at how to get the patient to take the right medicine in the 
right way, without increasing problems for the patient or increasing 
bureaucracy in the system. 
Mr. Tweedie: Do you feel that practice meetings would help in jointly developing the 
outcome measures on a practice basis? 
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Dr.B: 
Dr. C: 
Dr.B: 
Dr. A: 
This would certainly ease our workload and cut the paperwork down ... I 
suppose, though, we would need some national measures which could 
apply across the board ... practice level, of course, is where the effort is 
needed to make things work for the patient. 
There are, I'm sure you know, pharmacist advisors already in health 
authorities, but advice from a commercial background would be useful 
from a drug budgeting point of view ... but we would expect savings in 
drug bills to be ploughed back into patient care ... 
The pharmaceutical advisor's role could overlap with the one you are 
proposing at practice meetings for your people ... but, of course, the role 
you propose with the patient is a different matter altogether... you are 
certainly best placed for that 
I think overall we'd want to be able to see that patients were taking their 
medicines properly and keeping the drug cost under control. Patients do 
respond differently over a period of time on long tenn medication and we 
could look at that. .. for adjustments and updating ... we could also look at 
health gain measures if we keep it simple. Do you have anything of a 
more specific nature in your proposal? 
Mr. Tweedie: We are currently producing a booklet which outlines the whole service 
and perhaps we could let you have a fmal draft of this to look at and you 
might even wish to add a few paragraphs of your own, if your committee 
feels it can take these proposals forward on the lines we have discussed. 
Dr.B: That's a nice idea. .. if you could let us have that within two weeks we 
can put it to our practice committee ... if we miss that date, then the next 
slot is in five weeks time. 
Mr. Tweedie: We'll do our best to get that to you within the two week time frame. 
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Question 10 How may we progress mattersfrom here? 
Dr.B: 
Dr. A: 
Dr.C: 
Mr.D: 
Dr.B: 
We'll discuss your proposals at our next committee meeting, but I think 
we can say (looking to left and right) that we're pretty well sold on the 
idea. 
Yes, the pharmacist will be taking on new responsibilities, but the OP 
will not be devolving overall responsibility for the patient. To some 
extent we'll all have to manage our time a bit better, but we are getting 
busier and busier and it would be very helpful if the pharmacist could 
provide the sort ofinfonnation we've talked about to the patient. It's not 
so much a transference of a role, from us to you, but a question of 
plugging the gaps. I'm disappointed that the pharmacist is not included 
automatically in the primary care groups, but it's not critical. 
I would just like to confmn that there would not be commercial 
involvement of drug companies? 
The only involvement we see, at present, is that the industry may be 
useful for sponsoring joint meetings at local level... they will not have 
any part in the process of medicines selection or prioritisation for disease 
groups. 
I'm glad to hear that. .. it's a sensitive issue you know ... I think we've had 
a very positive meeting and I look forward to receiving your document in 
due course. 
Mr. Tweedie: Thank you for the time you have all spent in discussing this most 
important issue. We, for our part, look forward to progressing the 
proposals with you and perhaps we could meet again after I've seen the 
RCOP. 
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Summary 
The focus group can only be described as positive, in atmosphere and approach by the 
medical members. Collaboration was a central theme of the doctors overall attitude, 
together with a tacit assumption of doctor lead in the new process. Doctor autonomy, or 
in Maslow's terms of self actualisation and esteem, were clear implications in some of 
the question responses. 
Clearly, care must be taken to preserve the doctors· perception of the lead role in patient 
care and to ensure that pharmacist initiatives are, at the very lest, joint endeavours 
contextualised as support service rather than an independent intervention. A potential 
barrier to change in the GP network could well be increased paperwork and workload. 
A product design, (Chapter 4) should now take account of this, making the new 
prospect user friendly. 
This holds promise for the future and perhaps even the possibility of engaging the three 
prominent members of the OPC, as sponsors and leaders of the change process. 
Message source and opinion leadership, (Chapter 4) may be pursued with the GMC at a 
later stage. 
The Chairman of the GPC specifically requested total confidentiality in view of the 
sensitive nature of the discussions and the need to consult further with his 
committee. This guarantee was given. 
Meeting closed 5.28 pm. 
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APPENDIX 13D 
(Ref. Chapter 3 : Page 48) 
MEDICO-PHARMACEUTICAL LEADERSHIP FOCUS GROUP 
CONTENT ANALYSIS 
BMA 
GPC 
RCGP 
Introduction 
Abbreviations 
British Medical Association 
General Practitioner Committee 
Royal College of General Practitioners 
DH 
PCG 
Department of Health 
PrimaI)' Care Group 
Key themes have been extracted from the discussion recorded in Appendix 13C -
completed, and are set out below under the respective questions 1 - 10. There was, 
overall a collaborative spirit from the members of the ope group, tempered with 
caution. No particular barriers to progress were apparent, but there were a number of 
issues which, on analysis, are judged to be important to maintaining the co-operative 
stance. 
The following analysis is set out in abbreviated summary form, covering the main 
points and reinforced by quotation where this is deemed to be helpful. 
A summary of the meeting draws the main points together at the end of the analysis. 
Analysis 
Question 1 What is our general view of the sort of service doctors may see 
pharmacists fulfilling in the near future. bearing in mind recent 
Government policy on Health Care? 
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Key Themes - GP recognition of present level of inter-
professional collaboration 
Importance of compliance issues 
Formulary and drug effects tasks 
Question 2 What inter-professional relationship issues do we see as being important 
in new collaborative work between our two professions? 
Key Themes • Inter-professional collaboration 
Doctor dislike of added paperwork / workload 
Strong hints of doctor autonomy 
Dr. A... Proper agreement about the way... collaborative effort will 
work 
Dr. B ... Each practice will have its own view on priority diseases and 
care needs. 
Dr. C ... important to get agreementfrom each practice. 
-Question 3 What do we feel are the resource implications for future collaborative 
work such as described in our introduction? 
KeyThemes • Dislike of paperwork and workload (trial 
suggested by Dr. B). 
Interprofessional collaboration 
Agreement reached to approach RCGP for trialists 
Question 4 If doctors and pharmacists do engage in a new service together, what do 
we see as the main issues to be addressed, not already mentioned? 
Question 5 How do we feel progress could be made toward such joint goals as may 
be agreed? 
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The above two questions were subsumed by Question 3 and were not pressed 
individually having received firm indication of the way forward. 
Question 6 Do we feel that if a joint proposition could be achieved, then a proposal 
could be taken to the Secretary of State for Health: 
oj Separately? 
c) Jointly? 
Key Themes -Overall response was hesitant - the issue was portrayed as 
too far ahead. It was, therefore, not pursued. 
Collaboration still pursued. 
Question 7 What may be the difficulties for Government in: 
a) A separate approach? 
b) A joint approach? 
Again response was understandably brief and related to Question 6. However, Dr. B. 
briefly replied: 
'" I think we could probably see the Department jointly on the project 
you have in mind, but as far as remuneration goes, I think we would need 
to keep that separate. 
Key Themes - Collaboration accepted. 
Question 8 Do we see any education / training issues inherent in such a proposition 
for jOint working of the two professions? 
Key Themes· Doctor autonomy (self esteem) 
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Dr. A. .. educational requirements will be minimal on our side... you 
people will know what extra educational training you require ... as long 
as we are assured you are fully able to do the job ... 
- Collaboration between the two professions. 
- Relationship building. 
(Dr. A. further responded by again citing patient compliance as a major 
issue and in passing also mentioned relationship building and trust as 
matters to be considered.) 
Question 9 If a new role for pharmacy was agreed, what outcomes would our 
medical colleagues see as being crucial? 
Key Themes - Interprofessional collaboration; joint medical I 
phannaceutical approach. 
Doctor autonomy. 
Workload I paperwork apprehension. 
Question 10 How may we progress matters from here? 
Key Themes - Referral to BMA main committee. 
Dr. A. stressed that the GP would not be devolving 
responsibility for patient care. The proposed new 
pharmacy intervention would be ... plugging the 
gaps ... in present service. 
Doctor leading role I autonomy (self esteem) 
Doctor workload increasing. 
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Summary 
The doctor element of the focus group, positively and collaboratively viewed the subject 
as a practical dynamic, rather than a static intellectual discussion. As leaders of their 
profession, the doctors concerned were happy to suggest ways forward through piloting 
the scheme and engaging a joint intervention, rather than regarding the new proposition 
as a solely pharmacist initiative. 
Doctor autonomy underpinned the GPC approach as ~xemplified in the responses to 
questions 2, 8 and 10 which lay at the beginning and end of the focus group. 
Patient compliance again emerged as a substantial issue which was also reflected by the 
key informants and clearly represents a comfortable area for the doctor where the 
pharmacist could playa part. Also like the key informants, the focus group perceived 
the issues of drug interactions and adverse reactions as potential pharmacist 
responsibilities. Likewise, formulary development and drug economies, but therapeutic 
decisions clearly are perceived as the domain of the doctor. This supports the research 
by Sutters and Nathan, (Chapter 3 : 23). 
It was also interesting that there seemed to be a willingness to jointly approach the DH 
in discussing the principle of the proposition, but not Unreasonably the doctors did not 
see discussion progressing to matters of remuneration. 
A potential product deficiency emerged in discussions... increased paperwork and 
workload. The product design, (Chapter 3 : 35) must take account of this and in doing 
so perhaps become a determinant product benefit, (Chapter 3 = 33, 35). Otherwise it 
may become a significant barrier to change. 
As leaders of the medical profession, the doctors partaking in the focus group could 
subsequently become a key message source and leaders in opinion forming and, indeed, 
sponsors of the new proposition. This will be borne in mind when relating the whole 
study to the marketing discussion in Chapter 3. 
484 
PILOT SURVEYS 
APPENDICES 14, 15 
(Ref. Chapter 3 : Page 54) 
Purpose: To expose any anomalies in question phrasing, questionnaire 
instructions and receive feedback for any suggested amendments to 
these, as well as response categories. 
General Practitioner Survey (Appendix 14) 
For GPs, an initial sample of 150 was randomly selected by the computer and posted to 
GPs on 19th February 1999. As this was a pilot, no follow up mailing was sent out. Of 
79 responses, notes on the introductory letter indicated: 
• One GP had died 
• Two GPs had retired 
• One GP declined to partake 
• Two GPs had moved into hospital work from general practice 
The resulting 73 respondents' returns, were analysed for'comment, regarding the issues 
listed in purpose above. From this, the following amendments were made and the flnal 
survey (1000 GPs) adjusted accordingly: 
Response categories were tightened up e.g. Question 16 pilot t ... how important is the 
patient's perception of that quality?' 
Pilot: 'very important'; 'quite important'; 'hardly important'; 'not important' 
Changed to: 'important'; 'relatively important'; neither 'important' nor 'unimportant'; 
'relatively unimportant'; 'unimportant'. 
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An addition was made to the list of problem elderly patients may well have with 
medicines: 
'remembering to take the medication' 
Two questions were added: 
Question 7 'What is the source of your pharmacist help?' 
Question 15 'Do you feel the pharmacist should become a formal part 0/ the doctor's 
team, addressing selected items, agreed by you? ' 
Community Pharmacy Survey (Appendix 15) 
The same procedure was adopted for Newcastle Local Phannaceutical Committee (14 
members), also by prior arrangement with the secretary. On this occasion, the author 
introduced the draft questionnaire before handing it out, as: 
' ... a random survey to be posted to 850 independent community 
pharmacists in England and Wales, seeking their views on 
aspects of the new medicines management role proposed 
for community pharmacy ... ' 
-
The LPC are likewise politically representative of community pharmacists but also 
represent 'company chemists' and co-operatives. 
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APPENDIX 16 
(Ref. Chapter 3 : Page 50) 
RANDOM SAMPLE OF GPs ENGLAND AND WALES 
POSTAL SURVEY: Letter and Form 
(1,000 GPs) 
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John 0 Smart esc PhD MRPharmS 
Head of School 
Email: john.smart@port.ac.uk 
r F Jones, BSc., MSc., PhD., FRPharmS., FIPharmM 
Professor of Pharmacy Practice 
Direct Line: 
Fax No: 
Email: 
Dear Doctor 
023 9284 3685 
023 9284 3685 
ian. jones@port.ac.uk 
RECENT GOVERNMENT WHITE PAPERS-
DOCTOR & PHARMACIST COLLABORATION 
SURVEY OF GP'S : ENGLAND & WALES 
., 
Universityof 
Portsmouth 
School or Pharmacy and 
Biomedical Sciences 
St Michael's Building 
While Swan Road 
Portsmouth P01 20T 
England 
Tel: +44 (0)23 9284 3562 
Fax: +44 (0)23 9284 3565 
You will be aware of recent Government White Papers and documents, which set out 
possibilities of new collaboration between the health care professions. With the advent of the 
new PCTs, the potential for collaboration between doctors and pharmacists is substantial. 
Your views are being sought on potential elements of such services and some of the 
implications. Could you please spend a few minutes completing the enclosed questionnaire 
and return this in the business reply envelope. 
The questionnaire is strictly confidential and there is no need to record your name or address. 
You have been selected at random as one of 1,000 doctors chosen for this research. 
We appreciate that there are many demands on your time these days, but your assistance here 
will greatly help in addressing the future. Your answers will make an important contribution 
to this research, the general results of which will be published early next year in the medical 
and pharmaceutical press. 
Thank you for your time and help. 
Yours sincerely 
D~"Kf~/f!;;r;~~;i' ~ii'BS MRCGP DRCOG DCII DM) 
Secretary - General Practitioners Committee, NorthumberlandITyne & Wear 
~ ................ . 
Allen Tweedie MA MBA FRPharmS FCIM FRSH 
Chairman - Medicines Management Leadership Group 
........................................ 
Professor Ian Jones 
Professor of Pharmacy Practice, University of Portsmouth 
www.port.ac.uk 
John Wong PhD CBiol MIBiol FRSH 
Head of School 
Email: john.wong@port.ac.uk 
I F lones, BSc., MSc., PhD., FRPbarmS., FIPharmM 
Professor of Pharmacy Practice 
Direct Line: 023 92 843685 
Fax No: 023 92 843685 
Email: ian-iones(aloort.ac.uk 
20 November 2002 
Dear Doctor 
DOCTOR & PHARMACIST COLLABORATION 
SURVEY OF GPs ENGLAND & WALES 
Universityof 
Portsmouth 
School of Pharmacy and 
Biomedical Sciences 
St Michael's Building 
White Swan Road 
Ports.mouth P01 2DT 
England 
Tel: +44 (0)23 9284 3562 
Fax: +44 (0)23 9284 3565 
This is a 'follow up' letter intended for those doctors who have not yet replied to the first circulation 
of this survey sent three weeks ago. 
For serious research in this field it is standard practice to send a second copy to encourage those who 
have not responded to do so now. The initial response has been very encouraging and if publication 
of our results in the medical press next year is to be seriously meaningful a high response to this 
survey is both important and necessary. 
We believe that your collective views can make a valuable contribution to the future development of 
NHS medical and pharmaceutical services. 
Please find time to complete and return this survey. 
T.o those who have already completed and returned our survey - many thanks - and please 
discard this second circulation. 
Thank you for your time. 
Yours sincerely 
...... £......... . .......... . 
Dr Ken Megson BA (Ho s) MB BS MRCGP DRCOG DCH DMJ 
Secretary - General Pr titioners Committee, Northumberlandffyne & Wear 
C J~l,>-- C\~ . .l.. 
••• 1' •••••••••• 
Allen Tweedi~'MA MBA"FRP~S'FCIM FRSH 
Chainnan - Medicines Management Leadership Group 
:r:~ F. '~ 
P;~fe~'~~~' i~ 'j~~~~' '" ... '" .......... ~. 
Professor of Phannacy Practice, University of Portsmouth 
www.port.ac.uk 
NEW PARTNERSHIPS IN PRIMARY CARE? 
Conducted by : 
SURVEY OF GPs 
Allen Tweedie, Ken Megson & Ian Jones 
(University of Portsmouth) 
Note: This questionnaire is designed to assist us obtain information which will help steer 
the way forward into new collaboration between doctors and pharmacists in 
managing aspects of patient's medication. Please tick the appropriate boxes, unless 
otherwise indicated .. 
SECTION A 
This section consists of some brief questions of detail about your practice and some 
pharmacist and patient issues. 
Question 1 Please state the number of doctors in your practice .............................. .. 
1.1 
Of these, how many are partners? .............................. , ..................... . 
Question 2 Is your practice a dispensing practice? Yes 
o 
2.1 
1.2 
No 
o 
2.2 
Question 3 Approximately how many patients are in your practice? ........................ .. 
Question 4 Please tick the age groups you all come within 
20-under30 30-under40 40-under50 50-under60 60+ 
o 0 DOD 
4.1 4.2 4.3 4.4 4.5 
Question 5 Broadly, how would you describe the frequency with which you contact a 
dispensing pharmacist? 
Very often 
o 
Often 
o 
Periodically Rarely 
o 0 
5.1 5.2 5.3 5.4 
Question 6 Do you have a pharmacist work for you in the practice? 
Full Time 
o 
6.1 
Regular 
o 
6.2 
Periodically Rarely 
o 0 
6.3 6.4 
If you answered 'Never', please go to question 8. 
2 
Never 
o 
5.S 
Never 
o 
6.S 
Question 7 What is the source of your phannacist help? 
Health Authority peT Dispensing Phannacist 
0 0 0 
7.1 7.2 7.3 
Peripatetic Phannacist Phannacist Other - Please specify 
member of 
your own staff 
0 D· 0 
Question 8 If you answered 'Never' to question 6, would you like a phannacist to work 
with you in the future? 
Question 9 
Full Time 
o 
8.1 
Regular Part Time 
o 
8.2 
Periodically 
o 
8.3 
Never 
o 
8.4 
Please indicate the frequency with which you encounter the following 
medicines problems with patients. 
Very Often Often Periodically Never 
Troublesome Side Effects 0 0 0 0 
9.1 9.2 9.3 9.4 
Drug Interactions 0 0 0 0 
9.5 9.6 9.7 9.8 
Adverse Drug Reactions 0 0 0 0 
9.9 9.10 9.11 9.12 
Patient non-compliance 0 0 0 0 
9.13 9.14 9.15 9.16 
Poor response to treatment 0 0 0 D 
9.17 9.18 9.19 9.20 
Elderly patient confusion 0 0 0 0 
9.21 9.22 9.23 9.24 
Food & Drug interactions 0 0 0 0 
9.25 9.26 9.27 9.28 
NHS drugs & phannacy 0 0 0 D 
medicines interactions 9.29 9.30 9.31 9.32 
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Question 10 Please indicate what you believe to be the incidence of the following the 
potential problems elderly patients may have with medicines 
Very Often Often Periodically Never 
CapsulelTablet Size D D D 0 
10.1 10.2 10.3 10.4 
Calendar packs 0 0 0 0 
10.5 10.6 10.7 10.8 
Frequency of dose 0 0 D D 
10.9 10.10 10.11 10.12 
Multiplicity of drugs 0 0 0 0 
10.13 10.14 10.15 10.16 
Remembering to take the D 0 0 0 
Medication 10.17 10.18 10.19 10.20 
Taste of Medication 0 0 0 0 
10.21 10.22 10.23 10.24 
Other: Please state briefly 
............................................................................................. 
............................................................................................. 
............................................................................................. 
SECTIONB 
This section contains questions relating to Government policy in the 'New NHS' and an 
enhanced doctor/phannacist working relationship. Please tick the box that most closely 
reflects your views. 
Question 11 Government seem to be encouraging pharmacistlGP collaboration on aspects 
of medication review. Do you agree with this approach? (The detail is in the 
next question.) 
Strongly Agree 
D 
Agree 
D 
11.1 11.2 
Uncertain 
D 
11.3 
Disagree Strongly Disagree 
o D 
11.4 11.5 
lfyou ticked box 11.4 or 11.5, please go to question 13. 
4 
Question 12 . .Jfyou ticked any box from 11.1 to 11.3, which of the following items do you 
think a pharmacist could assist you with? (Please tick all appropriate boxes) 
12.l Comparisons of equivalent medicines' costs 0 
12.2 Patient compliance 0 
12.3 Drug interactions 0 
12.4 Replacing brands with generics 0 
12.5 Choice of medicines 0 
12.6 Advice to patients on food and drug interactions 0 
12.7 Advice to patients on pharmacy medicines & NHS drug 
interactions 0 
12.8 Optimum pack sizes 0 
12.9 Review of number of drugs taken 0 
12.10 Help with identifying sub-therapeutic dose levels D 
Question 13 If you ticked boxes 11.4 or 11.5 in question 11, please outline your reason 
here . 
............................................................................................. 
............................................................................................. 
Question 14 If a pharmacist worked with you to undertake a patient review of those 
medication issues agreed by you, how frequently should this be done for those 
on long term medication? 
Monthly o Bi-monthlyl 0 
14.1 14.1 
Four Monthly 0 Six monthly 0 
14.4 14.5 
Quarterly 0 
14.3 
Other: Please specify o 
14.6 
Question 15 Do you feel the pharmacist should become a formal part ofthe doctor's team, 
addressing selected items agreed by you? 
Yes D Uncertain 0 
15.1 15.2 
5 
No 0 
15.3 
SECTIONC 
This section contains questions relating to some health care issues arising from Government 
White Papers in recent years. Please tick the box that most closely reflects your view. 
Question 16 The quality of patient care in general practice may be very good, even though 
the patient may not be aware of that quality. How important is the patient's 
own perception of that quality? 
Important Relatively Neither Relatively Unimportant 
important important nor unimportant 
0 0 
unimportant 
0 0 0 
16.1 16.2 16.3 16.4 16.5 
Question 17 Quality of care and clinical excellence are recurrent themes in the White 
Papers. What is your perception of patient expectations of health care over 
recent years? 
Greatly 
Increased 
o 
17.1 
Somewhat 
Increased 
o 
17.2 
No change 
o 
17.3 
Somewhat 
Decreased 
o 
17.4 
Greatly 
Decreased 
o 
17.5 
Question 18 Patient's perception of quality of care may be a factor in their commitment to 
the therapy. Do you agree? 
Strongly Neither Strongly 
Agree Agree agree nor Disagree disagree 
Disagree 
0 0 0 0 0 
18.1 18.2 18.3 18.4 18.5 
Question 19 Patient perception of your overall service could be enhanced by a pharmacist 
medicines review service, directed by you. Do you agree? 
Strongly Neither Strongly 
Agree Agree agree nor Disagree Disagree 
Disagree 
0 0 0 0 0 
19.1 19.2 19.3 19.4 19.5 
Question 20 Please indicate in which ofthe following locations your practice is based. 
City Centre Town Centre Suburban Rural 
DOD 0 
Thank you for taking the time to help with this important survey of issues. The information 
will be treated in strict confidence and used only for general statistical purposes. 
6 
If you have any further infonnation that you think might be useful to the aims of this research 
please use the space below to explain. 
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APPENDIX 17 
(Ref. Chapter 3 : Page 50) 
RANDOM SAMPLE OF PROPRIETOR PHARMACISTS 
ENGLAND AND WALES POSTAL SURVEY: Letter and Form 
(750 Pharmacists) 
488 
John 0 Smart BSe PhD MRPharmS 
Head of School 
Email: johnsmart@porl.ac.uk 
1 F Jones, BSc., MSc., PhD., FRPharmS., FIPharmM 
Professor of Pharmacy Practice 
Direct line: 
Fax No: 
Email: 
023 9284 3685 
023 9284 3685 
ian.jones@port.ac.uk 
Dear Colleague 
DOCTOR & PHARMACIST COLLABORATION 
SURVEY OF INDEPENDENT PHARMACY 
PROPRIETORS : ENGLAND & 'VALES 
•. t 
Universityof 
Portsmouth 
School of Pharmacy and 
Biomedical Sciences 
St Mlchael"S BUilding 
White Swan Road 
Portsmouth POl 2DT 
England 
Tel: +44 (0)2392843562 
Fax: +44 (0)239284 3565 
You will be aware of government publications that set out possibilities of new collaboration 
between the health care professions. As part of an ongoing research programme at this 
School of Pharmacy your views are sought on potential elements of such collaboration and 
some of the implications. Your pharmacy is one of approximately 800 independently owned 
pharmacies selected from the RPSGB Register of Pharmacy Premises. 
Could you please spend a few minutes completing the enclosed questionnaire and then return 
it in the business reply envelope. The survey is strictly confidential and there is no record of 
your name or address. Your answers will be used for general statistical purposes only and the 
results will be published in the medical and pharmaceutical press early next year. 
We appreciate that there are many demands on your time these days but your assistance will 
greatly help in addressing the future - particularly for the independent pharmacy proprietor. 
Your answers wi11 make an important contribution to this research. 
Thank you for your time and help. 
Yours sincerely 
... , ..................................... . 
Allen Tweedie MA., MBA., FRPharmS 
Chairman: Medicines Management Leadership Group 
I/:?;~ I~~ 
.......................................... 
Dr Paul Rutter, B.Pharm., Ph.D., M.R.Phann.S. 
Phannacy Practice Division, University of Portsmouth 
.?;.~ ..... E· .... ~~~ 
Professor Ian Jones 
Professor of Phannacy Practice, University of Portsmouth 
www.port.ac.uk 
John Wong PhD CBlol MIB.ol FRSH 
Head of School 
Email: john.wong@port.ac.uk 
I F Jones, BSc., MSc., PhD., FRPhannS., FIPbarmM 
Professor ofPhannacy Practice 
Direct Line: 023 92 843685 
Fax No: 023 92 843685 
Email: ian.jones@oort.ac.uk 
20 November 2002 
Dear Colleague 
DOCTOR & PHARMACIST COLLABORATION 
SURVEY OF INDEPENDENT PHARMACY 
PROPRIETORS : ENGLAND & WALES 
., 
Universityof 
Portsmouth 
School of Pharmacy and 
Biomedical Sciences 
SI Michael's Building 
While Swan Road 
Portsmouth P01 2DT 
England 
Tel: -+44 (0)23 9284 3562 
Fax: -+44 (0)23 9284 3565 
This is a 'follow up' letter intended for those proprietors who have not yet replied to the first 
circulation of this survey sent three weeks ago. 
For serious research in this field it is standard practice to send a second copy to encourage those who 
have not responded to do so now. The initial response has been very encouraging and if publication 
of our results in the medical/pharmaceutical press next year is to be seriously meaningful a high 
response to this survey is both important and necessary. 
We believe that your collective views can make a valuable contribution to current thinking on the 
development of your role in providing future NHS pharmaceutical services. 
Please find time to complete and return this survey. 
To those who have already cooperated - many thanks - and please discard this reminder. 
Thank you for your time. 
Yours sincerely 
\ ~J/~, ~JY.~k, ¥- ..J.tl£t.:... 
'0 '" ••••••••••••••••••••••••••••••••••••• 
Allen Tweedie MA., MBA., FRPharmS 
Chairman: Medicines Management Leadership Group 
·<2 ~ 
.... / ...................................... , 
Dr Pau er, B.Phann., PhD., M.R.PharmS 
Phannacy Practice Division, University of Portsmouth 
k..M1 .... f. ... ~.~ ... 
Professor Ian Jones 
Professor of Pharmacy Practice, University of Portsmouth 
www.port.ac.uk 
SURVEY OF INDEPENDENT NHS PHARMACY CONTRACTORS ON NEW 
PHARMACIST RULES 
Conducted by Allen Tweedie, Ian Jones and I)au) Rutter 
Pharmacy Practice Division, University of Portsmouth 
Note: This questionnaire is designed to assist us obtain information which will help steer the way 
forward into new responsibilities within the 'New NHS'for pharmacy contractors. 
If the pharmacist completing the questionnaire is not the proprietor, please 
obtain his/her permission before continuing. 
SECTION A 
This section seeks some basic facts about you and the pharmacy you own or work in. Please 
tick the appropriate box unless otherwise directed. 
Question 1 - What gender are you? Female 0 Male 0 
1.1 1.2 
Question 2- What position do you hold? 
Owner Manager Assistant Phannacist Other 
(Please State) 
0 0 0 0 
......................... 
2.1 2.2 2.3 2.4 
Question 3 - How many pharmacies are in your 0 (Please place number in the box) 
group? 3.1 
Question 4 - What age group are you in? 
Under 25 yrs 
o 
4.1 
40-Under 45 yrs 
o 
4.5 
60-Under 65 yrs. 
o 
4.9 
25-Under 30 
o 
4.2 
45-Under 50 yrs. 
o 
4.6 
65yrs. and over 
o 
4.10 
30-Under 35 yrs 
o 
4.3 
50-Under 55 yrs 
o 
4.7 
35-Under 40 yrs. 
o 
4.4 
55-Under 60 yrs. 
o 
4.8 
Question s- On average, how many prescription items are dispensed in your phannacy 
each month? (The one you work in.) 
Under 1,000 0 5. ] 6,000-6,999 0 5.7 
1,000-1,999 0 5.2 7,000-7,999 0 5.8 
2,000-2,999 0 5.3 8,000-8,999 0 5.9 
3,000-3,999 0 5.4 9,000-9,999 0 5.10 
4,000-4,999 0 5.5 10,000-10,999 0 5.1] 
5,000-5,999 0 5.6 11,000 Plus 0 5.12 
Question 6- Approximately, what percentage of your total turnover is generated by NilS 
receipts? 
Under 10% 0 6.1 50-59% 0 6.6 
10-19% 0 6.2 60-69% 0 6.7 
20-29% 0 6.3 70-79% 0 6.8 
20-39% 0 6.4 80-89% 0 6.9 
40-49% 0 6.5 90% and over 0 6.]0 
Question 7 - What is the location of your pharmacy? 
Cityffown Suburban Rural Other 
Centre (controlled locality) (Please specify) 
0 0 0 0 
.................•.•.•..••. 
7.1 7.2 7.3 7.4 
Question 8 - How many dispensing assistants do you employ? 
Please place number(s) in appropriate boxes. 
Full Time Part Time 
(5 full working days) (less than 5 full working days) 
o o 
8.] 8.2 
Question 9 - How many of your dispensing assistants have a technician's certificate? 
Please place number(s) in boxes. 
Full Time Part Time 
(5 full working days) (less than 5 full working days) 
o o 
9.1 9.2 
2 
Question 10 - How many pharmacists regularly work with you in the pharmacy? (Not 
locums). Please place number(s) in boxes. 
Full Time Part Time 
(5 full working days) (less than 5 full working days) 
o o 
lO.l 10.2 
SECTIONB 
This section seeks your views about certain aspects of your role in the NHS. 
Please tick the appropriate box unless otherwise directed. 
Question 11 - How satisfied are you that the phannacist's skills are being fully used in the 
present contract? 
Very satisfied 
o 
11.1 
Satisfied 
o 
11.2 
Neither satisfied 
nor dissatisfied 
o 
11.3 
Dissatisfied Very dissatisfied 
o 0 
11.4 11.5 
Question 12 - How satisfied are you with current remuneration levels in your NBS contract? 
Very satisfied 
o 
12.1 
Satisfied 
o 
12.2 
Neither satisfied 
nor dissatisfied 
o 
12.3 
Dissatisfied Very dissatisfied 
o 0 
12.4 12.5 
Question 13 - How do you rate your present working relationship with the local GPs? 
Very satisfactory 
o 
13.1 
Satisfactory Neither satisfactory 
nor unsatisfactory 
o 0 
13.2 13.3 
Unsatisfactory Very unsatisfactory 
o 
13.4 
o 
13.5 
Question 14 - What do you assess would be the view of patients on greater pharmacist 
involvement with management of their NBS medicines? 
Very welcome Welcome 
o o 
14.1 14.2 
Neither welcome 
nor unwelcome 
o 
14.3 
Unwelcome Very unwelcome 
o 0 
14.4 14.5 
Question 15 - What do you assess would be the attitude of your local doctors to greater 
pharmacist involvement with patient medication management? 
Very welcome Welcome Neither welcome Unwelcome Very unwelcome 
nor unwelcome 
0 0 0 0 0 
15.1 15.2 15.3 15.4 15.5 
3 
Question 16 - Are you aware of the Government-backed PSNC 'medicines management' 
proposals for community pharmacy? 
In detail In some detail In outline Not sure Definitely not 
o o o o o 
16.1 16.2 16.3 ] 6.4 16.5 
SECTION C 
This section seeks your views about some possibilities for community pharmacists in the ?ear 
future, relating to a role in medicines management. Please tick the appropriate box or CIrcle 
the appropriate numbers in Question 17. 
First, a brief refresher on the medicines management initiative. 
Note: 'Medicines Management' is defined for this research as: 
"The systematic provision of medicines therapy, through a 
partnership of effort between patients and professionals, to deliver 
best patient outcome at minimised cost". 
In outline, the medicines management process has four phases for the pharmacist: 
i. Review of patient's drug regimen (from PMRs before interviewing 
the patient) for optimisation of pharmacology and cost. 
ii. Interview with patient by a predetermined process to discuss 
important issues. 
111. Communication of results of i) and ii) to GP, with 
recommendations (tick box form). 
IV. Implementation of agreed changes/action. 
Repeat the above cycle at agreed intervals. 
Note: In answering the following questions, please assume that full training in medicines 
management will be given to those who engage in the new role. 
Question 17 - In this new professional relationship between doctor and pharmacist, how 
would you ~ate the potential importance of each of the following factors? Please circle each 
of your chOices on a scale of 0-5. (0 = not important; 5 = most important) 
17.1 The Doctor's need to feel non-threatened by pharmacist involvement 
o 1 2 345 
17.2 The Doctor's need to be recognised as the lead health care professional 
O. 1 2 345 
17.3 The Doctor's need to be the final decision maker on medicines regimen 
o 1 2 3 4 5 
4 
17.4 The Doctor's need to have confidence in the phannacist's abilities 
o 1 2 345 
17.5 The Doctor's need to be sure ofconfidentia]ity in a11 matters 
o 1 2 3 4 5 
17.6 The Doctor's need to have confidence in the phannacy facilities for 
confidential consultation 
o 1 2 3 4 5 
Question 18 - How would you describe your present ability to undertake the medicines 
management (MM) role? 
Able now 
o 
18.1 
Able with suitable 
training 
o 
18.2 
Not Sure 
o 
18.3 
Unable Now 
o 
18.4 
Question 19 - Would you personally wish to undertake this new 1\11\1 service if remuneration 
is acceptable? 
Yes Not Sure No 
o o o 
19.1 19.2 19.3 
Question 20 - In the following list, who do you feel should not take up the new service? 
Please tick all appropriate boxes. 
Hospital phannacists 0 20.1 
Phannacists employed by GPs 0 20.2 
Freelance phannacists 0 20.3 
Doctors themselves 0 20.4 
Nurses 0 20.5 
Phannacists employed by the LPC 0 20.6 
Pharmacists employed by PCTs 0 20.7 
Phannacy contractors (ie. like you!) 0 20.8 
Please add any brief comment ........................................................................... . 
......•.....•..........................................•.•...•....••.•........................................... 
5 
Question 21 - If you require training to undertake the new role, what subjects among the 
fol1owing list would you select? Please tick all appropriate boxes. 
Clinical phannacology 0 21.1 
Drug economics 0 21.2 
Patho-physiology 0 21.3 
Interpersonal skil1s 0 21.4 
Disease management 0 21.5 
Techniques to motivate patients to comply 0 21.6 
Other (please specIfy) . • .•••••••.•••.•...•..• ..............................................•.............. .. 
•••••••••••••••.•••••••••••••••••••..•..•.•.•.•.••.••••...................•....•.............•.........•........ 
Question 22 - In the fol1owing list of training (CPO) options, which one would be your 
preferred route? 
Daytime lectures (locum funded) 0 22.1 
Evening lectures 0 22.2 
Distance learning packages 0 22.3 
Distance learning plus seminars 0 22.4 
Web based computer assisted learning 0 22.5 
Web based packages plus seminars 0 22.6 
Other (please specify) ..................................................................................... . 
•.•.••.•...................................•......•.•...............•...•..••........•.....•..•......•••.....•.. 
Question 23 - Assuming your present workload remains the same, do you believe you 
currently have time to undertake the medicines management service? 
Yes Not Sure No 
o o o 
23.] 23.2 23.3 
Question 24 - If you answered 'No' or 'Not Sure' in the previous question, could some of 
your workload be delegated to other staff, if they were fully trained? 
Yes Not Sure No 
o o o 
24.1 24.2 24.3 
6 
Question 25 - Do you think it is time for an entirely new phannacy contract? 
Yes Not Sure No 
o o o 
25.1 25.2 25.3 
Thank you for your time and commitment in addressing the important issues set out in 
this survey. Your responses will be used to help plan the way forward for community 
pharmacy. 
If you have any information you think would be useful to the aims of this research 
please use the space below to explain. 
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APPENDIX 18 
(Ref. Chapter 3 : Page 50) 
NEW PARTNERSHIPS IN PRIMARY CARE 
SURVEY QUESTIONNAIRE 
Conducted by: The University of Portsmouth 
Note: This questionnaire is designed to assist us obtain information which will help 
steer the way forward into new collaboration between doctors and pharmacists 
in managing aspects of the patient's medication. Please tick the appropriate 
boxes, unless otherwise indicated. 
SECTION A 
This section consists of some brief questions of detail about your practice and some 
pharmacist and patient issues. 
Question 1 (n=536) 1 2-4 5-7 
Please state the number of doctors in your practice 57 248 185 
(n=536) 1.1 
Of these, how many are partners? 56 213 179 
1.2 
Question 2 
Is your practice a dispensing practice? Yes No 
(n=538) [J [J 
2.1 2.2 
71 467 
Question 3 
Approximately how many patients are there in your practice? (n=527) 
under 2000 2000-3999 4000-5999 6000-7999 8000-9999 
21 97 86 93 81 
10,000+ 
49 
Question 4 
Please tick the age groups you all come within (n=526) 
20-under 30 30-under 40 40-under 50 50-under 60 60+ 
o 
4.1 
58 
o 
4.2 
305 
[J 
4.3 
385 
o 
4.4 
314 
489 
[J 
4.5 
84 
8+ 
46 
46 
QuestionS 
Broadly, how would you describe the frequency with which you contact a dispensing 
pharmacist? (n=538) 
Very often Often Periodically Rarely Never 
o 
5.1 
52 
Question 6 
o 
5.2 
173 
o 
5.3 
224 
o 
5.4 
82 
o 
5.5 
7 
Do you have a pharmacist work for you in the practice? (n=538) 
Full Time Regular Part Time Periodically Rarely Never 
o 
6.1 
12 
o 
6.2 
78 
o 
6.3 
108 
If you answered 'Never', please go to Question 8. 
Question 7 
o 
6.4 
92 
What is the source of your pharmacist help? (n=344) 
o 
6.S 
248 
Health Authority peT Dispensing Pharmacist 
000 
7.1 7.2 7.3 
20 238 57 
Peripatetic Pharmacist 
o 
7.4 
9 
Question 8 
Pharmacist member Other - Please specify 
of your 0\\11 staff 
o 
7.S 
15 
o 
7.6 
5 
If you answered 'Never' to Question 6, would you like a pharmacist to work for you in 
the future? (n=233) 
Full Time Regular Part Time Periodically Never 
o 0 0 0 
8.1 8.2 8.3 8.4 
9 62 126 36 
490 
Question 9 
Please indicate the frequency with which you encounter the following medicines 
problems with patients. (n=539) 
Very often Often Periodically Never 
Troublesome side effects D D D D 
9.1 9.2 9.3 9.4 
57 227 248 4 
Drug interactions D [J [J [J 
9.5 9.6 9.7 9.8 
13 108 402 15 
Adverse drug reactions D [J [J [J 
9.9 9.10 9.11 9.12 
12 57 455 15 
Patient non-compliance [J [J [J [J 
9.13 9.14 9.15 9.16 
71 240 226 2 
Poor response to treatment D [J [J [J 
9.17 9.18 9.19 9.20 
36 201 298 4 
Elderly patient confusion c [J [J 0 
9.21 9.22 9.23 9.24 
69 208 255 7 
Food & drug interactions [J 0 0 0 
9.25 9.26 9.27 9.28 
2 41 414 82 
NHS drugs & pharmacy 0 [J [J [J 
medicines interactions 9.29 9.30 9.31 9.32 
3 37 407: 7S 
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Question 10 
Please indicate what you believe to be the incidence of the following potential problems 
elderly patients may have with medicines. (n=535) 
Very often Often Periodically Never 
CapSUle/tablet size [] [] [] [] 
10.1 10.2 10.3 10.4 
26 193 312 4 
Calendar packs [] [] [] [J 
10.5 10.6 10.7 10.8 
21 135 336 43 
Frequency of dose [J [J [J [J 
10.9 10.10 10.11 10.12 
70 303 161 2 
Multiplicity of drugs [J [] [J [J 
10.13 10.14 10.15 10.16 
214 270 51 1 
Remembering to take [J [J [J [J 
the medication 10.17 10.18 10.19 10.20 
153 290 92 0 
Taste of medication 0 0 0 0 
10.21 10.22 10.23 10.24 
11 70 385 70 
Other: Please state briefly 
••••••••••••••• ••••••••••••••••••• 11 •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
....................................................... , .................................. : ................................................... . 
SECTIONB 
This section contains questions relating to Government policy in the 'New NHS' and an 
enhanced doctor I pharmacist working relationship. Please tick the box that most 
closely reflects your views. 
Question 11 
Government seem to be encouraging pharmacist / OP collaboration on aspects of 
medication review. Do you agree with this approach? (The detail is in the next 
question.) (n=539) 
Strongly agree 
o 
11.1 
90 
Agree Uncertain 
o Cl 
11.2 11.3 
317 109 
Disagree 
o 
11.4 
16 
Jfyou ticked box 11.4 or 11.5, please go to Question 13. 
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Strongly disagree 
Cl 
11.5 
7 
Question 12 
If you ticked any box from 11.1 to 11.3, which of the following items do you think: a 
pharmacist could assist you with? (please tick all appropriate boxes) (n=536) 
12.1 Comparisons of equivalent medicines' costs D 375 
12.2 Patient compliance D 391 
12.3 Drug interactions [J 399 
12.4 Replacing brands with generics D 339 
12.5 Choice of medicines [J 228 
12.6 Advice to patients on food and drug interactions D 414 
12.7 Advice to patients on pharmacy medicines & 
NHS drug interactions [J 403 
12.8 Optimum pack sizes D 332 
12.9 Review of number of drugs taken [J 366 
12.10 Help with identifying sub therapeutic dose levets [J 280 
Question 13 
If you ticked boxes 11.4 or 11.5 in Question 11, please outline your reason here . 
...................................................... ···································i·················· ............................... . 
............................................................................................................................................. 
Question 14 
If a pharmacist worked with you to undertake a patient review of those medication 
issues agreed by you, how frequently should this be done for those on long term 
medication? (n=513) 
Monthly Bi-monthly Quarterly 
0 0 0 
14.1 14.2 14.3 
24 20 163 
Four monthly Six monthly Other: Please specify 
0 0 0 
14.4 14.5 14.6 
20 250 36 
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Question 15 
Do you feel the pharmacist should become a fonnal part of the doctor's team addressing 
selected items agreed by you? (n=539) 
Yes 
o 
15.1 
294 
SECTIONC 
Uncertain 
o 
15.2 
185 
No 
o 
15.3 
60 
This section contains questions relating to some health care issues ansmg from 
Government White Papers in recent years. Please tick the box which most closely 
reflects your view. 
Question 16 
The quality of patient care in general practice may be very good, even though the 
patient may not be aware of that quality. How important is the patient's own perception 
of that quality? (n=539) 
Important Relatively Neither important Relatively Unimportant 
important nor unimportant unimportant 
0 D D D D 
16.1 16.2 16.3 16.4 16.5 
260 253 15 8 1 
~~ooI7 , 
Quality of care and clinical excellence are recurrent themes in the White Papers. What 
is your perception of patient expectations of health care over recent years? (n=539) 
Greatly Somewhat No change Somewhat Greatly 
decreased increased decreased decreased 
D 0 D 0 D 
17.1 17.2 17.3 17.4 17.5 
356 144 22 12 5 
Question 18 
Patient's perception of quality of care may be a factor in their commitment to the 
therapy. Do you agree? (n=540) 
Strongly Agree Neither agree Disagree Strongly 
agree nor disagree disagree 
0 0 c c 0 
18.1 18.2 18.3 18.4 18.5 
106 354 57 23 0 
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Question 19 
Patient perception of your overall service could be enhanced by a phannacist medicines 
review service, directed by you. Do you agree? (n=539) 
Strongly Agree Neither agree Disagree Strongly 
agree nor disagree disagree 
0 0 0 0 0 
19.1 19.2 19.3 19.4 19.5 
40 302 148 43 6 
Question 20 
Please indicate in which of the following locations your practice is based. (n=526) 
City centre 
q 
20.1 
62 
Town centre Suburban 
o 0 
20.2 20.3 
145 238 
Rural (controlled locality) 
o 
20.4 
89 
Thank you for taking time to help with this important survey of issues. The information 
will be treated in strict confidence and used only to explore the possibility of closer 
doctor I phannacist collaboration. 
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APPENDIX 19 
(Ref. Chapter 3: Page 50) 
SURVEY OF INDEPENDENT NHS PHARMACY 
CONTRACTORS ON NEW PHARMACIST ROLES 
Conducted by: Allen Tweedie, Ian Jones and Paul Rutter 
Pharmacy Practice Division, University of Portsmouth 
Note: This questionnaire is designed to assist us obtain information which will help 
steer the way forward into new responsibilities within the 'New NHS' for 
pharmacy contractors. 
If the pharmacist completing the questionnaire is not the proprietor, please 
obtain his I her permission before continuing. 
SECTION A 
This section seeks some basic facts about you and the pharmacy you own or work in. 
Please tick the appropriate boxes unless otherwise directed. (n=397) 
Question 1 
What gender are you? 
Question 2 
Female [J 
1.1 
80 
What position do you hold? (n=397) 
Owner Manager Assistant Pharmacist 
[J [J [J 
2.1 2.2 2.3 
294 76 9 
Question 3 
How many pharmacies are in your group? [J 
3.1 
1 2-4 5-7 
238 103 19 
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Male 
Other 
[J 
1.2 
317 
(Please state) 
[J 
.................................... , ........ 
2.4 
18 
(please place number in the box) 
8+ 
3S 
Question 4 
What age group are you in? (n=396) 
Under 25 25-under 30 3D-under 35 35-under4D 
0 0 0 0 
4.1 4.2 4.3 4.4 
0 18 40 49 
40-under45 45-under 50 50-under 55 55-under 60 
0 0 0 0 
4.5 4.6 4.7 4.8 
97 84 58 28 
60-under65 65+ 
0 0 
4.9 4.10 
16 8 
Question 5 
On average, how many prescription items are dispensed in your pharmacy each month? 
(The one you work in.) (n=388) 
Under 1,000 0 5.1 5 6,000-6,999 0 5.7 42 
1,000-1,999 0 5.2 12 7,000-7,999 0 5.8 15 
2,000-2,999 0 5.3 66 8,000-8,999 0 5.9 28 
3,000-3,999 0 5.4 67 9,000-9,999 0 5.19 12 
4,000-4,999 0 5.5 72 10,000-10,999 0 5.11 9 
5,000-5,999 0 5.6 SO 11,000+ 0 5.12 10 
Question 6 
Approximately, what percentage of your total turnover is generated by NHS receipts? 
(n=370) 
Under 10% 0 6.1 0 50-59% 0 6.6 16 
10-19% 0 6.2 4 60-69% 0 6.7 58 
20-29% 0 6.3 4 70-79% 0 6.8 102 
20-39% 0 6.4 2 80-89% 0 6.9 128 
40-49% 0 6.5 6 90%+ 0 6.10 SO 
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Question 7 
What is the location of your pharmacy? (n=392) 
City/town centre 
o 
7.1 
71 
Question 8 
Suburban 
o 
7.2 
231 
Rural Other 
(controlled locality) (please specify) 
o 
1.3 
10 
o 
1.4 
14 
How many dispensing assistants do you employ? Please place number(s) in appropriate 
boxes. (n=319) 
Full time 
(5 full working days) 
o 
8.1 
341 
Question 9 
Part time 
(less than 5 full working days) 
o 
8.2 
501 
How many of your dispensing assistants have a technician's certificate? Please place 
number(s) in boxes. (n=319) 
Full time 
(5 full working days) 
o 
9.1 
278 
Question 10 
Part time 
(less than 5 full working days) 
o 
9.2 
285 
How many pharmacists regularly work with you in the pharmacy (Not locums). Please 
place number(s) in boxes. (n=300) 
Full time 
(5 full working daysO 
o 
10.1 
90 
Part time 
(less than 5 full working days) 
o 
10.2 
126 
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SECTIONB 
This section seeks your views about certain aspects of your role in the NHS. 
Please tick the appropriate box unless otherwise directed. 
Question 11 
How satisfied are you that the pharmacist's skills are being fully used in the present 
contract? (n=399) 
Very satisfied Satisfied Neither satisfied Dissatisfied Very dissatisfied 
nor dissatisfied 
0 0 0 0 [J 
11.1 11.2 11.3 11.4 115 
9 64 115 175 36 
Question 12 
How satisfied are you with current remuneration levels in your NHS contract? 
Very satisfied Satisfied Neither satisfied Dissatisfied Very dissatisfied 
nor dissatisfied 
0 [J [J [J 0 
12.1 12.2 12.3 12.4 12.5 
0 17 46 176 162 
Question 13 
How do you rate your present working relationship with the local GPs? (n=394) 
Very Satisfactory 
o 
13.1 
99 
Very unsatisfactory 
[J 
13.5 
8 
Question 14 
Satisfactory Neither satisfied . Unsatisfactory 
nor unsatisfactory 
o [J 0 
13.2 13.3 13.4 
1~ 62 32 
What do you assess would be the view of patients on greater pharmacist involvement 
with management of their NHS medicines? (n=397) 
Very welcome Welcome Neither welcome Unwelcome Very 
nor unwelcome unwelcome 
[J [J [J [J [J 
14.1 14.2 14.3 14.4 14.5 
124 228 40 5 0 
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Question 15 
What do you assess would be the attitude of your local doctors to greater pharmacist 
involvement with patient medication management? (n=396) 
Very welcome Welcome Neither welcome Unwelcome Very 
nor unwelcome unwelcome 
CJ CJ 0 [J [J 
15.1 15.2 15.3 15.4 15.5 
S4 189 97 49 7 
Question 16 
Are you aware of the Government backed PSNC 'medicines management' proposals for 
community pharmacy? (n=401) 
In detail 
CJ 
In some detail 
o 
In outline 
o 
Not sure 
o 
Definitely not 
o 
16.1 16.2 16.3 16.4 16.5 
15 78 276 96 5 
SECTIONC 
This section seeks your views about some possibilities for community pharmacists in 
the near future, relating to a role in medicines management. Please tick the appropriate 
box or circle the appropriate numbers in Question 17. 
First, a brief refresher on the medicines management initiative. 
Note: 'Medicines Management' is defined for this rese,arch as: 
'The systematic provision of medicines therapy, through a 
partnership of effort between patients and professionals, 
to deliver best patient outcome at minimised cost.' 
In outline, the medicines management process has four phases for the pharmacist: 
i. Review of patient's drug regimen (from PMRs before interviewing the 
patient) for optimisation of pharmacology and cost. 
ii. Interview with patient by a predetermined process to discuss important 
issues. 
iii. Communication of results of i. and ii. to OP, with recommendations (tick 
box form). 
iv. Implementation of agreed changes I action. 
Repeat the above cycle at agreed intervals. 
500 
Note: In answering the following questions, please assume that full training in 
medicines management will be given to those who engage in the new role. 
Question 17 
In this new professional relationship between doctor and phannacist, how would you 
rate the potential importance of each of the following factors? Please circle each of 
your choices on a scale of 0-5. (0 = not important; 5 = most important) (n=401) 
17.1 The doctor's need to feel non-threatened by phannacist involvement 
7 0 8 1 23 2 50 3 133 4 180 5 
17.2 The doctor's need to be recognised as the lead health care professional 
9 0 8 1 26 2 73 3 134 4 151 5 
17.3 The doctor's need to be the final decision maker on medicines regimen 
10 0 7 1 27 2 54 3 125 4 177 5 
17.4 The doctor's need to have confidence in the phannacist's abilities 
1 0 2 1 1 2 14 3 103 4 280 5 
17.5 The doctor's need to be sure of confidentiality in all matters 
3 0 4 1 4 2 31 3 103 4 256 5 
17.6 The doctor's need to have confidence in the phannacy facilities for confidential 
consultation 
3 0 3 1 9 2 75 3 131 4 179 5 
Question 18 
How would you describe your present ability to undertake the medicines management 
(MM) role? (n=399) . 
Able now 
o 
18.1 
45 
Question 19 
Able with suitable training Not sure 
o 0 
18.2 18.3 
37 G 
Unable now 
o 
18.4 
25 
Would you personally wish to undertake this new MM service if remuneration is 
acceptable? (n=401) 
Yes 
o 
19.1 
324 
Not sure 
o 
19.2 
65 
No 
o 
19.3 
12 
501 
Question 20 
In the following list, who do you feel should not take up the new service? Please tick 
all appropriate boxes. (n=354) 
Hospital pharmacists [J 20.1 127 
Pharmacists employed by GPs [J 20.2 113 
Freelance pharmacists [J 20.3 179 
Doctors themselves [J 20.4 188 
Nurses 0 20.5 268 
Pharmacists employed by the LPC [J 20.6 112 
Pharmacists employed by peTs [J 20.7 126 
Pharmacy contractors (i.e. like youl) [J 20.8 36 
Please add an.y brief comment ............................................................................................ . 
............................................................................................................... " ............................ . 
Question 21 
If you require training to undertake the new role, what subjects among the following list 
would you select? Please tick all appropriate boxes. (n=390) 
Clinical pharmacology [J 21.1 328 
Drug economics [J 21.2 199 
Patho-physiology [J 21.3 237 
Interpersonal skills c 21.4 129 
Disease management [J 21.5 321 
Techniques to motivate patients to comply [J 21.6 224 
Other (please speciry) ....................................................................... " .... " .... " .... , .... , .... " .... , ... . 
................................................................................................................................................ 
502 
Question 22 
In the following list of training (CPD) options, which ~ would be your preferred 
route? (n=359) 
Daytime lectures (locum funded) 0 22.1 166 
Evening lectures 0 22.2 47 
Distance learning packages 0 22.3 86 
Distance learning plus seminars 0 22.4 57 
Web based computer assisted learning 0 22.5 20 
Web based packages plus seminars CJ 22.6 6 
Question 23 
Assuming your present workload remains the same, do you believe you currently have 
time to undertake the medicines management service? (n=399) 
Yes 
o 
23.1 
79 
Question 24 
Not sure 
o 
23.2 
107 
No 
CJ 
23.3 
213 
If you answered 'No' or 'Not sure' in the previous question, could some of your 
workload be delegated to other staff, if they were fully trained? (n=320) 
Yes 
o 
24.1 
164 
Question 25 
Not sure 
o 
24.2 
80 
No 
CJ 
24.3 
76 
Do you think it is time for an entirely new pharmacy contract? (n=394) 
Yes 
o 
25.1 
231 
Not sure 
o 
25.2 
110 
No 
[J 
25.3 
45 
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Thank you for your time and commitment in addressing the important issues set 
out in this survey. Your responses will be used to help plan the way forward for 
community pharmacy. 
If you have any information you think would be useful to the aims of this research 
please use the space below to explain. 
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